1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_1	[p1l52t82r142b106],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_1	[p1l155t81r255b106],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_1	[p1l267t82r318b106],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_1	[p1l331t82r406b106],
5	(	CD	NUMBER	(	num	6	SENT_1	[p1l419t81r510b112],
6	2013	CD	DATE	2013	dep	4	SENT_1	[p1l419t81r510b112],
7	)	CD	NUMBER	)	number	8	SENT_1	[p1l419t81r510b112],
8	139:135	CD	NUMBER	139:135	num	9	SENT_1	[p1l528t81r708b107],
9	—	NN	O	—	rcmod	6	SENT_1	[p1l528t81r708b107],
10	143	CD	NUMBER	143	num	11	SENT_1	[p1l528t81r708b107],
11	DOI	NNP	O	DOI	dep	9	SENT_1	[p1l52t124r114b150],
12	10.1007	CD	NUMBER	10.1007	num	11	SENT_1	[p1l130t124r526b150],
13	/	:	O	/	punct	14	SENT_1	[p1l130t124r526b150],
14	s10549-013	NN	O	s10549-013	dep	11	SENT_1	[p1l130t124r526b150],
15	—	CD	NUMBER	—	num	14	SENT_1	[p1l130t124r526b150],
16	2516	CD	DATE	2516	number	17	SENT_1	[p1l130t124r526b150],
17	—	CD	NUMBER	—	num	11	SENT_1	[p1l130t124r526b150],
18	z	SYM	O	z	dep	9	SENT_1	[p1l130t124r526b150],

1	Fixed-dose	JJ	O	fixed-dose	amod	2	SENT_2	[p1l53t342r351b389],
2	capecitabine	NN	O	capecitabine	_	0	SENT_2	[p1l373t342r717b402],
3	is	VBZ	O	be	cop	4	SENT_2	[p1l738t342r780b389],
4	feasible	JJ	O	feasible	dep	2	SENT_2	[p1l801t342r1026b389],
5	:	:	O	:	_	0	SENT_2	[p1l801t342r1026b389],
6	results	NNS	O	result	dep	2	SENT_2	[p1l1052t343r1233b389],
7	from	IN	O	from	_	0	SENT_2	[p1l1254t342r1391b389],
8	a	DT	O	a	det	12	SENT_2	[p1l1412t356r1443b389],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_2	[p1l1464t342r1932b402],
10	and	CC	O	and	_	0	SENT_2	[p1l53t417r156b463],
11	pharmacogenetic	JJ	O	pharmacogenetic	amod	12	SENT_2	[p1l180t416r656b476],
12	study	NN	O	study	prep_from	6	SENT_2	[p1l680t417r829b476],
13	in	IN	O	in	_	0	SENT_2	[p1l852t416r905b462],
14	metastatic	JJ	O	metastatic	amod	16	SENT_2	[p1l928t416r1212b463],
15	breast	NN	O	breast	nn	16	SENT_2	[p1l1235t417r1408b463],
16	cancer	NN	O	cancer	prep_in	12	SENT_2	[p1l1431t431r1614b463],

1	Michelle	NNP	PERSON	Michelle	_	0	SENT_3	[p1l52t551r205b581],
2	A.	NNP	PERSON	A.	nn	3	SENT_3	[p1l219t551r258b581],
3	Rudek	NNP	PERSON	Rudek	dep	1	SENT_3	[p1l274t551r390b581],
4	-	:	O	-	_	0	SENT_3	[p1l405t562r413b570],
5	Roisin	NNP	PERSON	Roisin	nn	7	SENT_3	[p1l428t551r540b581],
6	M.	NNP	PERSON	M.	nn	7	SENT_3	[p1l555t552r603b581],
7	Connolly	NNP	PERSON	Connolly	dep	1	SENT_3	[p1l620t551r779b589],
8	-	:	O	-	_	0	SENT_3	[p1l794t562r802b570],
9	Janelle	NNP	PERSON	Janelle	nn	11	SENT_3	[p1l817t551r941b584],
10	M.	NNP	PERSON	M.	nn	11	SENT_3	[p1l956t552r1004b581],
11	Hoskins	NNP	PERSON	Hoskins	dep	7	SENT_3	[p1l1020t551r1161b581],
12	-	:	O	-	_	0	SENT_3	[p1l1177t562r1185b570],
13	Elizabeth	NNP	PERSON	Elizabeth	nn	14	SENT_3	[p1l1199t551r1367b581],
14	Garrett-Mayer	NNP	PERSON	Garrett-Mayer	dep	1	SENT_3	[p1l1383t551r1650b589],
15	Stacie	NNP	PERSON	Stacie	nn	17	SENT_3	[p1l1666t562r1673b570, p1l53t603r157b633],
16	C.	NNP	PERSON	C.	nn	17	SENT_3	[p1l174t603r211b633],
17	Jeter	NNP	PERSON	Jeter	dep	14	SENT_3	[p1l227t603r317b636],
18	-	:	O	-	_	0	SENT_3	[p1l332t614r339b622],
19	Deborah	NNP	PERSON	Deborah	nn	21	SENT_3	[p1l354t603r508b633],
20	K.	NNP	PERSON	K.	nn	21	SENT_3	[p1l523t603r564b633],
21	Armstrong	NNP	PERSON	Armstrong	dep	14	SENT_3	[p1l579t603r775b641],
22	-	:	O	-	_	0	SENT_3	[p1l790t614r798b622],
23	John	NNP	PERSON	John	nn	25	SENT_3	[p1l812t604r899b636],
24	H.	NNP	PERSON	H.	nn	25	SENT_3	[p1l914t604r955b633],
25	Fetting	NNP	PERSON	Fetting	dep	21	SENT_3	[p1l971t603r1097b641],
26	-	:	O	-	_	0	SENT_3	[p1l1112t614r1120b622],
27	Vered	NNP	PERSON	Vered	nn	28	SENT_3	[p1l1135t603r1242b633],
28	Stearns	NNP	PERSON	Stearns	dep	14	SENT_3	[p1l1258t603r1390b633],
29	Laurie	NNP	PERSON	Laurie	nn	31	SENT_3	[p1l1405t614r1413b622, p1l53t655r171b685],
30	A.	NNP	PERSON	A.	nn	31	SENT_3	[p1l186t655r225b685],
31	Wright	NNP	PERSON	Wright	dep	28	SENT_3	[p1l241t655r370b693],
32	-	:	O	-	_	0	SENT_3	[p1l385t666r392b674],
33	Ming	NNP	PERSON	Ming	nn	34	SENT_3	[p1l407t655r501b693],
34	Zhao	NNP	PERSON	Zhao	dep	28	SENT_3	[p1l517t655r607b685],
35	-	:	O	-	_	0	SENT_3	[p1l622t666r630b674],
36	Stanley	NNP	PERSON	Stanley	nn	39	SENT_3	[p1l646t655r775b693],
37	P.	NNP	PERSON	P.	nn	39	SENT_3	[p1l791t655r825b685],
38	Watkins	NNP	PERSON	Watkins	nn	39	SENT_3	[p1l840t655r989b685],
39	Jr.	NNP	PERSON	Jr.	dep	34	SENT_3	[p1l1004t655r1052b688],
40	-	:	O	-	_	0	SENT_3	[p1l1068t666r1076b674],
41	Howard	NNP	PERSON	Howard	nn	46	SENT_3	[p1l1091t655r1235b685],
42	L.	NNP	PERSON	L.	nn	46	SENT_3	[p1l1250t655r1286b685],
43	McLeod	NNP	PERSON	McLeod	nn	46	SENT_3	[p1l1302t655r1449b685],
44	Nancy	NNP	PERSON	Nancy	nn	46	SENT_3	[p1l1464t666r1472b674, p1l7t723r238b798],
45	E.	NNP	PERSON	E.	nn	46	SENT_3	[p1l268t723r343b782],
46	Davidson	NNP	PERSON	Davidson	dep	39	SENT_3	[p1l376t721r716b782],
47	-	:	O	-	_	0	SENT_3	[p1l746t744r762b759],
48	Antonio	NNP	PERSON	Antonio	nn	50	SENT_3	[p1l793t721r1085b782],
49	C.	NNP	PERSON	C.	nn	50	SENT_3	[p1l1119t721r1195b783],
50	Wolff	NNP	PERSON	Wolff	dep	34	SENT_3	[p1l1228t721r1441b782],

1	Received	VBN	O	receive	_	0	SENT_4	[p1l7t953r292b1004],
2	:	:	O	:	_	0	SENT_4	[p1l7t953r292b1004],
3	14	CD	DATE	14	num	4	SENT_4	[p1l330t953r394b1003],
4	February	NNP	DATE	February	dobj	1	SENT_4	[p1l420t953r681b1019],
5	2013	CD	DATE	2013	num	4	SENT_4	[p1l709t954r847b1004],
6	/	:	O	/	punct	7	SENT_4	[p1l864t953r885b1004],
7	Accepted	JJ	O	accepted	dep	4	SENT_4	[p1l898t953r1187b1019],
8	:	:	O	:	_	0	SENT_4	[p1l898t953r1187b1019],
9	1	CD	DATE	1	dep	7	SENT_4	[p1l1225t954r1246b1003],
10	April	NNP	DATE	April	tmod	9	SENT_4	[p1l1279t953r1430b1019],
11	2013	CD	DATE	2013	num	10	SENT_4	[p1l1458t953r1634b1004],
12	/	:	O	/	punct	7	SENT_4	[p1l1458t953r1634b1004],
13	Published	VBN	O	publish	partmod	4	SENT_4	[p1l1647t953r1932b1004],
14	online	NN	O	online	prep	13	SENT_4	[p1l1959t953r2154b1004],
15	:	:	O	:	_	0	SENT_4	[p1l1959t953r2154b1004],
16	©	CD	NUMBER	©	dep	4	SENT_4	[p1l9t1039r60b1090],
17	Springer	NNP	ORGANIZATION	Springer	nn	18	SENT_4	[p1l90t1039r339b1105],
18	Science	NNP	ORGANIZATION	Science	dep	16	SENT_4	[p1l366t1039r886b1090],
19	+	CC	ORGANIZATION	+	_	0	SENT_4	[p1l366t1039r886b1090],
20	Business	NNP	ORGANIZATION	Business	nn	23	SENT_4	[p1l366t1039r886b1090],
21	Media	NNP	ORGANIZATION	Media	nn	23	SENT_4	[p1l914t1039r1099b1090],
22	New	NNP	ORGANIZATION	New	nn	23	SENT_4	[p1l1125t1040r1260b1090],
23	York	NNP	ORGANIZATION	York	dep	16	SENT_4	[p1l1286t1039r1435b1090],
24	2013	CD	DATE	2013	num	23	SENT_4	[p1l1461t1039r1600b1090],

1	Abstract	JJ	O	abstract	nsubjpass	8	SENT_5	[p1l7t1260r324b1321],
2	The	DT	O	the	det	6	SENT_5	[p1l412t1261r542b1321],
3	pro	JJ	O	pro	amod	6	SENT_5	[p1l604t1261r901b1338],
4	—	CD	NUMBER	—	num	6	SENT_5	[p1l604t1261r901b1338],
5	drug	NN	O	drug	nn	6	SENT_5	[p1l604t1261r901b1338],
6	capecitabine	NN	O	capecitabine	dep	1	SENT_5	[p1l965t1261r1392b1338],
7	is	VBZ	O	be	auxpass	8	SENT_5	[p1l1456t1261r1508b1321],
8	approved	VBN	O	approve	_	0	SENT_5	[p1l1574t1261r1890b1338],
9	for	IN	O	for	_	0	SENT_5	[p1l1952t1261r2051b1320],
10	treatment	NN	O	treatment	prep_for	8	SENT_5	[p1l7t1376r332b1427],
11	of	IN	O	of	_	0	SENT_5	[p1l371t1367r444b1427],
12	anthracycline	NN	O	anthracycline	nn	13	SENT_5	[p1l480t1367r965b1444],
13	—	NN	O	—	prep_of	10	SENT_5	[p1l480t1367r965b1444],
14	and	CC	O	and	_	0	SENT_5	[p1l1008t1367r1129b1427],
15	paclitaxel	NN	O	paclitaxel	prep_for	8	SENT_5	[p1l1167t1367r1817b1444],
16	—	CD	NUMBER	—	num	15	SENT_5	[p1l1167t1367r1817b1444],
17	resistant	JJ	O	resistant	amod	18	SENT_5	[p1l1167t1367r1817b1444],
18	metastatic	JJ	O	metastatic	amod	20	SENT_5	[p1l1855t1376r2046b1427, p1l10t1473r185b1533],
19	breast	NN	O	breast	nn	20	SENT_5	[p1l206t1473r411b1533],
20	cancer	NN	O	cancer	dep	15	SENT_5	[p1l430t1492r669b1533],
21	.	.	O	.	_	0	SENT_5	[p1l430t1492r669b1533],

1	However	RB	O	however	advmod	9	SENT_6	[p1l694t1475r1023b1544],
2	,	,	O	,	_	0	SENT_6	[p1l694t1475r1023b1544],
3	toxicity	NN	O	toxicity	nsubj	9	SENT_6	[p1l1046t1473r1307b1550],
4	and	CC	O	and	_	0	SENT_6	[p1l1329t1473r1449b1533],
5	large	JJ	O	large	amod	8	SENT_6	[p1l1469t1473r1638b1550],
6	interpatient	JJ	O	interpatient	amod	8	SENT_6	[p1l1658t1473r2050b1550],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_6	[p1l6t1579r576b1656],
8	variability	NN	O	variability	nsubj	9	SENT_6	[p1l601t1579r952b1656],
9	occur	VBP	O	occur	_	0	SENT_6	[p1l976t1598r1165b1639],
10	despite	IN	O	despite	_	0	SENT_6	[p1l1186t1579r1426b1656],
11	body	NN	O	body	nn	13	SENT_6	[p1l1447t1579r1617b1656],
12	surface	NN	O	surface	nn	13	SENT_6	[p1l1643t1579r1884b1639],
13	area	NN	O	area	prep_despite	9	SENT_6	[p1l1910t1598r2050b1639],
14	(	CD	NUMBER	(	num	16	SENT_6	[p1l10t1685r502b1762],
15	BSA	NN	O	bsa	nn	16	SENT_6	[p1l10t1685r502b1762],
16	)	NN	O	)	dep	13	SENT_6	[p1l10t1685r502b1762],
17	.	.	O	.	_	0	SENT_6	[p1l10t1685r502b1762],

1	—	NN	O	—	_	0	SENT_7	[p1l10t1685r502b1762],
2	.	.	O	.	_	0	SENT_7	[p1l10t1685r502b1762],

1	dosing	NN	O	dosing	_	0	SENT_8	[p1l10t1685r502b1762],
2	.	.	O	.	_	0	SENT_8	[p1l10t1685r502b1762],

1	We	PRP	O	we	nsubj	2	SENT_9	[p1l532t1686r649b1745],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_9	[p1l676t1685r1128b1762],
3	that	IN	O	that	complm	10	SENT_9	[p1l1154t1685r1282b1744],
4	a	DT	O	a	det	8	SENT_9	[p1l1309t1703r1344b1744],
5	ﬁxed	JJ	O	ﬁxed	amod	8	SENT_9	[p1l1371t1685r1723b1744],
6	—	NN	O	—	nn	8	SENT_9	[p1l1371t1685r1723b1744],
7	dose	NN	O	dose	nn	8	SENT_9	[p1l1371t1685r1723b1744],
8	schedule	NN	O	schedule	nsubj	10	SENT_9	[p1l1754t1685r2048b1744],
9	would	MD	O	would	aux	10	SENT_9	[p1l8t1790r219b1849],
10	simplify	VB	O	simplify	ccomp	2	SENT_9	[p1l260t1790r541b1867],
11	dosing	NN	O	dosing	dobj	10	SENT_9	[p1l580t1790r804b1867],
12	and	CC	O	and	_	0	SENT_9	[p1l844t1790r964b1849],
13	provide	VB	O	provide	conj_and	10	SENT_9	[p1l1001t1790r1261b1867],
14	an	DT	O	a	det	18	SENT_9	[p1l1302t1808r1379b1849],
15	effective	JJ	O	effective	amod	18	SENT_9	[p1l1417t1789r1714b1849],
16	and	CC	O	and	_	0	SENT_9	[p1l1755t1790r1876b1849],
17	safe	JJ	O	safe	conj_and	15	SENT_9	[p1l1916t1790r2048b1849],
18	alternative	NN	O	alternative	dobj	13	SENT_9	[p1l9t1896r368b1955],
19	to	TO	O	to	_	0	SENT_9	[p1l407t1904r471b1955],
20	BSA	NN	O	bsa	nn	21	SENT_9	[p1l511t1896r898b1955],
21	—	NN	O	—	prep_to	13	SENT_9	[p1l511t1896r898b1955],
22	based	VBN	O	base	partmod	21	SENT_9	[p1l511t1896r898b1955],
23	dosing	NN	O	dosing	dobj	22	SENT_9	[p1l937t1895r1180b1973],
24	.	.	O	.	_	0	SENT_9	[p1l937t1895r1180b1973],

1	We	PRP	O	we	nsubj	2	SENT_10	[p1l1221t1897r1338b1955],
2	conducted	VBD	O	conduct	_	0	SENT_10	[p1l1378t1896r1730b1955],
3	an	DT	O	a	det	5	SENT_10	[p1l1769t1914r1846b1955],
4	open	JJ	O	open	amod	5	SENT_10	[p1l1885t1914r2049b1973],
5	label	NN	O	label	dobj	2	SENT_10	[p1l7t2003r190b2073],
6	,	,	O	,	_	0	SENT_10	[p1l7t2003r190b2073],
7	single	JJ	O	single	amod	9	SENT_10	[p1l222t2003r602b2080],
8	—	NN	O	—	nn	9	SENT_10	[p1l222t2003r602b2080],
9	arm	NN	O	arm	appos	5	SENT_10	[p1l222t2003r602b2080],
10	,	,	O	,	_	0	SENT_10	[p1l222t2003r602b2080],
11	two-stage	JJ	O	two-stage	amod	12	SENT_10	[p1l630t2012r961b2080],
12	study	NN	O	study	appos	5	SENT_10	[p1l990t2003r1169b2080],
13	of	IN	O	of	_	0	SENT_10	[p1l1196t2003r1269b2063],
14	oral	JJ	O	oral	amod	15	SENT_10	[p1l1290t2003r1419b2063],
15	capecitabine	NN	O	capecitabine	prep_of	12	SENT_10	[p1l1446t2003r1873b2080],
16	with	IN	O	with	_	0	SENT_10	[p1l1899t2003r2049b2063],
17	ﬁxed	JJ	O	ﬁxed	prep_with	2	SENT_10	[p1l8t2109r176b2169],
18	starting	VBG	O	start	xcomp	2	SENT_10	[p1l199t2109r451b2186],
19	dose	NN	O	dose	nn	20	SENT_10	[p1l474t2109r626b2169],
20	(	NN	O	(	nsubj	22	SENT_10	[p1l651t2109r866b2182],
21	3,000	CD	NUMBER	3,000	num	22	SENT_10	[p1l651t2109r866b2182],
22	mg	NN	O	mg	ccomp	18	SENT_10	[p1l897t2128r1003b2186],
23	total	JJ	O	total	amod	25	SENT_10	[p1l1025t2109r1175b2169],
24	daily	JJ	SET	daily	amod	25	SENT_10	[p1l1198t2109r1366b2186],
25	dose	NN	O	dose	dobj	22	SENT_10	[p1l1388t2109r1540b2169],
26	in	IN	O	in	_	0	SENT_10	[p1l1562t2109r1626b2168],
27	two	CD	NUMBER	two	num	29	SENT_10	[p1l1647t2118r1772b2169],
28	divided	JJ	O	divided	amod	29	SENT_10	[p1l1794t2109r2049b2169],
29	doses	NNS	O	dose	prep_in	25	SENT_10	[p1l8t2215r193b2275],
30	x	CC	O	x	_	0	SENT_10	[p1l236t2233r280b2273],
31	14	CD	DURATION	14	num	32	SENT_10	[p1l329t2215r403b2274],
32	days	NNS	NUMBER	day	conj_x	25	SENT_10	[p1l435t2215r587b2292],
33	q21	CD	NUMBER	q21	num	34	SENT_10	[p1l648t2215r766b2292],
34	days	NNS	NUMBER	day	tmod	32	SENT_10	[p1l805t2215r985b2292],
35	)	RB	O	)	advmod	22	SENT_10	[p1l805t2215r985b2292],
36	in	IN	O	in	_	0	SENT_10	[p1l1046t2215r1111b2274],
37	patients	NNS	O	patient	prep_in	22	SENT_10	[p1l1168t2215r1433b2292],
38	with	IN	O	with	_	0	SENT_10	[p1l1493t2215r1643b2275],
39	metastatic	JJ	O	metastatic	amod	41	SENT_10	[p1l1702t2215r2047b2275],
40	breast	NN	O	breast	nn	41	SENT_10	[p1l6t2321r210b2381],
41	cancer	NN	O	cancer	prep_with	37	SENT_10	[p1l245t2340r484b2381],
42	.	.	O	.	_	0	SENT_10	[p1l245t2340r484b2381],

1	We	PRP	O	we	nsubj	2	SENT_11	[p1l522t2323r639b2381],
2	correlated	VBD	O	correlate	_	0	SENT_11	[p1l675t2321r1017b2381],
3	pharmacodynamic	JJ	O	pharmacodynamic	amod	4	SENT_11	[p1l1049t2321r1681b2398],
4	endpoints	NNS	O	endpoint	nsubj	5	SENT_11	[p1l1718t2321r2047b2398],
5	[	VBP	O	[	ccomp	2	SENT_11	[p1l13t2429r175b2504],
6	e.g.	FW	O	e.g.	dobj	5	SENT_11	[p1l13t2429r175b2504],
7	,	,	O	,	_	0	SENT_11	[p1l13t2429r175b2504],
8	efﬁcacy	NN	O	efﬁcacy	nn	10	SENT_11	[p1l248t2427r516b2504],
9	(	NN	O	(	nn	10	SENT_11	[p1l589t2428r938b2504],
10	response	NN	O	response	dobj	5	SENT_11	[p1l589t2428r938b2504],
11	)	CD	NUMBER	)	dep	10	SENT_11	[p1l589t2428r938b2504],
12	per	IN	O	per	_	0	SENT_11	[p1l1009t2446r1119b2504],
13	RECIST	NN	O	recist	nn	16	SENT_11	[p1l1186t2428r1478b2487],
14	and	CC	O	and	_	0	SENT_11	[p1l1549t2427r1670b2487],
15	toxicity	NN	O	toxicity	nn	16	SENT_11	[p1l1738t2427r2046b2504],
16	]	NN	O	]	prep_per	11	SENT_11	[p1l1738t2427r2046b2504],
17	,	,	O	,	_	0	SENT_11	[p1l1738t2427r2046b2504],
18	adherence	NN	O	adherence	conj_and	6	SENT_11	[p1l9t2533r352b2593],
19	and	CC	O	and	_	0	SENT_11	[p1l397t2533r517b2593],
20	pharmacokinetics/pharmacogenetics	NNS	O	pharmacokinetics/pharmacogenetics	conj_and	6	SENT_11	[p1l557t2533r1824b2610],
21	.	.	O	.	_	0	SENT_11	[p1l557t2533r1824b2610],

1	Sample	VB	O	sample	csubjpass	7	SENT_12	[p1l1873t2534r2046b2593, p1l6t2638r109b2715],
2	size	NN	O	size	dobj	1	SENT_12	[p1l162t2638r290b2697],
3	of	IN	O	of	_	0	SENT_12	[p1l340t2638r414b2697],
4	45	CD	NUMBER	45	num	5	SENT_12	[p1l456t2638r536b2698],
5	patients	NNS	O	patient	prep_of	2	SENT_12	[p1l588t2638r853b2715],
6	was	VBD	O	be	auxpass	7	SENT_12	[p1l904t2657r1032b2698],
7	required	VBN	O	require	_	0	SENT_12	[p1l1081t2638r1367b2715],
8	to	TO	O	to	aux	9	SENT_12	[p1l1415t2647r1479b2697],
9	detect	VB	O	detect	xcomp	7	SENT_12	[p1l1530t2638r1733b2697],
10	a	DT	O	a	det	14	SENT_12	[p1l1783t2656r1818b2697],
11	25	CD	PERCENT	25	number	12	SENT_12	[p1l1867t2637r1945b2698],
12	%	NN	PERCENT	%	amod	14	SENT_12	[p1l1984t2638r2045b2698],
13	response	NN	O	response	nn	14	SENT_12	[p1l6t2762r304b2821],
14	rate	NN	O	rate	dobj	9	SENT_12	[p1l324t2752r451b2803],
15	from	IN	O	from	_	0	SENT_12	[p1l473t2744r638b2803],
16	null	JJ	O	null	amod	18	SENT_12	[p1l657t2744r788b2803],
17	response	NN	O	response	nn	18	SENT_12	[p1l808t2762r1106b2821],
18	rate	NN	O	rate	prep_from	9	SENT_12	[p1l1126t2752r1253b2803],
19	of	IN	O	of	_	0	SENT_12	[p1l1276t2744r1349b2803],
20	10	CD	PERCENT	10	num	21	SENT_12	[p1l1372t2744r1447b2803],
21	%	NN	PERCENT	%	prep_of	18	SENT_12	[p1l1482t2744r1543b2803],
22	using	VBG	O	use	partmod	21	SENT_12	[p1l1567t2744r1750b2821],
23	a	DT	O	a	det	26	SENT_12	[p1l1773t2762r1808b2803],
24	Simon	NNP	MISC	Simon	nn	26	SENT_12	[p1l1830t2744r2049b2803],
25	two-stage	JJ	O	two-stage	amod	26	SENT_12	[p1l7t2859r338b2927],
26	design	NN	O	design	dobj	22	SENT_12	[p1l368t2850r607b2927],
27	.	.	O	.	_	0	SENT_12	[p1l368t2850r607b2927],

1	Twenty	CD	NUMBER	twenty	num	2	SENT_13	[p1l639t2850r1027b2927],
2	—	CD	NUMBER	—	nsubjpass	6	SENT_13	[p1l639t2850r1027b2927],
3	six	CD	NUMBER	six	num	4	SENT_13	[p1l639t2850r1027b2927],
4	patients	NNS	O	patient	dep	2	SENT_13	[p1l1056t2850r1321b2927],
5	were	VBD	O	be	auxpass	6	SENT_13	[p1l1351t2868r1514b2909],
6	enrolled	VBN	O	enrol	_	0	SENT_13	[p1l1545t2850r1825b2909],
7	in	IN	O	in	_	0	SENT_13	[p1l1853t2850r1917b2908],
8	the	DT	O	the	prep_in	6	SENT_13	[p1l1946t2850r2048b2909],

1	Michelle	NNP	PERSON	Michelle	nn	3	SENT_14	[p1l7t3139r264b3190],
2	A.	NNP	PERSON	A.	nn	3	SENT_14	[p1l291t3139r356b3190],
3	Rudek	NNP	PERSON	Rudek	nsubj	8	SENT_14	[p1l386t3139r575b3190],
4	and	CC	O	and	_	0	SENT_14	[p1l601t3139r704b3190],
5	Roisin	NNP	PERSON	Roisin	nn	7	SENT_14	[p1l730t3139r918b3190],
6	M.	NNP	PERSON	M.	nn	7	SENT_14	[p1l944t3140r1021b3190],
7	Connolly	NNP	PERSON	Connolly	nsubj	8	SENT_14	[p1l1051t3139r1319b3205],
8	contributed	VBD	O	contribute	_	0	SENT_14	[p1l1346t3139r1677b3190],
9	equally	RB	O	equally	advmod	8	SENT_14	[p1l1703t3139r1915b3205],
10	to	TO	O	to	_	0	SENT_14	[p1l1942t3147r1996b3190],
11	this	DT	O	this	det	12	SENT_14	[p1l7t3222r109b3273],
12	study	NN	O	study	prep_to	8	SENT_14	[p1l139t3222r306b3288],
13	.	.	O	.	_	0	SENT_14	[p1l139t3222r306b3288],

1	Presented	VBN	O	present	_	0	SENT_15	[p1l7t3398r288b3449],
2	in	IN	O	in	_	0	SENT_15	[p1l315t3398r370b3448],
3	part	NN	O	part	prep_in	1	SENT_15	[p1l394t3406r508b3464],
4	at	IN	O	at	_	0	SENT_15	[p1l535t3406r585b3449],
5	the	DT	O	the	det	7	SENT_15	[p1l611t3398r697b3449],
6	American	NNP	ORGANIZATION	American	nn	7	SENT_15	[p1l724t3398r1010b3449],
7	Society	NNP	ORGANIZATION	Society	prep_at	1	SENT_15	[p1l1038t3398r1252b3464],
8	of	IN	ORGANIZATION	of	_	0	SENT_15	[p1l1280t3398r1343b3449],
9	Clinical	JJ	ORGANIZATION	clinical	amod	10	SENT_15	[p1l1365t3398r1594b3449],
10	Oncology	NN	ORGANIZATION	oncology	prep_of	7	SENT_15	[p1l1622t3398r1905b3464],
11	(	CD	NUMBER	(	num	12	SENT_15	[p1l9t3481r244b3544],
12	ASCO	NNP	ORGANIZATION	ASCO	dep	10	SENT_15	[p1l9t3481r244b3544],
13	)	CD	NUMBER	)	num	12	SENT_15	[p1l9t3481r244b3544],
14	Annual	JJ	SET	annual	amod	10	SENT_15	[p1l273t3481r484b3532],
15	Meeting	VBG	O	meet	partmod	10	SENT_15	[p1l511t3481r768b3547],
16	,	,	O	,	_	0	SENT_15	[p1l511t3481r768b3547],
17	June	NNP	DATE	June	appos	7	SENT_15	[p1l796t3482r928b3532],
18	2011	CD	DATE	2011	num	17	SENT_15	[p1l956t3482r1114b3541],
19	,	,	O	,	_	0	SENT_15	[p1l956t3482r1114b3541],
20	Chicago	NNP	LOCATION	Chicago	appos	7	SENT_15	[p1l1143t3481r1399b3547],
21	,	,	O	,	_	0	SENT_15	[p1l1143t3481r1399b3547],
22	IL	NN	O	il	appos	20	SENT_15	[p1l1428t3482r1509b3532],
23	.	.	O	.	_	0	SENT_15	[p1l1428t3482r1509b3532],

1	M.	NNP	PERSON	M.	nn	3	SENT_16	[p2l7t35r84b85],
2	A.	NNP	PERSON	A.	nn	3	SENT_16	[p2l114t34r178b85],
3	Rudek	NNP	PERSON	Rudek	_	0	SENT_16	[p2l209t34r398b85],
4	(	CD	NUMBER	(	rcmod	3	SENT_16	[p2l425t30r550b96],
5	E	NN	O	e	dep	4	SENT_16	[p2l425t30r550b96],
6	)	SYM	O	)	dep	4	SENT_16	[p2l425t30r550b96],
7	-	:	O	-	_	0	SENT_16	[p2l583t61r591b69],
8	R.	NNP	PERSON	R.	dep	3	SENT_16	[p2l622t35r683b85],
9	M.	NNP	PERSON	M.	nn	10	SENT_16	[p2l713t35r789b85],
10	Connolly	NNP	PERSON	Connolly	dep	8	SENT_16	[p2l821t34r1088b99],
11	-	:	O	-	_	0	SENT_16	[p2l1120t61r1128b69],
12	S.	NNP	PERSON	S.	nn	17	SENT_16	[p2l1161t34r1212b85],
13	C.	NNP	PERSON	C.	nn	17	SENT_16	[p2l1242t34r1302b85],
14	Jeter	NNP	PERSON	Jeter	nn	17	SENT_16	[p2l1332t35r1469b85],
15	D.	NNP	PERSON	D.	nn	17	SENT_16	[p2l1500t61r1507b69, p2l7t120r72b170],
16	K.	NNP	PERSON	K.	nn	17	SENT_16	[p2l103t120r167b170],
17	Armstrong	NNP	PERSON	Armstrong	dep	3	SENT_16	[p2l196t119r508b184],
18	-	:	O	-	_	0	SENT_16	[p2l541t146r549b154],
19	J.	NNP	PERSON	J.	nn	21	SENT_16	[p2l579t120r620b170],
20	H.	NNP	PERSON	H.	nn	21	SENT_16	[p2l650t120r715b170],
21	Fetting	NNP	PERSON	Fetting	dep	17	SENT_16	[p2l745t119r949b184],
22	-	:	O	-	_	0	SENT_16	[p2l981t146r989b154],
23	V.	NNP	PERSON	V.	nn	27	SENT_16	[p2l1020t120r1085b170],
24	Steams	NNP	PERSON	Steams	nn	27	SENT_16	[p2l1116t119r1325b170],
25	L.	NNP	PERSON	L.	nn	27	SENT_16	[p2l1358t146r1366b154, p2l7t205r64b255],
26	A.	NNP	PERSON	A.	nn	27	SENT_16	[p2l94t204r159b255],
27	Wright	NNP	PERSON	Wright	dep	3	SENT_16	[p2l188t204r394b270],
28	-	:	O	-	_	0	SENT_16	[p2l425t232r433b239],
29	M.	NNP	PERSON	M.	nn	30	SENT_16	[p2l463t205r540b255],
30	Zhao	NNP	PERSON	Zhao	dep	27	SENT_16	[p2l570t204r718b255],
31	-	:	O	-	_	0	SENT_16	[p2l750t232r758b239],
32	A.	NN	PERSON	a.	dep	3	SENT_16	[p2l789t204r853b255],
33	C.	NNP	PERSON	C.	nn	39	SENT_16	[p2l884t204r944b255],
34	Wolff	NNP	PERSON	Wolff	nn	39	SENT_16	[p2l973t204r1151b255],
35	Sidney	NNP	PERSON	Sidney	nn	39	SENT_16	[p2l9t287r207b353],
36	Kimmel	NNP	PERSON	Kimmel	nn	39	SENT_16	[p2l235t288r470b338],
37	Comprehensive	NNP	O	Comprehensive	nn	39	SENT_16	[p2l498t287r952b353],
38	Cancer	NNP	O	Cancer	nn	39	SENT_16	[p2l980t288r1185b339],
39	Center	NNP	O	Center	rcmod	32	SENT_16	[p2l1210t288r1418b348],
40	,	,	O	,	_	0	SENT_16	[p2l1210t288r1418b348],
41	Johns	NNP	ORGANIZATION	Johns	nn	43	SENT_16	[p2l1446t288r1608b339],
42	Hopkins	NNP	ORGANIZATION	Hopkins	nn	43	SENT_16	[p2l1636t287r1879b353],
43	University	NNP	ORGANIZATION	University	appos	39	SENT_16	[p2l7t374r328b439],
44	,	,	O	,	_	0	SENT_16	[p2l7t374r328b439],
45	1650	CD	DATE	1650	num	47	SENT_16	[p2l364t374r500b425],
46	Orleans	NNP	LOCATION	Orleans	nn	47	SENT_16	[p2l528t374r750b425],
47	Street	NNP	LOCATION	Street	appos	39	SENT_16	[p2l779t374r961b434],
48	,	,	O	,	_	0	SENT_16	[p2l779t374r961b434],
49	CRB1	NN	O	crb1	nn	51	SENT_16	[p2l991t373r1383b434],
50	—	CD	NUMBER	—	num	51	SENT_16	[p2l991t373r1383b434],
51	1M52	NN	O	1m52	appos	39	SENT_16	[p2l991t373r1383b434],
52	,	,	O	,	_	0	SENT_16	[p2l991t373r1383b434],
53	Baltimore	NNP	LOCATION	Baltimore	appos	39	SENT_16	[p2l1412t374r1717b434],
54	,	,	O	,	_	0	SENT_16	[p2l1412t374r1717b434],
55	MD	NNP	O	MD	appos	39	SENT_16	[p2l7t459r121b508],
56	21231	CD	NUMBER	21231	num	55	SENT_16	[p2l149t458r343b518],
57	,	,	O	,	_	0	SENT_16	[p2l149t458r343b518],
58	USA	NNP	LOCATION	USA	appos	39	SENT_16	[p2l372t458r515b509],
59	e	SYM	O	e	dep	39	SENT_16	[p2l8t542r207b593],
60	—	CD	NUMBER	—	num	61	SENT_16	[p2l8t542r207b593],
61	mail	NN	O	mail	dep	3	SENT_16	[p2l8t542r207b593],
62	:	:	O	:	_	0	SENT_16	[p2l8t542r207b593],
63	mrudek2	NN	O	mrudek2	nn	64	SENT_16	[p2l239t543r495b593],
64	@jhmi.edu	NN	O	@jhmi.edu	dep	61	SENT_16	[p2l505t542r819b608],

1	J.	NNP	PERSON	J.	nn	3	SENT_17	[p2l7t715r47b765],
2	M.	NNP	PERSON	M.	nn	3	SENT_17	[p2l77t715r154b765],
3	Hoskins	NNP	PERSON	Hoskins	_	0	SENT_17	[p2l184t713r418b765],
4	-	:	O	-	_	0	SENT_17	[p2l452t741r460b749],
5	H.	NNP	PERSON	H.	nn	8	SENT_17	[p2l490t715r555b765],
6	L.	NNP	PERSON	L.	nn	8	SENT_17	[p2l584t715r642b765],
7	McLeod	NNP	PERSON	McLeod	nn	8	SENT_17	[p2l671t714r917b765],
8	University	NNP	ORGANIZATION	University	dep	3	SENT_17	[p2l7t798r312b864],
9	of	IN	ORGANIZATION	of	_	0	SENT_17	[p2l340t798r403b849],
10	North	NNP	ORGANIZATION	North	nn	11	SENT_17	[p2l423t799r591b849],
11	Carolina	NNP	ORGANIZATION	Carolina	prep_of	8	SENT_17	[p2l618t798r882b858],
12	,	,	O	,	_	0	SENT_17	[p2l618t798r882b858],
13	Chapel	NN	LOCATION	chapel	appos	11	SENT_17	[p2l912t799r1115b864],
14	Hill	NNP	LOCATION	Hill	nn	18	SENT_17	[p2l1142t798r1269b859],
15	,	,	O	,	_	0	SENT_17	[p2l1142t798r1269b859],
16	NC	NNP	O	NC	appos	18	SENT_17	[p2l1298t799r1412b859],
17	,	,	O	,	_	0	SENT_17	[p2l1298t799r1412b859],
18	USA	NNP	LOCATION	USA	dep	13	SENT_17	[p2l1441t799r1584b850],

1	Present	JJ	DATE	present	amod	2	SENT_18	[p2l6t971r230b1021],
2	Address	NN	O	address	_	0	SENT_18	[p2l249t969r506b1021],
3	:	:	O	:	_	0	SENT_18	[p2l249t969r506b1021],
4	J.	NNP	PERSON	J.	nn	8	SENT_18	[p2l7t1055r47b1105],
5	M.	NNP	PERSON	M.	nn	8	SENT_18	[p2l77t1055r154b1105],
6	Hoskins	NNP	PERSON	Hoskins	nn	8	SENT_18	[p2l184t1054r418b1105],
7	Gentris	NNP	ORGANIZATION	Gentris	nn	8	SENT_18	[p2l8t1139r218b1190],
8	Corporation	NNP	ORGANIZATION	Corporation	dep	2	SENT_18	[p2l240t1139r604b1205],
9	,	,	O	,	_	0	SENT_18	[p2l240t1139r604b1205],
10	133	CD	NUMBER	133	num	12	SENT_18	[p2l633t1140r730b1190],
11	Southcenter	NNP	ORGANIZATION	Southcenter	nn	12	SENT_18	[p2l755t1139r1101b1191],
12	Ct	NNP	ORGANIZATION	Ct	appos	8	SENT_18	[p2l1120t1140r1201b1199],
13	,	,	O	,	_	0	SENT_18	[p2l1120t1140r1201b1199],
14	Morrisville	NNP	LOCATION	Morrisville	appos	8	SENT_18	[p2l1223t1139r1565b1199],
15	,	,	O	,	_	0	SENT_18	[p2l1223t1139r1565b1199],
16	NC	NNP	O	NC	appos	8	SENT_18	[p2l1586t1140r1684b1190],
17	27560	CD	NUMBER	27560	num	16	SENT_18	[p2l1706t1139r1900b1199],
18	,	,	O	,	_	0	SENT_18	[p2l1706t1139r1900b1199],
19	USA	NNP	ORGANIZATION	USA	appos	8	SENT_18	[p2l7t1225r150b1275],
20	16	CD	DATE	16	num	19	SENT_18	[p2l7t1315r73b1368],
21	April	NNP	DATE	April	tmod	19	SENT_18	[p2l102t1315r260b1384],
22	2013	CD	DATE	2013	num	21	SENT_18	[p2l288t1316r434b1368],

1	ﬁrst	NN	O	ﬁrst	nn	3	SENT_19	[p2l14t1546r362b1627],
2	—	NN	O	—	nn	3	SENT_19	[p2l14t1546r362b1627],
3	stage	NN	O	stage	nsubj	7	SENT_19	[p2l14t1546r362b1627],
4	and	CC	O	and	_	0	SENT_19	[p2l408t1546r534b1609],
5	21	CD	NUMBER	21	conj_and	3	SENT_19	[p2l576t1546r653b1608],
6	were	VBD	O	be	cop	7	SENT_19	[p2l704t1566r874b1609],
7	evaluable	JJ	O	evaluable	_	0	SENT_19	[p2l918t1546r1258b1609],
8	after	IN	O	after	_	0	SENT_19	[p2l1303t1546r1466b1609],
9	a	DT	O	a	det	10	SENT_19	[p2l1508t1566r1545b1609],
10	median	NN	O	median	prep_after	7	SENT_19	[p2l1585t1546r1848b1609],
11	of	IN	O	of	_	0	SENT_19	[p2l1890t1546r1967b1609],
12	four	CD	NUMBER	four	num	13	SENT_19	[p2l2003t1546r2152b1609],
13	cycles	NNS	O	cycle	prep_of	10	SENT_19	[p2l13t1657r233b1738],
14	of	IN	O	of	_	0	SENT_19	[p2l287t1657r364b1720],
15	capecitabine	NN	O	capecitabine	prep_of	13	SENT_19	[p2l409t1657r874b1738],
16	.	.	O	.	_	0	SENT_19	[p2l409t1657r874b1738],

1	Two	CD	NUMBER	two	num	2	SENT_20	[p2l931t1659r1091b1720],
2	thirds	NNS	O	third	nsubj	5	SENT_20	[p2l1143t1657r1343b1720],
3	of	IN	O	of	_	0	SENT_20	[p2l1397t1657r1474b1720],
4	patients	NNS	O	patient	prep_of	2	SENT_20	[p2l1518t1657r1794b1738],
5	received	VBD	O	receive	dep	21	SENT_20	[p2l1846t1657r2150b1720],
6	either	CC	O	either	preconj	9	SENT_20	[p2l13t1768r217b1831],
7	the	DT	O	the	det	9	SENT_20	[p2l256t1768r363b1831],
8	same	JJ	O	same	amod	9	SENT_20	[p2l408t1788r586b1831],
9	dose	NN	O	dose	dobj	5	SENT_20	[p2l629t1768r789b1831],
10	or	CC	O	or	_	0	SENT_20	[p2l832t1788r904b1831],
11	a	DT	O	a	det	12	SENT_20	[p2l945t1788r982b1831],
12	dose	NN	O	dose	dobj	5	SENT_20	[p2l1023t1768r1183b1831],
13	500	CD	NUMBER	500	num	14	SENT_20	[p2l1226t1768r1356b1831],
14	mg	NN	O	mg	npadvmod	15	SENT_20	[p2l1389t1788r1500b1849],
15	lower	JJR	O	lower	advmod	5	SENT_20	[p2l1542t1768r1745b1831],
16	than	IN	O	than	_	0	SENT_20	[p2l1784t1768r1937b1831],
17	what	WP	O	what	prep_than	5	SENT_20	[p2l1978t1768r2150b1831],
18	would	MD	O	would	aux	21	SENT_20	[p2l13t1879r235b1942],
19	have	VB	O	have	aux	21	SENT_20	[p2l287t1879r455b1942],
20	been	VBN	O	be	auxpass	21	SENT_20	[p2l509t1879r677b1942],
21	administered	VBN	O	administer	_	0	SENT_20	[p2l733t1879r1195b1942],
22	with	IN	O	with	_	0	SENT_20	[p2l1249t1879r1406b1942],
23	a	DT	O	a	det	28	SENT_20	[p2l1462t1899r1498b1942],
24	commonly	RB	O	commonly	advmod	25	SENT_20	[p2l1552t1879r1933b1960],
25	used	VBN	O	use	amod	28	SENT_20	[p2l1987t1879r2150b1942],
26	2,000	CD	NUMBER	2,000	number	27	SENT_20	[p2l14t1989r211b2063],
27	mg/m2	CD	NUMBER	mg/m2	num	28	SENT_20	[p2l244t1970r485b2070],
28	BSA	NN	O	bsa	prep_with	21	SENT_20	[p2l544t1989r983b2070],
29	—	CD	NUMBER	—	num	31	SENT_20	[p2l544t1989r983b2070],
30	dosing	NN	O	dosing	nn	31	SENT_20	[p2l544t1989r983b2070],
31	schedule	NN	O	schedule	nsubjpass	21	SENT_20	[p2l1045t1989r1372b2051],
32	.	.	O	.	_	0	SENT_20	[p2l1045t1989r1372b2051],

1	Eight	CD	NUMBER	eight	num	2	SENT_21	[p2l1435t1989r1629b2070],
2	patients	NNS	O	patient	nsubj	3	SENT_21	[p2l1685t1989r1962b2070],
3	had	VBD	O	have	_	0	SENT_21	[p2l2022t1989r2150b2051],
4	stable	JJ	O	stable	amod	5	SENT_21	[p2l15t2100r219b2162],
5	disease	NN	O	disease	dobj	3	SENT_21	[p2l242t2100r498b2162],
6	but	CC	O	but	_	0	SENT_21	[p2l519t2100r633b2162],
7	progressed	VBD	O	progress	conj_but	3	SENT_21	[p2l653t2100r1040b2181],
8	after	IN	O	after	_	0	SENT_21	[p2l1063t2100r1225b2162],
9	a	DT	O	a	det	10	SENT_21	[p2l1247t2119r1284b2162],
10	median	NN	O	median	prep_after	7	SENT_21	[p2l1304t2100r1566b2162],
11	of	IN	O	of	_	0	SENT_21	[p2l1589t2099r1666b2162],
12	seven	CD	NUMBER	seven	num	13	SENT_21	[p2l1685t2119r1883b2162],
13	cycles	NNS	O	cycle	prep_of	10	SENT_21	[p2l1906t2100r2145b2181],
14	.	.	O	.	_	0	SENT_21	[p2l1906t2100r2145b2181],

1	Despite	IN	O	despite	_	0	SENT_22	[p2l12t2211r283b2292],
2	a	DT	O	a	det	5	SENT_22	[p2l350t2230r387b2273],
3	clinical	JJ	O	clinical	amod	5	SENT_22	[p2l450t2211r712b2273],
4	beneﬁt	NN	O	beneﬁt	nn	5	SENT_22	[p2l776t2210r1020b2273],
5	rate	NN	O	rate	prep_despite	14	SENT_22	[p2l1082t2220r1214b2273],
6	of	IN	O	of	_	0	SENT_22	[p2l1280t2211r1357b2273],
7	19	CD	PERCENT	19	num	8	SENT_22	[p2l1424t2211r1500b2274],
8	%	NN	PERCENT	%	prep_of	5	SENT_22	[p2l1538t2211r1626b2285],
9	,	,	O	,	_	0	SENT_22	[p2l1538t2211r1626b2285],
10	no	DT	O	no	det	12	SENT_22	[p2l1692t2230r1778b2273],
11	RECIST	NN	O	recist	nn	12	SENT_22	[p2l1843t2211r2150b2274],
12	responses	NNS	O	response	nsubjpass	14	SENT_22	[p2l11t2343r357b2404],
13	were	VBD	O	be	auxpass	14	SENT_22	[p2l395t2343r566b2386],
14	observed	VBN	O	observe	_	0	SENT_22	[p2l604t2323r925b2386],
15	following	VBG	O	follow	_	0	SENT_22	[p2l961t2323r1307b2404],
16	the	DT	O	the	det	18	SENT_22	[p2l1344t2323r1450b2386],
17	ﬁrst	JJ	O	ﬁrst	amod	18	SENT_22	[p2l1489t2323r1625b2386],
18	stage	NN	O	stage	prep_following	14	SENT_22	[p2l1663t2333r1841b2404],
19	and	CC	O	and	_	0	SENT_22	[p2l1881t2323r2007b2386],
20	the	DT	O	the	det	21	SENT_22	[p2l2042t2323r2149b2386],
21	study	NN	O	study	nsubjpass	23	SENT_22	[p2l15t2434r203b2515],
22	was	VBD	O	be	auxpass	23	SENT_22	[p2l234t2454r368b2497],
23	closed	VBN	O	close	conj_and	14	SENT_22	[p2l400t2434r644b2497],
24	.	.	O	.	_	0	SENT_22	[p2l400t2434r644b2497],

1	Dose	NN	O	dose	nn	3	SENT_23	[p2l678t2434r1262b2497],
2	—	NN	O	—	nn	3	SENT_23	[p2l678t2434r1262b2497],
3	reductions	NNS	O	reduction	nsubjpass	5	SENT_23	[p2l678t2434r1262b2497],
4	were	VBD	O	be	auxpass	5	SENT_23	[p2l1294t2454r1464b2497],
5	required	VBN	O	require	_	0	SENT_23	[p2l1494t2434r1793b2515],
6	for	IN	O	for	_	0	SENT_23	[p2l1822t2434r1925b2497],
7	grade	NN	O	grade	prep_for	5	SENT_23	[p2l1954t2434r2149b2515],
8	2	CD	NUMBER	2	num	7	SENT_23	[p2l14t2546r54b2607],
9	hand	NN	O	hand	nn	12	SENT_23	[p2l130t2545r493b2608],
10	—	CD	NUMBER	—	num	12	SENT_23	[p2l130t2545r493b2608],
11	foot	NN	O	foot	nn	12	SENT_23	[p2l130t2545r493b2608],
12	syndrome	NN	O	syndrome	dep	7	SENT_23	[p2l571t2545r917b2626],
13	(	CD	PERCENT	(	number	14	SENT_23	[p2l997t2545r1107b2622],
14	28	CD	PERCENT	28	num	15	SENT_23	[p2l997t2545r1107b2622],
15	%	NN	PERCENT	%	dep	12	SENT_23	[p2l1147t2545r1242b2622],
16	)	CD	NUMBER	)	dobj	5	SENT_23	[p2l1147t2545r1242b2622],
17	and	CC	O	and	_	0	SENT_23	[p2l1322t2545r1448b2608],
18	vomiting	VBG	O	vomit	conj_and	16	SENT_23	[p2l1523t2545r1845b2626],
19	(	CD	PERCENT	(	number	20	SENT_23	[p2l1924t2545r1989b2622],
20	5	CD	PERCENT	5	num	21	SENT_23	[p2l1924t2545r1989b2622],
21	%	NN	PERCENT	%	dep	16	SENT_23	[p2l2029t2545r2145b2622],
22	)	CD	NUMBER	)	dep	21	SENT_23	[p2l2029t2545r2145b2622],
23	.	.	O	.	_	0	SENT_23	[p2l2029t2545r2145b2622],

1	Adherence	NN	O	adherence	nsubj	3	SENT_24	[p2l12t2656r399b2719],
2	was	VBD	O	be	cop	3	SENT_24	[p2l442t2676r576b2719],
3	similar	JJ	O	similar	_	0	SENT_24	[p2l624t2656r869b2719],
4	when	WRB	O	when	advmod	9	SENT_24	[p2l911t2656r1102b2719],
5	using	VBG	O	use	csubj	9	SENT_24	[p2l1143t2656r1335b2737],
6	both	DT	O	both	det	7	SENT_24	[p2l1376t2656r1535b2719],
7	patient	NN	O	patient	dobj	5	SENT_24	[p2l1576t2656r2150b2737],
8	—	RB	O	—	advmod	5	SENT_24	[p2l1576t2656r2150b2737],
9	reported	VBD	O	report	advcl	3	SENT_24	[p2l1576t2656r2150b2737],
10	and	CC	O	and	_	0	SENT_24	[p2l14t2767r141b2830],
11	Medication	NNP	O	Medication	nn	12	SENT_24	[p2l177t2767r585b2830],
12	Event	NNP	O	Event	nsubj	13	SENT_24	[p2l622t2769r831b2830],
13	Monitoring	VBG	O	monitor	conj_and	9	SENT_24	[p2l867t2767r1273b2848],
14	System	NNP	O	System	nn	15	SENT_24	[p2l1314t2768r1574b2848],
15	methods	NNS	O	method	dobj	13	SENT_24	[p2l1611t2767r1931b2830],
16	.	.	O	.	_	0	SENT_24	[p2l1611t2767r1931b2830],

1	High	JJ	O	high	amod	3	SENT_25	[p2l1973t2767r2150b2848],
2	interpatient	JJ	O	interpatient	amod	3	SENT_25	[p2l12t2878r422b2959],
3	variability	NN	O	variability	nsubjpass	5	SENT_25	[p2l459t2878r826b2959],
4	was	VBD	O	be	auxpass	5	SENT_25	[p2l864t2898r998b2941],
5	observed	VBN	O	observe	_	0	SENT_25	[p2l1039t2878r1360b2941],
6	for	IN	O	for	_	0	SENT_25	[p2l1397t2878r1501b2941],
7	capecitabine	NN	O	capecitabine	nn	10	SENT_25	[p2l1537t2878r1984b2959],
8	and	CC	O	and	_	0	SENT_25	[p2l2024t2878r2150b2941],
9	metabolite	NN	O	metabolite	nn	10	SENT_25	[p2l12t2989r390b3051],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_for	5	SENT_25	[p2l446t2989r1098b3070],
11	,	,	O	,	_	0	SENT_25	[p2l446t2989r1098b3070],
12	but	CC	O	but	_	0	SENT_25	[p2l1156t2989r1270b3051],
13	was	VBD	O	be	auxpass	15	SENT_25	[p2l1325t3008r1459b3051],
14	not	RB	O	not	neg	15	SENT_25	[p2l1517t2998r1630b3051],
15	attributed	VBN	O	attribute	conj_but	5	SENT_25	[p2l1686t2989r2027b3051],
16	to	TO	O	to	aux	17	SENT_25	[p2l2082t2998r2149b3051],
17	observed	VBN	O	observe	xcomp	15	SENT_25	[p2l13t3099r335b3161],
18	pharmacogenetic	JJ	O	pharmacogenetic	amod	21	SENT_25	[p2l395t3099r1008b3180],
19	or	CC	O	or	_	0	SENT_25	[p2l1073t3118r1146b3161],
20	BSA	NN	O	bsa	conj_or	18	SENT_25	[p2l1207t3099r1378b3162],
21	differences	NNS	O	difference	dobj	17	SENT_25	[p2l1441t3098r1856b3161],
22	.	.	O	.	_	0	SENT_25	[p2l1441t3098r1856b3161],

1	Single	JJ	O	single	amod	3	SENT_26	[p2l1925t3099r2149b3180],
2	agent	NN	O	agent	nn	3	SENT_26	[p2l14t3219r206b3291],
3	activity	NN	O	activity	nsubj	23	SENT_26	[p2l245t3210r510b3291],
4	of	IN	O	of	_	0	SENT_26	[p2l549t3210r627b3272],
5	capecitabine	NN	O	capecitabine	prep_of	3	SENT_26	[p2l659t3210r1106b3291],
6	was	VBD	O	be	cop	7	SENT_26	[p2l1145t3229r1279b3272],
7	modest	JJ	O	modest	_	0	SENT_26	[p2l1318t3210r1576b3272],
8	in	IN	O	in	_	0	SENT_26	[p2l1613t3210r1681b3271],
9	our	PRP$	O	we	poss	10	SENT_26	[p2l1719t3229r1836b3272],
10	patients	NNS	O	patient	prep_in	7	SENT_26	[p2l1871t3210r2148b3291],
11	with	IN	O	with	_	0	SENT_26	[p2l13t3322r170b3385],
12	estrogen	NN	O	estrogen	nn	14	SENT_26	[p2l231t3332r532b3403],
13	receptor	NN	O	receptor	nn	14	SENT_26	[p2l591t3322r1199b3403],
14	—	NN	O	—	prep_with	7	SENT_26	[p2l591t3322r1199b3403],
15	positive	JJ	O	positive	amod	21	SENT_26	[p2l591t3322r1199b3403],
16	or	CC	O	or	_	0	SENT_26	[p2l1261t3342r1334b3385],
17	—	JJ	O	—	conj_or	15	SENT_26	[p2l1395t3322r1725b3403],
18	negative	JJ	O	negative	amod	21	SENT_26	[p2l1395t3322r1725b3403],
19	metastatic	JJ	O	metastatic	amod	21	SENT_26	[p2l1786t3322r2148b3385],
20	breast	NN	O	breast	nn	21	SENT_26	[p2l11t3433r226b3496],
21	cancer	NN	O	cancer	dep	7	SENT_26	[p2l261t3453r495b3496],
22	and	CC	O	and	_	0	SENT_26	[p2l531t3433r656b3496],
23	comparable	JJ	O	comparable	conj_and	7	SENT_26	[p2l693t3433r1109b3514],
24	to	TO	O	to	_	0	SENT_26	[p2l1145t3442r1212b3496],
25	recent	JJ	O	recent	amod	26	SENT_26	[p2l1247t3442r1466b3496],
26	studies	NNS	O	study	prep_to	23	SENT_26	[p2l1505t3433r1766b3496],
27	.	.	O	.	_	0	SENT_26	[p2l1505t3433r1766b3496],

1	BSA	NN	ORGANIZATION	bsa	nsubj	6	SENT_27	[p2l1807t3433r1978b3496],
2	was	VBD	O	be	cop	6	SENT_27	[p2l2014t3453r2148b3496],
3	not	RB	O	not	neg	6	SENT_27	[p2l12t3553r126b3607],
4	the	DT	O	the	det	6	SENT_27	[p2l156t3544r262b3607],
5	main	JJ	O	main	amod	6	SENT_27	[p2l294t3544r472b3607],
6	source	NN	O	source	_	0	SENT_27	[p2l505t3564r734b3607],
7	of	IN	O	of	_	0	SENT_27	[p2l766t3544r843b3607],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_27	[p2l866t3544r1464b3625],
9	variability	NN	O	variability	prep_of	6	SENT_27	[p2l1496t3544r1883b3625],
10	.	.	O	.	_	0	SENT_27	[p2l1496t3544r1883b3625],

1	Fixeddose	NN	O	fixeddose	nn	2	SENT_28	[p2l1918t3544r2147b3607, p2l13t3655r173b3718],
2	capecitabine	NN	O	capecitabine	nsubj	4	SENT_28	[p2l205t3655r652b3736],
3	is	VBZ	O	be	cop	4	SENT_28	[p2l682t3655r737b3718],
4	feasible	JJ	O	feasible	_	0	SENT_28	[p2l769t3655r1066b3730],
5	,	,	O	,	_	0	SENT_28	[p2l769t3655r1066b3730],
6	and	CC	O	and	_	0	SENT_28	[p2l1100t3655r1226b3718],
7	simpliﬁes	NNS	O	simpliﬁes	dep	8	SENT_28	[p2l1258t3655r1600b3736],
8	dosing	NN	O	dosing	conj_and	4	SENT_28	[p2l1632t3655r1886b3736],
9	.	.	O	.	_	0	SENT_28	[p2l1632t3655r1886b3736],

1	E.	NNP	PERSON	E.	nn	2	SENT_29	[p3l12t121r72b173],
2	Garrett	NNP	PERSON	Garrett	_	0	SENT_29	[p3l105t120r543b188],
3	.	.	O	.	_	0	SENT_29	[p3l105t120r543b188],

1	—	NN	O	—	_	0	SENT_30	[p3l105t120r543b188],
2	.	.	O	.	_	0	SENT_30	[p3l105t120r543b188],

1	Mayer	NNP	ORGANIZATION	Mayer	nn	3	SENT_31	[p3l105t120r543b188],
2	Medical	NNP	ORGANIZATION	Medical	nn	3	SENT_31	[p3l12t207r260b260],
3	University	NNP	ORGANIZATION	University	_	0	SENT_31	[p3l288t207r607b276],
4	of	IN	ORGANIZATION	of	_	0	SENT_31	[p3l637t207r702b260],
5	South	NNP	ORGANIZATION	South	nn	10	SENT_31	[p3l726t207r900b260],
6	Carolina	NNP	ORGANIZATION	Carolina	nn	10	SENT_31	[p3l928t207r1204b270],
7	,	,	O	,	_	0	SENT_31	[p3l928t207r1204b270],
8	Charleston	NNP	LOCATION	Charleston	appos	10	SENT_31	[p3l1236t207r1580b270],
9	,	,	O	,	_	0	SENT_31	[p3l1236t207r1580b270],
10	SC	NNP	O	SC	prep_of	3	SENT_31	[p3l1612t207r1717b270],
11	,	,	O	,	_	0	SENT_31	[p3l1612t207r1717b270],
12	USA	NNP	LOCATION	USA	dep	3	SENT_31	[p3l1747t207r1897b260],

1	S.	NNP	PERSON	S.	nn	4	SENT_32	[p3l14t385r67b438],
2	P.	NNP	PERSON	P.	nn	4	SENT_32	[p3l99t386r154b438],
3	Watkins	NNP	PERSON	Watkins	nn	4	SENT_32	[p3l184t385r436b438],
4	Jr.	NNP	PERSON	Jr.	_	0	SENT_32	[p3l465t386r533b438],
5	.	.	O	.	_	0	SENT_32	[p3l465t386r533b438],

1	Anne	NNP	ORGANIZATION	Anne	nn	4	SENT_33	[p3l12t475r174b527],
2	Arundel	NNP	ORGANIZATION	Arundel	nn	4	SENT_33	[p3l202t474r449b527],
3	Medical	NNP	ORGANIZATION	Medical	nn	4	SENT_33	[p3l477t474r725b527],
4	Center	NNP	ORGANIZATION	Center	_	0	SENT_33	[p3l754t475r971b537],
5	,	,	O	,	_	0	SENT_33	[p3l754t475r971b537],
6	Annapolis	NNP	LOCATION	Annapolis	nn	10	SENT_33	[p3l1002t474r1329b543],
7	,	,	O	,	_	0	SENT_33	[p3l1002t474r1329b543],
8	MD	NNP	O	MD	appos	10	SENT_33	[p3l1359t475r1496b537],
9	,	,	O	,	_	0	SENT_33	[p3l1359t475r1496b537],
10	USA	NNP	LOCATION	USA	appos	4	SENT_33	[p3l1525t474r1676b527],

1	N.	NNP	ORGANIZATION	N.	nn	4	SENT_34	[p3l12t653r80b705],
2	E.	NNP	ORGANIZATION	E.	nn	4	SENT_34	[p3l111t653r171b705],
3	Davidson	NNP	ORGANIZATION	Davidson	nn	4	SENT_34	[p3l202t651r492b705],
4	University	NNP	ORGANIZATION	University	dep	12	SENT_34	[p3l12t740r331b808],
5	of	IN	ORGANIZATION	of	_	0	SENT_34	[p3l361t739r426b793],
6	Pittsburgh	NNP	ORGANIZATION	Pittsburgh	nn	7	SENT_34	[p3l448t739r760b808],
7	Cancer	NNP	ORGANIZATION	Cancer	prep_of	4	SENT_34	[p3l788t740r1002b793],
8	Institute	NNP	ORGANIZATION	Institute	nn	11	SENT_34	[p3l1029t739r1276b793],
9	and	CC	O	and	_	0	SENT_34	[p3l1306t740r1413b793],
10	UPMC	NNP	ORGANIZATION	UPMC	nn	11	SENT_34	[p3l1440t740r1652b793],
11	Cancer	NNP	ORGANIZATION	Cancer	dep	12	SENT_34	[p3l1681t740r1896b793],
12	Center	NNP	ORGANIZATION	Center	_	0	SENT_34	[p3l13t828r230b890],
13	,	,	O	,	_	0	SENT_34	[p3l13t828r230b890],
14	Pittsburgh	NNP	LOCATION	Pittsburgh	appos	12	SENT_34	[p3l260t828r587b896],
15	,	,	O	,	_	0	SENT_34	[p3l260t828r587b896],
16	PA	NN	ORGANIZATION	pa	appos	12	SENT_34	[p3l618t828r729b891],
17	,	,	O	,	_	0	SENT_34	[p3l618t828r729b891],
18	USA	NNP	LOCATION	USA	appos	12	SENT_34	[p3l759t828r909b881],

1	@	SYM	O	@	dep	2	SENT_35	[p3l1782t1059r1859b1154],
2	Springer	NN	PERSON	springer	dep	7	SENT_35	[p3l1889t1082r2151b1157],
3	136	CD	NUMBER	136	num	2	SENT_35	[p3l56t1232r104b1257],
4	Breast	NN	ORGANIZATION	breast	nn	7	SENT_35	[p3l1450t1232r1540b1257],
5	Cancer	NN	ORGANIZATION	cancer	nn	7	SENT_35	[p3l1552t1232r1652b1257],
6	Res	NNP	ORGANIZATION	Res	nn	7	SENT_35	[p3l1664t1232r1716b1257],
7	Treat	NNP	ORGANIZATION	Treat	dep	11	SENT_35	[p3l1729t1232r1804b1257],
8	(	CD	NUMBER	(	num	9	SENT_35	[p3l1817t1232r1908b1262],
9	2013	CD	DATE	2013	dep	7	SENT_35	[p3l1817t1232r1908b1262],
10	)	CD	NUMBER	)	num	11	SENT_35	[p3l1817t1232r1908b1262],
11	l39	NN	O	l39	_	0	SENT_35	[p3l1925t1232r2105b1257],
12	:	:	O	:	_	0	SENT_35	[p3l1925t1232r2105b1257],
13	l35	NN	O	l35	dep	11	SENT_35	[p3l1925t1232r2105b1257],
14	—	CD	NUMBER	—	num	15	SENT_35	[p3l1925t1232r2105b1257],
15	l43	NN	O	l43	dep	13	SENT_35	[p3l1925t1232r2105b1257],

1	Keywords	NNPS	O	Keywords	_	0	SENT_36	[p3l8t1402r393b1482],
2	Breast	NN	O	breast	nn	3	SENT_36	[p3l486t1403r716b1464],
3	cancer	NN	O	cancer	dep	1	SENT_36	[p3l747t1421r981b1464],
4	-	:	O	-	_	0	SENT_36	[p3l1019t1436r1029b1445],
5	Capecitabine	NN	O	capecitabine	nn	6	SENT_36	[p3l1067t1402r1534b1483],
6	Pharmacokinetics	NNS	O	pharmacokinetic	dep	1	SENT_36	[p3l1574t1436r1584b1445, p3l7t1512r644b1575],
7	-	:	O	-	_	0	SENT_36	[p3l685t1546r694b1556],
8	Pharmacogenetics	NNS	O	pharmacogenetic	dep	6	SENT_36	[p3l732t1512r1384b1593],

1	Introduction	NN	O	introduction	_	0	SENT_37	[p3l7t1755r493b1819],

1	Capecitabine	NN	O	capecitabine	nsubj	5	SENT_38	[p3l8t1980r475b2061],
2	is	VBZ	O	be	cop	5	SENT_38	[p3l517t1980r572b2042],
3	an	DT	O	a	det	5	SENT_38	[p3l617t1999r697b2042],
4	oral	JJ	O	oral	amod	5	SENT_38	[p3l739t1980r875b2042],
5	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	_	0	SENT_38	[p3l917t1980r1523b2061],
6	pro	FW	O	pro	nn	8	SENT_38	[p3l1563t1980r1875b2061],
7	—	FW	O	—	nn	8	SENT_38	[p3l1563t1980r1875b2061],
8	drug	NN	O	drug	dep	5	SENT_38	[p3l1563t1980r1875b2061],
9	that	WDT	O	that	nsubjpass	11	SENT_38	[p3l1916t1980r2050b2042],
10	is	VBZ	O	be	auxpass	11	SENT_38	[p3l2090t1980r2146b2042],
11	approved	VBN	O	approve	conj_or	11	SENT_38	[p3l9t2091r341b2172],
12	for	IN	O	for	_	0	SENT_38	[p3l388t2090r492b2153],
13	the	DT	O	the	det	14	SENT_38	[p3l538t2091r645b2153],
14	treatment	NN	O	treatment	prep_for	11	SENT_38	[p3l694t2100r1034b2153],
15	of	IN	O	of	_	0	SENT_38	[p3l1083t2091r1160b2153],
16	anthracycline	NN	O	anthracycline	nn	24	SENT_38	[p3l1204t2090r1712b2172],
17	—	CD	NUMBER	—	num	16	SENT_38	[p3l1204t2090r1712b2172],
18	or	CC	O	or	_	0	SENT_38	[p3l1765t2110r1838b2153],
19	taXane	NN	O	taxane	npadvmod	21	SENT_38	[p3l1884t2100r2144b2153],
20	—	CD	NUMBER	—	num	19	SENT_38	[p3l1884t2100r2144b2153],
21	resistant	JJ	O	resistant	nn	24	SENT_38	[p3l6t2203r305b2266],
22	metastatic	JJ	O	metastatic	amod	24	SENT_38	[p3l341t2203r703b2266],
23	breast	NN	O	breast	nn	24	SENT_38	[p3l740t2203r955b2266],
24	cancer	NN	O	cancer	prep_of	14	SENT_38	[p3l990t2223r1225b2266],
25	alone	RB	O	alone	advmod	24	SENT_38	[p3l1261t2203r1450b2266],
26	or	CC	O	or	_	0	SENT_38	[p3l1489t2223r1561b2266],
27	in	IN	O	in	_	0	SENT_38	[p3l1596t2203r1664b2265],
28	combination	NN	O	combination	prep_in	11	SENT_38	[p3l1700t2203r2148b2266],
29	with	IN	O	with	_	0	SENT_38	[p3l8t2314r165b2377],
30	docetaxel	NN	O	docetaxel	prep_with	28	SENT_38	[p3l196t2314r538b2377],
31	at	IN	O	at	_	0	SENT_38	[p3l571t2324r633b2377],
32	a	DT	O	a	det	33	SENT_38	[p3l664t2334r701b2377],
33	dose	NN	O	dose	prep_at	30	SENT_38	[p3l731t2314r891b2377],
34	of	IN	O	of	_	0	SENT_38	[p3l924t2314r1001b2377],
35	2,500	CD	NUMBER	2,500	num	36	SENT_38	[p3l1026t2314r1224b2388],
36	mg/m2	NN	O	mg/m2	prep_of	33	SENT_38	[p3l1257t2295r1498b2395],
37	(	CD	NUMBER	(	num	41	SENT_38	[p3l1532t2314r1716b2391],
38	total	JJ	O	total	amod	41	SENT_38	[p3l1532t2314r1716b2391],
39	daily	JJ	SET	daily	amod	41	SENT_38	[p3l1748t2314r1924b2395],
40	dose	NN	O	dose	nn	41	SENT_38	[p3l1957t2314r2145b2391],
41	)	NN	O	)	tmod	11	SENT_38	[p3l1957t2314r2145b2391],
42	orally	RB	O	orally	advmod	43	SENT_38	[p3l8t2426r214b2507],
43	given	VBN	O	give	partmod	41	SENT_38	[p3l237t2426r435b2507],
44	in	IN	O	in	_	0	SENT_38	[p3l455t2426r523b2488],
45	two	CD	NUMBER	two	prep_in	43	SENT_38	[p3l544t2435r675b2489],
46	divided	VBN	O	divide	partmod	45	SENT_38	[p3l699t2426r966b2489],
47	daily	JJ	SET	daily	amod	48	SENT_38	[p3l988t2426r1164b2507],
48	doses	NNS	O	dose	dobj	46	SENT_38	[p3l1187t2426r1381b2489],
49	for	IN	O	for	_	0	SENT_38	[p3l1404t2426r1507b2489],
50	14	CD	DURATION	14	num	51	SENT_38	[p3l1536t2426r1613b2488],
51	days	NNS	NUMBER	day	prep_for	46	SENT_38	[p3l1647t2426r1807b2507],
52	followed	VBN	O	follow	partmod	51	SENT_38	[p3l1831t2426r2148b2489],
53	by	IN	O	by	_	0	SENT_38	[p3l6t2537r94b2618],
54	7	CD	DURATION	7	num	55	SENT_38	[p3l141t2539r179b2600],
55	days	NNS	NUMBER	day	agent	52	SENT_38	[p3l216t2537r375b2618],
56	of	IN	O	of	_	0	SENT_38	[p3l424t2537r501b2600],
57	rest	NN	O	rest	prep_of	55	SENT_38	[p3l539t2547r669b2600],
58	[	CD	NUMBER	[	num	57	SENT_38	[p3l720t2538r879b2613],
59	11	CD	NUMBER	11	num	60	SENT_38	[p3l720t2538r879b2613],
60	]	NN	O	]	dep	41	SENT_38	[p3l720t2538r879b2613],
61	.	.	O	.	_	0	SENT_38	[p3l720t2538r879b2613],

1	In	IN	O	in	_	0	SENT_39	[p3l929t2539r1001b2599],
2	the	DT	O	the	det	4	SENT_39	[p3l1046t2537r1153b2600],
3	initial	JJ	O	initial	amod	4	SENT_39	[p3l1200t2537r1408b2600],
4	studies	NNS	O	study	prep_in	28	SENT_39	[p3l1458t2537r1701b2600],
5	that	WDT	O	that	nsubj	6	SENT_39	[p3l1748t2537r1882b2600],
6	led	VBD	O	lead	rcmod	4	SENT_39	[p3l1927t2537r2035b2600],
7	to	TO	O	to	_	0	SENT_39	[p3l2080t2547r2146b2600],
8	approval	NN	O	approval	prep_to	6	SENT_39	[p3l9t2648r319b2729],
9	of	IN	O	of	_	0	SENT_39	[p3l379t2648r456b2711],
10	Capecitabine	NN	O	capecitabine	prep_of	8	SENT_39	[p3l509t2648r957b2729],
11	by	IN	O	by	_	0	SENT_39	[p3l1014t2648r1102b2729],
12	the	DT	O	the	det	14	SENT_39	[p3l1160t2648r1267b2711],
13	U.S.	NNP	ORGANIZATION	U.S.	nn	14	SENT_39	[p3l1326t2649r1478b2711],
14	Food	NNP	ORGANIZATION	Food	prep_by	6	SENT_39	[p3l1540t2648r1723b2711],
15	and	CC	ORGANIZATION	and	_	0	SENT_39	[p3l1782t2648r1908b2711],
16	Drug	NNP	ORGANIZATION	Drug	nn	17	SENT_39	[p3l1966t2650r2147b2729],
17	Administration	NNP	ORGANIZATION	Administration	conj_and	14	SENT_39	[p3l7t2759r550b2822],
18	(	CD	NUMBER	(	num	19	SENT_39	[p3l573t2760r826b2836],
19	FDA	NNP	ORGANIZATION	FDA	dep	14	SENT_39	[p3l573t2760r826b2836],
20	)	CD	NUMBER	)	num	19	SENT_39	[p3l573t2760r826b2836],
21	,	,	O	,	_	0	SENT_39	[p3l573t2760r826b2836],
22	the	DT	O	the	det	25	SENT_39	[p3l849t2759r956b2822],
23	overall	JJ	O	overall	amod	25	SENT_39	[p3l978t2759r1225b2822],
24	response	NN	O	response	nn	25	SENT_39	[p3l1245t2779r1556b2840],
25	rate	NN	O	rate	nsubj	28	SENT_39	[p3l1577t2769r1710b2822],
26	was	VBD	O	be	cop	28	SENT_39	[p3l1732t2779r1866b2822],
27	25.6	CD	PERCENT	25.6	num	28	SENT_39	[p3l1890t2759r2042b2822],
28	%	NN	PERCENT	%	_	0	SENT_39	[p3l2079t2760r2143b2822],
29	as	IN	O	as	_	0	SENT_39	[p3l9t2889r78b2932],
30	monotherapy	NN	O	monotherapy	prep_as	28	SENT_39	[p3l114t2870r586b2951],
31	[	CD	NUMBER	[	number	32	SENT_39	[p3l627t2870r717b2946],
32	6	CD	NUMBER	6	num	33	SENT_39	[p3l627t2870r717b2946],
33	]	NN	O	]	dep	30	SENT_39	[p3l627t2870r717b2946],
34	and	CC	O	and	_	0	SENT_39	[p3l759t2870r885b2932],
35	42	CD	PERCENT	42	num	36	SENT_39	[p3l919t2870r1005b2932],
36	%	NN	PERCENT	%	conj_and	30	SENT_39	[p3l1043t2870r1107b2933],
37	when	WRB	O	when	advmod	38	SENT_39	[p3l1145t2870r1337b2933],
38	combined	VBN	O	combine	dep	36	SENT_39	[p3l1372t2870r1725b2932],
39	with	IN	O	with	_	0	SENT_39	[p3l1759t2870r1916b2933],
40	doce	NN	O	doce	nn	43	SENT_39	[p3l1951t2870r2145b2932],
41	—	CD	NUMBER	—	num	43	SENT_39	[p3l1951t2870r2145b2932],
42	taxel	NN	O	taxel	nn	43	SENT_39	[p3l7t2980r180b3042],
43	[	NN	O	[	prep_with	38	SENT_39	[p3l216t2980r374b3055],
44	22	CD	NUMBER	22	num	45	SENT_39	[p3l216t2980r374b3055],
45	]	NN	O	]	dep	43	SENT_39	[p3l216t2980r374b3055],
46	.	.	O	.	_	0	SENT_39	[p3l216t2980r374b3055],

1	However	RB	O	however	advmod	9	SENT_40	[p3l408t2981r754b3053],
2	,	,	O	,	_	0	SENT_40	[p3l408t2981r754b3053],
3	clinical	JJ	O	clinical	amod	4	SENT_40	[p3l787t2980r1049b3042],
4	experience	NN	O	experience	nsubj	9	SENT_40	[p3l1080t2980r1467b3061],
5	with	IN	O	with	_	0	SENT_40	[p3l1497t2980r1654b3042],
6	this	DT	O	this	det	7	SENT_40	[p3l1683t2980r1809b3042],
7	drug	NN	O	drug	prep_with	4	SENT_40	[p3l1841t2980r2000b3061],
8	has	VBZ	O	have	aux	9	SENT_40	[p3l2030t2980r2146b3042],
9	led	VBN	O	lead	_	0	SENT_40	[p3l8t3091r116b3153],
10	to	TO	O	to	_	0	SENT_40	[p3l152t3100r218b3153],
11	the	DT	O	the	det	12	SENT_40	[p3l256t3091r363b3153],
12	observation	NN	O	observation	prep_to	9	SENT_40	[p3l402t3091r819b3153],
13	that	IN	O	that	complm	19	SENT_40	[p3l855t3091r989b3153],
14	signiﬁcant	JJ	O	signiﬁcant	dep	15	SENT_40	[p3l1028t3091r1398b3172],
15	gastrointestinal	JJ	O	gastrointestinal	amod	18	SENT_40	[p3l1436t3091r1982b3172],
16	and	CC	O	and	_	0	SENT_40	[p3l2022t3091r2148b3153],
17	dermatologic	JJ	O	dermatologic	amod	18	SENT_40	[p3l8t3203r479b3284],
18	toxicity	NN	O	toxicity	nsubj	19	SENT_40	[p3l514t3203r786b3284],
19	occurs	VBZ	O	occur	ccomp	9	SENT_40	[p3l821t3223r1051b3266],
20	at	IN	O	at	_	0	SENT_40	[p3l1087t3212r1149b3266],
21	high	JJ	O	high	amod	22	SENT_40	[p3l1181t3203r1339b3284],
22	frequency	NN	O	frequency	prep_at	19	SENT_40	[p3l1372t3203r1748b3284],
23	,	,	O	,	_	0	SENT_40	[p3l1372t3203r1748b3284],
24	as	RB	O	as	_	0	SENT_40	[p3l1786t3223r1855b3266],
25	well	RB	O	well	_	0	SENT_40	[p3l1890t3203r2041b3266],
26	as	IN	O	as	_	0	SENT_40	[p3l2077t3223r2146b3266],
27	wide	JJ	O	wide	amod	30	SENT_40	[p3l8t3314r179b3377],
28	interpatient	JJ	O	interpatient	amod	30	SENT_40	[p3l233t3314r643b3395],
29	pharmacokinetic	JJ	O	pharmacokinetic	amod	30	SENT_40	[p3l695t3314r1294b3395],
30	variability	NN	O	variability	conj_and	22	SENT_40	[p3l1349t3314r1737b3395],
31	,	,	O	,	_	0	SENT_40	[p3l1349t3314r1737b3395],
32	when	WRB	O	when	advmod	37	SENT_40	[p3l1794t3314r1986b3377],
33	the	DT	O	the	det	35	SENT_40	[p3l2040t3314r2147b3377],
34	recommended	VBN	O	recommend	amod	35	SENT_40	[p3l6t3425r516b3488],
35	dose	NN	O	dose	nsubjpass	37	SENT_40	[p3l537t3425r697b3488],
36	is	VBZ	O	be	auxpass	37	SENT_40	[p3l720t3425r775b3488],
37	administered	VBN	O	administer	dep	30	SENT_40	[p3l800t3425r1262b3488],
38	to	TO	O	to	_	0	SENT_40	[p3l1281t3434r1348b3488],
39	patients	NNS	O	patient	prep_to	37	SENT_40	[p3l1369t3425r1647b3506],
40	[	CD	NUMBER	[	number	41	SENT_40	[p3l1675t3425r1805b3501],
41	16	CD	NUMBER	16	dep	39	SENT_40	[p3l1675t3425r1805b3501],
42	,	,	O	,	_	0	SENT_40	[p3l1675t3425r1805b3501],
43	24	CD	NUMBER	24	num	44	SENT_40	[p3l1831t3425r1965b3501],
44	]	NN	O	]	appos	39	SENT_40	[p3l1831t3425r1965b3501],
45	.	.	O	.	_	0	SENT_40	[p3l1831t3425r1965b3501],

1	This	DT	O	this	nsubj	3	SENT_41	[p3l1990t3425r2146b3488],
2	has	VBZ	O	have	aux	3	SENT_41	[p3l7t3536r123b3599],
3	led	VBN	O	lead	_	0	SENT_41	[p3l155t3536r263b3599],
4	to	TO	O	to	_	0	SENT_41	[p3l291t3546r358b3599],
5	the	DT	O	the	det	9	SENT_41	[p3l389t3536r496b3599],
6	investigation	NN	O	investigation	nn	9	SENT_41	[p3l526t3536r989b3617],
7	and	CC	O	and	_	0	SENT_41	[p3l1021t3536r1148b3599],
8	clinical	JJ	O	clinical	nn	9	SENT_41	[p3l1177t3536r1440b3599],
9	use	NN	O	use	prep_to	3	SENT_41	[p3l1469t3556r1586b3599],
10	of	IN	O	of	_	0	SENT_41	[p3l1618t3536r1695b3599],
11	lower	JJR	O	lower	amod	12	SENT_41	[p3l1720t3536r1923b3599],
12	doses	NNS	O	dose	prep_of	9	SENT_41	[p3l1952t3536r2146b3599],
13	than	IN	O	than	_	0	SENT_41	[p3l7t3647r160b3710],
14	the	DT	O	the	det	16	SENT_41	[p3l182t3647r289b3710],
15	approved	VBN	O	approve	amod	16	SENT_41	[p3l314t3647r644b3728],
16	dose	NN	O	dose	prep_than	3	SENT_41	[p3l667t3647r847b3721],
17	,	,	O	,	_	0	SENT_41	[p3l667t3647r847b3721],
18	which	WDT	O	which	nsubj	19	SENT_41	[p3l873t3647r1090b3710],
19	appears	VBZ	O	appear	rcmod	16	SENT_41	[p3l1114t3667r1382b3728],
20	to	TO	O	to	aux	22	SENT_41	[p3l1406t3657r1473b3710],
21	be	VB	O	be	auxpass	22	SENT_41	[p3l1494t3647r1577b3710],
22	associated	VBN	O	associate	xcomp	19	SENT_41	[p3l1602t3647r1969b3710],
23	with	IN	O	with	_	0	SENT_41	[p3l1991t3647r2148b3710],
24	acceptable	JJ	O	acceptable	amod	25	SENT_41	[p4l9t22r385b103],
25	efﬁcacy	NN	O	efﬁcacy	prep_with	22	SENT_41	[p4l412t22r694b103],
26	and	CC	O	and	_	0	SENT_41	[p4l721t22r847b85],
27	reduced	VBD	O	reduce	rcmod	16	SENT_41	[p4l871t22r1155b85],
28	toxicity	NN	O	toxicity	nn	29	SENT_41	[p4l1180t22r1452b103],
29	[	NN	O	[	iobj	27	SENT_41	[p4l1485t23r1569b98],
30	3	CD	NUMBER	3	dobj	27	SENT_41	[p4l1485t23r1569b98],
31	,	,	O	,	_	0	SENT_41	[p4l1485t23r1569b98],
32	8	CD	NUMBER	8	dobj	27	SENT_41	[p4l1601t23r1659b96],
33	,	,	O	,	_	0	SENT_41	[p4l1601t23r1659b96],
34	25	CD	NUMBER	25	num	35	SENT_41	[p4l1689t22r1823b98],
35	]	NN	O	]	appos	32	SENT_41	[p4l1689t22r1823b98],
36	.	.	O	.	_	0	SENT_41	[p4l1689t22r1823b98],

1	Body	NN	O	body	nn	3	SENT_42	[p4l109t133r300b214],
2	surface	NN	O	surface	nn	3	SENT_42	[p4l361t133r615b195],
3	area	NN	O	area	_	0	SENT_42	[p4l675t152r822b195],
4	(	CD	NUMBER	(	num	6	SENT_42	[p4l881t133r1345b210],
5	BSA	NN	O	bsa	nn	6	SENT_42	[p4l881t133r1345b210],
6	)	NN	O	)	dep	3	SENT_42	[p4l881t133r1345b210],
7	.	.	O	.	_	0	SENT_42	[p4l881t133r1345b210],

1	—	NN	O	—	_	0	SENT_43	[p4l881t133r1345b210],
2	.	.	O	.	_	0	SENT_43	[p4l881t133r1345b210],

1	based	VBN	O	base	amod	2	SENT_44	[p4l881t133r1345b210],
2	dosing	NN	O	dosing	nsubj	8	SENT_44	[p4l1402t133r1638b214],
3	is	VBZ	O	be	cop	8	SENT_44	[p4l1696t133r1751b195],
4	the	DT	O	the	det	8	SENT_44	[p4l1810t133r1917b195],
5	most	RBS	O	most	advmod	6	SENT_44	[p4l1976t142r2149b195],
6	frequently	RB	O	frequently	advmod	7	SENT_44	[p4l8t242r375b324],
7	used	VBN	O	use	amod	8	SENT_44	[p4l412t243r575b305],
8	method	NN	O	method	_	0	SENT_44	[p4l612t243r880b305],
9	of	IN	O	of	_	0	SENT_44	[p4l917t243r995b305],
10	calculating	VBG	O	calculate	prepc_of	8	SENT_44	[p4l1026t243r1419b324],
11	drug	NN	O	drug	nn	12	SENT_44	[p4l1458t243r1618b324],
12	dose	NN	O	dose	dobj	10	SENT_44	[p4l1657t243r1817b305],
13	for	IN	O	for	_	0	SENT_44	[p4l1856t243r1960b305],
14	chemotherapeutic	JJ	O	chemotherapeutic	amod	15	SENT_44	[p4l1996t243r2145b305, p4l7t354r519b435],
15	agents	NNS	O	agent	prep_for	10	SENT_44	[p4l582t363r825b435],
16	.	.	O	.	_	0	SENT_44	[p4l582t363r825b435],

1	Traditionally	RB	O	traditionally	advmod	6	SENT_45	[p4l888t354r1376b435],
2	,	,	O	,	_	0	SENT_45	[p4l888t354r1376b435],
3	this	DT	O	this	det	4	SENT_45	[p4l1438t353r1564b416],
4	approach	NN	O	approach	nsubjpass	6	SENT_45	[p4l1627t354r1952b435],
5	was	VBD	O	be	auxpass	6	SENT_45	[p4l2011t373r2146b416],
6	thought	VBN	O	think	_	0	SENT_45	[p4l7t466r281b547],
7	to	TO	O	to	aux	8	SENT_45	[p4l312t476r379b529],
8	reduce	VB	O	reduce	xcomp	6	SENT_45	[p4l411t466r650b529],
9	variability	NN	O	variability	dobj	8	SENT_45	[p4l683t466r1051b547],
10	of	IN	O	of	_	0	SENT_45	[p4l1086t466r1163b529],
11	interpatient	JJ	O	interpatient	amod	13	SENT_45	[p4l1189t466r1599b547],
12	drug	NN	O	drug	nn	13	SENT_45	[p4l1632t466r1791b547],
13	exposure	NN	O	exposure	prep_of	9	SENT_45	[p4l1827t486r2146b547],
14	and	CC	O	and	_	0	SENT_45	[p4l9t577r136b640],
15	therefore	RB	O	therefore	advmod	13	SENT_45	[p4l159t577r481b640],
16	drug	NN	O	drug	nn	17	SENT_45	[p4l508t577r668b658],
17	effects	NNS	O	effect	conj_and	13	SENT_45	[p4l694t577r949b640],
18	.	.	O	.	_	0	SENT_45	[p4l694t577r949b640],

1	However	RB	O	however	advmod	6	SENT_46	[p4l979t579r1324b651],
2	,	,	O	,	_	0	SENT_46	[p4l979t579r1324b651],
3	it	PRP	O	it	nsubjpass	6	SENT_46	[p4l1352t577r1402b640],
4	has	VBZ	O	have	aux	6	SENT_46	[p4l1424t577r1540b640],
5	been	VBN	O	be	auxpass	6	SENT_46	[p4l1565t577r1734b640],
6	shown	VBN	O	show	_	0	SENT_46	[p4l1762t577r1990b640],
7	that	IN	O	that	complm	13	SENT_46	[p4l2014t577r2149b640],
8	BSA	NN	O	bsa	nsubj	13	SENT_46	[p4l7t688r414b751],
9	—	CD	NUMBER	—	num	8	SENT_46	[p4l7t688r414b751],
10	based	VBN	O	base	partmod	8	SENT_46	[p4l7t688r414b751],
11	approach	NN	O	approach	dobj	10	SENT_46	[p4l451t688r776b769],
12	still	RB	O	still	advmod	10	SENT_46	[p4l814t688r943b751],
13	results	VBZ	O	result	ccomp	6	SENT_46	[p4l978t688r1209b751],
14	in	IN	O	in	_	0	SENT_46	[p4l1246t688r1314b750],
15	large	JJ	O	large	amod	17	SENT_46	[p4l1348t688r1526b769],
16	interpatient	JJ	O	interpatient	amod	17	SENT_46	[p4l1561t688r1971b769],
17	variability	NN	O	variability	prep_in	13	SENT_46	[p4l2006t708r2145b751, p4l7t799r261b880],
18	in	IN	O	in	_	0	SENT_46	[p4l293t799r361b861],
19	drug	NN	O	drug	nn	20	SENT_46	[p4l395t799r555b880],
20	exposure	NN	O	exposure	prep_in	17	SENT_46	[p4l589t819r928b880],
21	.	.	O	.	_	0	SENT_46	[p4l589t819r928b880],

1	In	IN	O	in	_	0	SENT_47	[p4l965t801r1037b861],
2	a	DT	O	a	det	4	SENT_47	[p4l1072t819r1109b862],
3	retrospective	JJ	O	retrospective	amod	4	SENT_47	[p4l1139t799r1602b880],
4	analysis	NN	O	analysis	prep_in	20	SENT_47	[p4l1638t799r1921b880],
5	of	IN	O	of	_	0	SENT_47	[p4l1957t799r2034b862],
6	33	CD	NUMBER	33	num	8	SENT_47	[p4l2063t800r2143b862],
7	investigational	JJ	O	investigational	amod	8	SENT_47	[p4l7t910r535b991],
8	agents	NNS	O	agent	prep_of	4	SENT_47	[p4l563t920r786b991],
9	tested	VBN	O	test	partmod	8	SENT_47	[p4l814t910r1021b973],
10	in	IN	O	in	_	0	SENT_47	[p4l1046t910r1114b972],
11	phase	NN	O	phase	prep_in	9	SENT_47	[p4l1137t910r1340b991],
12	1	CD	NUMBER	1	num	14	SENT_47	[p4l1373t911r1399b972],
13	clinical	JJ	O	clinical	amod	14	SENT_47	[p4l1433t910r1695b973],
14	trials	NNS	O	trial	dep	11	SENT_47	[p4l1721t910r1918b984],
15	,	,	O	,	_	0	SENT_47	[p4l1721t910r1918b984],
16	BSAbased	JJ	O	bsabased	amod	17	SENT_47	[p4l1946t911r2145b973, p4l6t1021r210b1084],
17	dosing	NN	O	dosing	nsubjpass	20	SENT_47	[p4l254t1021r488b1102],
18	was	VBD	O	be	auxpass	20	SENT_47	[p4l533t1041r667b1084],
19	not	RB	O	not	neg	20	SENT_47	[p4l712t1031r826b1084],
20	associated	VBN	O	associate	_	0	SENT_47	[p4l869t1021r1236b1084],
21	with	IN	O	with	_	0	SENT_47	[p4l1279t1021r1436b1084],
22	a	DT	O	a	det	23	SENT_47	[p4l1480t1041r1517b1084],
23	reduction	NN	O	reduction	prep_with	20	SENT_47	[p4l1558t1021r1896b1084],
24	in	IN	O	in	_	0	SENT_47	[p4l1939t1021r2007b1083],
25	interpatient	JJ	O	interpatient	amod	26	SENT_47	[p4l2050t1021r2145b1083, p4l7t1132r347b1213],
26	variability	NN	O	variability	prep_in	23	SENT_47	[p4l373t1132r741b1213],
27	in	IN	O	in	_	0	SENT_47	[p4l769t1132r836b1194],
28	drug	NN	O	drug	nn	29	SENT_47	[p4l864t1132r1024b1213],
29	clearance	NN	O	clearance	prep_in	26	SENT_47	[p4l1053t1132r1389b1194],
30	for	IN	O	for	_	0	SENT_47	[p4l1418t1132r1521b1194],
31	capecitabine	NN	O	capecitabine	prep_for	20	SENT_47	[p4l1547t1132r1995b1213],
32	[	CD	NUMBER	[	number	33	SENT_47	[p4l2030t1132r2143b1208],
33	4	CD	NUMBER	4	num	34	SENT_47	[p4l2030t1132r2143b1208],
34	]	NN	O	]	dep	20	SENT_47	[p4l2030t1132r2143b1208],
35	.	.	O	.	_	0	SENT_47	[p4l2030t1132r2143b1208],

1	These	DT	O	these	det	2	SENT_48	[p4l7t1242r219b1304],
2	results	NNS	O	result	nsubj	3	SENT_48	[p4l246t1242r477b1304],
3	suggest	VBP	O	suggest	_	0	SENT_48	[p4l509t1251r773b1323],
4	that	IN	O	that	complm	12	SENT_48	[p4l799t1242r933b1304],
5	dosing	NN	O	dosing	nn	6	SENT_48	[p4l960t1242r1195b1323],
6	strategies	NNS	O	strategy	nsubjpass	12	SENT_48	[p4l1226t1242r1559b1323],
7	other	JJ	O	other	advmod	12	SENT_48	[p4l1588t1242r1772b1304],
8	than	IN	O	than	_	0	SENT_48	[p4l1797t1242r1949b1304],
9	BSA	NN	ORGANIZATION	bsa	prep_than	7	SENT_48	[p4l1976t1242r2148b1305],
10	should	MD	O	should	aux	12	SENT_48	[p4l10t1353r245b1415],
11	be	VB	O	be	auxpass	12	SENT_48	[p4l300t1353r383b1415],
12	evaluated	VBN	O	evaluate	ccomp	3	SENT_48	[p4l441t1353r785b1415],
13	when	WRB	O	when	advmod	14	SENT_48	[p4l841t1353r1033b1416],
14	developing	VBG	O	develop	advcl	12	SENT_48	[p4l1091t1353r1487b1434],
15	new	JJ	O	new	amod	19	SENT_48	[p4l1545t1372r1691b1415],
16	anti	JJ	O	anti	amod	19	SENT_48	[p4l1751t1353r2149b1415],
17	—	NN	O	—	nn	19	SENT_48	[p4l1751t1353r2149b1415],
18	cancer	NN	O	cancer	nn	19	SENT_48	[p4l1751t1353r2149b1415],
19	agents	NNS	O	agent	dobj	14	SENT_48	[p4l9t1475r252b1546],
20	.	.	O	.	_	0	SENT_48	[p4l9t1475r252b1546],

1	Alternative	JJ	O	alternative	amod	3	SENT_49	[p4l286t1465r689b1528],
2	dosing	NN	O	dosing	nn	3	SENT_49	[p4l719t1465r953b1546],
3	schedules	NNS	O	schedule	nsubjpass	30	SENT_49	[p4l986t1465r1329b1528],
4	for	IN	O	for	_	0	SENT_49	[p4l1360t1465r1463b1528],
5	capecitabine	NN	O	capecitabine	prep_for	3	SENT_49	[p4l1491t1465r1938b1546],
6	(	CD	NUMBER	(	num	5	SENT_49	[p4l1970t1466r2144b1546],
7	e.g.	FW	O	e.g.	amod	5	SENT_49	[p4l1970t1466r2144b1546],
8	,	,	O	,	_	0	SENT_49	[p4l1970t1466r2144b1546],
9	“	NN	O	“	nn	12	SENT_49	[p4l16t1576r258b1657],
10	7	CD	NUMBER	7	num	12	SENT_49	[p4l16t1576r258b1657],
11	—	NN	O	—	nn	12	SENT_49	[p4l16t1576r258b1657],
12	day	NN	DURATION	day	dep	7	SENT_49	[p4l16t1576r258b1657],
13	on/7-day	CD	DURATION	on/7-day	dep	12	SENT_49	[p4l293t1576r609b1657],
14	off	RP	O	off	prep	13	SENT_49	[p4l643t1576r822b1653],
15	”	CD	NUMBER	”	num	16	SENT_49	[p4l643t1576r822b1653],
16	)	CD	NUMBER	)	dep	14	SENT_49	[p4l643t1576r822b1653],
17	using	VBG	O	use	partmod	3	SENT_49	[p4l857t1576r1048b1657],
18	a	DT	O	a	det	20	SENT_49	[p4l1084t1596r1121b1639],
19	ﬁxed	JJ	O	ﬁxed	amod	20	SENT_49	[p4l1155t1576r1331b1639],
20	schedule	NN	O	schedule	dobj	17	SENT_49	[p4l1367t1576r1675b1639],
21	have	VBP	O	have	aux	25	SENT_49	[p4l1708t1576r1875b1639],
22	indeed	RB	O	indeed	advmod	25	SENT_49	[p4l1910t1576r2148b1639],
23	previously	RB	DATE	previously	advmod	25	SENT_49	[p4l6t1687r384b1768],
24	been	VBN	O	be	auxpass	25	SENT_49	[p4l421t1687r590b1750],
25	investigated	VBN	O	investigate	_	0	SENT_49	[p4l627t1687r1079b1768],
26	,	,	O	,	_	0	SENT_49	[p4l627t1687r1079b1768],
27	but	CC	O	but	_	0	SENT_49	[p4l1119t1687r1234b1750],
28	have	VBP	O	have	aux	30	SENT_49	[p4l1269t1687r1437b1750],
29	not	RB	O	not	neg	30	SENT_49	[p4l1475t1697r1589b1750],
30	reported	VBN	O	report	conj_but	25	SENT_49	[p4l1624t1687r1924b1768],
31	pharmacokinetic	JJ	O	pharmacokinetic	amod	34	SENT_49	[p4l1959t1687r2145b1768, p4l7t1798r444b1861],
32	or	CC	O	or	_	0	SENT_49	[p4l472t1818r545b1861],
33	pharmacogenetic	JJ	O	pharmacogenetic	amod	34	SENT_49	[p4l567t1798r1180b1879],
34	endpoints	NNS	O	endpoint	dobj	30	SENT_49	[p4l1208t1798r1553b1879],
35	to	TO	O	to	_	0	SENT_49	[p4l1578t1808r1645b1861],
36	date	NN	O	date	prep_to	30	SENT_49	[p4l1672t1798r1818b1861],
37	[	CD	NUMBER	[	number	38	SENT_49	[p4l1850t1799r1980b1874],
38	10	CD	NUMBER	10	dep	36	SENT_49	[p4l1850t1799r1980b1874],
39	,	,	O	,	_	0	SENT_49	[p4l1850t1799r1980b1874],
40	32	CD	NUMBER	32	num	41	SENT_49	[p4l2010t1799r2143b1874],
41	]	NN	O	]	appos	36	SENT_49	[p4l2010t1799r2143b1874],
42	.	.	O	.	_	0	SENT_49	[p4l2010t1799r2143b1874],

1	We	PRP	O	we	nsubj	2	SENT_50	[p4l108t1911r231b1972],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_50	[p4l268t1909r742b1990],
3	that	IN	O	that	complm	7	SENT_50	[p4l778t1909r912b1972],
4	a	DT	O	a	det	6	SENT_50	[p4l950t1929r987b1972],
5	ﬂat	NN	O	ﬂat	nn	6	SENT_50	[p4l1024t1909r1538b1972],
6	—	NN	O	—	nsubj	7	SENT_50	[p4l1024t1909r1538b1972],
7	ﬁxed	VBD	O	ﬁxed	ccomp	2	SENT_50	[p4l1024t1909r1538b1972],
8	—	CD	NUMBER	—	num	10	SENT_50	[p4l1024t1909r1538b1972],
9	dose	NN	O	dose	nn	10	SENT_50	[p4l1024t1909r1538b1972],
10	schedule	NN	O	schedule	nsubj	12	SENT_50	[p4l1579t1909r1888b1972],
11	would	MD	O	would	aux	12	SENT_50	[p4l1926t1909r2148b1972],
12	simplify	VB	O	simplify	ccomp	7	SENT_50	[p4l10t2020r304b2101],
13	dosing	NN	O	dosing	dobj	12	SENT_50	[p4l350t2020r585b2101],
14	and	CC	O	and	_	0	SENT_50	[p4l631t2020r758b2083],
15	provide	VB	O	provide	conj_and	12	SENT_50	[p4l800t2020r1072b2101],
16	an	DT	O	a	det	20	SENT_50	[p4l1119t2040r1200b2083],
17	effective	JJ	O	effective	amod	20	SENT_50	[p4l1245t2020r1556b2083],
18	and	CC	O	and	_	0	SENT_50	[p4l1603t2020r1730b2083],
19	safe	JJ	O	safe	conj_and	17	SENT_50	[p4l1776t2020r1914b2083],
20	alternative	NN	O	alternative	dobj	15	SENT_50	[p4l1961t2020r2145b2083, p4l7t2131r224b2194],
21	to	TO	O	to	_	0	SENT_50	[p4l274t2140r340b2193],
22	BSA	NN	O	bsa	nn	23	SENT_50	[p4l389t2131r796b2194],
23	—	NN	O	—	prep_to	15	SENT_50	[p4l389t2131r796b2194],
24	based	VBN	O	base	partmod	23	SENT_50	[p4l389t2131r796b2194],
25	dosing	NN	O	dosing	dobj	24	SENT_50	[p4l845t2131r1098b2212],
26	.	.	O	.	_	0	SENT_50	[p4l845t2131r1098b2212],

1	We	PRP	O	we	nsubj	3	SENT_51	[p4l1151t2132r1273b2194],
2	therefore	RB	O	therefore	advmod	3	SENT_51	[p4l1322t2131r1645b2193],
3	conducted	VBD	O	conduct	_	0	SENT_51	[p4l1695t2131r2062b2193],
4	a	DT	O	a	det	7	SENT_51	[p4l2112t2150r2149b2193],
5	phase	NN	O	phase	nn	7	SENT_51	[p4l6t2241r208b2322],
6	II	CD	NUMBER	ii	num	7	SENT_51	[p4l249t2242r306b2303],
7	trial	NN	O	trial	dobj	3	SENT_51	[p4l346t2240r489b2303],
8	in	IN	O	in	_	0	SENT_51	[p4l529t2241r597b2302],
9	patients	NNS	O	patient	prep_in	3	SENT_51	[p4l635t2241r912b2322],
10	with	IN	O	with	_	0	SENT_51	[p4l955t2241r1112b2303],
11	metastatic	JJ	O	metastatic	amod	13	SENT_51	[p4l1152t2241r1514b2303],
12	breast	NN	O	breast	nn	13	SENT_51	[p4l1554t2241r1769b2303],
13	cancer	NN	O	cancer	prep_with	9	SENT_51	[p4l1808t2260r2042b2303],
14	to	TO	O	to	aux	15	SENT_51	[p4l2080t2250r2146b2303],
15	explore	VB	O	explore	xcomp	3	SENT_51	[p4l8t2352r274b2433],
16	the	DT	O	the	det	17	SENT_51	[p4l306t2352r413b2414],
17	efﬁcacy	NN	O	efﬁcacy	dobj	15	SENT_51	[p4l446t2352r727b2433],
18	and	CC	O	and	_	0	SENT_51	[p4l761t2352r887b2414],
19	safety	NN	O	safety	conj_and	17	SENT_51	[p4l921t2351r1130b2433],
20	of	IN	O	of	_	0	SENT_51	[p4l1163t2352r1241b2414],
21	ﬂat	NN	O	ﬂat	nn	24	SENT_51	[p4l1267t2351r1572b2414],
22	—	CD	NUMBER	—	num	24	SENT_51	[p4l1267t2351r1572b2414],
23	dose	NN	O	dose	nn	24	SENT_51	[p4l1267t2351r1572b2414],
24	capecitabine	NN	O	capecitabine	prep_of	17	SENT_51	[p4l1605t2352r2053b2433],
25	at	IN	O	at	_	0	SENT_51	[p4l2087t2361r2149b2414],
26	3,000	CD	NUMBER	3,000	num	28	SENT_51	[p4l10t2464r206b2538],
27	mg	NN	O	mg	nn	28	SENT_51	[p4l239t2484r350b2545],
28	(	NN	O	(	prep_at	15	SENT_51	[p4l403t2464r588b2541],
29	total	JJ	O	total	amod	32	SENT_51	[p4l403t2464r588b2541],
30	daily	JJ	SET	daily	amod	32	SENT_51	[p4l640t2464r815b2545],
31	dose	NN	O	dose	nn	32	SENT_51	[p4l867t2464r1055b2541],
32	)	NN	O	)	dep	28	SENT_51	[p4l867t2464r1055b2541],
33	given	VBN	O	give	prep	32	SENT_51	[p4l1108t2464r1305b2545],
34	in	IN	O	in	pcomp	33	SENT_51	[p4l1355t2464r1422b2526],
35	two	CD	NUMBER	two	pobj	34	SENT_51	[p4l1471t2474r1602b2527],
36	divided	VBN	O	divide	partmod	35	SENT_51	[p4l1653t2464r1921b2527],
37	daily	JJ	SET	daily	amod	38	SENT_51	[p4l1970t2464r2147b2545],
38	doses	NNS	O	dose	dobj	36	SENT_51	[p4l8t2575r202b2638],
39	for	IN	O	for	_	0	SENT_51	[p4l241t2575r345b2638],
40	14	CD	DURATION	14	num	41	SENT_51	[p4l389t2575r466b2637],
41	days	NNS	NUMBER	day	prep_for	38	SENT_51	[p4l501t2575r680b2656],
42	,	,	O	,	_	0	SENT_51	[p4l501t2575r680b2656],
43	repeated	VBN	O	repeat	partmod	28	SENT_51	[p4l720t2575r1026b2656],
44	every	DT	SET	every	det	46	SENT_51	[p4l1062t2595r1259b2656],
45	21	CD	SET	21	num	46	SENT_51	[p4l1297t2575r1375b2637],
46	days	NNS	NUMBER	day	tmod	43	SENT_51	[p4l1416t2575r1595b2656],
47	.	.	O	.	_	0	SENT_51	[p4l1416t2575r1595b2656],

1	The	DT	O	the	det	2	SENT_52	[p4l1637t2575r1774b2638],
2	dose	NN	O	dose	nsubjpass	4	SENT_52	[p4l1813t2575r1973b2638],
3	was	VBD	O	be	auxpass	4	SENT_52	[p4l2011t2595r2146b2638],
4	selected	VBN	O	select	_	0	SENT_52	[p4l10t2685r296b2748],
5	based	VBN	O	base	_	0	SENT_52	[p4l330t2685r533b2748],
6	on	IN	O	on	prepc_based_on	4	SENT_52	[p4l569t2705r655b2748],
7	the	DT	O	the	det	11	SENT_52	[p4l689t2685r797b2748],
8	commonly	RB	O	commonly	advmod	9	SENT_52	[p4l834t2685r1215b2766],
9	used	VBN	O	use	amod	11	SENT_52	[p4l1250t2685r1413b2748],
10	dose	NN	O	dose	nn	11	SENT_52	[p4l1449t2685r1609b2748],
11	(	NN	O	(	pobj	4	SENT_52	[p4l1647t2686r1873b2762],
12	2,000	CD	NUMBER	2,000	num	13	SENT_52	[p4l1647t2686r1873b2762],
13	mg/m2	NN	O	mg/m2	nsubj	20	SENT_52	[p4l1906t2666r2148b2766],
14	with	IN	O	with	_	0	SENT_52	[p4l8t2797r165b2860],
15	rounding	VBG	O	round	prepc_with	13	SENT_52	[p4l213t2797r535b2878],
16	down	RP	O	down	prt	15	SENT_52	[p4l587t2797r783b2860],
17	to	TO	O	to	_	0	SENT_52	[p4l833t2807r899b2860],
18	nearest	JJS	O	nearest	prep_to	15	SENT_52	[p4l950t2807r1204b2860],
19	500	CD	NUMBER	500	num	20	SENT_52	[p4l1254t2797r1384b2860],
20	mg	NN	O	mg	rcmod	11	SENT_52	[p4l1417t2817r1528b2878],
21	multiple	JJ	O	multiple	amod	22	SENT_52	[p4l1579t2797r1905b2878],
22	)	NN	O	)	dobj	20	SENT_52	[p4l1579t2797r1905b2878],
23	for	IN	O	for	_	0	SENT_52	[p4l1958t2797r2062b2860],
24	a	DT	O	a	det	25	SENT_52	[p4l2112t2817r2149b2860],
25	woman	NN	O	woman	prep_for	22	SENT_52	[p4l7t2928r270b2970],
26	with	IN	O	with	_	0	SENT_52	[p4l340t2907r498b2970],
27	a	DT	O	a	det	28	SENT_52	[p4l570t2928r607b2970],
28	BSA	NN	O	bsa	prep_with	20	SENT_52	[p4l676t2908r848b2970],
29	of	IN	O	of	_	0	SENT_52	[p4l920t2907r997b2970],
30	1.7	CD	NUMBER	1.7	num	31	SENT_52	[p4l1070t2908r1168b2970],
31	m2	NN	O	m2	prep_of	28	SENT_52	[p4l1203t2889r1322b2970],
32	.	.	O	.	_	0	SENT_52	[p4l1203t2889r1322b2970],

1	We	PRP	O	we	nsubj	3	SENT_53	[p4l1397t2909r1519b2970],
2	also	RB	O	also	advmod	3	SENT_53	[p4l1593t2908r1732b2970],
3	evaluated	VBD	O	evaluate	_	0	SENT_53	[p4l1805t2908r2148b2970],
4	adherence	NN	O	adherence	dobj	3	SENT_53	[p4l9t3019r369b3082],
5	to	TO	O	to	_	0	SENT_53	[p4l438t3029r504b3082],
6	capecitabine	NN	O	capecitabine	prep_to	3	SENT_53	[p4l574t3019r1042b3100],
7	,	,	O	,	_	0	SENT_53	[p4l574t3019r1042b3100],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_53	[p4l1111t3019r1709b3100],
9	variability	NN	O	variability	appos	6	SENT_53	[p4l1779t3019r2147b3100],
10	associated	VBN	O	associate	partmod	9	SENT_53	[p4l9t3130r376b3192],
11	with	IN	O	with	_	0	SENT_53	[p4l423t3130r580b3193],
12	the	DT	O	the	det	13	SENT_53	[p4l627t3130r734b3192],
13	ﬂat	NN	O	ﬂat	prep_with	10	SENT_53	[p4l783t3130r1108b3204],
14	—	CD	NUMBER	—	num	15	SENT_53	[p4l783t3130r1108b3204],
15	dose	NN	O	dose	dep	13	SENT_53	[p4l783t3130r1108b3204],
16	,	,	O	,	_	0	SENT_53	[p4l783t3130r1108b3204],
17	pharmacogenetic	JJ	O	pharmacogenetic	amod	18	SENT_53	[p4l1158t3130r1771b3211],
18	contribution	NN	O	contribution	conj_and	13	SENT_53	[p4l1821t3130r2145b3192, p4l7t3241r145b3303],
19	to	TO	O	to	_	0	SENT_53	[p4l204t3250r271b3303],
20	pharmacokinetic	JJ	O	pharmacokinetic	amod	21	SENT_53	[p4l330t3241r929b3322],
21	variability	NN	O	variability	prep_to	18	SENT_53	[p4l990t3241r1378b3322],
22	,	,	O	,	_	0	SENT_53	[p4l990t3241r1378b3322],
23	and	CC	O	and	_	0	SENT_53	[p4l1442t3241r1569b3303],
24	correlation	NN	O	correlation	conj_and	13	SENT_53	[p4l1628t3241r2016b3303],
25	of	IN	O	of	prep	24	SENT_53	[p4l2076t3241r2153b3303],

1	@	IN	O	@	_	0	SENT_54	[p4l6t3484r83b3579],
2	Springer	NNP	PERSON	Springer	nn	3	SENT_54	[p4l113t3507r375b3582],
3	pharmacokinetics	NNS	O	pharmacokinetic	pobj	1	SENT_54	[p4l6t3608r639b3689],
4	and	CC	O	and	_	0	SENT_54	[p4l678t3608r804b3671],
5	pharmacogenetics	NNS	O	pharmacogenetic	conj_and	3	SENT_54	[p4l836t3608r1484b3689],
6	with	IN	O	with	_	0	SENT_54	[p4l1521t3608r1678b3671],
7	toxicity	NN	O	toxicity	prep_with	5	SENT_54	[p4l1712t3608r1985b3689],
8	and	CC	O	and	_	0	SENT_54	[p4l2022t3608r2148b3671],
9	efﬁcacy	NN	O	efﬁcacy	prep_with	5	SENT_54	[p4l8t3718r307b3799],
10	.	.	O	.	_	0	SENT_54	[p4l8t3718r307b3799],

1	Patients	NNS	O	patient	_	0	SENT_55	[p5l7t151r314b215],
2	and	CC	O	and	_	0	SENT_55	[p5l348t152r488b215],
3	methods	NNS	O	method	conj_and	1	SENT_55	[p5l521t152r841b215],

1	Study	NNP	O	Study	_	0	SENT_56	[p5l10t375r213b456],
2	oversight	NN	O	oversight	dep	1	SENT_56	[p5l248t375r580b456],

1	The	DT	O	the	det	2	SENT_57	[p5l7t598r144b661],
2	study	NN	O	study	nsubjpass	4	SENT_57	[p5l188t598r377b679],
3	was	VBD	O	be	auxpass	4	SENT_57	[p5l417t618r552b661],
4	designed	VBN	O	design	_	0	SENT_57	[p5l595t598r911b679],
5	by	IN	O	by	_	0	SENT_57	[p5l951t598r1038b679],
6	the	DT	O	the	det	9	SENT_57	[p5l1078t598r1186b661],
7	senior	JJ	O	senior	amod	9	SENT_57	[p5l1230t598r1445b661],
8	academic	JJ	O	academic	amod	9	SENT_57	[p5l1485t598r1821b661],
9	authors	NNS	O	author	agent	4	SENT_57	[p5l1865t598r2142b661],
10	.	.	O	.	_	0	SENT_57	[p5l1865t598r2142b661],

1	Data	NNS	O	datum	nsubjpass	15	SENT_58	[p5l7t711r176b772],
2	were	VBD	O	be	auxpass	3	SENT_58	[p5l213t729r384b772],
3	collected	VBN	O	collect	_	0	SENT_58	[p5l422t709r746b772],
4	by	IN	O	by	_	0	SENT_58	[p5l782t709r869b790],
5	the	DT	O	the	det	9	SENT_58	[p5l907t709r1014b772],
6	Johns	NNP	PERSON	Johns	nn	9	SENT_58	[p5l1052t709r1252b772],
7	Hopkins	NNP	PERSON	Hopkins	nn	9	SENT_58	[p5l1291t709r1591b790],
8	Breast	NN	O	breast	nn	9	SENT_58	[p5l1630t711r1859b772],
9	Cancer	NN	O	cancer	agent	3	SENT_58	[p5l1896t710r2149b772],
10	Program	NN	O	program	nn	13	SENT_58	[p5l7t821r315b901],
11	data	NNS	O	datum	nn	13	SENT_58	[p5l346t820r494b882],
12	management	NN	O	management	nn	13	SENT_58	[p5l523t829r983b901],
13	team	NN	O	team	dep	9	SENT_58	[p5l1012t829r1187b882],
14	and	CC	O	and	_	0	SENT_58	[p5l1219t820r1344b882],
15	analyzed	VBN	O	analyze	conj_and	3	SENT_58	[p5l1376t820r1693b901],
16	by	IN	O	by	_	0	SENT_58	[p5l1722t820r1810b901],
17	Dr.	NNP	O	Dr.	nn	18	SENT_58	[p5l1841t821r1951b882],
18	Garrett	NNP	PERSON	Garrett	prep_by	15	SENT_58	[p5l1987t820r2144b883, p5l6t932r392b1012],
19	.	.	O	.	_	0	SENT_58	[p5l1987t820r2144b883, p5l6t932r392b1012],

1	—	NN	O	—	_	0	SENT_59	[p5l1987t820r2144b883, p5l6t932r392b1012],
2	.	.	O	.	_	0	SENT_59	[p5l1987t820r2144b883, p5l6t932r392b1012],

1	Mayer	NNP	PERSON	Mayer	_	0	SENT_60	[p5l1987t820r2144b883, p5l6t932r392b1012],
2	as	IN	O	as	_	0	SENT_60	[p5l447t950r516b993],
3	the	DT	O	the	det	5	SENT_60	[p5l573t931r680b993],
4	lead	NN	O	lead	nn	5	SENT_60	[p5l736t931r885b993],
5	statistician	NN	O	statistician	prep_as	1	SENT_60	[p5l942t931r1341b993],
6	.	.	O	.	_	0	SENT_60	[p5l942t931r1341b993],

1	The	DT	O	the	det	3	SENT_61	[p5l1401t931r1538b993],
2	academic	JJ	O	academic	amod	3	SENT_61	[p5l1596t931r1931b993],
3	ﬁrst	NN	O	ﬁrst	nsubj	13	SENT_61	[p5l1990t931r2144b1005],
4	,	,	O	,	_	0	SENT_61	[p5l1990t931r2144b1005],
5	second	JJ	ORDINAL	second	nsubj	13	SENT_61	[p5l10t1042r274b1116],
6	,	,	O	,	_	0	SENT_61	[p5l10t1042r274b1116],
7	and	CC	O	and	_	0	SENT_61	[p5l316t1042r442b1104],
8	last	JJ	O	last	amod	9	SENT_61	[p5l479t1042r602b1104],
9	authors	NNS	O	author	nsubj	13	SENT_61	[p5l640t1042r898b1104],
10	of	IN	O	of	_	0	SENT_61	[p5l938t1042r1015b1104],
11	this	DT	O	this	det	12	SENT_61	[p5l1045t1042r1171b1104],
12	article	NN	O	article	prep_of	9	SENT_61	[p5l1212t1042r1433b1104],
13	prepared	VBD	O	prepare	_	0	SENT_61	[p5l1469t1042r1784b1123],
14	the	DT	O	the	det	16	SENT_61	[p5l1820t1042r1927b1104],
15	manuscript	NN	O	manuscript	nn	16	SENT_61	[p5l1965t1061r2145b1104, p5l7t1153r250b1234],
16	draft	NN	O	draft	dobj	13	SENT_61	[p5l288t1153r473b1216],
17	.	.	O	.	_	0	SENT_61	[p5l288t1153r473b1216],

1	All	DT	O	all	det	2	SENT_62	[p5l514t1153r626b1215],
2	coauthors	NNS	O	coauthor	nsubj	3	SENT_62	[p5l665t1153r1010b1216],
3	made	VBD	O	make	_	0	SENT_62	[p5l1049t1153r1241b1216],
4	additional	JJ	O	additional	amod	5	SENT_62	[p5l1280t1153r1637b1216],
5	contributions	NNS	O	contribution	dobj	3	SENT_62	[p5l1675t1153r2146b1216],
6	to	TO	O	to	_	0	SENT_62	[p5l7t1274r74b1327],
7	the	DT	O	the	det	8	SENT_62	[p5l99t1264r206b1327],
8	interpretation	NN	O	interpretation	prep_to	3	SENT_62	[p5l232t1264r716b1345],
9	of	IN	O	of	_	0	SENT_62	[p5l741t1264r818b1327],
10	the	DT	O	the	det	11	SENT_62	[p5l836t1264r944b1327],
11	data	NNS	O	datum	prep_of	8	SENT_62	[p5l970t1264r1118b1327],
12	and	CC	O	and	_	0	SENT_62	[p5l1143t1264r1270b1327],
13	subsequent	JJ	O	subsequent	amod	14	SENT_62	[p5l1296t1264r1691b1345],
14	editing	NN	O	editing	prep_of	8	SENT_62	[p5l1716t1264r1980b1345],
15	.	.	O	.	_	0	SENT_62	[p5l1716t1264r1980b1345],

1	The	DT	O	the	det	3	SENT_63	[p5l2010t1264r2147b1327],
2	pharmaceutical	JJ	O	pharmaceutical	amod	3	SENT_63	[p5l6t1375r557b1456],
3	sponsor	NN	O	sponsor	nsubj	4	SENT_63	[p5l600t1395r875b1456],
4	reviewed	VBN	O	review	_	0	SENT_63	[p5l913t1375r1242b1438],
5	the	DT	O	the	det	6	SENT_63	[p5l1281t1375r1388b1438],
6	manuscript	NN	O	manuscript	npadvmod	4	SENT_63	[p5l1429t1375r1828b1456],
7	prior	RB	O	prior	_	0	SENT_63	[p5l1867t1375r2041b1456],
8	to	TO	O	to	_	0	SENT_63	[p5l2080t1385r2146b1438],
9	submission	NN	O	submission	prep_prior_to	4	SENT_63	[p5l10t1485r409b1547],
10	but	CC	O	but	_	0	SENT_63	[p5l440t1485r555b1547],
11	was	VBD	O	be	auxpass	13	SENT_63	[p5l587t1504r721b1548],
12	not	RB	O	not	neg	13	SENT_63	[p5l755t1494r869b1547],
13	involved	VBN	O	involve	conj_but	4	SENT_63	[p5l901t1485r1214b1548],
14	in	IN	O	in	_	0	SENT_63	[p5l1246t1485r1314b1546],
15	its	PRP$	O	its	poss	16	SENT_63	[p5l1346t1485r1427b1547],
16	writing	NN	O	writing	prep_in	13	SENT_63	[p5l1461t1485r1736b1566],
17	.	.	O	.	_	0	SENT_63	[p5l1461t1485r1736b1566],

1	Eligibility	NN	O	eligibility	_	0	SENT_64	[p5l7t1708r371b1789],

1	Women	NNS	O	woman	nsubj	2	SENT_65	[p5l6t1933r290b1995],
2	(	VBP	O	(	_	0	SENT_65	[p5l340t1932r518b2009],
3	318	CD	DURATION	318	num	4	SENT_65	[p5l340t1932r518b2009],
4	years	NNS	NUMBER	year	nsubj	22	SENT_65	[p5l553t1951r739b2013],
5	or	CC	O	or	_	0	SENT_65	[p5l789t1951r862b1994],
6	older	JJR	O	older	amod	7	SENT_65	[p5l908t1932r1116b2009],
7	)	NN	O	)	nsubj	22	SENT_65	[p5l908t1932r1116b2009],
8	with	IN	O	with	_	0	SENT_65	[p5l1167t1932r1324b1995],
9	a	DT	O	a	prep_with	7	SENT_65	[p5l1372t1951r1409b1994],
10	histologically	RB	O	histologically	advmod	11	SENT_65	[p5l1454t1932r1942b2013],
11	conﬁrmed	VBN	O	conﬁrmed	partmod	9	SENT_65	[p5l1991t1951r2144b1994, p5l8t2043r240b2105],
12	metastatic	JJ	O	metastatic	amod	17	SENT_65	[p5l279t2043r641b2105],
13	(	NN	O	(	nn	17	SENT_65	[p5l685t2044r895b2124],
14	stage	NN	O	stage	nn	17	SENT_65	[p5l685t2044r895b2124],
15	4	CD	NUMBER	4	num	17	SENT_65	[p5l935t2043r1005b2120],
16	)	NN	O	)	nn	17	SENT_65	[p5l935t2043r1005b2120],
17	adenocarcinoma	NN	O	adenocarcinoma	dobj	11	SENT_65	[p5l1049t2043r1636b2105],
18	of	IN	O	of	_	0	SENT_65	[p5l1677t2043r1754b2105],
19	the	DT	O	the	det	20	SENT_65	[p5l1787t2043r1894b2105],
20	breast	NN	O	breast	prep_of	17	SENT_65	[p5l1934t2043r2149b2105],
21	were	VBD	O	be	cop	22	SENT_65	[p5l8t2174r178b2217],
22	eligible	JJ	O	eligible	ccomp	2	SENT_65	[p5l213t2154r500b2235],
23	.	.	O	.	_	0	SENT_65	[p5l213t2154r500b2235],

1	Additional	JJ	O	additional	amod	3	SENT_66	[p5l537t2154r920b2217],
2	eligibility	NN	O	eligibility	nn	3	SENT_66	[p5l954t2154r1302b2235],
3	criteria	NNS	O	criterion	nsubj	4	SENT_66	[p5l1337t2154r1592b2217],
4	included	VBD	O	include	_	0	SENT_66	[p5l1624t2154r1933b2217],
5	Eastern	NNP	ORGANIZATION	Eastern	nn	10	SENT_66	[p5l1965t2156r2145b2217, p5l8t2285r120b2328],
6	Cooperative	NNP	ORGANIZATION	Cooperative	nn	10	SENT_66	[p5l172t2265r608b2346],
7	Oncology	NNP	ORGANIZATION	Oncology	nn	10	SENT_66	[p5l662t2265r1012b2346],
8	Group	NNP	ORGANIZATION	Group	nn	10	SENT_66	[p5l1065t2266r1289b2346],
9	(	CD	NUMBER	(	num	10	SENT_66	[p5l1344t2266r1640b2342],
10	ECOG	NNP	O	ECOG	dobj	4	SENT_66	[p5l1344t2266r1640b2342],
11	)	CD	NUMBER	)	num	13	SENT_66	[p5l1344t2266r1640b2342],
12	performance	NN	O	performance	nn	13	SENT_66	[p5l1694t2265r2147b2346],
13	status	NN	O	status	dep	10	SENT_66	[p5l10t2386r207b2439],
14	(	CD	NUMBER	(	num	16	SENT_66	[p5l248t2376r398b2453],
15	PS	NNP	O	PS	nn	16	SENT_66	[p5l248t2376r398b2453],
16	)	NN	O	)	dep	10	SENT_66	[p5l248t2376r398b2453],
17	of	IN	O	of	_	0	SENT_66	[p5l439t2376r516b2439],
18	0-2	CD	NUMBER	0-2	prep_of	16	SENT_66	[p5l546t2376r698b2450],
19	;	:	O	;	_	0	SENT_66	[p5l546t2376r698b2450],
20	measurable	JJ	O	measurable	amod	21	SENT_66	[p5l738t2376r1146b2439],
21	disease	NN	O	disease	conj_and	10	SENT_66	[p5l1183t2376r1460b2450],
22	;	:	O	;	_	0	SENT_66	[p5l1183t2376r1460b2450],
23	adequate	JJ	O	adequate	amod	24	SENT_66	[p5l1503t2376r1817b2457],
24	hematologic	JJ	O	hematologic	amod	21	SENT_66	[p5l1854t2376r2145b2439, p5l7t2486r204b2567],
25	,	,	O	,	_	0	SENT_66	[p5l1854t2376r2145b2439, p5l7t2486r204b2567],
26	hepatic	JJ	O	hepatic	amod	21	SENT_66	[p5l251t2486r529b2567],
27	,	,	O	,	_	0	SENT_66	[p5l251t2486r529b2567],
28	and	CC	O	and	_	0	SENT_66	[p5l579t2486r705b2548],
29	renal	JJ	O	renal	amod	30	SENT_66	[p5l748t2486r926b2548],
30	function	NN	O	function	conj_and	21	SENT_66	[p5l971t2486r1289b2560],
31	;	:	O	;	_	0	SENT_66	[p5l971t2486r1289b2560],
32	and	CC	O	and	_	0	SENT_66	[p5l1340t2486r1466b2548],
33	up	RB	O	up	advmod	38	SENT_66	[p5l1509t2505r1596b2567],
34	to	TO	O	to	_	0	SENT_66	[p5l1641t2495r1707b2548],
35	three	CD	NUMBER	three	prep_to	33	SENT_66	[p5l1753t2486r1930b2548],
36	prior	JJ	O	prior	amod	38	SENT_66	[p5l1974t2486r2149b2567],
37	cytotoxic	JJ	O	cytotoxic	amod	38	SENT_66	[p5l8t2598r339b2679],
38	regimens	NNS	O	regimen	dobj	4	SENT_66	[p5l387t2598r715b2679],
39	for	IN	O	for	_	0	SENT_66	[p5l765t2598r868b2661],
40	metastatic	JJ	O	metastatic	amod	41	SENT_66	[p5l914t2598r1276b2661],
41	disease	NN	O	disease	prep_for	38	SENT_66	[p5l1328t2598r1602b2661],
42	.	.	O	.	_	0	SENT_66	[p5l1328t2598r1602b2661],

1	Prior	RB	O	prior	advmod	7	SENT_67	[p5l1655t2598r1833b2661],
2	therapy	NN	O	therapy	nsubjpass	7	SENT_67	[p5l1880t2598r2147b2679],
3	with	IN	O	with	_	0	SENT_67	[p5l8t2709r165b2772],
4	capecitabine	NN	O	capecitabine	prep_with	2	SENT_67	[p5l198t2709r645b2790],
5	was	VBD	O	be	auxpass	7	SENT_67	[p5l680t2729r814b2772],
6	not	RB	O	not	neg	7	SENT_67	[p5l848t2719r962b2772],
7	allowed	VBN	O	allow	_	0	SENT_67	[p5l995t2709r1293b2772],
8	.	.	O	.	_	0	SENT_67	[p5l995t2709r1293b2772],

1	Patients	NNS	O	patient	nsubjpass	26	SENT_68	[p5l109t2820r391b2882],
2	were	VBD	O	be	auxpass	3	SENT_68	[p5l456t2839r627b2883],
3	excluded	VBN	O	exclude	_	0	SENT_68	[p5l693t2820r1015b2882],
4	if	IN	O	if	mark	6	SENT_68	[p5l1079t2820r1137b2882],
5	they	PRP	O	they	nsubj	6	SENT_68	[p5l1195t2820r1347b2901],
6	had	VBD	O	have	advcl	3	SENT_68	[p5l1411t2820r1540b2882],
7	another	DT	O	another	det	9	SENT_68	[p5l1604t2820r1871b2882],
8	active	JJ	O	active	amod	9	SENT_68	[p5l1936t2820r2147b2883],
9	malignancy	NN	O	malignancy	dobj	6	SENT_68	[p5l7t2931r445b3012],
10	,	,	O	,	_	0	SENT_68	[p5l7t2931r445b3012],
11	serious	JJ	O	serious	amod	14	SENT_68	[p5l491t2931r737b2993],
12	concurrent	JJ	O	concurrent	amod	14	SENT_68	[p5l780t2940r1163b2993],
13	medical	JJ	O	medical	amod	14	SENT_68	[p5l1202t2931r1485b2993],
14	conditions	NNS	O	condition	conj_or	9	SENT_68	[p5l1526t2931r1917b3005],
15	,	,	O	,	_	0	SENT_68	[p5l1526t2931r1917b3005],
16	pregnancy	NN	O	pregnancy	conj_or	9	SENT_68	[p5l1959t2950r2145b3012, p5l7t3061r238b3123],
17	,	,	O	,	_	0	SENT_68	[p5l1959t2950r2145b3012, p5l7t3061r238b3123],
18	or	CC	O	or	_	0	SENT_68	[p5l279t3061r352b3104],
19	untreated	JJ	O	untreated	amod	21	SENT_68	[p5l386t3042r721b3104],
20	brain	NN	O	brain	nn	21	SENT_68	[p5l754t3042r938b3104],
21	metastases	NNS	O	metastase	conj_or	9	SENT_68	[p5l974t3051r1355b3104],
22	unless	IN	O	unless	mark	24	SENT_68	[p5l1393t3042r1613b3104],
23	small	JJ	O	small	amod	24	SENT_68	[p5l1654t3042r1843b3104],
24	volume	NN	O	volume	dep	21	SENT_68	[p5l1880t3042r2146b3105],
25	and	CC	O	and	_	0	SENT_68	[p5l9t3153r136b3216],
26	approved	VBN	O	approve	conj_and	3	SENT_68	[p5l170t3153r501b3234],
27	by	IN	O	by	_	0	SENT_68	[p5l532t3153r620b3234],
28	the	DT	O	the	det	30	SENT_68	[p5l653t3153r760b3216],
29	principal	JJ	O	principal	amod	30	SENT_68	[p5l793t3153r1112b3234],
30	investigator	NN	O	investigator	prep_by	26	SENT_68	[p5l1145t3153r1586b3234],
31	.	.	O	.	_	0	SENT_68	[p5l1145t3153r1586b3234],

1	Those	DT	O	those	nsubj	22	SENT_69	[p5l1624t3153r1841b3216],
2	with	IN	O	with	_	0	SENT_69	[p5l1875t3153r2032b3216],
3	an	DT	O	a	det	7	SENT_69	[p5l2067t3173r2148b3216],
4	active	JJ	O	active	amod	7	SENT_69	[p5l9t3264r219b3327],
5	gastrointestinal	JJ	O	gastrointestinal	amod	7	SENT_69	[p5l269t3264r816b3345],
6	malabsorption	NN	O	malabsorption	nn	7	SENT_69	[p5l864t3264r1377b3345],
7	illness	NN	O	illness	prep_with	1	SENT_69	[p5l1425t3264r1674b3338],
8	;	:	O	;	_	0	SENT_69	[p5l1425t3264r1674b3338],
9	prior	RB	O	prior	advmod	12	SENT_69	[p5l1724t3264r1900b3345],
10	unanticipated	JJ	O	unanticipated	amod	12	SENT_69	[p5l1945t3284r2144b3327, p5l7t3375r317b3456],
11	severe	JJ	O	severe	amod	12	SENT_69	[p5l389t3395r612b3438],
12	reaction	NN	O	reaction	dep	1	SENT_69	[p5l682t3375r971b3438],
13	to	TO	O	to	_	0	SENT_69	[p5l1040t3385r1107b3438],
14	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	nn	15	SENT_69	[p5l1179t3375r1785b3456],
15	therapy	NN	O	therapy	prep_to	12	SENT_69	[p5l1854t3375r2143b3456],
16	;	:	O	;	_	0	SENT_69	[p5l1854t3375r2143b3456],
17	known	VBN	O	know	_	0	SENT_69	[p5l6t3485r249b3547],
18	hypersensitivity	NN	O	hypersensitivity	dobj	17	SENT_69	[p5l283t3485r856b3566],
19	to	TO	O	to	_	0	SENT_69	[p5l892t3494r959b3547],
20	5-FU	NN	O	5-fu	prep_to	17	SENT_69	[p5l996t3484r1181b3548],
21	or	CC	O	or	_	0	SENT_69	[p5l1217t3504r1290b3547],
22	known	VBN	O	know	conj_or	17	SENT_69	[p5l1322t3485r1565b3548],
23	dihydropyrimi	NN	O	dihydropyrimus	nn	26	SENT_69	[p5l1601t3485r2145b3566],
24	—	CD	NUMBER	—	num	26	SENT_69	[p5l1601t3485r2145b3566],
25	dine	NN	O	dine	nn	26	SENT_69	[p5l8t3597r159b3660],
26	dehydrogenase	NN	O	dehydrogenase	dobj	22	SENT_69	[p5l192t3597r727b3678],
27	(	CD	NUMBER	(	num	30	SENT_69	[p5l762t3598r992b3675],
28	DPD	NN	O	dpd	nn	30	SENT_69	[p5l762t3598r992b3675],
29	)	NN	O	)	nn	30	SENT_69	[p5l762t3598r992b3675],
30	deﬁciency	NN	O	deﬁciency	nsubjpass	33	SENT_69	[p5l1027t3597r1394b3678],
31	were	VBD	O	be	auxpass	33	SENT_69	[p5l1426t3617r1596b3660],
32	also	RB	O	also	advmod	33	SENT_69	[p5l1630t3597r1770b3660],
33	excluded	VBN	O	exclude	rcmod	26	SENT_69	[p5l1803t3597r2142b3660],
34	.	.	O	.	_	0	SENT_69	[p5l1803t3597r2142b3660],

1	Concomitant	JJ	O	concomitant	amod	2	SENT_70	[p5l8t3708r472b3771],
2	use	NN	O	use	nsubjpass	15	SENT_70	[p5l509t3728r627b3771],
3	of	IN	O	of	_	0	SENT_70	[p5l669t3708r746b3771],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_70	[p5l781t3709r1099b3772],
5	substrates	NNS	O	substrate	prep_of	2	SENT_70	[p5l1144t3708r1491b3771],
6	(	CD	NUMBER	(	dep	5	SENT_70	[p5l1535t3708r1689b3786],
7	i.e.	FW	O	i.e.	dep	5	SENT_70	[p5l1535t3708r1689b3786],
8	,	,	O	,	_	0	SENT_70	[p5l1535t3708r1689b3786],
9	warfarin	NN	O	warfarin	conj_or	5	SENT_70	[p5l1733t3708r2036b3771],
10	or	CC	O	or	_	0	SENT_70	[p5l2076t3728r2149b3771],
11	phenytoin	NN	O	phenytoin	nn	12	SENT_70	[p6l6t24r392b105],
12	)	NN	O	)	conj_or	5	SENT_70	[p6l6t24r392b105],
13	was	VBD	O	be	auxpass	15	SENT_70	[p6l438t43r573b87],
14	not	RB	O	not	neg	15	SENT_70	[p6l617t33r731b86],
15	permitted	VBN	O	permit	_	0	SENT_70	[p6l772t24r1135b105],
16	.	.	O	.	_	0	SENT_70	[p6l772t24r1135b105],

1	The	DT	O	the	det	3	SENT_71	[p6l1182t24r1319b86],
2	clinical	JJ	O	clinical	amod	3	SENT_71	[p6l1364t24r1626b86],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_71	[p6l1669t24r1966b105],
4	was	VBD	O	be	auxpass	5	SENT_71	[p6l2011t43r2146b87],
5	approved	VBN	O	approve	_	0	SENT_71	[p6l9t135r341b216],
6	by	IN	O	by	_	0	SENT_71	[p6l365t135r453b216],
7	the	DT	O	the	det	12	SENT_71	[p6l480t135r587b197],
8	Johns	NNP	ORGANIZATION	Johns	nn	12	SENT_71	[p6l614t135r814b198],
9	Hopkins	NNP	ORGANIZATION	Hopkins	nn	12	SENT_71	[p6l843t135r1142b216],
10	Institutional	NNP	ORGANIZATION	Institutional	nn	12	SENT_71	[p6l1171t135r1603b197],
11	Review	NNP	ORGANIZATION	Review	nn	12	SENT_71	[p6l1631t135r1903b198],
12	Board	NNP	ORGANIZATION	Board	agent	5	SENT_71	[p6l1930t135r2148b197],
13	and	CC	O	and	_	0	SENT_71	[p6l9t246r136b308],
14	all	DT	O	all	det	15	SENT_71	[p6l165t246r250b308],
15	subjects	NNS	O	subject	nsubj	16	SENT_71	[p6l283t246r565b327],
16	provided	VBD	O	provide	conj_and	5	SENT_71	[p6l594t246r913b327],
17	written	VBN	O	write	dep	16	SENT_71	[p6l941t246r1194b308],
18	informed	VBN	O	inform	amod	19	SENT_71	[p6l1223t246r1551b308],
19	consent	NN	O	consent	dobj	17	SENT_71	[p6l1579t255r1852b308],
20	prior	RB	O	prior	advmod	19	SENT_71	[p6l1878t246r2053b327],
21	to	TO	O	to	aux	22	SENT_71	[p6l2080t255r2146b308],
22	study	VB	O	study	infmod	19	SENT_71	[p6l10t357r198b438],
23	drug	NN	O	drug	nn	24	SENT_71	[p6l233t357r393b438],
24	administration	NN	O	administration	dobj	22	SENT_71	[p6l428t357r963b420],
25	.	.	O	.	_	0	SENT_71	[p6l428t357r963b420],

1	Drug	NN	O	drug	nn	2	SENT_72	[p6l7t583r188b662],
2	dosage	NN	O	dosage	_	0	SENT_72	[p6l223t581r467b662],
3	and	CC	O	and	_	0	SENT_72	[p6l503t581r629b644],
4	administration	NN	O	administration	conj_and	2	SENT_72	[p6l663t581r1180b644],

1	Capecitabine	NN	O	capecitabine	nsubjpass	3	SENT_73	[p6l8t804r475b885],
2	was	VBD	O	be	auxpass	3	SENT_73	[p6l522t824r657b867],
3	provided	VBN	O	provide	_	0	SENT_73	[p6l703t804r1022b885],
4	as	IN	O	as	_	0	SENT_73	[p6l1069t824r1138b867],
5	500	CD	NUMBER	500	num	7	SENT_73	[p6l1187t804r1317b867],
6	mg	NN	O	mg	nn	7	SENT_73	[p6l1350t824r1462b885],
7	tablets	NNS	O	tablet	prep_as	3	SENT_73	[p6l1508t804r1739b867],
8	by	IN	O	by	_	0	SENT_73	[p6l1786t804r1873b885],
9	Roche	NNP	ORGANIZATION	Roche	nn	10	SENT_73	[p6l1920t804r2146b867],
10	Laboratories	NNPS	ORGANIZATION	Laboratories	agent	3	SENT_73	[p6l7t915r479b989],
11	,	,	ORGANIZATION	,	_	0	SENT_73	[p6l7t915r479b989],
12	Inc.	NNP	ORGANIZATION	Inc.	appos	10	SENT_73	[p6l520t917r650b978],
13	.	.	O	.	_	0	SENT_73	[p6l520t917r650b978],

1	It	PRP	O	it	nsubjpass	5	SENT_74	[p6l693t917r746b978],
2	was	VBD	O	be	auxpass	3	SENT_74	[p6l783t935r917b978],
3	stored	VBN	O	store	_	0	SENT_74	[p6l959t915r1174b978],
4	and	CC	O	and	_	0	SENT_74	[p6l1213t915r1339b978],
5	handled	VBN	O	handle	conj_and	3	SENT_74	[p6l1374t915r1659b978],
6	per	IN	O	per	_	0	SENT_74	[p6l1695t935r1810b996],
7	standard	JJ	O	standard	amod	8	SENT_74	[p6l1848t915r2149b978],
8	instructions	NNS	O	instruction	prep_per	3	SENT_74	[p6l7t1026r423b1088],
9	for	IN	O	for	_	0	SENT_74	[p6l467t1026r571b1088],
10	the	DT	O	the	det	13	SENT_74	[p6l611t1026r718b1088],
11	commercially	RB	O	commercially	advmod	12	SENT_74	[p6l762t1026r1255b1107],
12	available	JJ	O	available	amod	13	SENT_74	[p6l1300t1026r1620b1089],
13	product	NN	O	product	prep_for	8	SENT_74	[p6l1662t1026r1937b1107],
14	[	CD	NUMBER	[	number	15	SENT_74	[p6l1984t1026r2143b1102],
15	11	CD	NUMBER	11	num	16	SENT_74	[p6l1984t1026r2143b1102],
16	]	NN	O	]	dep	13	SENT_74	[p6l1984t1026r2143b1102],
17	.	.	O	.	_	0	SENT_74	[p6l1984t1026r2143b1102],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_75	[p6l7t1137r289b1200],
2	were	VBD	O	be	auxpass	3	SENT_75	[p6l316t1157r487b1200],
3	advised	VBN	O	advise	_	0	SENT_75	[p6l516t1137r787b1200],
4	to	TO	O	to	aux	5	SENT_75	[p6l811t1147r878b1200],
5	take	VB	O	take	xcomp	3	SENT_75	[p6l905t1137r1052b1200],
6	the	DT	O	the	det	7	SENT_75	[p6l1079t1137r1186b1200],
7	medication	NN	O	medication	dobj	5	SENT_75	[p6l1212t1137r1611b1200],
8	within	IN	O	within	_	0	SENT_75	[p6l1637t1137r1865b1200],
9	30	CD	DURATION	30	num	10	SENT_75	[p6l1893t1137r1977b1200],
10	min	NN	DURATION	min	prep_within	7	SENT_75	[p6l2010t1137r2148b1199],
11	after	IN	O	after	_	0	SENT_75	[p6l9t1249r171b1311],
12	the	DT	O	the	det	13	SENT_75	[p6l201t1249r308b1311],
13	ingestion	NN	O	ingestion	prep_after	5	SENT_75	[p6l340t1249r667b1330],
14	of	IN	O	of	_	0	SENT_75	[p6l699t1249r776b1311],
15	food	NN	O	food	prep_of	13	SENT_75	[p6l802t1249r964b1311],
16	and	CC	O	and	_	0	SENT_75	[p6l995t1249r1122b1311],
17	swallow	VB	O	swallow	conj_and	5	SENT_75	[p6l1155t1249r1448b1312],
18	with	IN	O	with	_	0	SENT_75	[p6l1480t1249r1637b1311],
19	~	NN	O	~	nn	21	SENT_75	[p6l1682t1249r1889b1312],
20	200	CD	NUMBER	200	num	21	SENT_75	[p6l1682t1249r1889b1312],
21	mL	NN	O	ml	prep_with	17	SENT_75	[p6l1922t1250r2044b1311],
22	of	IN	O	of	_	0	SENT_75	[p6l2076t1249r2153b1311],
23	water	NN	O	water	prep_of	21	SENT_75	[p6l8t1350r222b1403],
24	.	.	O	.	_	0	SENT_75	[p6l8t1350r222b1403],

1	The	DT	O	the	det	3	SENT_76	[p6l109t1452r246b1515],
2	starting	VBG	O	start	amod	3	SENT_76	[p6l290t1452r554b1533],
3	dose	NN	O	dose	nsubj	9	SENT_76	[p6l596t1452r756b1515],
4	of	IN	O	of	_	0	SENT_76	[p6l798t1452r875b1515],
5	capecitabine	NN	O	capecitabine	prep_of	3	SENT_76	[p6l910t1452r1357b1533],
6	was	VBD	O	be	cop	9	SENT_76	[p6l1399t1472r1533b1515],
7	3,000	CD	NUMBER	3,000	num	9	SENT_76	[p6l1577t1453r1774b1526],
8	mg	NN	O	mg	nn	9	SENT_76	[p6l1807t1472r1918b1533],
9	(	NN	O	(	_	0	SENT_76	[p6l1962t1452r2147b1529],
10	total	JJ	O	total	amod	13	SENT_76	[p6l1962t1452r2147b1529],
11	daily	JJ	SET	daily	amod	13	SENT_76	[p6l8t1563r184b1644],
12	dose	NN	O	dose	nn	13	SENT_76	[p6l224t1563r412b1640],
13	)	NN	O	)	nsubj	17	SENT_76	[p6l224t1563r412b1640],
14	given	VBN	O	give	prep	13	SENT_76	[p6l455t1563r652b1644],
15	in	IN	O	in	pcomp	14	SENT_76	[p6l691t1563r758b1625],
16	two	CD	NUMBER	two	pobj	15	SENT_76	[p6l796t1573r927b1626],
17	divided	VBN	O	divide	rcmod	9	SENT_76	[p6l968t1563r1235b1626],
18	daily	JJ	SET	daily	amod	19	SENT_76	[p6l1275t1563r1451b1644],
19	doses	NNS	O	dose	dobj	17	SENT_76	[p6l1491t1563r1684b1626],
20	for	IN	O	for	_	0	SENT_76	[p6l1725t1563r1829b1626],
21	14	CD	DURATION	14	num	22	SENT_76	[p6l1874t1563r1952b1625],
22	days	NNS	NUMBER	day	prep_for	17	SENT_76	[p6l1986t1563r2145b1644],
23	followed	VBN	O	follow	partmod	22	SENT_76	[p6l8t1672r325b1735],
24	by	IN	O	by	_	0	SENT_76	[p6l369t1673r456b1754],
25	7	CD	DURATION	7	num	26	SENT_76	[p6l503t1674r542b1735],
26	days	NNS	NUMBER	day	agent	23	SENT_76	[p6l577t1673r736b1754],
27	of	IN	O	of	_	0	SENT_76	[p6l786t1673r863b1735],
28	rest	NN	O	rest	nn	29	SENT_76	[p6l901t1682r1030b1735],
29	(	NN	O	(	prep_of	26	SENT_76	[p6l1077t1673r1138b1750],
30	1	CD	NUMBER	1	num	31	SENT_76	[p6l1077t1673r1138b1750],
31	cycle	NN	O	cycle	npadvmod	32	SENT_76	[p6l1192t1673r1379b1754],
32	=	JJ	O	=	amod	29	SENT_76	[p6l1415t1701r1476b1725],
33	21	CD	DURATION	21	num	34	SENT_76	[p6l1513t1673r1591b1734],
34	days	NNS	NUMBER	day	tmod	26	SENT_76	[p6l1632t1672r1841b1754],
35	)	RB	O	)	advmod	23	SENT_76	[p6l1632t1672r1841b1754],
36	.	.	O	.	_	0	SENT_76	[p6l1632t1672r1841b1754],

1	Missed	VBN	O	miss	_	0	SENT_77	[p6l1891t1673r2148b1735],
2	Breast	NN	O	breast	nn	5	SENT_77	[p6l52t1829r142b1854],
3	Cancer	NN	O	cancer	nn	5	SENT_77	[p6l155t1829r255b1854],
4	Res	NNP	O	Res	nn	5	SENT_77	[p6l267t1829r318b1854],
5	Treat	NNP	O	Treat	dobj	1	SENT_77	[p6l331t1829r406b1854],
6	(	CD	NUMBER	(	num	5	SENT_77	[p6l419t1829r510b1859],
7	2013	CD	DATE	2013	num	9	SENT_77	[p6l419t1829r510b1859],
8	)	CD	NUMBER	)	num	9	SENT_77	[p6l419t1829r510b1859],
9	l39	NN	O	l39	dep	5	SENT_77	[p6l528t1829r708b1854],
10	:	:	O	:	_	0	SENT_77	[p6l528t1829r708b1854],
11	l35	NN	O	l35	dep	5	SENT_77	[p6l528t1829r708b1854],
12	—	CD	NUMBER	—	num	11	SENT_77	[p6l528t1829r708b1854],
13	l43	NN	O	l43	dep	11	SENT_77	[p6l528t1829r708b1854],
14	137	CD	NUMBER	137	num	13	SENT_77	[p6l2058t1829r2106b1854],

1	doses	NNS	O	dose	nsubjpass	4	SENT_78	[p6l14t1997r208b2060],
2	were	VBD	O	be	auxpass	4	SENT_78	[p6l240t2017r410b2060],
3	not	RB	O	not	neg	4	SENT_78	[p6l441t2007r554b2060],
4	substituted	VBN	O	substitute	_	0	SENT_78	[p6l586t1997r987b2060],
5	.	.	O	.	_	0	SENT_78	[p6l586t1997r987b2060],

1	The	DT	O	the	det	3	SENT_79	[p6l1022t1997r1158b2060],
2	drug	NN	O	drug	nn	3	SENT_79	[p6l1190t1997r1349b2078],
3	vials	NNS	O	vial	nsubjpass	5	SENT_79	[p6l1380t1997r1545b2060],
4	were	VBD	O	be	auxpass	5	SENT_79	[p6l1578t2017r1748b2060],
5	ﬁtted	VBN	O	ﬁtted	_	0	SENT_79	[p6l1780t1997r1961b2060],
6	with	IN	O	with	_	0	SENT_79	[p6l1991t1997r2148b2060],
7	a	DT	O	a	det	9	SENT_79	[p6l16t2128r52b2171],
8	Medication	NNP	MISC	Medication	nn	9	SENT_79	[p6l119t2108r526b2171],
9	Event	NNP	MISC	Event	prep_with	5	SENT_79	[p6l594t2110r802b2171],
10	Monitoring	VBG	MISC	monitor	partmod	9	SENT_79	[p6l869t2108r1274b2189],
11	System	NNP	MISC	System	nn	14	SENT_79	[p6l1346t2109r1605b2189],
12	(	CD	NUMBER	(	num	14	SENT_79	[p6l1676t2109r1959b2186],
13	MEMS	NNP	O	MEMS	nn	14	SENT_79	[p6l1676t2109r1959b2186],
14	VI	NNP	O	VI	dobj	10	SENT_79	[p6l2031t2110r2143b2182],
15	;	:	O	;	_	0	SENT_79	[p6l2031t2110r2143b2182],
16	AARDEX	NNP	ORGANIZATION	AARDEX	nn	24	SENT_79	[p6l13t2219r383b2281],
17	Group	NNP	ORGANIZATION	Group	nn	24	SENT_79	[p6l442t2219r665b2300],
18	Ltd.	NNP	ORGANIZATION	Ltd.	nn	24	SENT_79	[p6l723t2219r887b2293],
19	,	,	O	,	_	0	SENT_79	[p6l723t2219r887b2293],
20	Sion	NNP	ORGANIZATION	Sion	appos	24	SENT_79	[p6l950t2219r1128b2293],
21	,	,	O	,	_	0	SENT_79	[p6l950t2219r1128b2293],
22	Switzerland	NNP	LOCATION	Switzerland	appos	24	SENT_79	[p6l1191t2219r1642b2296],
23	)	NNP	O	)	nn	24	SENT_79	[p6l1191t2219r1642b2296],
24	cap	NN	O	cap	dep	14	SENT_79	[p6l1703t2238r1823b2300],
25	for	IN	O	for	_	0	SENT_79	[p6l1881t2219r1985b2281],
26	the	DT	O	the	det	27	SENT_79	[p6l2040t2219r2147b2281],
27	duration	NN	O	duration	prep_for	24	SENT_79	[p6l14t2330r311b2392],
28	of	IN	O	of	_	0	SENT_79	[p6l358t2330r435b2392],
29	study	NN	O	study	nn	30	SENT_79	[p6l478t2330r666b2411],
30	therapy	NN	O	therapy	prep_of	27	SENT_79	[p6l712t2330r979b2411],
31	to	TO	O	to	aux	32	SENT_79	[p6l1025t2339r1092b2392],
32	collect	VB	O	collect	xcomp	10	SENT_79	[p6l1140t2330r1378b2392],
33	data	NNS	O	datum	dobj	32	SENT_79	[p6l1424t2330r1572b2392],
34	on	IN	O	on	_	0	SENT_79	[p6l1618t2349r1704b2392],
35	medication	NN	O	medication	nn	36	SENT_79	[p6l1750t2330r2148b2392],
36	adherence	NN	O	adherence	prep_on	32	SENT_79	[p6l15t2440r394b2502],
37	.	.	O	.	_	0	SENT_79	[p6l15t2440r394b2502],

1	Patients	NNS	O	patient	nsubj	3	SENT_80	[p6l441t2440r720b2502],
2	also	RB	O	also	advmod	3	SENT_80	[p6l766t2440r905b2502],
3	documented	VBN	O	document	_	0	SENT_80	[p6l949t2440r1386b2502],
4	drug	NN	O	drug	nn	5	SENT_80	[p6l1428t2440r1587b2521],
5	administration	NN	O	administration	dobj	3	SENT_80	[p6l1632t2440r2148b2502],
6	with	IN	O	with	_	0	SENT_80	[p6l14t2552r171b2615],
7	a	DT	O	a	det	10	SENT_80	[p6l202t2572r239b2615],
8	study	NN	O	study	nn	10	SENT_80	[p6l269t2552r457b2633],
9	drug	NN	O	drug	nn	10	SENT_80	[p6l488t2552r647b2633],
10	diary	NN	O	diary	prep_with	3	SENT_80	[p6l678t2552r877b2633],
11	.	.	O	.	_	0	SENT_80	[p6l678t2552r877b2633],

1	Pill	NN	O	pill	nn	2	SENT_81	[p6l910t2552r1033b2614],
2	counts	NNS	O	count	nsubjpass	4	SENT_81	[p6l1063t2562r1292b2615],
3	were	VBD	O	be	auxpass	4	SENT_81	[p6l1323t2572r1493b2615],
4	performed	VBN	O	perform	_	0	SENT_81	[p6l1522t2552r1896b2633],
5	by	IN	O	by	_	0	SENT_81	[p6l1923t2552r2011b2633],
6	the	DT	O	the	det	8	SENT_81	[p6l2040t2552r2147b2615],
7	study	NN	O	study	nn	8	SENT_81	[p6l17t2663r204b2744],
8	team	NN	O	team	agent	4	SENT_81	[p6l260t2672r451b2726],
9	.	.	O	.	_	0	SENT_81	[p6l260t2672r451b2726],

1	Dose	NN	O	dose	nn	2	SENT_82	[p6l511t2665r691b2726],
2	modiﬁcation	NN	O	modiﬁcation	nsubjpass	4	SENT_82	[p6l748t2663r1199b2726],
3	was	VBD	O	be	auxpass	4	SENT_82	[p6l1255t2683r1389b2726],
4	preferred	VBN	O	prefer	_	0	SENT_82	[p6l1445t2663r1773b2744],
5	over	IN	O	over	_	0	SENT_82	[p6l1829t2683r1987b2726],
6	the	DT	O	the	det	8	SENT_82	[p6l2040t2663r2147b2726],
7	concomitant	JJ	O	concomitant	amod	8	SENT_82	[p6l14t2774r457b2837],
8	use	NN	O	use	prep_over	4	SENT_82	[p6l495t2794r611b2837],
9	of	IN	O	of	_	0	SENT_82	[p6l652t2774r729b2837],
10	colony	NN	O	colony	nn	11	SENT_82	[p6l762t2774r1437b2855],
11	—	NN	O	—	prep_of	8	SENT_82	[p6l762t2774r1437b2855],
12	stimulating	VBG	O	stimulate	xcomp	4	SENT_82	[p6l762t2774r1437b2855],
13	factors	NNS	O	factor	dobj	12	SENT_82	[p6l1477t2774r1736b2837],
14	.	.	O	.	_	0	SENT_82	[p6l1477t2774r1736b2837],

1	Treatment	NN	O	treatment	nsubjpass	3	SENT_83	[p6l1780t2776r2149b2837],
2	was	VBD	O	be	auxpass	3	SENT_83	[p6l14t2905r148b2948],
3	continued	VBN	O	continue	_	0	SENT_83	[p6l204t2885r556b2948],
4	until	IN	O	until	_	0	SENT_83	[p6l608t2885r770b2948],
5	unacceptable	JJ	O	unacceptable	amod	6	SENT_83	[p6l822t2885r1290b2966],
6	toxicity	NN	O	toxicity	prep_until	3	SENT_83	[p6l1343t2885r1635b2966],
7	,	,	O	,	_	0	SENT_83	[p6l1343t2885r1635b2966],
8	disease	NN	O	disease	nn	9	SENT_83	[p6l1692t2885r1947b2948],
9	progression	NN	O	progression	prep_until	3	SENT_83	[p6l2000t2905r2145b2966, p6l15t2996r329b3077],
10	,	,	O	,	_	0	SENT_83	[p6l2000t2905r2145b2966, p6l15t2996r329b3077],
11	or	CC	O	or	_	0	SENT_83	[p6l365t3016r439b3059],
12	withdrawal	NN	O	withdrawal	conj_or	6	SENT_83	[p6l470t2996r870b3059],
13	of	IN	O	of	_	0	SENT_83	[p6l904t2996r981b3059],
14	consent	NN	O	consent	prep_of	12	SENT_83	[p6l1008t3006r1296b3059],
15	.	.	O	.	_	0	SENT_83	[p6l1008t3006r1296b3059],

1	Dose	NN	O	dose	nn	2	SENT_84	[p6l13t3221r194b3282],
2	modiﬁcation	NN	O	modiﬁcation	_	0	SENT_84	[p6l228t3220r679b3282],

1	Toxicity	NN	O	toxicity	_	0	SENT_85	[p6l13t3442r315b3523],
2	was	VBD	O	be	auxpass	3	SENT_85	[p6l348t3462r482b3505],
3	assessed	VBN	O	assess	rcmod	1	SENT_85	[p6l517t3442r816b3505],
4	using	VBG	O	use	xcomp	3	SENT_85	[p6l847t3442r1038b3523],
5	the	DT	O	the	det	8	SENT_85	[p6l1070t3442r1176b3505],
6	National	NNP	ORGANIZATION	National	nn	8	SENT_85	[p6l1208t3442r1514b3505],
7	Cancer	NNP	ORGANIZATION	Cancer	nn	8	SENT_85	[p6l1548t3443r1800b3505],
8	Institute	NNP	ORGANIZATION	Institute	dobj	4	SENT_85	[p6l1830t3442r2150b3505],
9	/	:	O	/	punct	1	SENT_85	[p6l1830t3442r2150b3505],
10	Division	NNP	O	Division	nsubj	20	SENT_85	[p6l13t3553r319b3616],
11	of	IN	O	of	_	0	SENT_85	[p6l359t3553r436b3616],
12	Cancer	NNP	O	Cancer	nn	16	SENT_85	[p6l470t3554r722b3616],
13	Treatment	NNP	O	Treatment	nn	16	SENT_85	[p6l758t3555r1128b3616],
14	Common	NNP	O	Common	nn	16	SENT_85	[p6l1166t3554r1496b3616],
15	Toxicity	NNP	O	Toxicity	nn	16	SENT_85	[p6l1534t3553r1836b3634],
16	Criteria	NNP	O	Criteria	prep_of	10	SENT_85	[p6l1876t3553r2149b3616],
17	for	IN	O	for	_	0	SENT_85	[p6l14t3663r117b3725],
18	Adverse	JJ	O	adverse	amod	19	SENT_85	[p6l160t3663r455b3725],
19	Events	NNS	O	event	prep_for	16	SENT_85	[p6l500t3665r739b3725],
20	(	VBP	O	(	dep	1	SENT_85	[p6l789t3663r967b3739],
21	NCI	NN	O	ncus	prep	20	SENT_85	[p6l789t3663r967b3739],
22	CTCAE	NN	O	ctca	nn	24	SENT_85	[p6l1012t3663r1330b3739],
23	)	CD	NUMBER	)	num	24	SENT_85	[p6l1012t3663r1330b3739],
24	version	NN	O	version	dep	21	SENT_85	[p6l1377t3663r1638b3725],
25	3	CD	NUMBER	3	num	24	SENT_85	[p6l1684t3663r1742b3725],
26	.	.	O	.	_	0	SENT_85	[p6l1684t3663r1742b3725],

1	Excessive	JJ	O	excessive	amod	2	SENT_86	[p6l1791t3663r2147b3725],
2	toxicity	NN	O	toxicity	nsubjpass	4	SENT_86	[p7l13t24r285b105],
3	was	VBD	O	be	auxpass	4	SENT_86	[p7l326t43r459b86],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_86	[p7l501t24r762b86],
5	as	IN	O	as	_	0	SENT_86	[p7l803t43r871b86],
6	capecitabine	NN	O	capecitabine	nn	7	SENT_86	[p7l912t24r1635b105],
7	—	NN	O	—	prep_as	4	SENT_86	[p7l912t24r1635b105],
8	related	JJ	O	related	amod	9	SENT_86	[p7l912t24r1635b105],
9	grade	NN	O	grade	dobj	4	SENT_86	[p7l1675t24r1869b105],
10	4	CD	NUMBER	4	num	11	SENT_86	[p7l1909t24r1951b85],
11	neutropenia	NN	O	neutropenia	dep	9	SENT_86	[p7l1990t43r2145b86, p7l13t136r307b217],
12	35	CD	DURATION	35	num	13	SENT_86	[p7l339t136r439b210],
13	days	NNS	NUMBER	day	tmod	9	SENT_86	[p7l475t136r634b217],
14	in	IN	O	in	_	0	SENT_86	[p7l664t136r731b198],
15	duration	NN	O	duration	nn	19	SENT_86	[p7l758t136r1073b210],
16	,	,	O	,	_	0	SENT_86	[p7l758t136r1073b210],
17	grade	NN	O	grade	dep	19	SENT_86	[p7l1105t136r1300b217],
18	4	CD	NUMBER	4	num	19	SENT_86	[p7l1327t137r1369b198],
19	thrombocytopenia	NN	O	thrombocytopenia	prep_in	9	SENT_86	[p7l1397t136r2049b217],
20	of	IN	O	of	_	0	SENT_86	[p7l2076t136r2153b199],
21	any	DT	O	any	det	22	SENT_86	[p7l16t267r140b328],
22	duration	NN	O	duration	prep_of	9	SENT_86	[p7l174t247r489b321],
23	,	,	O	,	_	0	SENT_86	[p7l174t247r489b321],
24	or	CC	O	or	_	0	SENT_86	[p7l526t267r599b310],
25	any	DT	O	any	det	26	SENT_86	[p7l631t267r756b328],
26	grade	NN	O	grade	conj_or	9	SENT_86	[p7l790t247r985b328],
27	3-4	CD	NUMBER	3-4	num	31	SENT_86	[p7l1021t248r1149b310],
28	non	JJ	O	non	amod	31	SENT_86	[p7l1182t247r1787b328],
29	—	JJ	O	—	amod	31	SENT_86	[p7l1182t247r1787b328],
30	hematologic	JJ	O	hematologic	amod	31	SENT_86	[p7l1182t247r1787b328],
31	toxicity	NN	O	toxicity	dep	26	SENT_86	[p7l1821t247r2111b328],
32	.	.	O	.	_	0	SENT_86	[p7l1821t247r2111b328],

1	Up	IN	O	up	prep	13	SENT_87	[p7l115t359r221b439],
2	to	TO	O	to	pcomp	1	SENT_87	[p7l265t367r331b420],
3	three	CD	NUMBER	three	num	5	SENT_87	[p7l375t358r551b420],
4	dose	NN	O	dose	nn	5	SENT_87	[p7l596t358r756b420],
5	reductions	NNS	O	reduction	pobj	2	SENT_87	[p7l799t358r1169b420],
6	below	IN	O	below	_	0	SENT_87	[p7l1213t358r1430b421],
7	the	DT	O	the	det	11	SENT_87	[p7l1474t358r1580b420],
8	initial	JJ	O	initial	amod	11	SENT_87	[p7l1624t358r1831b420],
9	cycle	NN	O	cycle	nn	11	SENT_87	[p7l1876t358r2062b439],
10	1	CD	NUMBER	1	num	11	SENT_87	[p7l2114t358r2140b420],
11	dose	NN	O	dose	prep_below	5	SENT_87	[p7l15t469r174b531],
12	were	VBD	O	be	auxpass	13	SENT_87	[p7l206t488r377b532],
13	permitted	VBN	O	permit	_	0	SENT_87	[p7l407t469r751b550],
14	(	RB	O	(	advmod	13	SENT_87	[p7l784t470r937b546],
15	one	CD	NUMBER	one	num	16	SENT_87	[p7l784t470r937b546],
16	fewer	JJR	O	fewer	dobj	13	SENT_87	[p7l969t469r1171b532],
17	500	CD	NUMBER	500	num	19	SENT_87	[p7l1202t469r1332b532],
18	mg	NN	O	mg	nn	19	SENT_87	[p7l1364t488r1475b550],
19	tablet	NN	O	tablet	nsubjpass	13	SENT_87	[p7l1507t469r1706b531],
20	per	IN	O	per	_	0	SENT_87	[p7l1734t488r1849b550],
21	day	NN	DURATION	day	prep_per	19	SENT_87	[p7l1879t469r2004b550],
22	per	IN	O	per	_	0	SENT_87	[p7l2034t488r2149b550],
23	cycle	NN	O	cycle	nn	24	SENT_87	[p7l15t580r248b661],
24	)	NN	O	)	prep_per	21	SENT_87	[p7l15t580r248b661],
25	.	.	O	.	_	0	SENT_87	[p7l15t580r248b661],

1	Dose	NN	O	dose	nn	2	SENT_88	[p7l288t581r469b642],
2	re	NN	O	re	nsubjpass	7	SENT_88	[p7l503t580r962b642],
3	—	CD	NUMBER	—	num	4	SENT_88	[p7l503t580r962b642],
4	escalation	NN	O	escalation	dep	2	SENT_88	[p7l503t580r962b642],
5	could	MD	O	could	aux	7	SENT_88	[p7l997t580r1195b642],
6	be	VB	O	be	auxpass	7	SENT_88	[p7l1227t580r1310b642],
7	considered	VBN	O	consider	_	0	SENT_88	[p7l1346t580r1733b642],
8	if	IN	O	if	mark	11	SENT_88	[p7l1767t580r1825b642],
9	the	DT	O	the	det	10	SENT_88	[p7l1854t580r1961b642],
10	subject	JJ	O	subject	nsubj	11	SENT_88	[p7l1999t580r2145b642, p7l6t691r143b772],
11	tolerated	VBD	O	tolerate	advcl	7	SENT_88	[p7l194t691r508b754],
12	the	DT	O	the	det	14	SENT_88	[p7l560t691r667b754],
13	reduced	VBN	O	reduce	amod	14	SENT_88	[p7l720t691r1003b754],
14	dose	NN	O	dose	dobj	11	SENT_88	[p7l1057t691r1217b754],
15	for	IN	O	for	_	0	SENT_88	[p7l1271t691r1374b754],
16	at	IN	O	at	quantmod	18	SENT_88	[p7l1428t701r1490b754],
17	least	JJS	O	least	mwe	16	SENT_88	[p7l1542t691r1705b754],
18	one	CD	NUMBER	one	num	19	SENT_88	[p7l1759t711r1884b754],
19	cycle	NN	O	cycle	prep_for	14	SENT_88	[p7l1938t691r2142b772],
20	.	.	O	.	_	0	SENT_88	[p7l1938t691r2142b772],

1	Instructions	NNS	O	instruction	nsubjpass	3	SENT_89	[p7l14t802r433b865],
2	were	VBD	O	be	auxpass	3	SENT_89	[p7l478t822r648b865],
3	provided	VBN	O	provide	_	0	SENT_89	[p7l691t802r1009b883],
4	for	IN	O	for	_	0	SENT_89	[p7l1051t802r1155b865],
5	the	DT	O	the	det	6	SENT_89	[p7l1195t802r1302b865],
6	management	NN	O	management	prep_for	3	SENT_89	[p7l1345t811r1803b883],
7	of	IN	O	of	_	0	SENT_89	[p7l1847t802r1924b865],
8	treatment	NN	O	treatment	nn	9	SENT_89	[p7l1960t811r2145b865, p7l14t913r467b976],
9	—	NN	O	—	prep_of	6	SENT_89	[p7l1960t811r2145b865, p7l14t913r467b976],
10	related	JJ	O	related	amod	11	SENT_89	[p7l1960t811r2145b865, p7l14t913r467b976],
11	diarrhea	NN	O	diarrhea	tmod	3	SENT_89	[p7l543t913r853b987],
12	,	,	O	,	_	0	SENT_89	[p7l543t913r853b987],
13	nausea/vomiting	VBG	O	nausea/vomiting	appos	11	SENT_89	[p7l932t913r1522b994],
14	and	CC	O	and	_	0	SENT_89	[p7l1601t913r1727b976],
15	hand	NN	O	hand	nn	18	SENT_89	[p7l1801t913r2149b976],
16	—	CD	NUMBER	—	num	18	SENT_89	[p7l1801t913r2149b976],
17	foot	NN	O	foot	nn	18	SENT_89	[p7l1801t913r2149b976],
18	syndrome	NN	O	syndrome	appos	11	SENT_89	[p7l17t1024r382b1105],
19	.	.	O	.	_	0	SENT_89	[p7l17t1024r382b1105],

1	Up	IN	O	up	prep	7	SENT_90	[p7l415t1026r520b1105],
2	to	TO	O	to	pcomp	1	SENT_90	[p7l550t1034r616b1087],
3	two	CD	NUMBER	two	num	5	SENT_90	[p7l645t1034r776b1087],
4	dose	NN	O	dose	nn	5	SENT_90	[p7l806t1024r965b1087],
5	escalations	NNS	O	escalation	pobj	2	SENT_90	[p7l995t1024r1384b1087],
6	were	VBD	O	be	auxpass	7	SENT_90	[p7l1415t1044r1586b1087],
7	permitted	VBN	O	permit	_	0	SENT_90	[p7l1613t1024r1958b1105],
8	after	IN	O	after	_	0	SENT_90	[p7l1987t1024r2149b1087],
9	the	DT	O	the	det	10	SENT_90	[p7l14t1135r120b1198],
10	ﬁrst	NN	O	ﬁrst	prep_after	7	SENT_90	[p7l157t1135r293b1198],
11	two	CD	NUMBER	two	num	12	SENT_90	[p7l326t1145r456b1198],
12	cycles	NNS	O	cycle	nsubj	13	SENT_90	[p7l493t1135r713b1216],
13	(	VBP	O	(	rcmod	10	SENT_90	[p7l752t1136r905b1213],
14	one	CD	NUMBER	one	num	16	SENT_90	[p7l752t1136r905b1213],
15	additional	JJ	O	additional	amod	16	SENT_90	[p7l942t1135r1296b1198],
16	500	CD	NUMBER	500	dobj	13	SENT_90	[p7l1333t1135r1463b1198],
17	mg	NN	O	mg	nn	18	SENT_90	[p7l1496t1155r1606b1216],
18	tablet	NN	O	tablet	nsubjpass	7	SENT_90	[p7l1642t1135r1841b1198],
19	per	IN	O	per	_	0	SENT_90	[p7l1873t1155r1988b1216],
20	day	NN	DURATION	day	prep_per	18	SENT_90	[p7l2021t1135r2147b1216],
21	each	DT	O	each	det	22	SENT_90	[p7l15t1246r176b1309],
22	cycle	NN	O	cycle	dep	18	SENT_90	[p7l226t1246r439b1327],
23	)	CD	NUMBER	)	num	22	SENT_90	[p7l226t1246r439b1327],
24	if	IN	O	if	mark	29	SENT_90	[p7l491t1246r549b1308],
25	no	DT	O	no	det	27	SENT_90	[p7l592t1266r678b1309],
26	excessive	JJ	O	excessive	amod	27	SENT_90	[p7l729t1246r1069b1309],
27	toxicity	NN	O	toxicity	nsubjpass	29	SENT_90	[p7l1118t1246r1390b1327],
28	was	VBD	O	be	auxpass	29	SENT_90	[p7l1439t1266r1574b1309],
29	observed	VBN	O	observe	dep	22	SENT_90	[p7l1625t1246r1946b1309],
30	in	IN	O	in	_	0	SENT_90	[p7l1994t1246r2062b1308],
31	a	DT	O	a	det	33	SENT_90	[p7l2112t1266r2149b1309],
32	previous	JJ	O	previous	amod	33	SENT_90	[p7l13t1357r317b1438],
33	cycle	NN	O	cycle	prep_in	29	SENT_90	[p7l353t1357r558b1438],
34	.	.	O	.	_	0	SENT_90	[p7l353t1357r558b1438],

1	Pretreatment	NN	O	pretreatment	_	0	SENT_91	[p7l14t1582r472b1643],
2	and	CC	O	and	_	0	SENT_91	[p7l505t1581r631b1643],
3	follow	VB	O	follow	conj_and	1	SENT_91	[p7l663t1581r894b1643],
4	up	RP	O	up	prt	3	SENT_91	[p7l926t1600r1013b1662],
5	studies	NNS	O	study	dobj	3	SENT_91	[p7l1049t1581r1291b1643],

1	Baseline	NN	O	baseline	nn	2	SENT_92	[p7l14t1804r319b1867],
2	evaluations	NNS	O	evaluation	nsubj	3	SENT_92	[p7l353t1804r758b1867],
3	included	VBD	O	include	_	0	SENT_92	[p7l791t1804r1099b1867],
4	routine	JJ	O	routine	amod	5	SENT_92	[p7l1129t1804r1381b1867],
5	history	NN	O	history	dobj	3	SENT_92	[p7l1413t1804r1660b1885],
6	and	CC	O	and	_	0	SENT_92	[p7l1694t1804r1819b1867],
7	physical	JJ	O	physical	amod	8	SENT_92	[p7l1849t1804r2147b1885],
8	examination	NN	O	examination	conj_and	5	SENT_92	[p7l15t1915r475b1989],
9	,	,	O	,	_	0	SENT_92	[p7l15t1915r475b1989],
10	complete	JJ	O	complete	amod	12	SENT_92	[p7l532t1915r858b1996],
11	blood	NN	O	blood	nn	12	SENT_92	[p7l910t1915r1113b1978],
12	counts	NNS	O	count	conj_and	5	SENT_92	[p7l1166t1924r1416b1989],
13	,	,	O	,	_	0	SENT_92	[p7l1166t1924r1416b1989],
14	serum	NN	O	serum	nn	15	SENT_92	[p7l1475t1935r1689b1978],
15	chemistries	NNS	O	chemistry	conj_and	5	SENT_92	[p7l1742t1915r2146b1978],
16	and	CC	O	and	_	0	SENT_92	[p7l16t2026r142b2089],
17	radiologic	JJ	O	radiologic	amod	18	SENT_92	[p7l176t2026r537b2107],
18	evaluations	NNS	O	evaluation	conj_and	5	SENT_92	[p7l575t2026r1000b2089],
19	.	.	O	.	_	0	SENT_92	[p7l575t2026r1000b2089],

1	Clinical	JJ	O	clinical	amod	2	SENT_93	[p7l1041t2026r1323b2089],
2	evaluations	NNS	O	evaluation	nsubjpass	7	SENT_93	[p7l1360t2026r1764b2089],
3	and	CC	O	and	_	0	SENT_93	[p7l1804t2026r1930b2089],
4	laboratory	NN	O	laboratory	nn	5	SENT_93	[p7l1966t2026r2145b2089, p7l13t2147r225b2218],
5	tests	NNS	O	test	conj_and	2	SENT_93	[p7l258t2147r413b2200],
6	were	VBD	O	be	auxpass	7	SENT_93	[p7l448t2157r619b2200],
7	repeated	VBN	O	repeat	_	0	SENT_93	[p7l652t2137r955b2218],
8	monthly	RB	SET	monthly	advmod	7	SENT_93	[p7l988t2137r1283b2218],
9	for	IN	O	for	_	0	SENT_93	[p7l1317t2137r1421b2200],
10	the	DT	O	the	det	11	SENT_93	[p7l1452t2137r1559b2200],
11	ﬁrst	NN	O	ﬁrst	prep_for	7	SENT_93	[p7l1593t2137r1729b2200],
12	two	CD	NUMBER	two	num	13	SENT_93	[p7l1761t2147r1892b2200],
13	cycles	NNS	O	cycle	dep	11	SENT_93	[p7l1926t2137r2145b2218],
14	and	CC	O	and	_	0	SENT_93	[p7l16t2248r142b2311],
15	then	RB	O	then	advmod	19	SENT_93	[p7l184t2248r337b2311],
16	every	DT	O	every	quantmod	17	SENT_93	[p7l381t2268r577b2329],
17	two	CD	NUMBER	two	num	18	SENT_93	[p7l621t2258r751b2311],
18	cycles	NNS	O	cycle	npadvmod	19	SENT_93	[p7l797t2248r1016b2329],
19	thereafter	RB	O	thereafter	dep	11	SENT_93	[p7l1062t2248r1422b2311],
20	.	.	O	.	_	0	SENT_93	[p7l1062t2248r1422b2311],

1	Response	NN	O	response	nsubjpass	6	SENT_94	[p7l1470t2250r1810b2329],
2	of	IN	O	of	_	0	SENT_94	[p7l1856t2248r1933b2311],
3	measurable	JJ	O	measurable	amod	4	SENT_94	[p7l1970t2268r2145b2311, p7l17t2359r269b2421],
4	lesions	NNS	O	lesion	prep_of	1	SENT_94	[p7l317t2359r561b2421],
5	was	VBD	O	be	auxpass	6	SENT_94	[p7l609t2378r743b2422],
6	assessed	VBN	O	assess	dep	14	SENT_94	[p7l792t2359r1091b2421],
7	using	VBG	O	use	xcomp	6	SENT_94	[p7l1136t2359r1327b2440],
8	Response	NN	O	response	nn	10	SENT_94	[p7l1374t2360r1714b2440],
9	Evaluation	NN	O	evaluation	nn	10	SENT_94	[p7l1760t2359r2147b2421],
10	Criteria	NNS	O	criterion	dobj	7	SENT_94	[p7l15t2470r288b2533],
11	in	IN	O	in	_	0	SENT_94	[p7l316t2470r383b2532],
12	Solid	JJ	O	solid	amod	13	SENT_94	[p7l415t2470r601b2533],
13	Tumors	NNS	O	tumor	prep_in	7	SENT_94	[p7l629t2471r903b2532],
14	(	VBP	O	(	_	0	SENT_94	[p7l938t2470r1298b2547],
15	RECIST	NN	O	recist	nn	16	SENT_94	[p7l938t2470r1298b2547],
16	)	NN	O	)	dobj	14	SENT_94	[p7l938t2470r1298b2547],
17	after	IN	O	after	_	0	SENT_94	[p7l1332t2470r1494b2532],
18	every	DT	O	every	det	20	SENT_94	[p7l1523t2489r1719b2551],
19	four	CD	NUMBER	four	num	20	SENT_94	[p7l1750t2470r1898b2532],
20	cycles	NNS	O	cycle	prep_after	14	SENT_94	[p7l1926t2470r2145b2551],
21	[	CD	NUMBER	[	num	23	SENT_94	[p7l20t2581r133b2655],
22	7	CD	NUMBER	7	amod	23	SENT_94	[p7l20t2581r133b2655],
23	]	NN	O	]	nsubj	14	SENT_94	[p7l20t2581r133b2655],
24	.	.	O	.	_	0	SENT_94	[p7l20t2581r133b2655],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_95	[p7l190t2580r470b2642],
2	were	VBD	O	be	auxpass	3	SENT_95	[p7l526t2599r695b2643],
3	followed	VBN	O	follow	_	0	SENT_95	[p7l750t2580r1066b2642],
4	for	IN	O	for	_	0	SENT_95	[p7l1118t2579r1222b2642],
5	toxicity	NN	O	toxicity	nn	6	SENT_95	[p7l1272t2580r1544b2661],
6	assessment	NN	O	assessment	prep_for	3	SENT_95	[p7l1599t2589r1994b2642],
7	for	IN	O	for	_	0	SENT_95	[p7l2046t2579r2150b2642],
8	30	CD	DURATION	30	num	9	SENT_95	[p7l16t2693r100b2755],
9	days	NNS	NUMBER	day	prep_for	6	SENT_95	[p7l134t2692r292b2773],
10	after	IN	O	after	_	0	SENT_95	[p7l328t2692r491b2755],
11	going	VBG	O	go	prepc_after	3	SENT_95	[p7l523t2692r722b2773],
12	off	RP	O	off	prt	11	SENT_95	[p7l757t2692r1099b2773],
13	—	CD	NUMBER	—	num	14	SENT_95	[p7l757t2692r1099b2773],
14	study	NN	O	study	dobj	11	SENT_95	[p7l757t2692r1099b2773],
15	.	.	O	.	_	0	SENT_95	[p7l757t2692r1099b2773],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_96	[p7l14t2916r614b2979],
2	sampling	NN	O	sampling	_	0	SENT_96	[p7l651t2916r973b2997],
3	and	CC	O	and	_	0	SENT_96	[p7l1009t2916r1135b2979],
4	analysis	NN	O	analysis	conj_and	2	SENT_96	[p7l1169t2916r1451b2997],

1	Capecitabine	NN	O	capecitabine	nsubjpass	33	SENT_97	[p7l15t3139r480b3220],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_97	[p7l509t3139r1106b3220],
3	samples	NNS	O	sample	nsubjpass	5	SENT_97	[p7l1140t3139r1422b3220],
4	were	VBD	O	be	auxpass	5	SENT_97	[p7l1453t3159r1624b3202],
5	collected	VBN	O	collect	rcmod	1	SENT_97	[p7l1654t3139r1978b3202],
6	pretreatment	NN	O	pretreatment	nn	10	SENT_97	[p7l2004t3159r2145b3220, p7l14t3260r353b3313],
7	and	CC	O	and	_	0	SENT_97	[p7l378t3250r504b3313],
8	post	NN	O	post	nn	10	SENT_97	[p7l526t3260r1045b3331],
9	—	NN	O	—	nn	10	SENT_97	[p7l526t3260r1045b3331],
10	treatment	NN	O	treatment	dobj	5	SENT_97	[p7l526t3260r1045b3331],
11	at	IN	O	at	_	0	SENT_97	[p7l1070t3260r1132b3313],
12	0.25	CD	NUMBER	0.25	prep_at	5	SENT_97	[p7l1156t3250r1327b3324],
13	,	,	O	,	_	0	SENT_97	[p7l1156t3250r1327b3324],
14	0.5	CD	NUMBER	0.5	conj_and	12	SENT_97	[p7l1356t3250r1483b3324],
15	,	,	O	,	_	0	SENT_97	[p7l1356t3250r1483b3324],
16	l	NN	O	l	conj_and	12	SENT_97	[p7l1520t3251r1573b3325],
17	,	,	O	,	_	0	SENT_97	[p7l1520t3251r1573b3325],
18	2	CD	NUMBER	2	conj_and	12	SENT_97	[p7l1601t3251r1661b3324],
19	,	,	O	,	_	0	SENT_97	[p7l1601t3251r1661b3324],
20	3	CD	NUMBER	3	conj_and	12	SENT_97	[p7l1691t3251r1749b3324],
21	,	,	O	,	_	0	SENT_97	[p7l1691t3251r1749b3324],
22	4	CD	NUMBER	4	conj_and	12	SENT_97	[p7l1776t3251r1838b3324],
23	,	,	O	,	_	0	SENT_97	[p7l1776t3251r1838b3324],
24	5	CD	NUMBER	5	conj_and	12	SENT_97	[p7l1867t3250r1927b3324],
25	,	,	O	,	_	0	SENT_97	[p7l1867t3250r1927b3324],
26	6	CD	NUMBER	6	conj_and	12	SENT_97	[p7l1956t3250r1995b3313],
27	and	CC	O	and	_	0	SENT_97	[p7l2022t3250r2148b3313],
28	8	CD	NUMBER	8	num	31	SENT_97	[p7l18t3361r53b3424],
29	h.	NN	O	h.	nn	31	SENT_97	[p7l88t3361r148b3423],
30	Trough	NN	O	trough	nn	31	SENT_97	[p7l196t3361r457b3442],
31	levels	NNS	O	level	conj_and	12	SENT_97	[p7l500t3361r705b3424],
32	were	VBD	O	be	auxpass	33	SENT_97	[p7l751t3380r921b3424],
33	evaluated	VBN	O	evaluate	_	0	SENT_97	[p7l966t3361r1308b3424],
34	by	IN	O	by	_	0	SENT_97	[p7l1350t3361r1437b3442],
35	obtaining	VBG	O	obtain	agent	33	SENT_97	[p7l1482t3361r1817b3442],
36	samples	NNS	O	sample	dobj	35	SENT_97	[p7l1864t3361r2146b3442],
37	within	IN	O	within	_	0	SENT_97	[p7l14t3472r240b3535],
38	30	CD	DURATION	30	num	39	SENT_97	[p7l268t3472r352b3535],
39	min	NN	DURATION	min	prep_within	35	SENT_97	[p7l385t3472r522b3534],
40	prior	RB	O	prior	_	0	SENT_97	[p7l545t3472r720b3553],
41	to	TO	O	to	_	0	SENT_97	[p7l743t3481r809b3534],
42	the	DT	O	the	det	44	SENT_97	[p7l835t3472r942b3534],
43	dose	NN	O	dose	nn	44	SENT_97	[p7l968t3472r1128b3534],
44	administration	NN	O	administration	prep_prior_to	39	SENT_97	[p7l1156t3472r1671b3534],
45	on	IN	O	on	_	0	SENT_97	[p7l1696t3491r1783b3534],
46	days	NNS	DURATION	day	prep_on	39	SENT_97	[p7l1808t3472r1967b3553],
47	2	CD	NUMBER	2	dep	39	SENT_97	[p7l1995t3472r2055b3546],
48	,	,	O	,	_	0	SENT_97	[p7l1995t3472r2055b3546],
49	8	CD	NUMBER	8	num	47	SENT_97	[p7l2087t3472r2144b3546],
50	,	,	O	,	_	0	SENT_97	[p7l2087t3472r2144b3546],
51	and	CC	NUMBER	and	_	0	SENT_97	[p7l16t3583r142b3645],
52	15	CD	NUMBER	15	dep	39	SENT_97	[p7l191t3583r266b3646],
53	of	IN	O	of	_	0	SENT_97	[p7l312t3583r389b3645],
54	cycle	NN	O	cycle	prep_of	47	SENT_97	[p7l426t3583r611b3664],
55	1	CD	NUMBER	1	num	54	SENT_97	[p7l663t3583r688b3645],
56	with	IN	O	with	_	0	SENT_97	[p7l738t3583r894b3646],
57	optional	JJ	O	optional	amod	59	SENT_97	[p7l938t3583r1227b3664],
58	weekly	JJ	SET	weekly	amod	59	SENT_97	[p7l1271t3583r1525b3664],
59	samples	NNS	O	sample	prep_with	35	SENT_97	[p7l1571t3583r1853b3664],
60	for	IN	O	for	_	0	SENT_97	[p7l1897t3583r2000b3645],
61	the	DT	O	the	det	62	SENT_97	[p7l2040t3583r2147b3645],
62	duration	NN	O	duration	prep_for	59	SENT_97	[p7l15t3694r311b3757],
63	of	IN	O	of	_	0	SENT_97	[p7l386t3694r463b3757],
64	the	DT	O	the	det	65	SENT_97	[p7l531t3694r637b3757],
65	study	NN	O	study	prep_of	62	SENT_97	[p7l716t3694r921b3775],
66	.	.	O	.	_	0	SENT_97	[p7l716t3694r921b3775],

1	Tetrahydrouridine	NNP	PERSON	Tetrahydrouridine	nsubjpass	9	SENT_98	[p7l1001t3694r1671b3775],
2	,	,	O	,	_	0	SENT_98	[p7l1001t3694r1671b3775],
3	a	DT	O	a	det	6	SENT_98	[p7l1750t3714r1787b3757],
4	cytidine	NN	O	cytidine	nn	6	SENT_98	[p7l1861t3694r2146b3775],
5	deaminase	NN	O	deaminase	nn	6	SENT_98	[p8l15t22r390b84],
6	inhibitor	NN	O	inhibitor	appos	1	SENT_98	[p8l424t22r750b95],
7	,	,	O	,	_	0	SENT_98	[p8l424t22r750b95],
8	was	VBD	O	be	auxpass	9	SENT_98	[p8l786t42r920b84],
9	added	VBN	O	add	_	0	SENT_98	[p8l957t22r1168b84],
10	at	IN	O	at	_	0	SENT_98	[p8l1202t31r1264b84],
11	a	DT	O	a	det	13	SENT_98	[p8l1297t42r1334b84],
12	ﬁnal	JJ	O	ﬁnal	amod	13	SENT_98	[p8l1367t22r1522b84],
13	concentration	NN	O	concentration	prep_at	9	SENT_98	[p8l1556t22r2043b84],
14	of	IN	O	of	_	0	SENT_98	[p8l2076t22r2153b84],
15	400	CD	NUMBER	400	num	16	SENT_98	[p8l13t133r145b196],
16	nM	NN	O	nm	prep_of	13	SENT_98	[p8l177t135r299b195],
17	to	TO	O	to	aux	18	SENT_98	[p8l362t142r429b196],
18	increase	VB	O	increase	xcomp	9	SENT_98	[p8l494t133r786b196],
19	the	DT	O	the	det	20	SENT_98	[p8l850t133r957b196],
20	stability	NN	O	stability	dobj	18	SENT_98	[p8l1024t133r1308b214],
21	of	IN	O	of	_	0	SENT_98	[p8l1374t133r1451b196],
22	capecitabine	NN	O	capecitabine	prep_of	20	SENT_98	[p8l1510t133r1956b214],
23	and	CC	O	and	_	0	SENT_98	[p8l2022t133r2148b196],
24	metabolites	NNS	O	metabolite	prep_of	20	SENT_98	[p8l14t244r424b307],
25	in	IN	O	in	_	0	SENT_98	[p8l458t244r526b306],
26	plasma	NN	O	plasma	prep_in	18	SENT_98	[p8l556t244r810b325],
27	during	IN	O	during	_	0	SENT_98	[p8l842t244r1072b325],
28	storage	NN	O	storage	prep_during	18	SENT_98	[p8l1108t254r1361b325],
29	in	IN	O	in	_	0	SENT_98	[p8l1394t244r1461b306],
30	the	DT	O	the	det	32	SENT_98	[p8l1493t244r1600b307],
31	freezer	NN	O	freezer	nn	32	SENT_98	[p8l1633t244r1882b307],
32	[	NN	O	[	prep_in	28	SENT_98	[p8l1918t244r2003b320],
33	5	CD	NUMBER	5	dep	32	SENT_98	[p8l1918t244r2003b320],
34	,	,	O	,	_	0	SENT_98	[p8l1918t244r2003b320],
35	26	CD	NUMBER	26	appos	32	SENT_98	[p8l2040t244r2144b318],
36	,	,	O	,	_	0	SENT_98	[p8l2040t244r2144b318],
37	34	CD	NUMBER	34	num	38	SENT_98	[p8l11t356r143b432],
38	]	NN	O	]	appos	35	SENT_98	[p8l11t356r143b432],
39	.	.	O	.	_	0	SENT_98	[p8l11t356r143b432],

1	Capecitabine	NN	O	capecitabine	nsubj	4	SENT_99	[p8l190t355r657b437],
2	and	CC	O	and	_	0	SENT_99	[p8l701t356r827b419],
3	metabolites	NNS	O	metabolite	conj_and	1	SENT_99	[p8l867t355r1279b419],
4	(	VBP	O	(	_	0	SENT_99	[p8l1325t349r2149b437],
5	5	CD	NUMBER	5	number	6	SENT_99	[p8l1325t349r2149b437],
6	—	CD	NUMBER	—	num	8	SENT_99	[p8l1325t349r2149b437],
7	ﬂuoro	NN	O	ﬂuoro	nn	8	SENT_99	[p8l1325t349r2149b437],
8	—	NN	O	—	dobj	4	SENT_99	[p8l1325t349r2149b437],
9	5	CD	NUMBER	5	dep	8	SENT_99	[p8l1325t349r2149b437],
10	’	SYM	O	’	dep	8	SENT_99	[p8l1325t349r2149b437],
11	-	:	O	-	_	0	SENT_99	[p8l1325t349r2149b437],
12	deoXycyti	NN	O	deoxycytus	nsubj	14	SENT_99	[p8l1325t349r2149b437],
13	—	CD	NUMBER	—	num	12	SENT_99	[p8l1325t349r2149b437],
14	dine	VBP	O	dine	parataxis	4	SENT_99	[p8l9t468r160b531],
15	(	CD	NUMBER	(	number	16	SENT_99	[p8l190t461r594b546],
16	5	CD	NUMBER	5	num	17	SENT_99	[p8l190t461r594b546],
17	’	NN	O	’	dobj	14	SENT_99	[p8l190t461r594b546],
18	.	.	O	.	_	0	SENT_99	[p8l190t461r594b546],

1	—	NN	O	—	_	0	SENT_100	[p8l190t461r594b546],
2	.	.	O	.	_	0	SENT_100	[p8l190t461r594b546],

1	DFCR	NN	O	dfcr	nn	2	SENT_101	[p8l190t461r594b546],
2	)	NN	O	)	_	0	SENT_101	[p8l190t461r594b546],
3	,	,	O	,	_	0	SENT_101	[p8l190t461r594b546],
4	5	CD	NUMBER	5	num	5	SENT_101	[p8l624t461r1557b549],
5	—	NN	O	—	appos	2	SENT_101	[p8l624t461r1557b549],
6	ﬂuoro	NN	O	ﬂuoro	rcmod	5	SENT_101	[p8l624t461r1557b549],
7	—	CD	NUMBER	—	number	8	SENT_101	[p8l624t461r1557b549],
8	5	CD	NUMBER	5	dep	6	SENT_101	[p8l624t461r1557b549],
9	’	SYM	O	’	dep	6	SENT_101	[p8l624t461r1557b549],
10	-	:	O	-	_	0	SENT_101	[p8l624t461r1557b549],
11	dexoxyuridine	NN	O	dexoxyuridine	dep	2	SENT_101	[p8l624t461r1557b549],
12	(	CD	NUMBER	(	number	13	SENT_101	[p8l1586t461r1995b546],
13	5	CD	NUMBER	5	num	14	SENT_101	[p8l1586t461r1995b546],
14	’	NN	O	’	dep	11	SENT_101	[p8l1586t461r1995b546],
15	.	.	O	.	_	0	SENT_101	[p8l1586t461r1995b546],

1	—	NN	O	—	_	0	SENT_102	[p8l1586t461r1995b546],
2	.	.	O	.	_	0	SENT_102	[p8l1586t461r1995b546],

1	DFUR	NN	O	dfur	_	0	SENT_103	[p8l1586t461r1995b546],
2	)	NN	O	)	dep	1	SENT_103	[p8l1586t461r1995b546],
3	,	,	O	,	_	0	SENT_103	[p8l1586t461r1995b546],
4	and	CC	O	and	_	0	SENT_103	[p8l2026t468r2152b531],
5	5	CD	NUMBER	5	dep	1	SENT_103	[p8l10t579r222b656],
6	.	.	O	.	_	0	SENT_103	[p8l10t579r222b656],

1	—	NN	O	—	_	0	SENT_104	[p8l10t579r222b656],
2	.	.	O	.	_	0	SENT_104	[p8l10t579r222b656],

1	FU	NNP	O	FU	nn	3	SENT_105	[p8l10t579r222b656],
2	)	NN	O	)	nn	3	SENT_105	[p8l10t579r222b656],
3	concentrations	NNS	O	concentration	nsubjpass	5	SENT_105	[p8l280t579r801b641],
4	were	VBD	O	be	auxpass	5	SENT_105	[p8l859t598r1030b642],
5	measured	VBN	O	measure	_	0	SENT_105	[p8l1085t579r1430b641],
6	using	VBG	O	use	xcomp	5	SENT_105	[p8l1483t579r1675b660],
7	a	DT	O	a	dobj	6	SENT_105	[p8l1732t598r1769b641],
8	validated	VBN	O	validate	partmod	7	SENT_105	[p8l1823t579r2152b641],
9	analytical	JJ	O	analytical	amod	10	SENT_105	[p8l10t690r357b771],
10	assay	NN	O	assay	dobj	8	SENT_105	[p8l422t709r613b771],
11	consisting	VBG	O	consist	xcomp	8	SENT_105	[p8l677t690r1037b771],
12	of	IN	O	of	_	0	SENT_105	[p8l1103t690r1180b752],
13	high	JJ	O	high	amod	15	SENT_105	[p8l1236t690r1880b771],
14	—	NN	O	—	nn	15	SENT_105	[p8l1236t690r1880b771],
15	performance	NN	O	performance	prep_of	11	SENT_105	[p8l1236t690r1880b771],
16	liquid	JJ	O	liquid	amod	17	SENT_105	[p8l1944t690r2152b771],
17	chromatography	NN	O	chromatography	dobj	11	SENT_105	[p8l9t800r596b881],
18	with	IN	O	with	_	0	SENT_105	[p8l625t800r782b862],
19	tandem	JJ	O	tandem	amod	22	SENT_105	[p8l809t800r1074b862],
20	mass	NN	O	mass	nn	22	SENT_105	[p8l1101t819r1276b862],
21	spectrometric	JJ	O	spectrometric	amod	22	SENT_105	[p8l1309t800r1793b881],
22	detection	NN	O	detection	prep_with	17	SENT_105	[p8l1824t800r2151b862],
23	over	IN	O	over	_	0	SENT_105	[p8l9t932r167b975],
24	the	DT	O	the	det	25	SENT_105	[p8l196t912r303b975],
25	range	NN	O	range	prep_over	22	SENT_105	[p8l334t932r532b993],
26	of	IN	O	of	_	0	SENT_105	[p8l564t912r641b975],
27	50	CD	NUMBER	50	number	28	SENT_105	[p8l668t912r1045b986],
28	—	CD	NUMBER	—	num	29	SENT_105	[p8l668t912r1045b986],
29	l0	NN	O	l0	prep_of	25	SENT_105	[p8l668t912r1045b986],
30	,000	CD	NUMBER	,000	num	31	SENT_105	[p8l668t912r1045b986],
31	ng/mL	NN	O	ng/ml	dep	29	SENT_105	[p8l1078t913r1316b993],
32	[	CD	NUMBER	[	number	33	SENT_105	[p8l1353t913r1512b988],
33	34	CD	NUMBER	34	num	34	SENT_105	[p8l1353t913r1512b988],
34	]	NN	O	]	dep	31	SENT_105	[p8l1353t913r1512b988],
35	.	.	O	.	_	0	SENT_105	[p8l1353t913r1512b988],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_106	[p8l1547t912r2150b975],
2	parameters	NNS	O	parameter	nsubjpass	4	SENT_106	[p8l7t1032r400b1104],
3	were	VBD	O	be	auxpass	4	SENT_106	[p8l432t1043r603b1086],
4	calculated	VBN	O	calculate	_	0	SENT_106	[p8l634t1023r999b1086],
5	by	IN	O	by	_	0	SENT_106	[p8l1027t1023r1114b1104],
6	standard	JJ	O	standard	amod	8	SENT_106	[p8l1148t1023r1448b1086],
7	noncompartmental	JJ	O	noncompartmental	amod	8	SENT_106	[p8l1477t1023r2151b1104],
8	methods	NNS	O	method	agent	4	SENT_106	[p8l8t1134r309b1197],
9	using	VBG	O	use	partmod	8	SENT_106	[p8l361t1134r553b1215],
10	WinNonlin	NNP	O	WinNonlin	dobj	9	SENT_106	[p8l603t1134r1008b1197],
11	professional	JJ	O	professional	amod	13	SENT_106	[p8l1057t1134r1494b1215],
12	(	NN	O	(	nn	13	SENT_106	[p8l1549t1134r1838b1211],
13	version	NN	O	version	nsubj	18	SENT_106	[p8l1549t1134r1838b1211],
14	5.3	CD	NUMBER	5.3	num	15	SENT_106	[p8l1891t1134r2026b1211],
15	)	NN	O	)	npadvmod	16	SENT_106	[p8l1891t1134r2026b1211],
16	as	IN	O	as	advmod	18	SENT_106	[p8l2081t1154r2150b1197],
17	previously	RB	DATE	previously	advmod	18	SENT_106	[p8l7t1245r386b1326],
18	described	VBN	O	describe	rcmod	10	SENT_106	[p8l432t1245r775b1308],
19	[	NN	O	[	tmod	18	SENT_106	[p8l826t1246r911b1321],
20	1	CD	NUMBER	1	num	19	SENT_106	[p8l826t1246r911b1321],
21	,	,	O	,	_	0	SENT_106	[p8l826t1246r911b1321],
22	14	CD	NUMBER	14	num	23	SENT_106	[p8l969t1246r1095b1321],
23	]	NN	O	]	appos	19	SENT_106	[p8l969t1246r1095b1321],
24	.	.	O	.	_	0	SENT_106	[p8l969t1246r1095b1321],

1	The	DT	O	the	det	2	SENT_107	[p8l1145t1245r1282b1308],
2	effect	NN	O	effect	nsubjpass	12	SENT_107	[p8l1329t1245r1532b1308],
3	of	IN	O	of	_	0	SENT_107	[p8l1578t1245r1656b1308],
4	BSA	NN	ORGANIZATION	bsa	prep_of	2	SENT_107	[p8l1695t1246r1866b1308],
5	on	IN	O	on	_	0	SENT_107	[p8l1913t1265r1999b1308],
6	the	DT	O	the	det	8	SENT_107	[p8l2044t1245r2151b1308],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_107	[p8l7t1356r606b1437],
8	parameters	NNS	O	parameter	prep_on	4	SENT_107	[p8l645t1366r1038b1437],
9	of	IN	O	of	_	0	SENT_107	[p8l1079t1356r1156b1419],
10	capecitabine	NN	O	capecitabine	prep_of	8	SENT_107	[p8l1188t1356r1637b1437],
11	was	VBD	O	be	auxpass	12	SENT_107	[p8l1676t1376r1810b1419],
12	assessed	VBN	O	assess	_	0	SENT_107	[p8l1852t1356r2152b1419],
13	as	IN	O	as	mark	15	SENT_107	[p8l10t1486r79b1529],
14	previously	RB	DATE	previously	advmod	15	SENT_107	[p8l112t1467r491b1548],
15	described	VBN	O	describe	advcl	12	SENT_107	[p8l524t1467r867b1529],
16	[	NN	O	[	nn	18	SENT_107	[p8l906t1467r1020b1543],
17	4	CD	NUMBER	4	num	18	SENT_107	[p8l906t1467r1020b1543],
18	]	NN	O	]	dobj	15	SENT_107	[p8l906t1467r1020b1543],
19	.	.	O	.	_	0	SENT_107	[p8l906t1467r1020b1543],

1	Adherence	NN	O	adherence	nn	2	SENT_108	[p8l8t1691r396b1754],
2	studies	NNS	O	study	_	0	SENT_108	[p8l432t1691r675b1754],

1	Patients	NNS	O	patient	nsubj	2	SENT_109	[p8l8t1915r290b1978],
2	completed	VBD	O	complete	_	0	SENT_109	[p8l317t1915r691b1996],
3	a	DT	O	a	det	5	SENT_109	[p8l716t1935r753b1978],
4	pill	NN	O	pill	nn	5	SENT_109	[p8l775t1915r894b1996],
5	diary	NN	O	diary	dobj	2	SENT_109	[p8l920t1915r1101b1996],
6	noting	VBG	O	note	partmod	5	SENT_109	[p8l1126t1915r1353b1996],
7	the	DT	O	the	det	8	SENT_109	[p8l1379t1915r1486b1978],
8	date	NN	O	date	dobj	6	SENT_109	[p8l1512t1915r1658b1978],
9	and	CC	O	and	_	0	SENT_109	[p8l1686t1915r1812b1978],
10	time	NN	O	time	conj_and	8	SENT_109	[p8l1836t1915r1993b1978],
11	that	IN	O	that	complm	15	SENT_109	[p8l2019t1915r2153b1978],
12	each	DT	O	each	det	13	SENT_109	[p8l9t2026r171b2089],
13	dose	NN	O	dose	nsubjpass	15	SENT_109	[p8l205t2026r365b2089],
14	was	VBD	O	be	auxpass	15	SENT_109	[p8l398t2046r533b2089],
15	taken	VBN	O	take	ccomp	6	SENT_109	[p8l566t2026r779b2100],
16	,	,	O	,	_	0	SENT_109	[p8l566t2026r779b2100],
17	including	VBG	O	include	_	0	SENT_109	[p8l814t2026r1152b2107],
18	any	DT	O	any	det	20	SENT_109	[p8l1186t2046r1311b2107],
19	dose	NN	O	dose	nn	20	SENT_109	[p8l1345t2026r1506b2089],
20	modiﬁcation	NN	O	modiﬁcation	prep_including	2	SENT_109	[p8l1539t2026r1993b2089],
21	and	CC	O	and	_	0	SENT_109	[p8l2026t2026r2152b2089],
22	reason	NN	O	reason	prep_including	2	SENT_109	[p8l7t2157r258b2199],
23	.	.	O	.	_	0	SENT_109	[p8l7t2157r258b2199],

1	In	IN	O	in	_	0	SENT_110	[p8l293t2138r366b2199],
2	addition	NN	O	addition	prep_in	7	SENT_110	[p8l397t2137r708b2211],
3	,	,	O	,	_	0	SENT_110	[p8l397t2137r708b2211],
4	the	DT	O	the	det	5	SENT_110	[p8l741t2137r849b2199],
5	MEMS	NNP	O	MEMS	nsubjpass	7	SENT_110	[p8l879t2137r1137b2200],
6	was	VBD	O	be	auxpass	7	SENT_110	[p8l1171t2157r1306b2200],
7	utilized	VBN	O	utilize	_	0	SENT_110	[p8l1337t2137r1608b2199],
8	to	TO	O	to	aux	9	SENT_110	[p8l1637t2146r1703b2199],
9	collect	VB	O	collect	xcomp	7	SENT_110	[p8l1735t2137r1975b2199],
10	data	NNS	O	datum	dobj	9	SENT_110	[p8l2005t2137r2153b2199],
11	on	IN	O	on	_	0	SENT_110	[p8l9t2269r96b2312],
12	medication	NN	O	medication	nn	13	SENT_110	[p8l127t2249r525b2312],
13	adherence	NN	O	adherence	prep_on	9	SENT_110	[p8l559t2249r939b2312],
14	.	.	O	.	_	0	SENT_110	[p8l559t2249r939b2312],

1	If	IN	O	if	mark	6	SENT_111	[p8l974t2249r1037b2311],
2	the	DT	O	the	det	4	SENT_111	[p8l1062t2249r1170b2312],
3	MEMS	NNP	O	MEMS	nn	4	SENT_111	[p8l1201t2250r1459b2312],
4	cap	NN	O	cap	nsubjpass	6	SENT_111	[p8l1495t2269r1616b2330],
5	was	VBD	O	be	auxpass	6	SENT_111	[p8l1649t2269r1783b2312],
6	removed	VBN	O	remove	advcl	10	SENT_111	[p8l1815t2249r2149b2324],
7	,	,	O	,	_	0	SENT_111	[p8l1815t2249r2149b2324],
8	it	PRP	O	it	nsubjpass	10	SENT_111	[p8l8t2360r57b2423],
9	was	VBD	O	be	auxpass	10	SENT_111	[p8l83t2380r217b2423],
10	presumed	VBN	O	presume	_	0	SENT_111	[p8l244t2360r593b2441],
11	that	IN	O	that	complm	14	SENT_111	[p8l619t2360r753b2423],
12	the	DT	O	the	det	13	SENT_111	[p8l778t2360r885b2423],
13	patient	NN	O	patient	nsubj	14	SENT_111	[p8l911t2360r1156b2441],
14	took	VBD	O	take	ccomp	10	SENT_111	[p8l1181t2360r1341b2423],
15	the	DT	O	the	det	16	SENT_111	[p8l1365t2360r1472b2423],
16	medication	NN	O	medication	dobj	14	SENT_111	[p8l1499t2360r1898b2423],
17	within	IN	O	within	_	0	SENT_111	[p8l1925t2360r2152b2423],
18	30	CD	DURATION	30	num	19	SENT_111	[p8l11t2471r95b2534],
19	min	NN	DURATION	min	prep_within	14	SENT_111	[p8l128t2471r284b2533],
20	.	.	O	.	_	0	SENT_111	[p8l128t2471r284b2533],

1	Adherence	NN	O	adherence	nsubjpass	3	SENT_112	[p8l324t2471r711b2533],
2	was	VBD	O	be	auxpass	3	SENT_112	[p8l748t2490r882b2534],
3	calculated	VBN	O	calculate	_	0	SENT_112	[p8l921t2471r1286b2533],
4	utilizing	VBG	O	utilize	xcomp	3	SENT_112	[p8l1320t2471r1619b2552],
5	both	DT	O	both	det	6	SENT_112	[p8l1654t2471r1814b2533],
6	methods	NNS	O	method	dobj	4	SENT_112	[p8l1849t2471r2150b2533],
7	based	VBN	O	base	_	0	SENT_112	[p8l7t2582r212b2644],
8	on	IN	O	on	prepc_based_on	4	SENT_112	[p8l271t2601r357b2644],
9	the	DT	O	the	det	10	SENT_112	[p8l415t2582r522b2644],
10	number	NN	O	number	pobj	4	SENT_112	[p8l581t2582r856b2644],
11	of	IN	O	of	_	0	SENT_112	[p8l914t2582r991b2644],
12	doses	NNS	O	dose	prep_of	10	SENT_112	[p8l1045t2582r1239b2644],
13	administered	VBN	O	administer	partmod	12	SENT_112	[p8l1302t2582r1764b2644],
14	per	IN	O	per	_	0	SENT_112	[p8l1821t2601r1937b2663],
15	total	JJ	O	total	amod	16	SENT_112	[p8l1994t2582r2151b2644],
16	number	NN	O	number	prep_per	13	SENT_112	[p8l8t2693r283b2755],
17	of	IN	O	of	_	0	SENT_112	[p8l315t2693r392b2755],
18	doses	NNS	O	dose	prep_of	16	SENT_112	[p8l419t2693r614b2755],
19	per	IN	O	per	_	0	SENT_112	[p8l647t2712r762b2774],
20	cycle	NN	O	cycle	nn	22	SENT_112	[p8l794t2693r981b2774],
21	(	NN	O	(	nn	22	SENT_112	[p8l1017t2693r1086b2770],
22	n	NN	O	n	prep_per	18	SENT_112	[p8l1017t2693r1086b2770],
23	=	JJ	O	=	amod	22	SENT_112	[p8l1123t2721r1183b2745],
24	28	CD	NUMBER	28	num	25	SENT_112	[p8l1220t2693r1355b2770],
25	)	NN	O	)	dep	23	SENT_112	[p8l1220t2693r1355b2770],
26	.	.	O	.	_	0	SENT_112	[p8l1220t2693r1355b2770],

1	Pharmacogenomic	JJ	O	pharmacogenomic	amod	2	SENT_113	[p8l8t2916r676b2997],
2	studies	NNS	O	study	_	0	SENT_113	[p8l713t2916r956b2979],

1	The	DT	O	the	det	2	SENT_114	[p8l8t3139r145b3202],
2	three	CD	NUMBER	three	nsubj	4	SENT_114	[p8l192t3139r545b3220],
3	—	JJ	O	—	amod	4	SENT_114	[p8l192t3139r545b3220],
4	step	NN	O	step	_	0	SENT_114	[p8l192t3139r545b3220],
5	enzymatic	JJ	O	enzymatic	amod	6	SENT_114	[p8l593t3139r959b3220],
6	process	NN	O	process	dobj	4	SENT_114	[p8l1006t3159r1273b3220],
7	of	IN	O	of	_	0	SENT_114	[p8l1322t3139r1399b3202],
8	pro	FW	O	pro	nn	11	SENT_114	[p8l1438t3139r1750b3220],
9	—	FW	O	—	nn	11	SENT_114	[p8l1438t3139r1750b3220],
10	drug	NN	O	drug	nn	11	SENT_114	[p8l1438t3139r1750b3220],
11	activation	NN	O	activation	prep_of	6	SENT_114	[p8l1799t3139r2152b3202],
12	from	IN	O	from	_	0	SENT_114	[p8l9t3251r181b3314],
13	capecitabine	NN	O	capecitabine	prep_from	11	SENT_114	[p8l210t3251r658b3332],
14	to	TO	O	to	_	0	SENT_114	[p8l687t3260r754b3314],
15	5	CD	NUMBER	5	number	16	SENT_114	[p8l785t3244r1113b3314],
16	’	CD	NUMBER	’	prep_to	4	SENT_114	[p8l785t3244r1113b3314],
17	.	.	O	.	_	0	SENT_114	[p8l785t3244r1113b3314],

1	—	NN	O	—	_	0	SENT_115	[p8l785t3244r1113b3314],
2	.	.	O	.	_	0	SENT_115	[p8l785t3244r1113b3314],

1	DFCR	NN	ORGANIZATION	dfcr	_	0	SENT_116	[p8l785t3244r1113b3314],
2	and	CC	O	and	_	0	SENT_116	[p8l1142t3251r1268b3314],
3	then	RB	O	then	advmod	5	SENT_116	[p8l1296t3251r1449b3314],
4	5	CD	NUMBER	5	num	5	SENT_116	[p8l1478t3244r1810b3314],
5	’	NN	O	’	conj_and	1	SENT_116	[p8l1478t3244r1810b3314],
6	.	.	O	.	_	0	SENT_116	[p8l1478t3244r1810b3314],

1	—	NN	O	—	_	0	SENT_117	[p8l1478t3244r1810b3314],
2	.	.	O	.	_	0	SENT_117	[p8l1478t3244r1810b3314],

1	DFUR	NN	ORGANIZATION	dfur	nsubjpass	5	SENT_118	[p8l1478t3244r1810b3314],
2	has	VBZ	O	have	aux	5	SENT_118	[p8l1837t3251r1954b3314],
3	been	VBN	O	be	auxpass	5	SENT_118	[p8l1983t3251r2152b3314],
4	well	RB	O	well	advmod	5	SENT_118	[p8l9t3362r160b3425],
5	described	VBN	O	describe	_	0	SENT_118	[p8l193t3362r552b3425],
6	.	.	O	.	_	0	SENT_118	[p8l193t3362r552b3425],

1	Thymidine	NN	O	thymidine	nn	2	SENT_119	[p8l588t3362r981b3443],
2	phosphorylase	NN	O	phosphorylase	_	0	SENT_119	[p8l1011t3362r1529b3443],
3	(	CD	NUMBER	(	num	5	SENT_119	[p8l1563t3363r1719b3440],
4	TP	NN	O	tp	nn	5	SENT_119	[p8l1563t3363r1719b3440],
5	)	NN	O	)	dep	2	SENT_119	[p8l1563t3363r1719b3440],
6	as	IN	O	as	_	0	SENT_119	[p8l1755t3382r1823b3425],
7	the	DT	O	the	det	9	SENT_119	[p8l1855t3362r1963b3425],
8	ﬁnal	JJ	O	ﬁnal	amod	9	SENT_119	[p8l1995t3362r2151b3425],
9	enzyme	NN	O	enzyme	prep_as	5	SENT_119	[p8l9t3492r285b3554],
10	involved	VBN	O	involve	partmod	2	SENT_119	[p8l322t3473r635b3536],
11	in	IN	O	in	_	0	SENT_119	[p8l669t3473r737b3535],
12	the	DT	O	the	det	13	SENT_119	[p8l772t3473r879b3535],
13	conversion	NN	O	conversion	prep_in	10	SENT_119	[p8l915t3473r1306b3535],
14	to	TO	O	to	_	0	SENT_119	[p8l1341t3482r1408b3535],
15	5	CD	NUMBER	5	prep_to	10	SENT_119	[p8l1445t3473r1631b3536],
16	.	.	O	.	_	0	SENT_119	[p8l1445t3473r1631b3536],

1	—	NN	O	—	_	0	SENT_120	[p8l1445t3473r1631b3536],
2	.	.	O	.	_	0	SENT_120	[p8l1445t3473r1631b3536],

1	FU	NNP	O	FU	nsubj	4	SENT_121	[p8l1445t3473r1631b3536],
2	is	VBZ	O	be	cop	4	SENT_121	[p8l1665t3473r1721b3535],
3	tumor	NN	O	tumor	nn	4	SENT_121	[p8l1757t3482r1971b3535],
4	speciﬁc	NN	O	speciﬁc	_	0	SENT_121	[p8l2008t3492r2149b3554, p8l9t3584r159b3646],
5	and	CC	O	and	_	0	SENT_121	[p8l221t3584r348b3646],
6	selectively	RB	O	selectively	advmod	7	SENT_121	[p8l408t3584r789b3665],
7	upregulated	VBN	O	upregulate	conj_and	4	SENT_121	[p8l846t3584r1271b3665],
8	by	IN	O	by	_	0	SENT_121	[p8l1328t3584r1415b3665],
9	capecitabine	NN	O	capecitabine	prep_by	7	SENT_121	[p8l1475t3584r1943b3665],
10	,	,	O	,	_	0	SENT_121	[p8l1475t3584r1943b3665],
11	[	CD	NUMBER	[	number	12	SENT_121	[p8l2011t3584r2146b3660],
12	28	CD	NUMBER	28	num	13	SENT_121	[p8l2011t3584r2146b3660],
13	]	NN	O	]	appos	9	SENT_121	[p8l2011t3584r2146b3660],
14	while	IN	O	while	_	0	SENT_121	[p8l9t3695r205b3758],
15	5	CD	NUMBER	5	prep_while	7	SENT_121	[p8l245t3695r430b3758],
16	.	.	O	.	_	0	SENT_121	[p8l245t3695r430b3758],

1	—	NN	O	—	_	0	SENT_122	[p8l245t3695r430b3758],
2	.	.	O	.	_	0	SENT_122	[p8l245t3695r430b3758],

1	FU	NNP	O	FU	nsubjpass	3	SENT_123	[p8l245t3695r430b3758],
2	is	VBZ	O	be	auxpass	3	SENT_123	[p8l467t3695r523b3757],
3	inactivated	VBN	O	inactivate	_	0	SENT_123	[p8l562t3695r957b3758],
4	by	IN	O	by	_	0	SENT_123	[p8l992t3695r1080b3776],
5	dihydropyrimidine	NN	O	dihydropyrimidine	nn	6	SENT_123	[p8l1119t3695r1791b3776],
6	dehydrogenase	NN	O	dehydrogenase	agent	3	SENT_123	[p8l1830t3695r2149b3776, p9l9t42r251b103],

1	(	NN	O	(	nn	2	SENT_124	[p9l281t23r576b99],
2	DPYD	NN	O	dpyd	_	0	SENT_124	[p9l281t23r576b99],
3	)	CD	NUMBER	)	number	4	SENT_124	[p9l281t23r576b99],
4	[	CD	NUMBER	[	dep	2	SENT_124	[p9l612t23r771b98],
5	12	CD	NUMBER	12	num	6	SENT_124	[p9l612t23r771b98],
6	]	NN	O	]	dep	4	SENT_124	[p9l612t23r771b98],
7	.	.	O	.	_	0	SENT_124	[p9l612t23r771b98],

1	Due	JJ	O	due	_	0	SENT_125	[p9l802t24r948b85],
2	to	TO	O	to	_	0	SENT_125	[p9l976t31r1043b85],
3	the	DT	O	the	det	6	SENT_125	[p9l1071t22r1178b85],
4	small	JJ	O	small	amod	6	SENT_125	[p9l1209t22r1398b85],
5	sample	NN	O	sample	nn	6	SENT_125	[p9l1429t22r1678b103],
6	size	NN	O	size	prep_due_to	13	SENT_125	[p9l1709t22r1862b96],
7	,	,	O	,	_	0	SENT_125	[p9l1709t22r1862b96],
8	genetic	JJ	O	genetic	amod	9	SENT_125	[p9l1894t22r2150b103],
9	associations	NNS	O	association	nsubj	13	SENT_125	[p9l10t133r440b196],
10	with	IN	O	with	_	0	SENT_125	[p9l478t133r636b196],
11	pharmacodynamic	JJ	O	pharmacodynamic	amod	12	SENT_125	[p9l671t133r1334b214],
12	markers	NNS	O	marker	prep_with	9	SENT_125	[p9l1373t133r1659b196],
13	(	VBP	O	(	_	0	SENT_125	[p9l1700t134r1874b214],
14	e.g.	FW	O	e.g.	nsubjpass	21	SENT_125	[p9l1700t134r1874b214],
15	,	,	O	,	_	0	SENT_125	[p9l1700t134r1874b214],
16	thymidylate	NN	O	thymidylate	nn	17	SENT_125	[p9l1914t133r2149b214, p9l9t244r226b325],
17	synthase	NN	O	synthase	appos	14	SENT_125	[p9l299t244r630b325],
18	)	CD	NUMBER	)	dep	17	SENT_125	[p9l299t244r630b325],
19	were	VBD	O	be	auxpass	21	SENT_125	[p9l704t264r875b307],
20	not	RB	O	not	neg	21	SENT_125	[p9l945t254r1059b307],
21	assessed	VBN	O	assess	ccomp	13	SENT_125	[p9l1129t244r1447b307],
22	.	.	O	.	_	0	SENT_125	[p9l1129t244r1447b307],

1	The	DT	O	the	det	2	SENT_126	[p9l1521t244r1658b307],
2	relationship	NN	O	relationship	nsubjpass	54	SENT_126	[p9l1727t244r2150b325],
3	between	IN	O	between	_	0	SENT_126	[p9l7t354r307b416],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_126	[p9l342t354r941b435],
5	parameters	NNS	O	parameter	prep_between	2	SENT_126	[p9l978t363r1371b435],
6	and	CC	O	and	_	0	SENT_126	[p9l1411t354r1538b416],
7	genetic	JJ	O	genetic	amod	8	SENT_126	[p9l1574t354r1830b435],
8	variants	NNS	O	variant	conj_and	5	SENT_126	[p9l1869t354r2150b416],
9	involved	VBN	O	involve	partmod	8	SENT_126	[p9l8t466r322b529],
10	in	IN	O	in	_	0	SENT_126	[p9l367t466r435b528],
11	drug	NN	O	drug	nn	12	SENT_126	[p9l482t466r642b547],
12	disposition	NN	O	disposition	prep_in	9	SENT_126	[p9l690t466r1082b547],
13	of	IN	O	of	_	0	SENT_126	[p9l1130t466r1207b529],
14	capecitabine	NN	O	capecitabine	prep_of	12	SENT_126	[p9l1248t466r1696b547],
15	(	CD	NUMBER	(	num	14	SENT_126	[p9l1745t467r1919b547],
16	e.g.	FW	O	e.g.	dep	14	SENT_126	[p9l1745t467r1919b547],
17	,	,	O	,	_	0	SENT_126	[p9l1745t467r1919b547],
18	carboxylesterase	NN	O	carboxylesterase	nn	20	SENT_126	[p9l1970t466r2149b529, p9l9t577r451b658],
19	(	NN	O	(	nn	20	SENT_126	[p9l500t578r716b655],
20	CES	NN	O	ce	conj_and	14	SENT_126	[p9l500t578r716b655],
21	)	CD	NUMBER	)	number	22	SENT_126	[p9l500t578r716b655],
22	[	CD	NUMBER	[	dep	20	SENT_126	[p9l770t578r930b653],
23	17	CD	NUMBER	17	num	24	SENT_126	[p9l770t578r930b653],
24	]	NN	O	]	dep	22	SENT_126	[p9l770t578r930b653],
25	,	,	O	,	_	0	SENT_126	[p9l770t578r930b653],
26	cytidine	NN	O	cytidine	nn	27	SENT_126	[p9l979t577r1266b658],
27	deaminase	NN	O	deaminase	conj_and	14	SENT_126	[p9l1313t577r1689b640],
28	(	CD	NUMBER	(	num	42	SENT_126	[p9l1739t578r1979b655],
29	CDA	NNP	ORGANIZATION	CDA	nn	42	SENT_126	[p9l1739t578r1979b655],
30	)	CD	NUMBER	)	num	42	SENT_126	[p9l1739t578r1979b655],
31	[	CD	NUMBER	[	num	42	SENT_126	[p9l2034t578r2149b653],
32	9	CD	NUMBER	9	num	42	SENT_126	[p9l2034t578r2149b653],
33	]	NN	O	]	nn	42	SENT_126	[p9l2034t578r2149b653],
34	,	,	O	,	_	0	SENT_126	[p9l2034t578r2149b653],
35	dihydropyrimidine	NN	O	dihydropyrimidine	dep	42	SENT_126	[p9l9t688r681b769],
36	dehydrogenase	NN	O	dehydrogenase	nn	42	SENT_126	[p9l737t688r1274b769],
37	(	CD	NUMBER	(	num	42	SENT_126	[p9l1331t689r1626b765],
38	DPYD	NN	O	dpyd	nn	42	SENT_126	[p9l1331t689r1626b765],
39	)	CD	NUMBER	)	num	42	SENT_126	[p9l1331t689r1626b765],
40	[	NN	O	[	nn	42	SENT_126	[p9l1690t688r1805b764],
41	2	CD	NUMBER	2	num	42	SENT_126	[p9l1690t688r1805b764],
42	]	NN	O	]	rcmod	27	SENT_126	[p9l1690t688r1805b764],
43	,	,	O	,	_	0	SENT_126	[p9l1690t688r1805b764],
44	and	CC	O	and	_	0	SENT_126	[p9l1864t688r1991b750],
45	the	DT	O	the	det	48	SENT_126	[p9l2044t688r2151b750],
46	solute	JJ	O	solute	amod	48	SENT_126	[p9l11t799r220b861],
47	carrier	NN	O	carrier	nn	48	SENT_126	[p9l247t799r482b861],
48	SLC28Al	NN	O	slc28al	prep_of	12	SENT_126	[p9l507t799r858b862],
49	[	CD	NUMBER	[	number	50	SENT_126	[p9l898t799r1066b876],
50	18	CD	NUMBER	18	num	52	SENT_126	[p9l898t799r1066b876],
51	]	NN	O	]	nn	52	SENT_126	[p9l898t799r1066b876],
52	)	NN	O	)	dep	48	SENT_126	[p9l898t799r1066b876],
53	were	VBD	O	be	auxpass	54	SENT_126	[p9l1094t818r1265b861],
54	explored	VBN	O	explore	_	0	SENT_126	[p9l1292t799r1605b880],
55	[	RB	O	[	advmod	54	SENT_126	[p9l1636t799r1794b875],
56	24	CD	NUMBER	24	num	57	SENT_126	[p9l1636t799r1794b875],
57	]	NN	O	]	dobj	54	SENT_126	[p9l1636t799r1794b875],
58	.	.	O	.	_	0	SENT_126	[p9l1636t799r1794b875],

1	Genomic	JJ	O	genomic	amod	2	SENT_127	[p9l1825t799r2150b862],
2	DNA	NN	O	dna	nsubjpass	4	SENT_127	[p9l8t910r200b973],
3	was	VBD	O	be	auxpass	4	SENT_127	[p9l237t929r372b973],
4	isolated	VBN	O	isolate	_	0	SENT_127	[p9l410t910r689b972],
5	using	VBG	O	use	xcomp	4	SENT_127	[p9l725t910r917b991],
6	the	DT	O	the	det	19	SENT_127	[p9l954t910r1062b972],
7	Gentra	NNP	O	Gentra	nn	19	SENT_127	[p9l1101t910r1343b973],
8	Puregene	NNP	O	Puregene	nn	19	SENT_127	[p9l1379t911r1712b991],
9	kit	NN	O	kit	nn	19	SENT_127	[p9l1748t910r1844b972],
10	(	CD	NUMBER	(	num	19	SENT_127	[p9l1882t910r2153b987],
11	Gentra	NNP	ORGANIZATION	Gentra	nn	19	SENT_127	[p9l1882t910r2153b987],
12	Systems	NNPS	ORGANIZATION	Systems	nn	19	SENT_127	[p9l10t1022r331b1102],
13	,	,	ORGANIZATION	,	_	0	SENT_127	[p9l10t1022r331b1102],
14	Inc.	NNP	ORGANIZATION	Inc.	dep	19	SENT_127	[p9l386t1023r543b1095],
15	,	,	O	,	_	0	SENT_127	[p9l386t1023r543b1095],
16	Minneapolis	NNP	LOCATION	Minneapolis	appos	19	SENT_127	[p9l597t1021r1075b1102],
17	,	,	O	,	_	0	SENT_127	[p9l597t1021r1075b1102],
18	MN	NN	O	mn	dep	19	SENT_127	[p9l1128t1022r1299b1098],
19	)	NN	O	)	nsubj	20	SENT_127	[p9l1128t1022r1299b1098],
20	following	VBG	O	follow	dep	5	SENT_127	[p9l1354t1021r1707b1102],
21	the	DT	O	the	det	22	SENT_127	[p9l1758t1021r1868b1084],
22	manufacturers	NNS	O	manufacturer	nsubj	23	SENT_127	[p9l1920t1041r2148b1084, p9l9t1132r351b1195],
23	’	VBP	O	’	ccomp	20	SENT_127	[p9l1920t1041r2148b1084, p9l9t1132r351b1195],
24	instructions	NNS	O	instruction	dobj	23	SENT_127	[p9l416t1132r863b1195],
25	.	.	O	.	_	0	SENT_127	[p9l416t1132r863b1195],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_128	[p9l926t1132r1230b1213],
2	were	VBD	O	be	auxpass	3	SENT_128	[p9l1289t1152r1462b1195],
3	genotyped	VBN	O	genotype	_	0	SENT_128	[p9l1520t1132r1901b1213],
4	using	VBG	O	use	xcomp	3	SENT_128	[p9l1955t1132r2151b1213],
5	Pyrosequencing	NN	O	pyrosequencing	nn	6	SENT_128	[p9l8t1243r579b1324],
6	assays	NNS	O	assay	dobj	4	SENT_128	[p9l659t1263r882b1324],
7	for	IN	O	for	_	0	SENT_128	[p9l960t1243r1064b1306],
8	CDA	NNP	ORGANIZATION	CDA	prep_for	4	SENT_128	[p9l1139t1243r1324b1306],
9	K27Q	NN	O	k27q	nn	12	SENT_128	[p9l1402t1243r1617b1321],
10	(	CD	NUMBER	(	num	12	SENT_128	[p9l1695t1243r2148b1320],
11	rs207267l	NN	O	rs207267l	nn	12	SENT_128	[p9l1695t1243r2148b1320],
12	)	NN	O	)	dep	8	SENT_128	[p9l1695t1243r2148b1320],
13	,	,	O	,	_	0	SENT_128	[p9l1695t1243r2148b1320],
14	CES2	NN	O	ces2	prep_for	4	SENT_128	[p9l9t1354r380b1417],
15	—	CD	NUMBER	—	num	14	SENT_128	[p9l9t1354r380b1417],
16	83O	NN	O	83o	nn	19	SENT_128	[p9l9t1354r380b1417],
17	(	CD	NUMBER	(	num	19	SENT_128	[p9l521t1353r1019b1431],
18	rs11075646	NN	O	rs11075646	nn	19	SENT_128	[p9l521t1353r1019b1431],
19	)	NN	O	)	dep	14	SENT_128	[p9l521t1353r1019b1431],
20	,	,	O	,	_	0	SENT_128	[p9l521t1353r1019b1431],
21	DPYD	NN	O	dpyd	prep_for	4	SENT_128	[p9l1159t1354r1556b1416],
22	*	CD	NUMBER	*	num	21	SENT_128	[p9l1159t1354r1556b1416],
23	2A	NN	O	2a	nn	26	SENT_128	[p9l1159t1354r1556b1416],
24	(	CD	NUMBER	(	num	26	SENT_128	[p9l1695t1354r2148b1431],
25	rs3918290	NN	O	rs3918290	nn	26	SENT_128	[p9l1695t1354r2148b1431],
26	)	NN	O	)	dep	21	SENT_128	[p9l1695t1354r2148b1431],
27	,	,	O	,	_	0	SENT_128	[p9l1695t1354r2148b1431],
28	DYPD	NN	O	dypd	nn	29	SENT_128	[p9l8t1466r335b1529],
29	*	NN	O	*	conj_and	8	SENT_128	[p9l8t1466r335b1529],
30	5	CD	NUMBER	5	number	31	SENT_128	[p9l8t1466r335b1529],
31	(	CD	NUMBER	(	num	33	SENT_128	[p9l382t1466r835b1544],
32	rs1801l59	NN	O	rs1801l59	nn	33	SENT_128	[p9l382t1466r835b1544],
33	)	NN	O	)	dep	29	SENT_128	[p9l382t1466r835b1544],
34	,	,	O	,	_	0	SENT_128	[p9l382t1466r835b1544],
35	and	CC	O	and	_	0	SENT_128	[p9l880t1466r1007b1529],
36	SLC28A1	NN	O	slc28a1	nn	37	SENT_128	[p9l1049t1467r1400b1529],
37	V1891	NN	O	v1891	prep_for	4	SENT_128	[p9l1448t1467r1675b1530],
38	(	CD	NUMBER	(	num	40	SENT_128	[p9l1718t1467r2149b1544],
39	rs2290272	NN	O	rs2290272	nn	40	SENT_128	[p9l1718t1467r2149b1544],
40	)	NN	O	)	dep	37	SENT_128	[p9l1718t1467r2149b1544],
41	as	IN	O	as	mark	43	SENT_128	[p9l10t1598r79b1641],
42	previously	RB	DATE	previously	advmod	43	SENT_128	[p9l119t1578r497b1659],
43	described	VBN	O	describe	advcl	3	SENT_128	[p9l539t1578r881b1641],
44	[	NN	O	[	dobj	43	SENT_128	[p9l927t1579r1012b1654],
45	2	CD	NUMBER	2	num	44	SENT_128	[p9l927t1579r1012b1654],
46	,	,	O	,	_	0	SENT_128	[p9l927t1579r1012b1654],
47	9	CD	NUMBER	9	appos	44	SENT_128	[p9l1056t1579r1116b1652],
48	,	,	O	,	_	0	SENT_128	[p9l1056t1579r1116b1652],
49	17	CD	NUMBER	17	num	50	SENT_128	[p9l1168t1579r1294b1654],
50	]	NN	O	]	appos	47	SENT_128	[p9l1168t1579r1294b1654],
51	.	.	O	.	_	0	SENT_128	[p9l1168t1579r1294b1654],

1	Primers	NNS	O	primer	nsubjpass	9	SENT_129	[p9l1338t1578r1613b1641],
2	for	IN	O	for	_	0	SENT_129	[p9l1655t1578r1759b1641],
3	the	DT	O	the	det	7	SENT_129	[p9l1797t1578r1904b1641],
4	CES2	NN	O	ces2	nn	7	SENT_129	[p9l1945t1579r2150b1641],
5	and	CC	O	and	_	0	SENT_129	[p9l10t1689r137b1751],
6	SLC28Al	NN	O	slc28al	conj_and	4	SENT_129	[p9l167t1689r518b1752],
7	SNPs	NNS	O	snp	prep_for	1	SENT_129	[p9l556t1689r748b1752],
8	were	VBD	O	be	auxpass	9	SENT_129	[p9l779t1708r950b1752],
9	designed	VBN	O	design	_	0	SENT_129	[p9l979t1689r1298b1770],
10	using	VBG	O	use	xcomp	9	SENT_129	[p9l1324t1689r1516b1770],
11	PyroMark	NNP	O	PyroMark	nn	14	SENT_129	[p9l1545t1689r1909b1770],
12	Assay	NN	O	assay	nn	14	SENT_129	[p9l1935t1689r2151b1770],
13	Design	NNP	O	Design	nn	14	SENT_129	[p9l8t1800r260b1881],
14	Software	NNP	O	Software	dobj	10	SENT_129	[p9l289t1800r608b1863],
15	2.0	CD	NUMBER	2.0	advmod	10	SENT_129	[p9l637t1800r763b1863],
16	.	.	O	.	_	0	SENT_129	[p9l637t1800r763b1863],

1	The	DT	O	the	det	3	SENT_130	[p9l795t1800r932b1862],
2	PCR	NN	O	pcr	nn	3	SENT_130	[p9l959t1800r1127b1863],
3	primers	NNS	O	primer	nsubj	9	SENT_130	[p9l1151t1800r1424b1881],
4	for	IN	O	for	_	0	SENT_130	[p9l1452t1800r1556b1862],
5	CES2	NN	O	ces2	nn	6	SENT_130	[p9l1582t1800r1952b1863],
6	—	NN	O	—	prep_for	3	SENT_130	[p9l1582t1800r1952b1863],
7	830	CD	NUMBER	830	num	6	SENT_130	[p9l1582t1800r1952b1863],
8	were	VBD	O	be	cop	9	SENT_130	[p9l1980t1819r2151b1863],
9	AGTTTATTGCCCCCTCCTATCGA	NNP	O	AGTTTATTGCCCCCTCCTATCGA	_	0	SENT_130	[p9l8t1911r1361b1974],
10	(	CD	NUMBER	(	num	9	SENT_130	[p9l1477t1911r2149b1992],
11	forward	RB	O	forward	advmod	9	SENT_130	[p9l1477t1911r2149b1992],
12	—	JJ	O	—	amod	14	SENT_130	[p9l1477t1911r2149b1992],
13	biotinyla	NN	O	biotinylum	nn	14	SENT_130	[p9l1477t1911r2149b1992],
14	—	NN	O	—	nsubj	30	SENT_130	[p9l1477t1911r2149b1992],
15	ted	VBD	O	ted	rcmod	9	SENT_130	[p9l8t2022r142b2099],
16	)	CD	NUMBER	)	nsubj	27	SENT_130	[p9l8t2022r142b2099],
17	and	CC	O	and	_	0	SENT_130	[p9l177t2022r302b2085],
18	GGGAATCCTCTCTTCAAACCTGTCC	NN	O	gggaatcctctcttcaaacctgtcc	conj_and	16	SENT_130	[p9l334t2023r1816b2085],
19	(	CD	NUMBER	(	num	18	SENT_130	[p9l1851t2023r2149b2100],
20	reverse	NN	O	reverse	nn	27	SENT_130	[p9l1851t2023r2149b2100],
21	,	,	O	,	_	0	SENT_130	[p9l1851t2023r2149b2100],
22	annealing	NN	O	annealing	dep	27	SENT_130	[p9l10t2134r350b2215],
23	temperature	NN	O	temperature	nn	27	SENT_130	[p9l380t2144r801b2215],
24	60	CD	NUMBER	60	num	27	SENT_130	[p9l833t2134r919b2197],
25	°	NN	O	°	nn	27	SENT_130	[p9l952t2134r1089b2211],
26	C	NN	O	c	nn	27	SENT_130	[p9l952t2134r1089b2211],
27	)	NN	O	)	xcomp	15	SENT_130	[p9l952t2134r1089b2211],
28	,	,	O	,	_	0	SENT_130	[p9l952t2134r1089b2211],
29	and	CC	O	and	_	0	SENT_130	[p9l1125t2134r1250b2197],
30	were	VBD	O	be	rcmod	9	SENT_130	[p9l1280t2154r1450b2197],
31	GGCCCCACAAC	NNP	O	GGCCCCACAAC	nn	32	SENT_130	[p9l1482t2135r2151b2197],
32	TAGCACTCACT	NNP	O	TAGCACTCACT	nsubj	33	SENT_130	[p9l8t2245r661b2308],
33	(	VBD	O	(	ccomp	30	SENT_130	[p9l694t2245r1474b2326],
34	forward	RB	O	forward	advmod	35	SENT_130	[p9l694t2245r1474b2326],
35	—	JJ	O	—	dobj	33	SENT_130	[p9l694t2245r1474b2326],
36	biotinylated	VBN	O	biotinylate	partmod	35	SENT_130	[p9l694t2245r1474b2326],
37	)	NN	O	)	nn	40	SENT_130	[p9l694t2245r1474b2326],
38	and	CC	O	and	_	0	SENT_130	[p9l1508t2245r1633b2308],
39	GTGGGGGT	NN	O	gtgggggt	conj_and	37	SENT_130	[p9l1664t2245r2152b2308],
40	GCAATGCTGA	NN	O	gcaatgctga	dobj	36	SENT_130	[p9l10t2355r617b2418],
41	(	CD	NUMBER	(	num	42	SENT_130	[p9l645t2355r942b2432],
42	reverse	NN	O	reverse	dep	40	SENT_130	[p9l645t2355r942b2432],
43	,	,	O	,	_	0	SENT_130	[p9l645t2355r942b2432],
44	annealing	NN	O	annealing	nn	45	SENT_130	[p9l973t2355r1312b2436],
45	temperature	NN	O	temperature	appos	40	SENT_130	[p9l1339t2364r1759b2436],
46	62	CD	NUMBER	62	num	49	SENT_130	[p9l1787t2354r1873b2418],
47	°	NN	O	°	nn	49	SENT_130	[p9l1907t2354r2022b2432],
48	C	NN	O	c	nn	49	SENT_130	[p9l1907t2354r2022b2432],
49	)	NN	O	)	dep	45	SENT_130	[p9l1907t2354r2022b2432],
50	for	IN	O	for	prep	36	SENT_130	[p9l2051t2354r2153b2417],

1	@	IN	O	@	_	0	SENT_131	[p9l1783t2598r1860b2693],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_131	[p9l1890t2621r2153b2696],

1	138	CD	NUMBER	138	num	2	SENT_132	[p9l56t2771r103b2796],
2	Breast	NN	O	breast	_	0	SENT_132	[p9l1450t2771r1540b2796],
3	Cancer	NN	O	cancer	dep	7	SENT_132	[p9l1552t2771r1652b2796],
4	Res	NNP	O	Res	nn	5	SENT_132	[p9l1664t2771r1716b2796],
5	Treat	NNP	O	Treat	dep	3	SENT_132	[p9l1729t2771r1804b2796],
6	(	CD	NUMBER	(	dep	7	SENT_132	[p9l1817t2771r1908b2801],
7	2013	CD	DATE	2013	dep	2	SENT_132	[p9l1817t2771r1908b2801],
8	)	CD	NUMBER	)	num	9	SENT_132	[p9l1817t2771r1908b2801],
9	l39	NN	O	l39	dep	7	SENT_132	[p9l1925t2771r2105b2796],
10	:	:	O	:	_	0	SENT_132	[p9l1925t2771r2105b2796],
11	l35	NN	O	l35	dep	2	SENT_132	[p9l1925t2771r2105b2796],
12	—	CD	NUMBER	—	num	13	SENT_132	[p9l1925t2771r2105b2796],
13	l43	NN	O	l43	dep	11	SENT_132	[p9l1925t2771r2105b2796],

1	SLC28Al	NN	O	slc28al	_	0	SENT_133	[p9l9t2940r357b3002],
2	V1891	NN	O	v1891	dep	1	SENT_133	[p9l390t2940r631b3003],
3	.	.	O	.	_	0	SENT_133	[p9l390t2940r631b3003],

1	The	DT	O	the	det	4	SENT_134	[p9l661t2939r797b3002],
2	intemal	JJ	O	intemal	amod	4	SENT_134	[p9l824t2939r1091b3002],
3	sequencing	NN	O	sequencing	nn	4	SENT_134	[p9l1121t2939r1513b3020],
4	primers	NNS	O	primer	nsubj	7	SENT_134	[p9l1538t2939r1805b3020],
5	were	VBD	O	be	cop	7	SENT_134	[p9l1834t2959r2003b3002],
6	CG	JJ	O	cg	amod	7	SENT_134	[p9l2031t2940r2151b3002],
7	ATGAGCGCGCTGG	NN	O	atgagcgcgctgg	_	0	SENT_134	[p9l7t3051r802b3113],
8	and	CC	O	and	_	0	SENT_134	[p9l870t3050r994b3113],
9	CAGGAATCTGCGTGT	NN	O	caggaatctgcgtgt	conj_and	7	SENT_134	[p9l1060t3051r1981b3125],
10	,	,	O	,	_	0	SENT_134	[p9l1060t3051r1981b3125],
11	for	IN	O	for	_	0	SENT_134	[p9l2050t3050r2152b3113],
12	CES2	NN	O	ces2	prep_for	7	SENT_134	[p9l8t3162r212b3225],
13	and	CC	O	and	_	0	SENT_134	[p9l261t3162r386b3224],
14	SLC28A1	NN	O	slc28a1	prep_for	7	SENT_134	[p9l436t3162r808b3236],
15	,	,	O	,	_	0	SENT_134	[p9l436t3162r808b3236],
16	respectively	RB	O	respectively	advmod	7	SENT_134	[p9l858t3162r1302b3243],
17	,	,	O	,	_	0	SENT_134	[p9l858t3162r1302b3243],
18	and	CC	O	and	_	0	SENT_134	[p9l1355t3162r1480b3224],
19	the	DT	O	the	det	20	SENT_134	[p9l1526t3162r1632b3224],
20	sequences	NNS	O	sequence	nsubj	25	SENT_134	[p9l1684t3181r2034b3243],
21	to	TO	O	to	aux	22	SENT_134	[p9l2084t3171r2151b3224],
22	analyze	VB	O	analyze	infmod	20	SENT_134	[p9l9t3273r275b3354],
23	were	VBD	O	be	cop	25	SENT_134	[p9l359t3292r528b3336],
24	GGSATCGATAGGAGGGGGCAATAAA	NNP	O	GGSATCGATAGGAGGGGGCAATAAA	nn	25	SENT_134	[p9l612t3273r2151b3336],
25	CTA	NNP	ORGANIZATION	CTA	conj_and	7	SENT_134	[p9l8t3384r184b3447],
26	and	CC	O	and	_	0	SENT_134	[p9l278t3384r403b3446],
27	TCRTCGCTCTCCTCTTTGCCTGCTCAAA	NNP	O	TCRTCGCTCTCCTCTTTGCCTGCTCAAA	conj_and	7	SENT_134	[p9l495t3384r2148b3458],
28	,	,	O	,	_	0	SENT_134	[p9l495t3384r2148b3458],
29	respectively	RB	O	respectively	advmod	25	SENT_134	[p9l6t3496r449b3577],
30	.	.	O	.	_	0	SENT_134	[p9l6t3496r449b3577],

1	Statistical	JJ	O	statistical	amod	2	SENT_135	[p9l9t3720r361b3783],
2	analysis	NN	O	analysis	_	0	SENT_135	[p9l396t3720r680b3801],

1	For	IN	O	for	_	0	SENT_136	[p10l7t134r130b195],
2	the	DT	O	the	det	3	SENT_136	[p10l155t132r260b195],
3	purposes	NNS	O	purpose	prep_for	18	SENT_136	[p10l288t152r599b213],
4	of	IN	O	of	_	0	SENT_136	[p10l629t132r706b195],
5	the	DT	O	the	det	7	SENT_136	[p10l726t132r833b195],
6	primary	JJ	O	primary	amod	7	SENT_136	[p10l859t132r1138b213],
7	endpoint	NN	O	endpoint	prep_of	3	SENT_136	[p10l1166t132r1475b213],
8	of	IN	O	of	_	0	SENT_136	[p10l1502t132r1579b195],
9	response	NN	O	response	nn	10	SENT_136	[p10l1599t152r1906b213],
10	rate	NN	O	rate	prep_of	7	SENT_136	[p10l1932t142r2082b206],
11	,	,	O	,	_	0	SENT_136	[p10l1932t142r2082b206],
12	a	DT	O	a	det	16	SENT_136	[p10l2115t152r2152b195],
13	two	CD	NUMBER	two	num	16	SENT_136	[p10l7t252r347b324],
14	—	JJ	O	—	amod	16	SENT_136	[p10l7t252r347b324],
15	stage	NN	O	stage	nn	16	SENT_136	[p10l7t252r347b324],
16	design	NN	O	design	nsubjpass	18	SENT_136	[p10l381t243r609b324],
17	was	VBD	O	be	auxpass	18	SENT_136	[p10l642t262r774b306],
18	used	VBN	O	use	_	0	SENT_136	[p10l808t243r985b305],
19	.	.	O	.	_	0	SENT_136	[p10l808t243r985b305],

1	If	IN	O	if	mark	7	SENT_137	[p10l1022t243r1086b305],
2	two	CD	NUMBER	two	nn	5	SENT_137	[p10l1110t252r1240b305],
3	or	CC	O	or	_	0	SENT_137	[p10l1275t262r1348b305],
4	fewer	JJR	O	fewer	conj_or	2	SENT_137	[p10l1378t243r1578b306],
5	responses	NNS	O	response	nsubjpass	7	SENT_137	[p10l1608t262r1947b324],
6	were	VBD	O	be	auxpass	7	SENT_137	[p10l1981t262r2151b305],
7	seen	VBN	O	see	advcl	21	SENT_137	[p10l10t373r163b416],
8	in	IN	O	in	_	0	SENT_137	[p10l192t354r259b416],
9	the	DT	O	the	det	13	SENT_137	[p10l288t354r394b416],
10	ﬁrst	NN	O	ﬁrst	nn	13	SENT_137	[p10l425t354r561b416],
11	22	CD	NUMBER	22	num	13	SENT_137	[p10l590t354r675b416],
12	evaluable	JJ	O	evaluable	amod	13	SENT_137	[p10l706t354r1040b416],
13	patients	NNS	O	patient	prep_in	7	SENT_137	[p10l1070t354r1342b435],
14	(	IN	O	(	_	0	SENT_137	[p10l1376t354r1538b431],
15	ﬁrst	JJ	O	ﬁrst	amod	16	SENT_137	[p10l1376t354r1538b431],
16	stage	NN	O	stage	prep_(	7	SENT_137	[p10l1569t355r1794b435],
17	)	CD	NUMBER	)	dep	16	SENT_137	[p10l1569t355r1794b435],
18	,	,	O	,	_	0	SENT_137	[p10l1569t355r1794b435],
19	the	DT	O	the	det	20	SENT_137	[p10l1826t354r1932b416],
20	study	NN	O	study	nsubj	21	SENT_137	[p10l1966t354r2150b435],
21	was	VBD	O	be	_	0	SENT_137	[p10l8t484r141b528],
22	to	TO	O	to	aux	24	SENT_137	[p10l166t474r231b527],
23	be	VB	O	be	auxpass	24	SENT_137	[p10l255t465r338b527],
24	suspended	VBN	O	suspend	xcomp	21	SENT_137	[p10l365t465r745b546],
25	.	.	O	.	_	0	SENT_137	[p10l365t465r745b546],

1	If	IN	O	if	mark	7	SENT_138	[p10l772t465r835b527],
2	three	CD	NUMBER	three	num	5	SENT_138	[p10l852t465r1026b527],
3	or	CC	O	or	_	0	SENT_138	[p10l1052t484r1124b527],
4	more	JJR	O	more	num	5	SENT_138	[p10l1145t484r1325b527],
5	responses	NNS	O	response	nsubjpass	7	SENT_138	[p10l1348t484r1687b546],
6	were	VBD	O	be	auxpass	7	SENT_138	[p10l1713t484r1882b528],
7	seen	VBN	O	see	_	0	SENT_138	[p10l1909t484r2061b527],
8	in	IN	O	in	prep	7	SENT_138	[p10l2084t465r2152b527],

1	Table	NNP	O	Table	_	0	SENT_139	[p10l8t687r191b740],
2	1	CD	NUMBER	1	num	5	SENT_139	[p10l223t687r252b740],
3	Baseline	NN	O	baseline	nn	5	SENT_139	[p10l303t687r564b740],
4	patient	NN	O	patient	nn	5	SENT_139	[p10l592t687r800b756],
5	characteristics	NNS	O	characteristic	dep	1	SENT_139	[p10l828t687r1262b740],

1	Characteristics	NNS	O	characteristic	_	0	SENT_140	[p10l8t832r458b885],
2	Number	NN	O	number	dep	1	SENT_140	[p10l1656t832r1907b885],
3	of	IN	O	of	_	0	SENT_140	[p10l1658t922r1724b975],
4	patients	NNS	O	patient	prep_of	2	SENT_140	[p10l1745t922r1981b991],
5	(	CD	NUMBER	(	num	6	SENT_140	[p10l1660t1012r1718b1077],
6	n	NN	O	n	npadvmod	7	SENT_140	[p10l1660t1012r1718b1077],
7	=	JJ	O	=	amod	4	SENT_140	[p10l1749t1036r1801b1056],
8	26	CD	NUMBER	26	num	9	SENT_140	[p10l1832t1011r1928b1077],
9	)	NN	O	)	dep	1	SENT_140	[p10l1832t1011r1928b1077],

1	Age	NNP	O	Age	_	0	SENT_141	[p10l8t1181r149b1249],
2	,	,	O	,	_	0	SENT_141	[p10l8t1181r149b1249],
3	years	NNS	DURATION	year	appos	1	SENT_141	[p10l179t1197r337b1249],
4	Median	JJ	O	median	amod	5	SENT_141	[p10l57t1276r290b1329],
5	53	CD	NUMBER	53	dep	1	SENT_141	[p10l1811t1276r1880b1329],
6	Range	NNP	O	Range	dep	5	SENT_141	[p10l58t1371r251b1439],
7	32-73	CD	NUMBER	32-73	num	6	SENT_141	[p10l1697t1370r1880b1423],

1	BSA	NN	O	bsa	dep	6	SENT_142	[p10l8t1485r154b1538],
2	(	CD	NUMBER	(	dep	1	SENT_142	[p10l183t1468r315b1550],
3	m2	NN	O	m2	dep	6	SENT_142	[p10l183t1468r315b1550],
4	)	CD	NUMBER	)	num	3	SENT_142	[p10l183t1468r315b1550],
5	Median	JJ	O	median	amod	6	SENT_142	[p10l57t1579r290b1633],
6	1.89	CD	NUMBER	1.89	dep	9	SENT_142	[p10l1855t1580r1977b1633],
7	Range	NNP	O	Range	dep	6	SENT_142	[p10l58t1676r251b1744],
8	1.63-2	CD	NUMBER	1.63-2	num	9	SENT_142	[p10l1855t1675r2144b1728],
9	.21	CD	NUMBER	.21	_	0	SENT_142	[p10l1855t1675r2144b1728],

1	Race	NN	O	race	_	0	SENT_143	[p10l8t1770r158b1822],

1	Caucasian	JJ	MISC	caucasian	amod	2	SENT_144	[p10l59t1864r371b1918],
2	16	CD	NUMBER	16	_	0	SENT_144	[p10l1817t1864r1883b1918],
3	Black	JJ	O	black	amod	4	SENT_144	[p10l58t1960r236b2013],
4	9	CD	NUMBER	9	dep	2	SENT_144	[p10l1849t1960r1882b2014],
5	Other	JJ	O	other	amod	6	SENT_144	[p10l59t2054r231b2107],
6	1	CD	NUMBER	1	dep	2	SENT_144	[p10l1855t2055r1877b2107],

1	ECOG	NN	ORGANIZATION	ecog	_	0	SENT_145	[p10l7t2150r214b2203],
2	performance	NN	O	performance	nn	3	SENT_145	[p10l240t2149r625b2218],
3	status	NN	O	status	dep	1	SENT_145	[p10l656t2157r824b2202],

1	Disease	NN	O	disease	nn	2	SENT_146	[p10l7t2435r242b2488],
2	status	NN	O	status	_	0	SENT_146	[p10l273t2442r441b2488],

1	Locally	RB	O	locally	advmod	2	SENT_147	[p10l57t2529r289b2598],
2	advanced	JJ	O	advanced	amod	3	SENT_147	[p10l319t2529r605b2582],
3	O	NN	O	o	_	0	SENT_147	[p10l1848t2530r1883b2582],
4	Metastatic	JJ	O	metastatic	dep	3	SENT_147	[p10l57t2624r373b2677],
5	26	CD	NUMBER	26	dep	3	SENT_147	[p10l1811t2624r1883b2678],

1	Location	NNP	O	Location	_	0	SENT_148	[p10l7t2720r279b2773],
2	of	IN	O	of	_	0	SENT_148	[p10l307t2720r372b2773],
3	disease	NN	O	disease	prep_of	1	SENT_148	[p10l395t2720r613b2773],

1	Visceral	JJ	O	visceral	amod	2	SENT_149	[p10l58t2815r310b2868],
2	3	CD	NUMBER	3	dep	13	SENT_149	[p10l1850t2815r1880b2868],
3	Non-visceral	JJ	O	non-visceral	amod	4	SENT_149	[p10l57t2909r450b2963],
4	4	CD	NUMBER	4	dep	2	SENT_149	[p10l1847t2910r1883b2962],
5	Both	CC	O	both	dep	4	SENT_149	[p10l58t3004r205b3058],
6	19	CD	NUMBER	19	num	7	SENT_149	[p10l1817t3005r1883b3058],
7	ER/PR-positive/HER2-neg	NN	O	er/pr-positive/her2-neg	conj	4	SENT_149	[p10l7t3100r832b3169],
8	12	CD	NUMBER	12	num	9	SENT_149	[p10l1817t3100r1884b3152],
9	HER2-pos	NNS	O	her2-po	dep	13	SENT_149	[p10l58t3194r376b3263],
10	3	CD	NUMBER	3	num	13	SENT_149	[p10l1850t3195r1880b3247],
11	ER	NN	O	er	nn	13	SENT_149	[p10l57t3291r283b3358],
12	—	NN	O	—	nn	13	SENT_149	[p10l57t3291r283b3358],
13	pos	NN	O	po	dep	21	SENT_149	[p10l57t3291r283b3358],
14	2	CD	NUMBER	2	num	17	SENT_149	[p10l1849t3290r1883b3342],
15	ER	NN	O	er	nn	17	SENT_149	[p10l57t3386r288b3453],
16	—	NN	O	—	nn	17	SENT_149	[p10l57t3386r288b3453],
17	neg	NN	O	neg	dep	13	SENT_149	[p10l57t3386r288b3453],
18	1	CD	NUMBER	1	num	21	SENT_149	[p10l1855t3385r1877b3437],
19	Triple-negative	JJ	O	triple-negative	amod	21	SENT_149	[p10l8t3479r478b3548],
20	(	NN	O	(	nn	21	SENT_149	[p10l508t3480r973b3545],
21	ER,PR,HER-2	NN	O	er,pr,her-2	dep	25	SENT_149	[p10l508t3480r973b3545],
22	negative	JJ	O	negative	amod	23	SENT_149	[p10l1002t3479r1283b3548],
23	)	NN	O	)	dep	21	SENT_149	[p10l1002t3479r1283b3548],
24	11	CD	NUMBER	11	num	25	SENT_149	[p10l1817t3480r1877b3532],
25	No.	NN	O	no.	_	0	SENT_149	[p10l7t3576r114b3627],
26	of	IN	O	of	_	0	SENT_149	[p10l146t3574r212b3627],
27	patients	NNS	O	patient	prep_of	25	SENT_149	[p10l233t3574r469b3643],
28	treated	VBN	O	treat	partmod	27	SENT_149	[p10l498t3574r706b3627],
29	with	IN	O	with	_	0	SENT_149	[p10l733t3574r867b3628],
30	prior	JJ	O	prior	amod	31	SENT_149	[p10l893t3574r1042b3643],
31	chemotherapy	NN	O	chemotherapy	prep_with	28	SENT_149	[p10l1068t3574r1499b3643],
32	for	IN	O	for	_	0	SENT_149	[p10l61t3663r150b3716],
33	metastatic	JJ	O	metastatic	amod	34	SENT_149	[p10l176t3663r483b3716],
34	disease	NN	O	disease	prep_for	31	SENT_149	[p10l514t3663r731b3716],

1	Number	NN	O	number	_	0	SENT_150	[p11l7t28r257b81],
2	of	IN	O	of	_	0	SENT_150	[p11l284t28r350b81],
3	prior	JJ	O	prior	amod	5	SENT_150	[p11l371t28r521b97],
4	chemotherapy	NN	O	chemotherapy	nn	5	SENT_150	[p11l547t28r978b97],
5	regimens	NNS	O	regimen	prep_of	1	SENT_150	[p11l1005t28r1283b97],
6	for	IN	O	for	_	0	SENT_150	[p11l1312t28r1400b81],
7	metastatic	JJ	O	metastatic	amod	8	SENT_150	[p11l1427t28r1735b81],
8	disease	NN	O	disease	prep_for	1	SENT_150	[p11l1765t28r1982b81],

1	1	CD	NUMBER	1	num	2	SENT_151	[p11l65t124r87b176],
2	2	CD	NUMBER	2	_	0	SENT_151	[p11l1849t124r1883b176],
3	2	CD	NUMBER	2	number	4	SENT_151	[p11l59t219r93b271],
4	4	CD	NUMBER	4	num	6	SENT_151	[p11l1847t219r1883b271],
5	Median	JJ	O	median	amod	6	SENT_151	[p11l7t313r239b366],
6	no.	NN	O	no.	dep	2	SENT_151	[p11l267t330r356b366],
7	of	IN	O	of	_	0	SENT_151	[p11l388t313r454b366],
8	regimens	NNS	O	regimen	prep_of	6	SENT_151	[p11l476t313r754b382],
9	for	IN	O	for	_	0	SENT_151	[p11l783t313r871b366],
10	metastatic	JJ	O	metastatic	amod	12	SENT_151	[p11l897t313r1205b366],
11	disease	NN	O	disease	nn	12	SENT_151	[p11l1236t313r1452b366],
12	o	NN	O	o	prep_for	8	SENT_151	[p11l1658t314r1693b367],
13	(	CD	NUMBER	(	num	15	SENT_151	[p11l1723t314r1882b379],
14	0-2	CD	NUMBER	0-2	num	15	SENT_151	[p11l1723t314r1882b379],
15	)	NN	O	)	dep	2	SENT_151	[p11l1723t314r1882b379],

1	(	NN	O	(	_	0	SENT_152	[p11l64t403r278b471],
2	range	NN	O	range	nn	3	SENT_152	[p11l64t403r278b471],
3	)	NN	O	)	dep	1	SENT_152	[p11l64t403r278b471],

1	ER	NN	O	er	nn	7	SENT_153	[p11l6t551r98b602],
2	estrogen	NN	O	estrogen	nn	7	SENT_153	[p11l148t557r404b618],
3	receptor	NN	O	receptor	nn	7	SENT_153	[p11l453t557r718b618],
4	,	,	O	,	_	0	SENT_153	[p11l453t557r718b618],
5	PR	NN	O	pr	dep	7	SENT_153	[p11l769t551r861b602],
6	progesterone	NN	O	progesterone	nn	7	SENT_153	[p11l910t557r1303b618],
7	receptor	NN	O	receptor	_	0	SENT_153	[p11l1352t557r1618b618],
8	,	,	O	,	_	0	SENT_153	[p11l1352t557r1618b618],
9	ECOG	NNP	ORGANIZATION	ECOG	nn	13	SENT_153	[p11l1668t550r1876b603],
10	Eastern	NNP	ORGANIZATION	Eastern	nn	13	SENT_153	[p11l1923t551r2151b602],
11	Cooperative	NNP	ORGANIZATION	Cooperative	nn	13	SENT_153	[p11l8t637r378b706],
12	Oncology	NNP	ORGANIZATION	Oncology	nn	13	SENT_153	[p11l408t638r706b706],
13	Group	NNP	ORGANIZATION	Group	appos	7	SENT_153	[p11l735t638r925b706],

1	@	IN	O	@	_	0	SENT_154	[p11l6t868r83b963],
2	Springer	NNP	PERSON	Springer	prep_@	9	SENT_154	[p11l113t891r376b966],
3	the	DT	O	the	det	5	SENT_154	[p11l8t993r113b1056],
4	ﬁrst	JJ	O	ﬁrst	amod	5	SENT_154	[p11l143t993r277b1056],
5	stage	NN	O	stage	dep	2	SENT_154	[p11l307t1003r501b1074],
6	,	,	O	,	_	0	SENT_154	[p11l307t1003r501b1074],
7	enrollment	NN	O	enrollment	appos	2	SENT_154	[p11l532t993r912b1056],
8	would	MD	O	would	aux	9	SENT_154	[p11l939t993r1158b1056],
9	continue	VB	O	continue	_	0	SENT_154	[p11l1185t993r1485b1056],
10	to	TO	O	to	aux	11	SENT_154	[p11l1513t1003r1579b1056],
11	~	VB	O	~	xcomp	9	SENT_154	[p11l1621t993r1779b1056],
12	45	CD	NUMBER	45	num	14	SENT_154	[p11l1621t993r1779b1056],
13	evaluable	JJ	O	evaluable	amod	14	SENT_154	[p11l1810t993r2145b1056],
14	patients	NNS	O	patient	dobj	11	SENT_154	[p11l7t1104r279b1185],
15	(	CD	NUMBER	(	num	17	SENT_154	[p11l320t1104r590b1182],
16	second	JJ	NUMBER	second	amod	17	SENT_154	[p11l320t1104r590b1182],
17	stage	NN	O	stage	nsubj	9	SENT_154	[p11l630t1105r852b1185],
18	)	CD	NUMBER	)	num	17	SENT_154	[p11l630t1105r852b1185],
19	.	.	O	.	_	0	SENT_154	[p11l630t1105r852b1185],

1	This	DT	O	this	det	2	SENT_155	[p11l894t1104r1048b1167],
2	design	NN	O	design	nsubj	3	SENT_155	[p11l1087t1104r1315b1185],
3	provided	VBN	O	provide	_	0	SENT_155	[p11l1350t1104r1664b1185],
4	80	CD	PERCENT	80	number	5	SENT_155	[p11l1703t1105r1786b1167],
5	%	NN	PERCENT	%	amod	6	SENT_155	[p11l1821t1105r1886b1167],
6	power	NN	O	power	dobj	3	SENT_155	[p11l1926t1124r2147b1185],
7	with	IN	O	with	_	0	SENT_155	[p11l9t1215r163b1278],
8	5	CD	PERCENT	5	number	9	SENT_155	[p11l188t1215r225b1278],
9	%	NN	PERCENT	%	amod	10	SENT_155	[p11l264t1215r328b1278],
10	type	NN	O	type	prep_with	3	SENT_155	[p11l356t1216r565b1296],
11	.	.	O	.	_	0	SENT_155	[p11l356t1216r565b1296],

1	—	NN	O	—	_	0	SENT_156	[p11l356t1216r565b1296],
2	.	.	O	.	_	0	SENT_156	[p11l356t1216r565b1296],

1	I	PRP	O	I	dep	2	SENT_157	[p11l356t1216r565b1296],
2	error	NN	O	error	nsubj	6	SENT_157	[p11l589t1234r758b1277],
3	(	CD	NUMBER	(	num	5	SENT_157	[p11l783t1215r1180b1292],
4	two	CD	NUMBER	two	num	5	SENT_157	[p11l783t1215r1180b1292],
5	—	NN	O	—	dep	2	SENT_157	[p11l783t1215r1180b1292],
6	sided	VBD	O	side	_	0	SENT_157	[p11l783t1215r1180b1292],
7	)	CD	NUMBER	)	dobj	6	SENT_157	[p11l783t1215r1180b1292],
8	to	TO	O	to	aux	9	SENT_157	[p11l1206t1224r1273b1277],
9	detect	VB	O	detect	xcomp	6	SENT_157	[p11l1298t1215r1508b1277],
10	a	DT	O	a	det	12	SENT_157	[p11l1532t1234r1569b1277],
11	response	NN	O	response	nn	12	SENT_157	[p11l1590t1234r1896b1296],
12	rate	NN	O	rate	dobj	9	SENT_157	[p11l1920t1224r2049b1277],
13	of	IN	O	of	_	0	SENT_157	[p11l2075t1215r2152b1277],
14	25	CD	PERCENT	25	num	15	SENT_157	[p11l9t1325r91b1389],
15	%	NN	PERCENT	%	prep_of	12	SENT_157	[p11l130t1326r194b1389],
16	from	IN	O	from	_	0	SENT_157	[p11l239t1326r409b1388],
17	a	DT	O	a	det	19	SENT_157	[p11l450t1345r487b1388],
18	null	JJ	O	null	amod	19	SENT_157	[p11l526t1326r661b1388],
19	rate	NN	O	rate	prep_from	9	SENT_157	[p11l700t1335r831b1388],
20	of	IN	O	of	_	0	SENT_157	[p11l873t1325r950b1388],
21	10	CD	PERCENT	10	num	22	SENT_157	[p11l992t1326r1070b1389],
22	%	NN	PERCENT	%	prep_of	19	SENT_157	[p11l1105t1326r1190b1389],
23	.	.	O	.	_	0	SENT_157	[p11l1105t1326r1190b1389],

1	Differences	NNS	O	difference	nsubjpass	5	SENT_158	[p11l1234t1326r1641b1388],
2	in	IN	O	in	_	0	SENT_158	[p11l1683t1326r1751b1388],
3	adherence	NN	O	adherence	prep_in	1	SENT_158	[p11l1792t1326r2145b1388],
4	were	VBD	O	be	auxpass	5	SENT_158	[p11l9t1456r178b1499],
5	compared	VBN	O	compare	dep	16	SENT_158	[p11l256t1437r602b1518],
6	between	IN	O	between	_	0	SENT_158	[p11l677t1437r971b1499],
7	patient	NN	O	patient	prep_between	5	SENT_158	[p11l1046t1437r1609b1518],
8	—	CD	NUMBER	—	num	7	SENT_158	[p11l1046t1437r1609b1518],
9	reported	VBD	O	report	partmod	7	SENT_158	[p11l1046t1437r1609b1518],
10	and	CC	O	and	_	0	SENT_158	[p11l1686t1437r1811b1499],
11	MEMS	NN	O	mem	nn	12	SENT_158	[p11l1887t1437r2142b1500],
12	methods	NNS	O	method	nsubj	13	SENT_158	[p11l8t1549r304b1612],
13	using	VBG	O	use	conj_and	5	SENT_158	[p11l345t1549r534b1630],
14	a	DT	O	a	det	15	SENT_158	[p11l577t1569r614b1612],
15	Wilcoxon	NNP	PERSON	Wilcoxon	dobj	13	SENT_158	[p11l653t1549r1001b1612],
16	signed	VBD	O	sign	_	0	SENT_158	[p11l1045t1549r1457b1630],
17	—	CD	NUMBER	—	num	19	SENT_158	[p11l1045t1549r1457b1630],
18	rank	NN	O	rank	nn	19	SENT_158	[p11l1045t1549r1457b1630],
19	test	NN	O	test	nsubj	16	SENT_158	[p11l1495t1558r1632b1612],
20	.	.	O	.	_	0	SENT_158	[p11l1495t1558r1632b1612],

1	Patients	NNS	O	patient	nsubjpass	14	SENT_159	[p11l1678t1549r1953b1612],
2	who	WP	O	who	nsubj	4	SENT_159	[p11l1996t1549r2145b1612],
3	were	VBD	O	be	cop	4	SENT_159	[p11l9t1680r178b1723],
4	adherent	JJ	O	adherent	rcmod	1	SENT_159	[p11l233t1660r535b1723],
5	and	CC	O	and	_	0	SENT_159	[p11l587t1660r712b1723],
6	for	IN	O	for	dep	12	SENT_159	[p11l765t1660r867b1723],
7	which	WDT	O	which	pobj	6	SENT_159	[p11l918t1660r1132b1723],
8	complete	JJ	O	complete	amod	10	SENT_159	[p11l1186t1660r1506b1741],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	10	SENT_159	[p11l1559t1660r2144b1741],
10	sampling	NN	O	sampling	nsubjpass	12	SENT_159	[p11l11t1771r329b1852],
11	were	VBD	O	be	auxpass	12	SENT_159	[p11l387t1791r556b1834],
12	collected	VBN	O	collect	rcmod	1	SENT_159	[p11l615t1771r931b1834],
13	were	VBD	O	be	auxpass	14	SENT_159	[p11l988t1791r1158b1834],
14	considered	VBN	O	consider	_	0	SENT_159	[p11l1216t1771r1596b1834],
15	evaluable	JJ	O	evaluable	acomp	14	SENT_159	[p11l1653t1771r1987b1834],
16	for	IN	O	for	_	0	SENT_159	[p11l2045t1771r2147b1834],
17	pharmacokinetic	JJ	O	pharmacokinetic	amod	18	SENT_159	[p11l7t1882r593b1963],
18	analysis	NN	O	analysis	prep_for	14	SENT_159	[p11l628t1882r905b1963],
19	and	CC	O	and	_	0	SENT_159	[p11l940t1882r1064b1945],
20	were	VBD	O	be	auxpass	21	SENT_159	[p11l1095t1902r1265b1945],
21	included	VBN	O	include	conj_and	14	SENT_159	[p11l1296t1882r1598b1945],
22	in	IN	O	in	_	0	SENT_159	[p11l1629t1882r1697b1944],
23	the	DT	O	the	det	25	SENT_159	[p11l1727t1882r1832b1945],
24	descriptive	JJ	O	descriptive	amod	25	SENT_159	[p11l1866t1882r2144b1963, p11l8t1993r139b2056],
25	statistics	NNS	O	statistics	prep_in	21	SENT_159	[p11l180t1993r494b2056],
26	.	.	O	.	_	0	SENT_159	[p11l180t1993r494b2056],

1	Allele	NN	O	allele	nn	2	SENT_160	[p11l536t1993r750b2056],
2	frequencies	NNS	O	frequency	nsubjpass	4	SENT_160	[p11l789t1993r1190b2074],
3	were	VBD	O	be	auxpass	4	SENT_160	[p11l1231t2013r1399b2056],
4	calculated	VBN	O	calculate	_	0	SENT_160	[p11l1439t1993r1795b2056],
5	by	IN	O	by	_	0	SENT_160	[p11l1831t1993r1918b2074],
6	allele	NN	O	allele	nn	7	SENT_160	[p11l1958t1993r2145b2056],
7	counting	NN	O	counting	agent	4	SENT_160	[p11l9t2104r314b2185],
8	and	CC	O	and	_	0	SENT_160	[p11l348t2104r472b2166],
9	deviations	NNS	O	deviation	agent	4	SENT_160	[p11l504t2104r861b2166],
10	from	IN	O	from	_	0	SENT_160	[p11l894t2104r1065b2166],
11	Hardy	NNP	PERSON	Hardy	prep_from	4	SENT_160	[p11l1095t2104r1705b2185],
12	.	.	O	.	_	0	SENT_160	[p11l1095t2104r1705b2185],

1	—	NN	O	—	_	0	SENT_161	[p11l1095t2104r1705b2185],
2	.	.	O	.	_	0	SENT_161	[p11l1095t2104r1705b2185],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_162	[p11l1095t2104r1705b2185],
2	equilibrium	NN	O	equilibrium	nsubjpass	4	SENT_162	[p11l1737t2104r2147b2185],
3	were	VBD	O	be	auxpass	4	SENT_162	[p11l9t2234r178b2277],
4	assessed	VBN	O	assess	_	0	SENT_162	[p11l221t2214r516b2276],
5	using	VBG	O	use	xcomp	4	SENT_162	[p11l556t2214r744b2295],
6	X2	NN	O	x2	nn	7	SENT_162	[p11l789t2195r862b2294],
7	tests	NNS	O	test	dobj	5	SENT_162	[p11l904t2223r1076b2276],
8	.	.	O	.	_	0	SENT_162	[p11l904t2223r1076b2276],

1	The	DT	O	the	det	2	SENT_163	[p11l1122t2214r1257b2276],
2	Fisher	NNP	PERSON	Fisher	poss	5	SENT_163	[p11l1300t2214r1578b2276],
3	’s	POS	O	’s	_	0	SENT_163	[p11l1300t2214r1578b2276],
4	exact	JJ	O	exact	amod	5	SENT_163	[p11l1622t2224r1808b2276],
5	test	NN	O	test	nsubjpass	7	SENT_163	[p11l1849t2224r1971b2276],
6	was	VBD	O	be	auxpass	7	SENT_163	[p11l2011t2234r2144b2277],
7	used	VBN	O	use	_	0	SENT_163	[p11l8t2326r169b2388],
8	to	TO	O	to	aux	9	SENT_163	[p11l199t2335r265b2388],
9	determine	VB	O	determine	xcomp	7	SENT_163	[p11l297t2326r647b2388],
10	the	DT	O	the	det	11	SENT_163	[p11l679t2326r784b2388],
11	association	NN	O	association	dobj	9	SENT_163	[p11l818t2326r1205b2388],
12	between	IN	O	between	_	0	SENT_163	[p11l1235t2326r1529b2388],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_163	[p11l1559t2326r2144b2407],
14	parameters	NNS	O	parameter	prep_between	11	SENT_163	[p11l7t2447r411b2518],
15	,	,	O	,	_	0	SENT_163	[p11l7t2447r411b2518],
16	tumor	NN	O	tumor	nn	17	SENT_163	[p11l442t2447r653b2500],
17	response	NN	O	response	prep_between	11	SENT_163	[p11l678t2457r1002b2518],
18	,	,	O	,	_	0	SENT_163	[p11l678t2457r1002b2518],
19	and	CC	O	and	_	0	SENT_163	[p11l1035t2437r1159b2500],
20	genetic	JJ	O	genetic	amod	21	SENT_163	[p11l1187t2437r1437b2518],
21	variants	NNS	O	variant	prep_between	11	SENT_163	[p11l1467t2437r1760b2500],
22	.	.	O	.	_	0	SENT_163	[p11l1467t2437r1760b2500],

1	All	DT	O	all	det	3	SENT_164	[p11l1792t2437r1902b2499],
2	P	NN	O	p	nn	3	SENT_164	[p11l1929t2440r1984b2499],
3	values	NNS	O	value	nsubjpass	5	SENT_164	[p11l2011t2437r2143b2500, p11l8t2568r121b2611],
4	were	VBD	O	be	auxpass	5	SENT_164	[p11l157t2568r325b2611],
5	two-sided	JJ	O	two-sided	_	0	SENT_164	[p11l358t2548r722b2622],
6	,	,	O	,	_	0	SENT_164	[p11l358t2548r722b2622],
7	not	RB	O	not	neg	8	SENT_164	[p11l756t2558r869b2611],
8	adjusted	VBN	O	adjust	conj_and	5	SENT_164	[p11l902t2548r1192b2629],
9	for	IN	O	for	_	0	SENT_164	[p11l1224t2548r1326b2611],
10	multiple	JJ	O	multiple	amod	11	SENT_164	[p11l1357t2548r1648b2629],
11	comparisons	NNS	O	comparison	prep_for	8	SENT_164	[p11l1682t2548r2143b2629],
12	,	,	O	,	_	0	SENT_164	[p11l1682t2548r2143b2629],
13	and	CC	O	and	_	0	SENT_164	[p11l10t2659r134b2722],
14	were	VBD	O	be	auxpass	15	SENT_164	[p11l166t2679r335b2722],
15	considered	VBN	O	consider	conj_and	5	SENT_164	[p11l367t2659r746b2722],
16	signiﬁcant	NN	O	signiﬁcant	npadvmod	20	SENT_164	[p11l780t2659r1143b2740],
17	at	IN	O	at	_	0	SENT_164	[p11l1174t2669r1236b2722],
18	a	DT	O	a	det	19	SENT_164	[p11l1268t2679r1305b2722],
19	P	NN	O	p	prep_at	16	SENT_164	[p11l1334t2661r1388b2721],
20	<	JJR	O	<	acomp	15	SENT_164	[p11l1420t2673r1477b2722],
21	0.05	CD	NUMBER	0.05	advmod	15	SENT_164	[p11l1508t2659r1676b2722],
22	.	.	O	.	_	0	SENT_164	[p11l1508t2659r1676b2722],

1	Results	NNS	O	result	_	0	SENT_165	[p11l9t2902r284b2963],

1	Patient	NN	O	patient	nn	2	SENT_166	[p11l8t3124r256b3187],
2	characteristics	NNS	O	characteristic	_	0	SENT_166	[p11l289t3124r800b3187],

1	Thirty	CD	NUMBER	thirty	num	2	SENT_167	[p11l8t3347r229b3428],
2	patients	NNS	O	patient	nsubjpass	8	SENT_167	[p11l279t3347r555b3428],
3	with	IN	O	with	_	0	SENT_167	[p11l607t3347r764b3410],
4	metastatic	JJ	O	metastatic	amod	6	SENT_167	[p11l812t3347r1174b3410],
5	breast	NN	O	breast	nn	6	SENT_167	[p11l1223t3347r1438b3410],
6	cancer	NN	O	cancer	prep_with	2	SENT_167	[p11l1486t3367r1720b3410],
7	were	VBD	O	be	auxpass	8	SENT_167	[p11l1768t3367r1939b3410],
8	consented	VBN	O	consent	_	0	SENT_167	[p11l1989t3367r2142b3410, p11l11t3458r236b3521],
9	between	IN	O	between	_	0	SENT_167	[p11l261t3458r559b3521],
10	August	NNP	DATE	August	prep_between	8	SENT_167	[p11l585t3459r843b3539],
11	2005	CD	DATE	2005	num	10	SENT_167	[p11l869t3458r1040b3521],
12	and	CC	O	and	_	0	SENT_167	[p11l1073t3458r1199b3521],
13	December	NNP	DATE	December	conj_and	10	SENT_167	[p11l1224t3458r1593b3521],
14	2008	CD	DATE	2008	num	13	SENT_167	[p11l1619t3459r1813b3521],
15	.	.	O	.	_	0	SENT_167	[p11l1619t3459r1813b3521],

1	TwentysiX	CD	NUMBER	twentysix	num	2	SENT_168	[p11l1843t3460r2143b3539, p11l11t3569r110b3632],
2	patients	NNS	O	patient	nsubjpass	15	SENT_168	[p11l144t3569r422b3650],
3	were	VBD	O	be	auxpass	4	SENT_168	[p11l459t3589r630b3632],
4	eligible	JJ	O	eligible	rcmod	2	SENT_168	[p11l666t3569r933b3650],
5	and	CC	O	and	_	0	SENT_168	[p11l971t3569r1097b3632],
6	initiated	VBN	O	initiate	rcmod	2	SENT_168	[p11l1132t3569r1426b3632],
7	treatment	NN	O	treatment	dobj	6	SENT_168	[p11l1460t3579r1800b3632],
8	on	IN	O	on	_	0	SENT_168	[p11l1835t3569r2144b3650],
9	—	NN	O	—	nn	10	SENT_168	[p11l1835t3569r2144b3650],
10	study	NN	O	study	prep_on	6	SENT_168	[p11l1835t3569r2144b3650],
11	and	CC	O	and	_	0	SENT_168	[p11l10t3679r136b3741],
12	patient	NN	O	patient	nn	13	SENT_168	[p11l191t3679r436b3760],
13	characteristics	NNS	O	characteristic	conj_and	10	SENT_168	[p11l493t3679r1004b3741],
14	are	VBP	O	be	auxpass	15	SENT_168	[p11l1064t3698r1169b3741],
15	summarized	VBN	O	summarize	_	0	SENT_168	[p11l1230t3679r1665b3741],
16	in	IN	O	in	_	0	SENT_168	[p11l1721t3679r1789b3740],
17	Table	NNP	O	Table	prep_in	15	SENT_168	[p11l1846t3679r2048b3741],
18	1	CD	NUMBER	1	num	17	SENT_168	[p11l2089t3679r2141b3741],
19	.	.	O	.	_	0	SENT_168	[p11l2089t3679r2141b3741],

1	A	DT	O	a	det	2	SENT_169	[p12l8t23r71b84],
2	total	NN	O	total	nsubjpass	9	SENT_169	[p12l96t22r253b85],
3	of	IN	O	of	_	0	SENT_169	[p12l281t22r358b85],
4	115	CD	NUMBER	115	num	5	SENT_169	[p12l386t22r505b85],
5	cycles	NNS	O	cycle	prep_of	2	SENT_169	[p12l536t22r756b103],
6	of	IN	O	of	_	0	SENT_169	[p12l784t22r861b85],
7	therapy	NN	O	therapy	prep_of	5	SENT_169	[p12l881t22r1148b103],
8	were	VBD	O	be	auxpass	9	SENT_169	[p12l1175t42r1345b85],
9	administered	VBN	O	administer	_	0	SENT_169	[p12l1374t22r1835b85],
10	and	CC	O	and	_	0	SENT_169	[p12l1863t22r1988b85],
11	ﬁve	JJ	O	ﬁve	amod	12	SENT_169	[p12l2015t22r2145b85],
12	patients	NNS	O	patient	nsubj	13	SENT_169	[p12l7t133r284b214],
13	did	VBD	O	do	conj_and	9	SENT_169	[p12l322t133r434b196],
14	not	RB	O	not	neg	15	SENT_169	[p12l467t143r581b196],
15	complete	JJ	O	complete	amod	16	SENT_169	[p12l614t133r941b214],
16	cycle	NN	O	cycle	dobj	13	SENT_169	[p12l977t133r1163b214],
17	1	CD	NUMBER	1	tmod	13	SENT_169	[p12l1207t134r1259b196],
18	.	.	O	.	_	0	SENT_169	[p12l1207t134r1259b196],

1	The	DT	O	the	det	3	SENT_170	[p12l1298t133r1434b196],
2	median	JJ	O	median	amod	3	SENT_170	[p12l1469t133r1733b196],
3	number	NN	O	number	nsubj	10	SENT_170	[p12l1767t133r2040b196],
4	of	IN	O	of	_	0	SENT_170	[p12l2074t133r2151b196],
5	cycles	NNS	O	cycle	prep_of	3	SENT_170	[p12l9t244r228b325],
6	initiated	VBN	O	initiate	partmod	5	SENT_170	[p12l264t244r557b306],
7	was	VBD	O	be	cop	10	SENT_170	[p12l590t263r724b307],
8	four	CD	NUMBER	four	num	10	SENT_170	[p12l759t244r907b306],
9	(	NN	O	(	nn	10	SENT_170	[p12l941t245r1164b325],
10	range	NN	O	range	_	0	SENT_170	[p12l941t245r1164b325],
11	1-16	CD	NUMBER	1-16	num	12	SENT_170	[p12l1206t244r1422b321],
12	)	NN	O	)	dep	10	SENT_170	[p12l1206t244r1422b321],
13	.	.	O	.	_	0	SENT_170	[p12l1206t244r1422b321],

1	Dose	NN	O	dose	nn	2	SENT_171	[p12l8t469r189b531],
2	modiﬁcations	NNS	O	modiﬁcations	_	0	SENT_171	[p12l222t468r707b531],

1	All	PDT	O	all	predet	3	SENT_172	[p12l8t691r120b753],
2	the	DT	O	the	det	3	SENT_172	[p12l160t691r267b754],
3	patients	NNS	O	patient	nsubj	4	SENT_172	[p12l307t691r585b772],
4	received	VBD	O	receive	_	0	SENT_172	[p12l625t691r930b754],
5	the	DT	O	the	det	7	SENT_172	[p12l969t691r1076b754],
6	pre	JJ	O	pre	amod	7	SENT_172	[p12l1116t691r1524b772],
7	—	NN	O	—	dobj	4	SENT_172	[p12l1116t691r1524b772],
8	deﬁned	VBN	O	deﬁned	partmod	7	SENT_172	[p12l1116t691r1524b772],
9	starting	VBG	O	start	xcomp	8	SENT_172	[p12l1567t691r1830b772],
10	dose	NN	O	dose	dobj	9	SENT_172	[p12l1872t691r2032b754],
11	of	IN	O	of	_	0	SENT_172	[p12l2074t691r2151b754],
12	capecitabine	NN	O	capecitabine	prep_of	10	SENT_172	[p12l9t802r456b883],
13	of	IN	O	of	_	0	SENT_172	[p12l486t802r563b865],
14	3,000	CD	NUMBER	3,000	num	15	SENT_172	[p12l587t802r784b876],
15	mg	NN	O	mg	prep_of	12	SENT_172	[p12l817t822r927b883],
16	orally	RB	O	orally	advmod	17	SENT_172	[p12l957t802r1163b883],
17	daily	JJ	SET	daily	amod	15	SENT_172	[p12l1193t802r1368b883],
18	given	VBN	O	give	prep	9	SENT_172	[p12l1399t802r1595b883],
19	in	IN	O	in	pcomp	18	SENT_172	[p12l1623t802r1690b864],
20	two	CD	NUMBER	two	num	22	SENT_172	[p12l1718t812r1849b865],
21	divided	JJ	O	divided	amod	22	SENT_172	[p12l1879t802r2146b865],
22	doses	NNS	O	dose	pobj	19	SENT_172	[p12l9t912r223b974],
23	.	.	O	.	_	0	SENT_172	[p12l9t912r223b974],

1	Two	CD	NUMBER	two	num	2	SENT_173	[p12l260t913r421b974],
2	thirds	NNS	O	third	nsubj	6	SENT_173	[p12l456t912r656b974],
3	of	IN	O	of	_	0	SENT_173	[p12l693t912r770b974],
4	the	DT	O	the	det	5	SENT_173	[p12l797t912r903b974],
5	patients	NNS	O	patient	prep_of	2	SENT_173	[p12l937t912r1214b993],
6	received	VBD	O	receive	_	0	SENT_173	[p12l1248t911r1552b974],
7	either	CC	O	either	prep	6	SENT_173	[p12l1587t912r1790b974],
8	the	DT	O	the	det	10	SENT_173	[p12l1822t912r1929b974],
9	same	JJ	O	same	amod	10	SENT_173	[p12l1966t931r2145b974],
10	dose	NN	O	dose	dep	7	SENT_173	[p12l9t1024r169b1087],
11	or	CC	O	or	_	0	SENT_173	[p12l196t1044r269b1087],
12	a	DT	O	a	det	16	SENT_173	[p12l293t1044r330b1087],
13	500	CD	NUMBER	500	num	14	SENT_173	[p12l355t1024r485b1087],
14	mg	NN	O	mg	npadvmod	15	SENT_173	[p12l517t1044r628b1105],
15	lower	JJR	O	lower	amod	16	SENT_173	[p12l654t1024r857b1087],
16	dose	NN	O	dose	conj_or	10	SENT_173	[p12l881t1024r1041b1087],
17	compared	VBN	O	compare	_	0	SENT_173	[p12l1067t1024r1420b1105],
18	to	TO	O	to	prepc_compared_to	16	SENT_173	[p12l1443t1034r1510b1087],
19	what	WP	O	what	nsubjpass	23	SENT_173	[p12l1536t1024r1709b1087],
20	would	MD	O	would	aux	23	SENT_173	[p12l1732t1024r1954b1087],
21	have	VB	O	have	aux	23	SENT_173	[p12l1977t1024r2144b1087],
22	been	VBN	O	be	auxpass	23	SENT_173	[p12l7t1135r175b1198],
23	administered	VBN	O	administer	pcomp	16	SENT_173	[p12l232t1135r694b1198],
24	with	IN	O	with	_	0	SENT_173	[p12l748t1135r905b1198],
25	a	DT	O	a	det	29	SENT_173	[p12l961t1155r998b1198],
26	commonly	RB	O	commonly	advmod	27	SENT_173	[p12l1052t1135r1434b1216],
27	used	VBN	O	use	amod	29	SENT_173	[p12l1488t1135r1651b1198],
28	BSA-dosing	JJ	O	bsa-dosing	amod	29	SENT_173	[p12l1705t1135r2145b1216],
29	schedule	NN	O	schedule	prep_with	23	SENT_173	[p12l11t1245r320b1307],
30	(	CD	NUMBER	(	number	31	SENT_173	[p12l378t1245r603b1322],
31	2,000	CD	NUMBER	2,000	num	32	SENT_173	[p12l378t1245r603b1322],
32	mg/m2	NN	O	mg/m2	dobj	6	SENT_173	[p12l637t1226r878b1326],
33	with	IN	O	with	_	0	SENT_173	[p12l932t1245r1089b1308],
34	rounding	VBG	O	round	prepc_with	32	SENT_173	[p12l1143t1245r1464b1326],
35	down	RP	O	down	prt	34	SENT_173	[p12l1521t1245r1716b1308],
36	to	TO	O	to	_	0	SENT_173	[p12l1771t1255r1837b1308],
37	nearest	JJS	O	nearest	prep_to	34	SENT_173	[p12l1893t1255r2147b1308],
38	500	CD	NUMBER	500	num	39	SENT_173	[p12l10t1357r140b1420],
39	mg	NN	O	mg	dep	37	SENT_173	[p12l172t1376r283b1438],
40	multiple	JJ	O	multiple	amod	41	SENT_173	[p12l316t1357r663b1438],
41	)	NN	O	)	dep	39	SENT_173	[p12l316t1357r663b1438],
42	.	.	O	.	_	0	SENT_173	[p12l316t1357r663b1438],

1	There	EX	O	there	expl	2	SENT_174	[p12l699t1357r906b1419],
2	was	VBD	O	be	dep	14	SENT_174	[p12l939t1376r1073b1420],
3	no	DT	O	no	det	4	SENT_174	[p12l1107t1376r1193b1419],
4	correlation	NN	O	correlation	nsubj	2	SENT_174	[p12l1226t1357r1614b1419],
5	between	IN	O	between	_	0	SENT_174	[p12l1644t1357r1943b1420],
6	BSA	NN	ORGANIZATION	bsa	prep_between	4	SENT_174	[p12l1974t1357r2146b1420],
7	and	CC	O	and	_	0	SENT_174	[p12l10t1468r136b1530],
8	those	DT	O	those	det	9	SENT_174	[p12l164t1468r351b1530],
9	patients	NNS	O	patient	conj_and	4	SENT_174	[p12l379t1468r655b1549],
10	who	WP	O	who	nsubj	11	SENT_174	[p12l687t1468r837b1531],
11	had	VBD	O	have	rcmod	9	SENT_174	[p12l867t1468r995b1530],
12	their	PRP$	O	they	poss	13	SENT_174	[p12l1023t1468r1187b1530],
13	dose	NN	O	dose	dobj	11	SENT_174	[p12l1216t1468r1376b1530],
14	escalated	VBD	O	escalate	_	0	SENT_174	[p12l1406t1468r1733b1530],
15	or	CC	O	or	_	0	SENT_174	[p12l1764t1487r1836b1530],
16	reduced	VBD	O	reduce	conj_or	14	SENT_174	[p12l1862t1468r2146b1530],
17	(	CD	NUMBER	(	num	18	SENT_174	[p12l11t1580r91b1656],
18	P	NN	O	p	nsubj	19	SENT_174	[p12l11t1580r91b1656],
19	>	JJR	O	>	xcomp	16	SENT_174	[p12l124t1594r181b1642],
20	0.05	CD	NUMBER	0.05	num	21	SENT_174	[p12l213t1579r414b1656],
21	)	NN	O	)	nsubj	14	SENT_174	[p12l213t1579r414b1656],
22	.	.	O	.	_	0	SENT_174	[p12l213t1579r414b1656],

1	In	IN	O	in	_	0	SENT_175	[p12l452t1581r524b1641],
2	the	DT	O	the	det	3	SENT_175	[p12l557t1579r664b1642],
3	case	NN	O	case	prep_in	19	SENT_175	[p12l699t1599r849b1642],
4	of	IN	O	of	_	0	SENT_175	[p12l885t1579r962b1642],
5	two	CD	NUMBER	two	num	6	SENT_175	[p12l989t1589r1120b1642],
6	patients	NNS	O	patient	prep_of	3	SENT_175	[p12l1153t1579r1450b1660],
7	,	,	O	,	_	0	SENT_175	[p12l1153t1579r1450b1660],
8	dose	NN	O	dose	nn	9	SENT_175	[p12l1488t1579r1648b1642],
9	escalation	NN	O	escalation	nsubjpass	19	SENT_175	[p12l1683t1579r2040b1642],
10	of	IN	O	of	_	0	SENT_175	[p12l2074t1579r2151b1642],
11	capecitabine	NN	O	capecitabine	prep_of	9	SENT_175	[p12l9t1690r456b1771],
12	to	TO	O	to	_	0	SENT_175	[p12l495t1700r562b1753],
13	3,500	CD	NUMBER	3,500	num	14	SENT_175	[p12l604t1690r800b1764],
14	mg	NN	O	mg	prep_to	11	SENT_175	[p12l833t1710r944b1771],
15	total	JJ	O	total	amod	17	SENT_175	[p12l984t1690r1142b1753],
16	daily	JJ	SET	daily	amod	17	SENT_175	[p12l1182t1690r1358b1771],
17	dose	NN	O	dose	dep	14	SENT_175	[p12l1399t1690r1558b1753],
18	was	VBD	O	be	auxpass	19	SENT_175	[p12l1598t1710r1733b1753],
19	performed	VBN	O	perform	_	0	SENT_175	[p12l1772t1690r2146b1771],
20	after	IN	O	after	_	0	SENT_175	[p12l10t1801r172b1864],
21	cycles	NNS	O	cycle	prep_after	19	SENT_175	[p12l197t1801r417b1882],
22	3	CD	NUMBER	3	num	21	SENT_175	[p12l447t1802r482b1864],
23	and	CC	O	and	_	0	SENT_175	[p12l514t1801r640b1864],
24	5	CD	NUMBER	5	prep_after	19	SENT_175	[p12l666t1801r703b1864],
25	of	IN	O	of	_	0	SENT_175	[p12l734t1801r811b1864],
26	therapy	NN	O	therapy	prep_of	21	SENT_175	[p12l829t1801r1115b1882],
27	.	.	O	.	_	0	SENT_175	[p12l829t1801r1115b1882],

1	For	IN	O	for	_	0	SENT_176	[p12l1145t1803r1268b1864],
2	the	DT	O	the	det	4	SENT_176	[p12l1292t1801r1399b1864],
3	former	JJ	O	former	amod	4	SENT_176	[p12l1426t1801r1669b1864],
4	patient	NN	O	patient	prep_for	12	SENT_176	[p12l1691t1801r1955b1882],
5	,	,	O	,	_	0	SENT_176	[p12l1691t1801r1955b1882],
6	dose	NN	O	dose	nn	7	SENT_176	[p12l1985t1801r2144b1864],
7	reduction	NN	O	reduction	nsubjpass	12	SENT_176	[p12l7t1911r346b1973],
8	to	TO	O	to	_	0	SENT_176	[p12l371t1920r438b1973],
9	3,000	CD	NUMBER	3,000	num	10	SENT_176	[p12l467t1911r664b1985],
10	mg	NN	O	mg	prep_to	7	SENT_176	[p12l697t1930r808b1992],
11	was	VBD	O	be	auxpass	12	SENT_176	[p12l835t1930r969b1973],
12	required	VBN	O	require	_	0	SENT_176	[p12l996t1911r1296b1992],
13	after	IN	O	after	_	0	SENT_176	[p12l1323t1911r1485b1973],
14	cycle	NN	O	cycle	nn	26	SENT_176	[p12l1510t1911r1696b1992],
15	5	CD	NUMBER	5	num	14	SENT_176	[p12l1725t1910r1761b1974],
16	due	JJ	O	due	_	0	SENT_176	[p12l1793t1911r1918b1973],
17	to	TO	O	to	_	0	SENT_176	[p12l1944t1920r2011b1973],
18	the	DT	O	the	det	19	SENT_176	[p12l2038t1911r2145b1973],
19	development	NN	O	development	prep_due_to	26	SENT_176	[p12l9t2022r472b2103],
20	of	IN	O	of	_	0	SENT_176	[p12l546t2022r623b2084],
21	grade	NN	O	grade	nn	23	SENT_176	[p12l693t2022r887b2103],
22	2	CD	NUMBER	2	num	23	SENT_176	[p12l964t2022r1005b2083],
23	hand	NN	O	hand	prep_of	19	SENT_176	[p12l1079t2022r1443b2084],
24	—	CD	NUMBER	—	num	23	SENT_176	[p12l1079t2022r1443b2084],
25	foot	NN	O	foot	nn	26	SENT_176	[p12l1079t2022r1443b2084],
26	syndrome	NN	O	syndrome	prep_after	12	SENT_176	[p12l1519t2022r1885b2103],
27	.	.	O	.	_	0	SENT_176	[p12l1519t2022r1885b2103],

1	Dose	NN	O	dose	nn	2	SENT_177	[p12l1964t2023r2145b2084],
2	reductions	NNS	O	reduction	nsubjpass	4	SENT_177	[p12l7t2134r379b2197],
3	are	VBP	O	be	auxpass	4	SENT_177	[p12l415t2154r519b2197],
4	described	VBN	O	describe	_	0	SENT_177	[p12l554t2134r896b2197],
5	below	IN	O	below	prep	4	SENT_177	[p12l926t2134r1144b2197],
6	with	IN	O	with	pcomp	5	SENT_177	[p12l1177t2134r1334b2197],
7	safety	NN	O	safety	nn	8	SENT_177	[p12l1370t2134r1578b2215],
8	data	NNS	O	datum	pobj	6	SENT_177	[p12l1613t2134r1777b2197],
9	.	.	O	.	_	0	SENT_177	[p12l1613t2134r1777b2197],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_178	[p12l8t2358r305b2439],

1	Twenty	CD	NUMBER	twenty	num	2	SENT_179	[p12l8t2583r431b2662],
2	—	CD	NUMBER	—	nsubj	6	SENT_179	[p12l8t2583r431b2662],
3	one	CD	NUMBER	one	num	4	SENT_179	[p12l8t2583r431b2662],
4	patients	NNS	O	patient	dep	2	SENT_179	[p12l448t2581r719b2662],
5	were	VBD	O	be	cop	6	SENT_179	[p12l738t2601r906b2644],
6	evaluable	JJ	O	evaluable	_	0	SENT_179	[p12l924t2581r1258b2644],
7	for	IN	O	for	_	0	SENT_179	[p12l1276t2581r1378b2644],
8	response	NN	O	response	prep_for	6	SENT_179	[p12l1392t2601r1715b2662],
9	.	.	O	.	_	0	SENT_179	[p12l1392t2601r1715b2662],

1	Five	CD	NUMBER	five	_	0	SENT_180	[p12l1736t2581r1890b2644],
2	did	VBD	O	do	partmod	1	SENT_180	[p12l1909t2581r2019b2644],
3	not	RB	O	not	neg	5	SENT_180	[p12l2035t2591r2147b2644],
4	complete	JJ	O	complete	amod	5	SENT_180	[p12l9t2692r330b2773],
5	cycle	NN	O	cycle	dobj	2	SENT_180	[p12l363t2692r546b2773],
6	1	CD	NUMBER	1	num	5	SENT_180	[p12l588t2693r643b2766],
7	;	:	O	;	_	0	SENT_180	[p12l588t2693r643b2766],
8	three	CD	NUMBER	three	num	9	SENT_180	[p12l678t2692r852b2755],
9	patients	NNS	O	patient	nsubj	10	SENT_180	[p12l884t2692r1156b2773],
10	developed	VBD	O	develop	ccomp	19	SENT_180	[p12l1190t2692r1550b2773],
11	progressive	JJ	O	progressive	amod	12	SENT_180	[p12l1580t2692r1984b2773],
12	disease	NN	O	disease	dobj	10	SENT_180	[p12l2017t2692r2144b2755, p12l9t2823r158b2866],
13	during	IN	O	during	_	0	SENT_180	[p12l204t2803r431b2884],
14	cycle	NN	O	cycle	prep_during	10	SENT_180	[p12l477t2803r660b2884],
15	1	CD	NUMBER	1	num	14	SENT_180	[p12l714t2804r767b2877],
16	,	,	O	,	_	0	SENT_180	[p12l714t2804r767b2877],
17	one	CD	NUMBER	one	num	18	SENT_180	[p12l816t2823r940b2866],
18	patient	NN	O	patient	nsubj	19	SENT_180	[p12l985t2803r1225b2884],
19	developed	VBD	O	develop	dep	5	SENT_180	[p12l1270t2803r1630b2884],
20	a	DT	O	a	det	23	SENT_180	[p12l1676t2823r1713b2866],
21	right	JJ	O	right	amod	23	SENT_180	[p12l1756t2803r1922b2884],
22	atrial	JJ	O	atrial	amod	23	SENT_180	[p12l1969t2803r2146b2866],
23	thrombosis	NN	O	thrombosis	dobj	19	SENT_180	[p12l8t2913r395b2975],
24	and	CC	O	and	_	0	SENT_180	[p12l413t2913r539b2975],
25	congestive	JJ	O	congestive	amod	27	SENT_180	[p12l553t2913r926b2994],
26	heart	NN	O	heart	nn	27	SENT_180	[p12l942t2913r1118b2975],
27	failure	NN	O	failure	dobj	19	SENT_180	[p12l1132t2912r1358b2975],
28	after	IN	O	after	_	0	SENT_180	[p12l1377t2913r1536b2975],
29	4	CD	DURATION	4	num	30	SENT_180	[p12l1549t2913r1590b2974],
30	days	NNS	NUMBER	day	prep_after	23	SENT_180	[p12l1623t2913r1781b2994],
31	of	IN	O	of	_	0	SENT_180	[p12l1798t2912r1875b2975],
32	therapy	NN	O	therapy	nn	36	SENT_180	[p12l1883t2913r2145b2994],
33	Breast	NN	ORGANIZATION	breast	nn	36	SENT_180	[p12l52t3069r142b3094],
34	Cancer	NN	ORGANIZATION	cancer	nn	36	SENT_180	[p12l155t3069r255b3094],
35	Res	NNP	ORGANIZATION	Res	nn	36	SENT_180	[p12l267t3069r318b3094],
36	Treat	NNP	ORGANIZATION	Treat	prep_of	30	SENT_180	[p12l331t3069r406b3094],
37	(	CD	NUMBER	(	num	38	SENT_180	[p12l419t3069r510b3099],
38	2013	CD	DATE	2013	tmod	19	SENT_180	[p12l419t3069r510b3099],
39	)	CD	NUMBER	)	num	40	SENT_180	[p12l419t3069r510b3099],
40	l39	NN	O	l39	dep	38	SENT_180	[p12l528t3069r708b3094],
41	:	:	O	:	_	0	SENT_180	[p12l528t3069r708b3094],
42	l35	NN	O	l35	nn	43	SENT_180	[p12l528t3069r708b3094],
43	—	NN	O	—	dep	1	SENT_180	[p12l528t3069r708b3094],
44	143	CD	NUMBER	143	number	45	SENT_180	[p12l528t3069r708b3094],
45	139	CD	NUMBER	139	dep	43	SENT_180	[p12l2058t3069r2106b3094],

1	and	CC	O	and	cc	4	SENT_181	[p12l9t3237r134b3300],
2	one	CD	NUMBER	one	num	3	SENT_181	[p12l151t3257r275b3300],
3	patient	NN	O	patient	nsubj	4	SENT_181	[p12l290t3237r532b3318],
4	had	VBD	O	have	_	0	SENT_181	[p12l546t3237r673b3300],
5	an	DT	O	a	det	8	SENT_181	[p12l690t3257r771b3300],
6	ongoing	JJ	O	ongoing	amod	8	SENT_181	[p12l788t3237r1073b3318],
7	wound	NN	O	wound	nn	8	SENT_181	[p12l1091t3237r1329b3300],
8	infection	NN	O	infection	dobj	4	SENT_181	[p12l1345t3237r1656b3300],
9	that	WDT	O	that	dep	11	SENT_181	[p12l1673t3237r1805b3300],
10	pre	JJ	O	pre	amod	11	SENT_181	[p12l1818t3237r2152b3318],
11	—	NN	O	—	dep	8	SENT_181	[p12l1818t3237r2152b3318],
12	dated	JJ	O	dated	amod	14	SENT_181	[p12l1818t3237r2152b3318],
13	study	NN	O	study	nn	14	SENT_181	[p12l10t3348r195b3429],
14	entry	NN	O	entry	dep	11	SENT_181	[p12l240t3358r437b3429],
15	.	.	O	.	_	0	SENT_181	[p12l240t3358r437b3429],

1	No	DT	O	no	det	2	SENT_182	[p12l483t3350r588b3411],
2	responses	NNS	O	response	nsubjpass	7	SENT_182	[p12l632t3368r971b3429],
3	by	IN	O	by	_	0	SENT_182	[p12l1014t3348r1102b3429],
4	RECIST	NN	O	recist	nn	5	SENT_182	[p12l1145t3349r1448b3411],
5	criteria	NNS	O	criterion	prep_by	2	SENT_182	[p12l1493t3348r1741b3411],
6	were	VBD	O	be	auxpass	7	SENT_182	[p12l1783t3368r1952b3411],
7	seen	VBN	O	see	_	0	SENT_182	[p12l1999t3368r2152b3411],
8	(	NN	O	(	nn	11	SENT_182	[p12l10t3459r342b3540],
9	response	NN	O	response	nn	11	SENT_182	[p12l10t3459r342b3540],
10	rate	NN	O	rate	nn	11	SENT_182	[p12l360t3468r492b3521],
11	o	NN	O	o	dobj	7	SENT_182	[p12l511t3459r552b3522],
12	%	NN	O	%	prep	7	SENT_182	[p12l588t3459r702b3536],
13	)	CD	NUMBER	)	dep	12	SENT_182	[p12l588t3459r702b3536],
14	.	.	O	.	_	0	SENT_182	[p12l588t3459r702b3536],

1	Nine	CD	NUMBER	nine	num	2	SENT_183	[p12l725t3459r895b3521],
2	patients	NNS	O	patient	nsubj	3	SENT_183	[p12l913t3459r1185b3540],
3	had	VBD	O	have	_	0	SENT_183	[p12l1204t3459r1331b3521],
4	stable	JJ	O	stable	amod	5	SENT_183	[p12l1352t3459r1552b3521],
5	disease	NN	O	disease	dobj	3	SENT_183	[p12l1572t3459r1823b3521],
6	after	IN	O	after	_	0	SENT_183	[p12l1844t3459r2004b3521],
7	two	CD	NUMBER	two	num	8	SENT_183	[p12l2020t3468r2150b3522],
8	cycles	NNS	O	cycle	prep_after	3	SENT_183	[p12l8t3570r243b3651],
9	.	.	O	.	_	0	SENT_183	[p12l8t3570r243b3651],

1	Clinical	JJ	O	clinical	amod	3	SENT_184	[p12l265t3570r541b3633],
2	beneﬁt	NN	O	beneﬁt	nn	3	SENT_184	[p12l557t3570r799b3632],
3	rate	NN	O	rate	nsubj	21	SENT_184	[p12l812t3579r962b3644],
4	,	,	O	,	_	0	SENT_184	[p12l812t3579r962b3644],
5	deﬁned	VBN	O	deﬁned	partmod	3	SENT_184	[p12l983t3570r1241b3632],
6	as	IN	O	as	_	0	SENT_184	[p12l1258t3589r1327b3632],
7	complete	JJ	O	complete	amod	8	SENT_184	[p12l1345t3570r1667b3651],
8	response	NN	O	response	prep_as	5	SENT_184	[p12l1683t3589r1990b3651],
9	plus	CC	O	plus	prep	8	SENT_184	[p12l2005t3570r2150b3651],
10	partial	JJ	O	partial	amod	11	SENT_184	[p12l6t3680r230b3761],
11	response	NN	O	response	dep	9	SENT_184	[p12l271t3699r577b3761],
12	plus	CC	O	plus	_	0	SENT_184	[p12l617t3680r761b3761],
13	stable	JJ	O	stable	amod	14	SENT_184	[p12l806t3680r1007b3742],
14	disease	NN	O	disease	conj_plus	8	SENT_184	[p12l1049t3680r1299b3742],
15	(	CD	NUMBER	(	num	17	SENT_184	[p12l1343t3680r1508b3757],
16	SD	NN	O	sd	nn	17	SENT_184	[p12l1343t3680r1508b3757],
17	)	NN	O	)	dep	14	SENT_184	[p12l1343t3680r1508b3757],
18	324	CD	DURATION	324	num	19	SENT_184	[p12l1557t3680r1703b3753],
19	weeks	NNS	NUMBER	week	tmod	8	SENT_184	[p12l1735t3680r1973b3754],
20	,	,	O	,	_	0	SENT_184	[p12l1735t3680r1973b3754],
21	was	VBD	O	be	_	0	SENT_184	[p12l2016t3699r2149b3742],

1	19	CD	PERCENT	19	num	2	SENT_185	[p13l16t23r93b86],
2	%	NN	PERCENT	%	_	0	SENT_185	[p13l129t23r194b85],
3	(	CD	NUMBER	(	number	4	SENT_185	[p13l216t22r389b99],
4	four	CD	NUMBER	four	num	5	SENT_185	[p13l216t22r389b99],
5	patients	NNS	O	patient	dep	2	SENT_185	[p13l402t22r674b103],
6	with	IN	O	with	_	0	SENT_185	[p13l691t22r847b85],
7	SD	NN	O	sd	prep_with	5	SENT_185	[p13l864t23r971b85],
8	324	CD	DURATION	324	num	9	SENT_185	[p13l994t23r1141b96],
9	weeks	NNS	NUMBER	week	dep	2	SENT_185	[p13l1173t22r1437b99],
10	)	CD	NUMBER	)	dep	9	SENT_185	[p13l1173t22r1437b99],
11	.	.	O	.	_	0	SENT_185	[p13l1173t22r1437b99],

1	Twelve	CD	NUMBER	twelve	num	2	SENT_186	[p13l1457t22r1720b85],
2	patients	NNS	O	patient	nsubj	10	SENT_186	[p13l1736t22r2008b103],
3	had	VBD	O	have	_	0	SENT_186	[p13l2025t22r2152b85],
4	progressive	JJ	O	progressive	amod	5	SENT_186	[p13l6t133r410b214],
5	disease	NN	O	disease	dobj	3	SENT_186	[p13l439t133r690b196],
6	as	IN	O	as	_	0	SENT_186	[p13l720t153r788b196],
7	best	JJS	O	best	amod	8	SENT_186	[p13l815t133r959b196],
8	response	NN	O	response	prep_as	5	SENT_186	[p13l983t153r1290b214],
9	and	CC	O	and	_	0	SENT_186	[p13l1319t133r1445b196],
10	stopped	VBD	O	stop	conj_and	3	SENT_186	[p13l1474t133r1744b214],
11	study	NN	O	study	nn	12	SENT_186	[p13l1773t133r1958b214],
12	therapy	NN	O	therapy	dobj	10	SENT_186	[p13l1986t133r2148b196, p13l9t264r132b325],
13	after	IN	O	after	_	0	SENT_186	[p13l156t244r315b307],
14	a	DT	O	a	det	15	SENT_186	[p13l337t264r374b307],
15	median	NN	O	median	prep_after	10	SENT_186	[p13l393t244r653b307],
16	of	IN	O	of	_	0	SENT_186	[p13l675t244r752b307],
17	four	CD	NUMBER	four	num	18	SENT_186	[p13l766t244r912b307],
18	cycles	NNS	O	cycle	npadvmod	19	SENT_186	[p13l933t244r1149b325],
19	(	JJ	O	(	amod	22	SENT_186	[p13l1174t245r1395b325],
20	range	NN	O	range	nn	22	SENT_186	[p13l1174t245r1395b325],
21	2-4	CD	NUMBER	2-4	num	22	SENT_186	[p13l1417t244r1592b321],
22	)	NN	O	)	prep_of	15	SENT_186	[p13l1417t244r1592b321],
23	.	.	O	.	_	0	SENT_186	[p13l1417t244r1592b321],

1	Median	JJ	O	median	amod	2	SENT_187	[p13l1617t244r1887b307],
2	time	NN	O	time	nsubj	8	SENT_187	[p13l1907t244r2062b307],
3	to	TO	O	to	_	0	SENT_187	[p13l2084t254r2151b307],
4	treatment	NN	O	treatment	nn	5	SENT_187	[p13l7t365r341b418],
5	failure	NN	O	failure	prep_to	2	SENT_187	[p13l364t355r592b418],
6	was	VBD	O	be	cop	8	SENT_187	[p13l616t375r749b418],
7	12	CD	DURATION	12	num	8	SENT_187	[p13l784t356r862b417],
8	weeks	NNS	NUMBER	week	dep	20	SENT_187	[p13l894t355r1111b418],
9	(	JJ	O	(	amod	10	SENT_187	[p13l1139t356r1359b436],
10	range	NN	O	range	attr	8	SENT_187	[p13l1139t356r1359b436],
11	6-48	CD	NUMBER	6-48	num	12	SENT_187	[p13l1385t355r1585b432],
12	)	NN	O	)	dep	10	SENT_187	[p13l1385t355r1585b432],
13	and	CC	O	and	_	0	SENT_187	[p13l1613t355r1738b418],
14	the	DT	O	the	det	16	SENT_187	[p13l1761t355r1867b418],
15	median	JJ	O	median	amod	16	SENT_187	[p13l1892t355r2152b418],
16	number	NN	O	number	conj_and	10	SENT_187	[p13l7t466r278b529],
17	of	IN	O	of	_	0	SENT_187	[p13l301t466r378b529],
18	cycles	NNS	O	cycle	prep_of	16	SENT_187	[p13l396t466r613b547],
19	was	VBD	O	be	cop	20	SENT_187	[p13l639t486r772b529],
20	seven	CD	NUMBER	seven	_	0	SENT_187	[p13l801t486r997b529],
21	(	CD	NUMBER	(	num	24	SENT_187	[p13l1024t467r1245b547],
22	range	NN	O	range	nn	24	SENT_187	[p13l1024t467r1245b547],
23	2-16	CD	NUMBER	2-16	num	24	SENT_187	[p13l1270t466r1490b544],
24	)	NN	O	)	nsubj	20	SENT_187	[p13l1270t466r1490b544],
25	.	.	O	.	_	0	SENT_187	[p13l1270t466r1490b544],

1	Safety	NN	O	safety	_	0	SENT_188	[p13l10t690r234b771],
2	and	CC	O	and	_	0	SENT_188	[p13l270t690r396b752],
3	tolerability	NN	O	tolerability	conj_and	1	SENT_188	[p13l428t690r822b771],

1	Potentially	RB	O	potentially	advmod	14	SENT_189	[p13l7t913r395b994],
2	treatment	NN	O	treatment	nsubjpass	14	SENT_189	[p13l423t913r1039b976],
3	—	CD	NUMBER	—	num	2	SENT_189	[p13l423t913r1039b976],
4	re1ated	VBN	O	re1ate	partmod	2	SENT_189	[p13l423t913r1039b976],
5	toxicities	NNS	O	toxicity	dobj	4	SENT_189	[p13l1066t913r1392b976],
6	of	IN	O	of	_	0	SENT_189	[p13l1423t913r1500b976],
7	all	DT	O	all	det	8	SENT_189	[p13l1522t913r1608b976],
8	grades	NNS	O	grade	prep_of	5	SENT_189	[p13l1637t913r1866b994],
9	and	CC	O	and	cc	8	SENT_189	[p13l1896t913r2022b976],
10	for	IN	O	for	_	0	SENT_189	[p13l2049t913r2153b976],
11	all	DT	O	all	det	12	SENT_189	[p13l9t1024r95b1087],
12	cycles	NNS	O	cycle	prep_for	4	SENT_189	[p13l137t1024r357b1105],
13	are	VBP	O	be	auxpass	14	SENT_189	[p13l401t1044r506b1087],
14	listed	VBN	O	list	_	0	SENT_189	[p13l548t1024r742b1087],
15	in	IN	O	in	_	0	SENT_189	[p13l781t1024r849b1086],
16	Table	NNP	O	Table	prep_in	14	SENT_189	[p13l889t1024r1091b1087],
17	2	CD	NUMBER	2	num	16	SENT_189	[p13l1126t1025r1185b1087],
18	.	.	O	.	_	0	SENT_189	[p13l1126t1025r1185b1087],

1	No	DT	O	no	det	3	SENT_190	[p13l1229t1026r1336b1087],
2	unexpected	JJ	O	unexpected	amod	3	SENT_190	[p13l1377t1024r1786b1105],
3	capecita	NN	O	capecita	nsubjpass	10	SENT_190	[p13l1827t1024r2148b1105],
4	—	CD	NUMBER	—	num	5	SENT_190	[p13l1827t1024r2148b1105],
5	bine	NN	O	bine	dep	3	SENT_190	[p13l6t1135r437b1198],
6	—	RB	O	—	advmod	7	SENT_190	[p13l6t1135r437b1198],
7	related	JJ	O	related	amod	8	SENT_190	[p13l6t1135r437b1198],
8	toxicities	NNS	O	toxicity	dep	5	SENT_190	[p13l464t1135r792b1198],
9	were	VBD	O	be	auxpass	10	SENT_190	[p13l822t1155r994b1198],
10	observed	VBN	O	observe	_	0	SENT_190	[p13l1024t1135r1363b1198],
11	.	.	O	.	_	0	SENT_190	[p13l1024t1135r1363b1198],

1	Grade	NNP	O	Grade	nsubj	10	SENT_191	[p13l1397t1135r1612b1198],
2	3	CD	NUMBER	3	num	1	SENT_191	[p13l1644t1135r1679b1198],
3	drug	NN	O	drug	dep	1	SENT_191	[p13l1713t1135r2151b1216],
4	—	CD	NUMBER	—	num	3	SENT_191	[p13l1713t1135r2151b1216],
5	re1ated	VBN	O	re1ate	partmod	1	SENT_191	[p13l1713t1135r2151b1216],
6	toxicities	NNS	O	toxicity	dobj	5	SENT_191	[p13l7t1245r335b1307],
7	were	VBD	O	be	cop	8	SENT_191	[p13l364t1264r534b1307],
8	infrequent	JJ	O	infrequent	_	0	SENT_191	[p13l562t1244r931b1326],
9	and	CC	O	and	_	0	SENT_191	[p13l958t1245r1085b1307],
10	included	VBD	O	include	conj_and	8	SENT_191	[p13l1111t1245r1420b1307],
11	fatigue	NN	O	fatigue	nn	13	SENT_191	[p13l1445t1245r1693b1326],
12	(	NN	O	(	nn	13	SENT_191	[p13l1723t1245r1791b1322],
13	n	NN	O	n	dobj	10	SENT_191	[p13l1723t1245r1791b1322],
14	=	JJ	O	=	amod	16	SENT_191	[p13l1828t1273r1889b1297],
15	1	CD	NUMBER	1	tmod	14	SENT_191	[p13l1933t1245r1994b1322],
16	)	NN	O	)	dep	13	SENT_191	[p13l1933t1245r1994b1322],
17	and	CC	O	and	_	0	SENT_191	[p13l2025t1245r2152b1307],
18	hand-foot	NN	O	hand-foot	dobj	10	SENT_191	[p13l7t1357r372b1420],
19	syndrome	NN	O	syndrome	nn	21	SENT_191	[p13l423t1357r771b1438],
20	(	CD	NUMBER	(	num	21	SENT_191	[p13l825t1358r1041b1435],
21	HFS	NNP	O	HFS	dep	18	SENT_191	[p13l825t1358r1041b1435],
22	)	CD	NUMBER	)	number	23	SENT_191	[p13l825t1358r1041b1435],
23	(	CD	NUMBER	(	num	24	SENT_191	[p13l1096t1358r1165b1435],
24	n	NN	O	n	dobj	8	SENT_191	[p13l1096t1358r1165b1435],
25	=	JJ	O	=	amod	24	SENT_191	[p13l1201t1386r1262b1410],
26	2	CD	NUMBER	2	number	27	SENT_191	[p13l1299t1358r1388b1435],
27	)	CD	NUMBER	)	dep	25	SENT_191	[p13l1299t1358r1388b1435],
28	.	.	O	.	_	0	SENT_191	[p13l1299t1358r1388b1435],

1	The	DT	O	the	det	5	SENT_192	[p13l1443t1357r1580b1420],
2	most	RBS	O	most	advmod	5	SENT_192	[p13l1630t1367r1804b1420],
3	frequent	JJ	O	frequent	amod	5	SENT_192	[p13l1853t1357r2152b1438],
4	non	JJ	O	non	amod	5	SENT_192	[p13l7t1468r681b1549],
5	—	NN	O	—	nsubj	10	SENT_192	[p13l7t1468r681b1549],
6	hematological	JJ	O	hematological	amod	8	SENT_192	[p13l7t1468r681b1549],
7	adverse	JJ	O	adverse	amod	8	SENT_192	[p13l720t1468r989b1531],
8	events	NNS	O	event	dep	5	SENT_192	[p13l1026t1478r1251b1531],
9	were	VBD	O	be	cop	10	SENT_192	[p13l1289t1488r1460b1531],
10	HFS	NNP	O	HFS	_	0	SENT_192	[p13l1496t1469r1653b1531],
11	(	CD	PERCENT	(	num	10	SENT_192	[p13l1696t1469r1807b1546],
12	77	CD	PERCENT	77	number	13	SENT_192	[p13l1696t1469r1807b1546],
13	%	NN	PERCENT	%	amod	10	SENT_192	[p13l1847t1469r1964b1546],
14	)	CD	NUMBER	)	dep	10	SENT_192	[p13l1847t1469r1964b1546],
15	,	,	O	,	_	0	SENT_192	[p13l1847t1469r1964b1546],
16	fatigue	NN	O	fatigue	conj_and	10	SENT_192	[p13l2003t1468r2148b1531, p13l8t1597r134b1659],
17	(	CD	PERCENT	(	number	18	SENT_192	[p13l190t1578r296b1655],
18	61	CD	PERCENT	61	num	19	SENT_192	[p13l190t1578r296b1655],
19	%	NN	PERCENT	%	dep	16	SENT_192	[p13l341t1578r458b1655],
20	)	CD	NUMBER	)	dep	16	SENT_192	[p13l341t1578r458b1655],
21	,	,	O	,	_	0	SENT_192	[p13l341t1578r458b1655],
22	nausea	NN	O	nausea	conj_and	10	SENT_192	[p13l514t1597r758b1640],
23	(	CD	PERCENT	(	num	22	SENT_192	[p13l811t1578r925b1655],
24	54	CD	PERCENT	54	number	25	SENT_192	[p13l811t1578r925b1655],
25	%	NN	PERCENT	%	amod	22	SENT_192	[p13l962t1578r1080b1655],
26	)	CD	NUMBER	)	dep	22	SENT_192	[p13l962t1578r1080b1655],
27	,	,	O	,	_	0	SENT_192	[p13l962t1578r1080b1655],
28	mucositis	NN	O	mucositis	conj_and	10	SENT_192	[p13l1135t1578r1477b1640],
29	(	CD	PERCENT	(	number	30	SENT_192	[p13l1533t1578r1645b1655],
30	27	CD	PERCENT	27	num	31	SENT_192	[p13l1533t1578r1645b1655],
31	%	NN	PERCENT	%	dep	28	SENT_192	[p13l1684t1578r1802b1655],
32	)	CD	NUMBER	)	dep	28	SENT_192	[p13l1684t1578r1802b1655],
33	,	,	O	,	_	0	SENT_192	[p13l1684t1578r1802b1655],
34	diarrhea	NN	O	diarrhea	conj_and	10	SENT_192	[p13l1858t1578r2152b1640],
35	(	CD	PERCENT	(	number	36	SENT_192	[p13l10t1690r122b1767],
36	27	CD	PERCENT	27	num	37	SENT_192	[p13l10t1690r122b1767],
37	%	NN	PERCENT	%	dep	34	SENT_192	[p13l161t1690r279b1767],
38	)	CD	NUMBER	)	dep	34	SENT_192	[p13l161t1690r279b1767],
39	,	,	O	,	_	0	SENT_192	[p13l161t1690r279b1767],
40	and	CC	O	and	_	0	SENT_192	[p13l341t1690r468b1752],
41	vomiting	VBG	O	vomit	conj_and	10	SENT_192	[p13l525t1690r847b1771],
42	(	CD	PERCENT	(	number	43	SENT_192	[p13l908t1690r1018b1767],
43	23	CD	PERCENT	23	dep	44	SENT_192	[p13l908t1690r1018b1767],
44	%	NN	PERCENT	%	dep	41	SENT_192	[p13l1059t1690r1175b1767],
45	)	CD	NUMBER	)	dep	41	SENT_192	[p13l1059t1690r1175b1767],
46	.	.	O	.	_	0	SENT_192	[p13l1059t1690r1175b1767],

1	Doses	NNS	O	dose	nsubjpass	3	SENT_193	[p13l1238t1691r1452b1752],
2	were	VBD	O	be	auxpass	3	SENT_193	[p13l1513t1709r1684b1753],
3	reduced	VBN	O	reduce	_	0	SENT_193	[p13l1741t1690r2026b1752],
4	to	TO	O	to	_	0	SENT_193	[p13l2083t1699r2150b1752],
5	2,500	CD	NUMBER	2,500	num	6	SENT_193	[p13l9t1801r206b1875],
6	mg	NN	O	mg	prep_to	3	SENT_193	[p13l239t1820r351b1882],
7	in	IN	O	in	_	0	SENT_193	[p13l376t1801r444b1863],
8	six	CD	NUMBER	six	num	9	SENT_193	[p13l471t1801r570b1863],
9	patients	NNS	O	patient	npadvmod	14	SENT_193	[p13l594t1801r871b1882],
10	due	JJ	O	due	_	0	SENT_193	[p13l899t1801r1025b1863],
11	to	TO	O	to	_	0	SENT_193	[p13l1050t1810r1116b1863],
12	grade	NN	O	grade	prep_due_to	14	SENT_193	[p13l1143t1801r1339b1882],
13	2	CD	NUMBER	2	num	12	SENT_193	[p13l1365t1801r1406b1863],
14	HFS	NNS	ORGANIZATION	hf	prep_in	6	SENT_193	[p13l1430t1801r1609b1864],
15	.	.	O	.	_	0	SENT_193	[p13l1430t1801r1609b1864],

1	Three	CD	NUMBER	three	nsubj	5	SENT_194	[p13l1639t1801r1846b1863],
2	of	IN	O	of	_	0	SENT_194	[p13l1873t1801r1950b1863],
3	these	DT	O	these	det	4	SENT_194	[p13l1968t1801r2150b1863],
4	patients	NNS	O	patient	prep_of	1	SENT_194	[p13l6t1912r283b1993],
5	reduced	VBD	O	reduce	_	0	SENT_194	[p13l337t1912r621b1975],
6	dose	NN	O	dose	iobj	5	SENT_194	[p13l674t1912r834b1975],
7	a	DT	DURATION	a	det	9	SENT_194	[p13l889t1932r926b1975],
8	second	JJ	DURATION	second	amod	9	SENT_194	[p13l980t1912r1225b1975],
9	time	NN	O	time	dobj	5	SENT_194	[p13l1277t1912r1454b1986],
10	,	,	O	,	_	0	SENT_194	[p13l1277t1912r1454b1986],
11	to	TO	O	to	_	0	SENT_194	[p13l1509t1922r1576b1975],
12	2,000	CD	NUMBER	2,000	num	13	SENT_194	[p13l1630t1913r1828b1986],
13	mg	NN	O	mg	prep_to	5	SENT_194	[p13l1861t1932r1993b1993],
14	,	,	O	,	_	0	SENT_194	[p13l1861t1932r1993b1993],
15	for	IN	O	for	_	0	SENT_194	[p13l2049t1912r2153b1975],
16	recurrent	JJ	O	recurrent	amod	17	SENT_194	[p13l6t2032r332b2086],
17	grade	NN	O	grade	prep_for	5	SENT_194	[p13l373t2023r568b2104],
18	2	CD	NUMBER	2	num	19	SENT_194	[p13l612t2023r652b2085],
19	HFS	NNS	ORGANIZATION	hf	nsubj	25	SENT_194	[p13l694t2023r851b2086],
20	and	CC	O	and	_	0	SENT_194	[p13l898t2023r1024b2086],
21	one	CD	NUMBER	one	nsubj	25	SENT_194	[p13l1066t2043r1191b2086],
22	of	IN	O	of	_	0	SENT_194	[p13l1234t2023r1312b2086],
23	these	DT	O	these	det	24	SENT_194	[p13l1346t2023r1528b2086],
24	three	CD	NUMBER	three	prep_of	21	SENT_194	[p13l1570t2023r1747b2086],
25	reduced	VBD	O	reduce	rcmod	17	SENT_194	[p13l1788t2023r2073b2086],
26	a	DT	O	a	det	28	SENT_194	[p13l2115t2043r2152b2086],
27	third	JJ	ORDINAL	third	amod	28	SENT_194	[p13l7t2134r176b2197],
28	time	NN	O	time	dobj	25	SENT_194	[p13l230t2134r387b2197],
29	to	TO	O	to	_	0	SENT_194	[p13l442t2143r509b2197],
30	1,500	CD	NUMBER	1,500	num	31	SENT_194	[p13l572t2134r763b2208],
31	mg	NN	O	mg	prep_to	25	SENT_194	[p13l796t2154r907b2215],
32	for	IN	O	for	_	0	SENT_194	[p13l963t2134r1067b2197],
33	grade	NN	O	grade	nn	35	SENT_194	[p13l1120t2134r1316b2215],
34	3	CD	NUMBER	3	num	35	SENT_194	[p13l1373t2134r1409b2197],
35	HFS	NN	ORGANIZATION	hf	prep_for	25	SENT_194	[p13l1468t2134r1647b2197],
36	.	.	O	.	_	0	SENT_194	[p13l1468t2134r1647b2197],

1	One	CD	NUMBER	one	num	2	SENT_195	[p13l1707t2135r1851b2197],
2	patient	NN	O	patient	nsubj	3	SENT_195	[p13l1906t2134r2152b2215],
3	reduced	VBD	O	reduce	_	0	SENT_195	[p13l6t2245r291b2308],
4	dose	NN	O	dose	dobj	3	SENT_195	[p13l326t2245r487b2308],
5	in	IN	O	in	_	0	SENT_195	[p13l523t2245r591b2307],
6	cycle	NN	O	cycle	prep_in	3	SENT_195	[p13l627t2246r813b2326],
7	1	CD	NUMBER	1	number	8	SENT_195	[p13l858t2246r884b2307],
8	due	JJ	O	due	amod	6	SENT_195	[p13l927t2245r1053b2308],
9	to	TO	O	to	_	0	SENT_195	[p13l1090t2255r1156b2308],
10	grade	NN	O	grade	nn	12	SENT_195	[p13l1193t2245r1389b2326],
11	2	CD	NUMBER	2	num	12	SENT_195	[p13l1427t2246r1467b2307],
12	vomiting	NN	O	vomiting	prep_to	3	SENT_195	[p13l1503t2245r1844b2326],
13	.	.	O	.	_	0	SENT_195	[p13l1503t2245r1844b2326],

1	Among	IN	O	among	_	0	SENT_196	[p13l1884t2246r2150b2326],
2	the	DT	O	the	det	4	SENT_196	[p13l7t2356r114b2419],
3	two	CD	NUMBER	two	num	4	SENT_196	[p13l160t2366r291b2419],
4	patients	NNS	O	patient	prep_among	16	SENT_196	[p13l336t2356r613b2437],
5	whose	WP$	O	whose	poss	6	SENT_196	[p13l660t2356r886b2419],
6	dose	NN	O	dose	nsubjpass	8	SENT_196	[p13l933t2356r1093b2419],
7	was	VBD	O	be	auxpass	8	SENT_196	[p13l1139t2376r1274b2419],
8	escalated	VBN	O	escalate	rcmod	4	SENT_196	[p13l1321t2356r1650b2419],
9	to	TO	O	to	_	0	SENT_196	[p13l1694t2366r1761b2419],
10	3,500	CD	NUMBER	3,500	num	11	SENT_196	[p13l1808t2356r2005b2430],
11	mg	NN	O	mg	prep_to	8	SENT_196	[p13l2038t2376r2150b2437],
12	daily	RB	SET	daily	advmod	8	SENT_196	[p13l8t2467r204b2548],
13	,	,	O	,	_	0	SENT_196	[p13l8t2467r204b2548],
14	both	CC	O	both	nsubj	16	SENT_196	[p13l239t2467r398b2530],
15	only	RB	O	only	advmod	16	SENT_196	[p13l432t2467r587b2548],
16	received	VBD	O	receive	_	0	SENT_196	[p13l619t2467r925b2530],
17	the	DT	O	the	det	19	SENT_196	[p13l956t2467r1063b2530],
18	higher	JJR	O	higher	amod	19	SENT_196	[p13l1095t2467r1326b2548],
19	dose	NN	O	dose	dobj	16	SENT_196	[p13l1357t2467r1518b2530],
20	for	IN	O	for	_	0	SENT_196	[p13l1551t2467r1655b2530],
21	1	CD	NUMBER	1	num	22	SENT_196	[p13l1694t2468r1720b2529],
22	cycle	NN	O	cycle	prep_for	16	SENT_196	[p13l1761t2467r1967b2548],
23	.	.	O	.	_	0	SENT_196	[p13l1761t2467r1967b2548],

1	One	CD	NUMBER	one	_	0	SENT_197	[p13l2006t2468r2150b2530],

1	Table	NNP	O	Table	dep	3	SENT_198	[p13l8t2711r191b2764],
2	2	CD	NUMBER	2	num	1	SENT_198	[p13l219t2710r255b2763],
3	Treatment-related	JJ	O	treatment-related	amod	5	SENT_198	[p13l303t2710r852b2763],
4	side	JJ	O	side	amod	5	SENT_198	[p13l881t2710r999b2763],
5	effects	NNS	O	effect	_	0	SENT_198	[p13l1028t2710r1228b2763],
6	occurring	VBG	O	occur	partmod	5	SENT_198	[p13l1258t2710r1548b2779],
7	in	IN	O	in	_	0	SENT_198	[p13l1576t2710r1634b2763],
8	>	JJR	O	>	prep_in	6	SENT_198	[p13l1662t2711r1741b2763],
9	1	CD	NUMBER	1	num	10	SENT_198	[p13l1662t2711r1741b2763],
10	patient	NN	O	patient	dep	8	SENT_198	[p13l1775t2710r1983b2779],

1	Toxicity	NN	O	toxicity	_	0	SENT_199	[p13l7t2855r264b2924],
2	Total	JJ	O	total	amod	4	SENT_199	[p13l843t2855r1002b2908],
3	events	NNS	O	event	nn	4	SENT_199	[p13l1031t2863r1222b2908],
4	n	NN	O	n	dep	1	SENT_199	[p13l1442t2873r1477b2908],
5	=	JJ	O	=	amod	4	SENT_199	[p13l1508t2880r1560b2900],
6	26	CD	NUMBER	26	tmod	5	SENT_199	[p13l1591t2855r1663b2909],

1	G1	NN	O	g1	_	0	SENT_200	[p13l1443t3001r1526b3054],
2	G2	NN	O	g2	nn	3	SENT_200	[p13l1753t3001r1842b3054],
3	G3	NN	O	g3	dep	1	SENT_200	[p13l2061t3001r2147b3054],

1	Anemia	NN	O	anemia	dep	8	SENT_201	[p13l7t3190r249b3243],
2	3	CD	NUMBER	3	number	3	SENT_201	[p13l883t3191r913b3243],
3	2	CD	NUMBER	2	dep	1	SENT_201	[p13l1481t3191r1516b3243],
4	1	CD	NUMBER	1	dep	3	SENT_201	[p13l1758t3191r1781b3243],
5	Fatigue	NN	ORGANIZATION	fatigue	dep	8	SENT_201	[p13l7t3284r234b3353],
6	16	CD	NUMBER	16	num	5	SENT_201	[p13l851t3284r916b3338],
7	1	CD	NUMBER	1	num	8	SENT_201	[p13l1450t3285r1472b3337],
8	1	CD	NUMBER	1	dep	15	SENT_201	[p13l1488t3285r1510b3337],
9	4	CD	NUMBER	4	number	10	SENT_201	[p13l1751t3285r1787b3337],
10	1	CD	NUMBER	1	num	11	SENT_201	[p13l2068t3285r2090b3337],
11	Anorexia	NN	ORGANIZATION	anorexia	dep	8	SENT_201	[p13l7t3379r291b3432],
12	5	CD	NUMBER	5	number	13	SENT_201	[p13l882t3379r914b3432],
13	3	CD	NUMBER	3	amod	11	SENT_201	[p13l1482t3379r1513b3432],
14	2	CD	NUMBER	2	num	15	SENT_201	[p13l1752t3379r1787b3431],
15	Nausea	NN	ORGANIZATION	nausea	dep	19	SENT_201	[p13l7t3473r231b3525],
16	14	CD	NUMBER	14	num	19	SENT_201	[p13l851t3472r917b3525],
17	12	CD	NUMBER	12	number	18	SENT_201	[p13l1449t3472r1515b3525],
18	2	CD	NUMBER	2	amod	19	SENT_201	[p13l1752t3473r1786b3525],
19	Vomiting	NN	O	vomiting	dep	23	SENT_201	[p13l7t3566r298b3635],
20	6	CD	NUMBER	6	number	21	SENT_201	[p13l882t3566r916b3620],
21	3	CD	NUMBER	3	num	19	SENT_201	[p13l1482t3567r1513b3620],
22	3	CD	NUMBER	3	dep	19	SENT_201	[p13l1753t3567r1783b3620],
23	Diarrhea	NN	O	diarrhea	dep	26	SENT_201	[p13l8t3660r274b3714],
24	7	CD	NUMBER	7	num	23	SENT_201	[p13l881t3662r915b3714],
25	6	CD	NUMBER	6	num	26	SENT_201	[p13l1482t3660r1515b3714],
26	1	CD	NUMBER	1	_	0	SENT_201	[p13l1758t3661r1781b3713],

1	Constipation	NN	O	constipation	nn	9	SENT_202	[p14l8t27r397b96],
2	Dyspepsia	NN	O	dyspepsia	nn	9	SENT_202	[p14l7t120r324b189],
3	Taste	NN	O	taste	nn	9	SENT_202	[p14l8t215r171b267],
4	alteration	NN	O	alteration	nn	9	SENT_202	[p14l201t214r487b267],
5	Mucositis	NN	O	mucositis	nn	9	SENT_202	[p14l7t308r305b361],
6	Pain	NN	O	pain	nn	9	SENT_202	[p14l7t403r448b456],
7	—	CD	NUMBER	—	num	9	SENT_202	[p14l7t403r448b456],
8	abdomen	NN	O	abdomen	nn	9	SENT_202	[p14l7t403r448b456],
9	NOS	NN	MISC	no	_	0	SENT_202	[p14l474t403r622b456],
10	Hand-foot	JJ	MISC	hand-foot	amod	11	SENT_202	[p14l8t497r320b550],
11	reaction	NN	O	reaction	dep	9	SENT_202	[p14l346t497r592b550],
12	2	CD	NUMBER	2	dep	11	SENT_202	[p14l844t497r878b549],
13	Rash	NNP	O	Rash	dep	9	SENT_202	[p14l8t590r158b643],

1	2	CD	NUMBER	2	num	2	SENT_203	[p14l882t591r916b643],
2	Headache	NN	O	headache	dep	14	SENT_203	[p14l8t685r307b738],
3	5	CD	NUMBER	5	num	5	SENT_203	[p14l882t684r914b738],
4	Sensory	NN	O	sensory	nn	5	SENT_203	[p14l9t779r251b847],
5	neuropathy	NN	O	neuropathy	dep	2	SENT_203	[p14l278t779r620b847],
6	3	CD	NUMBER	3	number	7	SENT_203	[p14l883t779r913b832],
7	G	NN	O	g	amod	5	SENT_203	[p14l881t27r917b550],
8	-	:	O	-	_	0	SENT_203	[p14l881t27r917b550],
9	|	NN	O	|	dep	5	SENT_203	[p14l881t27r917b550],
10	>	JJR	O	>	amod	11	SENT_203	[p14l881t27r917b550],
11	O	NN	O	o	dep	9	SENT_203	[p14l881t27r917b550],
12	‘	CD	NUMBER	‘	num	13	SENT_203	[p14l881t27r917b550],
13	\	NN	O	\	dep	14	SENT_203	[p14l881t27r917b550],
14	l	NN	O	l	dep	29	SENT_203	[p14l881t27r917b550],
15	\	CD	NUMBER	\	num	14	SENT_203	[p14l881t27r917b550],
16	JO	NN	O	jo	nn	19	SENT_203	[p14l881t27r917b550],
17	‘	CD	NUMBER	‘	num	19	SENT_203	[p14l881t27r917b550],
18	\	NN	O	\	nn	19	SENT_203	[p14l881t27r917b550],
19	l	NN	O	l	dep	14	SENT_203	[p14l881t27r917b550],
20	\	CD	NUMBER	\	number	21	SENT_203	[p14l881t27r917b550],
21	)	CD	NUMBER	)	num	26	SENT_203	[p14l881t27r917b550],
22	\	NN	O	\	nn	26	SENT_203	[p14l1752t215r1787b551],
23	D	NN	O	d	nn	26	SENT_203	[p14l1752t215r1787b551],
24	[	CD	NUMBER	[	num	26	SENT_203	[p14l1752t215r1787b551],
25	\	NN	O	\	nn	26	SENT_203	[p14l1752t215r1787b551],
26	J	NN	O	j	dep	19	SENT_203	[p14l1752t215r1787b551],
27	\	CD	NUMBER	\	num	29	SENT_203	[p14l1752t215r1787b551],
28	lr	NN	O	lr	nn	29	SENT_203	[p14l1752t215r1787b551],
29	—	NN	O	—	dep	37	SENT_203	[p14l1752t215r1787b551],
30	2	CD	NUMBER	2	number	31	SENT_203	[p14l1481t27r1516b79],
31	6	CD	NUMBER	6	num	33	SENT_203	[p14l1482t120r1515b173],
32	1	CD	NUMBER	1	number	33	SENT_203	[p14l1488t215r1510b267],
33	1	CD	NUMBER	1	dep	29	SENT_203	[p14l1488t309r1510b361],
34	2	CD	NUMBER	2	number	35	SENT_203	[p14l1481t403r1516b455],
35	9	CD	NUMBER	9	amod	33	SENT_203	[p14l1481t497r1515b551],
36	1	CD	NUMBER	1	num	37	SENT_203	[p14l1488t591r1510b643],
37	4	CD	NUMBER	4	_	0	SENT_203	[p14l1480t685r1516b737],

1	Number	NN	O	number	nsubj	13	SENT_204	[p14l7t926r257b979],
2	of	IN	O	of	_	0	SENT_204	[p14l291t926r357b979],
3	worst	JJS	O	worst	amod	4	SENT_204	[p14l387t934r555b979],
4	grade	NN	O	grade	prep_of	1	SENT_204	[p14l590t926r757b995],
5	adverse	JJ	O	adverse	amod	6	SENT_204	[p14l793t926r1023b979],
6	events	NNS	O	event	dep	1	SENT_204	[p14l1059t934r1250b979],
7	possibly	RB	O	possibly	advmod	6	SENT_204	[p14l1286t926r1555b995],
8	,	,	O	,	_	0	SENT_204	[p14l1286t926r1555b995],
9	probably	RB	O	probably	advmod	13	SENT_204	[p14l1593t926r1879b995],
10	,	,	O	,	_	0	SENT_204	[p14l1593t926r1879b995],
11	or	CC	O	or	_	0	SENT_204	[p14l1918t943r1980b979],
12	deﬁnitely	RB	O	deﬁnitely	advmod	13	SENT_204	[p14l2014t926r2149b979, p14l7t1014r179b1083],
13	attributed	VBN	O	attribute	_	0	SENT_204	[p14l222t1014r512b1067],
14	to	TO	O	to	_	0	SENT_204	[p14l552t1022r609b1067],
15	capecitabine	NN	O	capecitabine	prep_to	13	SENT_204	[p14l650t1014r1031b1083],
16	during	IN	O	during	_	0	SENT_204	[p14l1073t1014r1268b1083],
17	study	NN	O	study	nn	19	SENT_204	[p14l1312t1014r1472b1083],
18	drug	NN	O	drug	nn	19	SENT_204	[p14l1514t1014r1650b1083],
19	administration	NN	O	administration	prep_during	15	SENT_204	[p14l1693t1014r2147b1067],
20	.	.	O	.	_	0	SENT_204	[p14l1693t1014r2147b1067],

1	Toxicities	NNS	O	toxicity	nsubjpass	3	SENT_205	[p14l7t1103r310b1156],
2	are	VBP	O	be	auxpass	3	SENT_205	[p14l341t1120r430b1156],
3	graded	VBN	O	grade	_	0	SENT_205	[p14l460t1103r665b1172],
4	per	IN	O	per	_	0	SENT_205	[p14l692t1120r789b1172],
5	the	DT	O	the	det	8	SENT_205	[p14l816t1103r907b1156],
6	NCI	NNP	ORGANIZATION	NCI	nn	8	SENT_205	[p14l935t1104r1064b1156],
7	CTCAE	NNP	O	CTCAE	nn	8	SENT_205	[p14l1093t1103r1340b1156],
8	version	NN	O	version	prep_per	3	SENT_205	[p14l1368t1103r1591b1156],
9	3	CD	NUMBER	3	num	10	SENT_205	[p14l1621t1103r1650b1156],
10	criteria	NNS	O	criterion	nn	11	SENT_205	[p14l1682t1103r1898b1156],
11	G1	NN	O	g1	dobj	3	SENT_205	[p14l10t1198r93b1251],
12	Grade	NNP	O	Grade	dep	11	SENT_205	[p14l127t1197r310b1251],
13	1	CD	NUMBER	1	num	12	SENT_205	[p14l345t1198r390b1260],
14	,	,	O	,	_	0	SENT_205	[p14l345t1198r390b1260],
15	G2	NN	O	g2	appos	11	SENT_205	[p14l423t1198r509b1251],
16	Grade	NNP	O	Grade	dep	15	SENT_205	[p14l540t1197r723b1251],
17	2	CD	NUMBER	2	num	16	SENT_205	[p14l753t1198r804b1260],
18	,	,	O	,	_	0	SENT_205	[p14l753t1198r804b1260],
19	G3	NN	O	g3	appos	11	SENT_205	[p14l837t1198r923b1251],
20	Grade	NNP	O	Grade	dep	19	SENT_205	[p14l954t1197r1136b1251],
21	3	CD	NUMBER	3	num	20	SENT_205	[p14l1167t1198r1218b1260],
22	,	,	O	,	_	0	SENT_205	[p14l1167t1198r1218b1260],
23	NOS	NN	O	no	appos	11	SENT_205	[p14l1245t1198r1391b1251],
24	not	RB	O	not	neg	23	SENT_205	[p14l1417t1205r1514b1250],
25	otherwise	RB	O	otherwise	advmod	26	SENT_205	[p14l1541t1197r1835b1251],
26	speciﬁed	JJ	O	speciﬁed	amod	27	SENT_205	[p14l1865t1197r2133b1266],
27	patient	NN	O	patient	nsubj	31	SENT_205	[p14l7t1300r252b1381],
28	was	VBD	O	be	cop	31	SENT_205	[p14l281t1320r416b1363],
29	later	RB	O	later	advmod	31	SENT_205	[p14l447t1300r606b1363],
30	dose	NN	O	dose	nn	31	SENT_205	[p14l635t1300r1111b1363],
31	—	NN	O	—	rcmod	23	SENT_205	[p14l635t1300r1111b1363],
32	reduced	VBD	O	reduce	rcmod	31	SENT_205	[p14l635t1300r1111b1363],
33	to	TO	O	to	_	0	SENT_205	[p14l1140t1310r1206b1363],
34	3,000	CD	NUMBER	3,000	num	35	SENT_205	[p14l1239t1301r1435b1375],
35	mg	NN	O	mg	prep_to	32	SENT_205	[p14l1468t1320r1579b1381],
36	daily	RB	SET	daily	advmod	35	SENT_205	[p14l1611t1300r1786b1381],
37	for	IN	O	for	_	0	SENT_205	[p14l1817t1300r1920b1363],
38	grade	NN	O	grade	nn	40	SENT_205	[p14l1949t1300r2145b1381],
39	2	CD	NUMBER	2	num	40	SENT_205	[p14l9t1412r49b1473],
40	HFS	NNS	ORGANIZATION	hf	prep_for	35	SENT_205	[p14l83t1412r240b1474],
41	while	IN	O	while	mark	44	SENT_205	[p14l277t1411r472b1474],
42	the	DT	O	the	det	43	SENT_205	[p14l506t1411r613b1474],
43	other	JJ	O	other	nsubj	44	SENT_205	[p14l647t1411r831b1474],
44	had	VBD	O	have	advcl	32	SENT_205	[p14l861t1411r989b1474],
45	progressive	JJ	O	progressive	amod	46	SENT_205	[p14l1019t1411r1431b1492],
46	disease	NN	O	disease	dobj	44	SENT_205	[p14l1465t1411r1739b1474],
47	.	.	O	.	_	0	SENT_205	[p14l1465t1411r1739b1474],

1	Adherence	NN	O	adherence	_	0	SENT_206	[p14l8t1635r394b1696],

1	Utilizing	VBG	O	utilize	partmod	19	SENT_207	[p14l8t1857r324b1938],
2	the	DT	O	the	det	3	SENT_207	[p14l361t1857r468b1920],
3	patient	NN	O	patient	nsubj	5	SENT_207	[p14l502t1857r1077b1938],
4	—	RB	O	—	advmod	5	SENT_207	[p14l502t1857r1077b1938],
5	reported	VBD	O	report	ccomp	1	SENT_207	[p14l502t1857r1077b1938],
6	method	NN	O	method	dobj	5	SENT_207	[p14l1111t1857r1397b1931],
7	,	,	O	,	_	0	SENT_207	[p14l1111t1857r1397b1931],
8	46	CD	PERCENT	46	num	9	SENT_207	[p14l1436t1857r1522b1920],
9	%	NN	PERCENT	%	nsubj	19	SENT_207	[p14l1560t1857r1624b1920],
10	(	CD	NUMBER	(	number	11	SENT_207	[p14l1665t1857r1779b1934],
11	12	CD	NUMBER	12	num	9	SENT_207	[p14l1665t1857r1779b1934],
12	of	IN	O	of	_	0	SENT_207	[p14l1815t1857r1892b1920],
13	26	CD	NUMBER	26	num	14	SENT_207	[p14l1923t1857r2036b1934],
14	)	NN	O	)	prep_of	9	SENT_207	[p14l1923t1857r2036b1934],
15	of	IN	O	of	_	0	SENT_207	[p14l2074t1857r2151b1920],
16	patients	NNS	O	patient	prep_of	14	SENT_207	[p14l7t1968r284b2049],
17	did	VBD	O	do	aux	19	SENT_207	[p14l340t1968r453b2031],
18	not	RB	O	not	neg	19	SENT_207	[p14l505t1978r619b2031],
19	report	VB	O	report	_	0	SENT_207	[p14l670t1977r884b2049],
20	missing	VBG	O	miss	xcomp	19	SENT_207	[p14l936t1968r1212b2049],
21	any	DT	O	any	det	23	SENT_207	[p14l1268t1988r1393b2049],
22	capecitabine	NN	O	capecitabine	nn	23	SENT_207	[p14l1448t1968r1895b2049],
23	doses	NNS	O	dose	dobj	20	SENT_207	[p14l1950t1968r2143b2031],
24	although	IN	O	although	mark	33	SENT_207	[p14l10t2079r320b2160],
25	a	DT	O	a	det	26	SENT_207	[p14l370t2099r407b2142],
26	time	NN	O	time	nsubjpass	33	SENT_207	[p14l453t2079r611b2142],
27	of	IN	O	of	_	0	SENT_207	[p14l660t2079r737b2142],
28	dose	NN	O	dose	nn	29	SENT_207	[p14l780t2079r940b2142],
29	administration	NN	O	administration	prep_of	26	SENT_207	[p14l990t2079r1507b2142],
30	was	VBD	O	be	auxpass	33	SENT_207	[p14l1554t2099r1689b2142],
31	not	RB	O	not	neg	33	SENT_207	[p14l1739t2089r1852b2142],
32	always	RB	O	always	advmod	33	SENT_207	[p14l1900t2079r2143b2160],
33	recorded	VBN	O	record	advcl	19	SENT_207	[p14l7t2190r338b2253],
34	.	.	O	.	_	0	SENT_207	[p14l7t2190r338b2253],

1	Of	IN	O	of	_	0	SENT_208	[p14l362t2190r458b2253],
2	those	DT	O	those	prep_of	15	SENT_208	[p14l470t2191r656b2253],
3	that	WDT	O	that	nsubj	4	SENT_208	[p14l674t2190r808b2253],
4	reported	VBD	O	report	rcmod	2	SENT_208	[p14l824t2190r1122b2271],
5	missed	VBN	O	miss	amod	6	SENT_208	[p14l1140t2190r1387b2253],
6	doses	NNS	O	dose	dobj	4	SENT_208	[p14l1405t2190r1619b2264],
7	,	,	O	,	_	0	SENT_208	[p14l1405t2190r1619b2264],
8	14	CD	PERCENT	14	num	9	SENT_208	[p14l1649t2191r1726b2252],
9	%	NN	PERCENT	%	nsubj	15	SENT_208	[p14l1763t2191r1828b2253],
10	(	CD	NUMBER	(	number	11	SENT_208	[p14l1852t2191r1920b2268],
11	2	CD	TIME	2	num	9	SENT_208	[p14l1852t2191r1920b2268],
12	of	IN	TIME	of	_	0	SENT_208	[p14l1940t2190r2017b2253],
13	14	CD	TIME	14	num	14	SENT_208	[p14l2037t2191r2143b2268],
14	)	NN	O	)	prep_of	9	SENT_208	[p14l2037t2191r2143b2268],
15	reported	VBD	O	report	_	0	SENT_208	[p14l7t2301r307b2382],
16	missing	VBG	O	miss	xcomp	15	SENT_208	[p14l325t2301r600b2382],
17	ﬁve	NN	O	ﬁve	nn	20	SENT_208	[p14l621t2301r751b2364],
18	or	CC	O	or	_	0	SENT_208	[p14l772t2321r845b2364],
19	fewer	JJR	O	fewer	conj_or	17	SENT_208	[p14l862t2301r1065b2364],
20	doses	NNS	O	dose	dobj	16	SENT_208	[p14l1084t2301r1298b2376],
21	,	,	O	,	_	0	SENT_208	[p14l1084t2301r1298b2376],
22	46	CD	PERCENT	46	num	23	SENT_208	[p14l1320t2301r1406b2364],
23	%	NN	PERCENT	%	nsubj	29	SENT_208	[p14l1443t2302r1508b2364],
24	(	CD	NUMBER	(	number	25	SENT_208	[p14l1534t2302r1600b2379],
25	7	CD	TIME	7	num	23	SENT_208	[p14l1534t2302r1600b2379],
26	of	IN	TIME	of	_	0	SENT_208	[p14l1622t2301r1699b2364],
27	14	CD	TIME	14	num	28	SENT_208	[p14l1721t2302r1827b2379],
28	)	NN	O	)	prep_of	23	SENT_208	[p14l1721t2302r1827b2379],
29	reported	VBD	O	report	ccomp	15	SENT_208	[p14l1847t2301r2147b2382],
30	missing	VBG	O	miss	xcomp	29	SENT_208	[p14l8t2412r283b2493],
31	six	CD	NUMBER	six	number	33	SENT_208	[p14l317t2412r416b2474],
32	to	TO	O	to	dep	33	SENT_208	[p14l445t2421r511b2474],
33	14	CD	NUMBER	14	num	34	SENT_208	[p14l549t2412r627b2474],
34	doses	NNS	O	dose	dobj	30	SENT_208	[p14l657t2412r872b2486],
35	,	,	O	,	_	0	SENT_208	[p14l657t2412r872b2486],
36	1	CD	PERCENT	1	num	37	SENT_208	[p14l913t2412r938b2474],
37	%	NN	PERCENT	%	nsubj	43	SENT_208	[p14l982t2412r1047b2475],
38	(	CD	NUMBER	(	number	39	SENT_208	[p14l1082t2412r1143b2489],
39	1	CD	TIME	1	num	37	SENT_208	[p14l1082t2412r1143b2489],
40	of	IN	TIME	of	_	0	SENT_208	[p14l1181t2412r1258b2474],
41	14	CD	TIME	14	num	42	SENT_208	[p14l1289t2412r1395b2489],
42	)	NN	O	)	prep_of	37	SENT_208	[p14l1289t2412r1395b2489],
43	reported	VBD	O	report	ccomp	15	SENT_208	[p14l1426t2412r1725b2493],
44	missing	VBG	O	miss	xcomp	43	SENT_208	[p14l1753t2412r2029b2493],
45	19	CD	NUMBER	19	num	46	SENT_208	[p14l2067t2412r2143b2475],
46	doses	NNS	O	dose	dobj	44	SENT_208	[p14l9t2523r224b2597],
47	,	,	O	,	_	0	SENT_208	[p14l9t2523r224b2597],
48	and	CC	O	and	_	0	SENT_208	[p14l260t2523r386b2585],
49	29	CD	PERCENT	29	num	50	SENT_208	[p14l418t2523r501b2586],
50	%	NN	PERCENT	%	nsubj	58	SENT_208	[p14l540t2523r604b2586],
51	(	CD	NUMBER	(	number	52	SENT_208	[p14l641t2523r710b2600],
52	4	CD	TIME	4	num	50	SENT_208	[p14l641t2523r710b2600],
53	of	IN	TIME	of	_	0	SENT_208	[p14l743t2523r820b2585],
54	14	CD	TIME	14	num	55	SENT_208	[p14l853t2523r959b2600],
55	)	NN	O	)	prep_of	50	SENT_208	[p14l853t2523r959b2600],
56	did	VBD	O	do	aux	58	SENT_208	[p14l994t2523r1106b2585],
57	not	RB	O	not	neg	58	SENT_208	[p14l1136t2532r1250b2585],
58	document	VB	O	document	conj_and	15	SENT_208	[p14l1280t2523r1632b2585],
59	dosing	NN	O	dosing	nn	60	SENT_208	[p14l1663t2523r1898b2604],
60	times	NNS	O	time	dobj	58	SENT_208	[p14l1931t2523r2140b2585],
61	.	.	O	.	_	0	SENT_208	[p14l1931t2523r2140b2585],

1	According	VBG	O	accord	_	0	SENT_209	[p14l8t2633r384b2714],
2	to	TO	O	to	prepc_according_to	20	SENT_209	[p14l419t2642r485b2695],
3	the	DT	O	the	det	5	SENT_209	[p14l521t2633r627b2695],
4	MEMS	NN	O	mem	nn	5	SENT_209	[p14l662t2633r919b2695],
5	method	NN	O	method	pobj	20	SENT_209	[p14l957t2633r1226b2695],
6	of	IN	O	of	_	0	SENT_209	[p14l1260t2632r1337b2695],
7	documentation	NN	O	documentation	prep_of	5	SENT_209	[p14l1366t2632r1917b2707],
8	,	,	O	,	_	0	SENT_209	[p14l1366t2632r1917b2707],
9	50	CD	PERCENT	50	num	10	SENT_209	[p14l1956t2632r2040b2695],
10	%	NN	PERCENT	%	nsubj	20	SENT_209	[p14l2077t2633r2141b2695],
11	(	CD	NUMBER	(	number	12	SENT_209	[p14l11t2746r120b2822],
12	13	CD	NUMBER	13	num	10	SENT_209	[p14l11t2746r120b2822],
13	of	IN	O	of	_	0	SENT_209	[p14l145t2745r223b2808],
14	26	CD	NUMBER	26	num	15	SENT_209	[p14l237t2745r350b2822],
15	)	NN	O	)	prep_of	10	SENT_209	[p14l237t2745r350b2822],
16	of	IN	O	of	_	0	SENT_209	[p14l372t2745r449b2808],
17	patients	NNS	O	patient	prep_of	15	SENT_209	[p14l461t2745r737b2826],
18	did	VBD	O	do	aux	20	SENT_209	[p14l760t2745r872b2808],
19	not	RB	O	not	neg	20	SENT_209	[p14l890t2755r1004b2808],
20	miss	VB	O	miss	_	0	SENT_209	[p14l1021t2745r1182b2808],
21	any	DT	O	any	det	23	SENT_209	[p14l1204t2765r1328b2826],
22	capecitabine	NN	O	capecitabine	nn	23	SENT_209	[p14l1349t2745r1796b2826],
23	doses	NNS	O	dose	dobj	20	SENT_209	[p14l1817t2745r2030b2808],
24	.	.	O	.	_	0	SENT_209	[p14l1817t2745r2030b2808],

1	Of	IN	O	of	_	0	SENT_210	[p14l2056t2745r2152b2808],
2	those	DT	O	those	det	3	SENT_210	[p14l8t2856r194b2919],
3	patients	NNS	O	patient	prep_of	49	SENT_210	[p14l243t2856r520b2937],
4	with	IN	O	with	_	0	SENT_210	[p14l571t2856r727b2919],
5	documented	VBN	O	document	amod	7	SENT_210	[p14l777t2856r1214b2919],
6	missing	VBG	O	miss	amod	7	SENT_210	[p14l1262t2856r1537b2937],
7	doses	NNS	O	dose	prep_with	3	SENT_210	[p14l1588t2856r1781b2919],
8	with	IN	O	with	_	0	SENT_210	[p14l1833t2856r1989b2919],
9	the	DT	O	the	det	11	SENT_210	[p14l2038t2856r2145b2919],
10	MEMS	NN	O	mem	nn	11	SENT_210	[p14l8t2967r265b3030],
11	method	NN	O	method	prep_with	7	SENT_210	[p14l295t2967r582b3041],
12	,	,	O	,	_	0	SENT_210	[p14l295t2967r582b3041],
13	23	CD	PERCENT	23	num	14	SENT_210	[p14l613t2967r694b3030],
14	%	NN	PERCENT	%	nsubj	49	SENT_210	[p14l735t2967r799b3030],
15	(	CD	NUMBER	(	number	16	SENT_210	[p14l832t2967r897b3044],
16	3	CD	TIME	3	num	14	SENT_210	[p14l832t2967r897b3044],
17	of	IN	TIME	of	_	0	SENT_210	[p14l929t2967r1006b3030],
18	13	CD	TIME	13	number	19	SENT_210	[p14l1034t2967r1140b3044],
19	)	CD	NUMBER	)	num	21	SENT_210	[p14l1034t2967r1140b3044],
20	missed	VBN	O	miss	amod	21	SENT_210	[p14l1169t2967r1417b3030],
21	ﬁve	NN	O	ﬁve	prep_of	14	SENT_210	[p14l1443t2967r1573b3030],
22	or	CC	O	or	_	0	SENT_210	[p14l1601t2987r1674b3030],
23	fewer	JJR	O	fewer	amod	24	SENT_210	[p14l1699t2967r1902b3030],
24	doses	NNS	O	dose	conj_or	21	SENT_210	[p14l1927t2967r2142b3041],
25	,	,	O	,	_	0	SENT_210	[p14l1927t2967r2142b3041],
26	46	CD	PERCENT	46	num	27	SENT_210	[p14l8t3079r94b3142],
27	%	NN	PERCENT	%	appos	24	SENT_210	[p14l131t3080r196b3142],
28	(	CD	NUMBER	(	number	29	SENT_210	[p14l222t3079r290b3157],
29	6	CD	TIME	6	num	27	SENT_210	[p14l222t3079r290b3157],
30	of	IN	TIME	of	_	0	SENT_210	[p14l311t3079r389b3142],
31	13	CD	TIME	13	number	32	SENT_210	[p14l410t3080r516b3157],
32	)	CD	NUMBER	)	num	37	SENT_210	[p14l410t3080r516b3157],
33	missed	VBN	O	miss	amod	37	SENT_210	[p14l538t3079r786b3142],
34	six	CD	NUMBER	six	number	36	SENT_210	[p14l807t3079r906b3142],
35	to	TO	O	to	dep	36	SENT_210	[p14l925t3089r992b3142],
36	14	CD	NUMBER	14	num	37	SENT_210	[p14l1021t3080r1099b3141],
37	doses	NNS	O	dose	prep_of	27	SENT_210	[p14l1120t3079r1334b3154],
38	,	,	O	,	_	0	SENT_210	[p14l1120t3079r1334b3154],
39	and	CC	O	and	_	0	SENT_210	[p14l1359t3079r1485b3142],
40	31	CD	PERCENT	31	num	41	SENT_210	[p14l1506t3080r1583b3142],
41	%	NN	PERCENT	%	prep_of	27	SENT_210	[p14l1627t3080r1691b3142],
42	(	CD	NUMBER	(	number	43	SENT_210	[p14l1717t3080r1785b3157],
43	4	CD	TIME	4	num	41	SENT_210	[p14l1717t3080r1785b3157],
44	of	IN	TIME	of	_	0	SENT_210	[p14l1807t3079r1884b3142],
45	13	CD	TIME	13	num	46	SENT_210	[p14l1905t3080r2011b3157],
46	)	NN	O	)	prep_of	41	SENT_210	[p14l1905t3080r2011b3157],
47	did	VBD	O	do	aux	49	SENT_210	[p14l2034t3079r2146b3142],
48	not	RB	O	not	neg	49	SENT_210	[p14l8t3201r122b3254],
49	turn	VB	O	turn	_	0	SENT_210	[p14l149t3201r291b3254],
50	in	IN	O	in	_	0	SENT_210	[p14l319t3191r387b3253],
51	the	DT	O	the	det	53	SENT_210	[p14l415t3191r522b3254],
52	MEMS	NN	O	mem	nn	53	SENT_210	[p14l551t3192r808b3254],
53	device	NN	O	device	prep_in	49	SENT_210	[p14l842t3191r1073b3254],
54	to	TO	O	to	aux	55	SENT_210	[p14l1101t3201r1168b3254],
55	calculate	VB	O	calculate	xcomp	49	SENT_210	[p14l1199t3191r1516b3254],
56	this	DT	O	this	det	57	SENT_210	[p14l1545t3191r1670b3254],
57	information	NN	O	information	dobj	55	SENT_210	[p14l1700t3191r2140b3254],
58	.	.	O	.	_	0	SENT_210	[p14l1700t3191r2140b3254],

1	Two	CD	NUMBER	two	nsubj	14	SENT_211	[p14l8t3305r169b3366],
2	of	IN	O	of	_	0	SENT_211	[p14l215t3303r292b3366],
3	the	DT	O	the	det	5	SENT_211	[p14l330t3303r437b3366],
4	four	CD	NUMBER	four	num	5	SENT_211	[p14l482t3303r631b3366],
5	patients	NNS	O	patient	prep_of	1	SENT_211	[p14l672t3303r949b3384],
6	who	WP	O	who	nsubj	9	SENT_211	[p14l996t3303r1146b3366],
7	did	VBD	O	do	aux	9	SENT_211	[p14l1192t3303r1304b3366],
8	not	RB	O	not	neg	9	SENT_211	[p14l1347t3313r1461b3366],
9	participate	VB	O	participate	rcmod	5	SENT_211	[p14l1503t3303r1882b3384],
10	in	IN	O	in	_	0	SENT_211	[p14l1927t3303r1994b3365],
11	the	DT	O	the	det	12	SENT_211	[p14l2038t3303r2145b3366],
12	patient	NN	O	patient	prep_in	9	SENT_211	[p14l7t3414r582b3495],
13	—	RB	O	—	advmod	14	SENT_211	[p14l7t3414r582b3495],
14	reported	VBD	O	report	_	0	SENT_211	[p14l7t3414r582b3495],
15	method	NN	O	method	nsubj	19	SENT_211	[p14l625t3414r893b3476],
16	also	RB	O	also	advmod	19	SENT_211	[p14l939t3414r1077b3476],
17	did	VBD	O	do	aux	19	SENT_211	[p14l1124t3414r1236b3476],
18	not	RB	O	not	neg	19	SENT_211	[p14l1279t3423r1392b3476],
19	turn	VB	O	turn	ccomp	14	SENT_211	[p14l1435t3423r1577b3476],
20	in	IN	O	in	_	0	SENT_211	[p14l1622t3414r1689b3476],
21	the	DT	O	the	det	23	SENT_211	[p14l1733t3414r1840b3476],
22	MEMS	NN	O	mem	nn	23	SENT_211	[p14l1884t3414r2141b3477],
23	device	NN	O	device	prep_in	19	SENT_211	[p14l9t3525r258b3587],
24	.	.	O	.	_	0	SENT_211	[p14l9t3525r258b3587],

1	However	RB	O	however	advmod	10	SENT_212	[p14l321t3526r667b3599],
2	,	,	O	,	_	0	SENT_212	[p14l321t3526r667b3599],
3	in	IN	O	in	_	0	SENT_212	[p14l727t3525r795b3587],
4	assessing	VBG	O	assess	prepc_in	10	SENT_212	[p14l854t3525r1182b3606],
5	overall	JJ	O	overall	amod	6	SENT_212	[p14l1242t3525r1487b3587],
6	adherence	NN	O	adherence	dobj	4	SENT_212	[p14l1548t3525r1928b3599],
7	,	,	O	,	_	0	SENT_212	[p14l1548t3525r1928b3599],
8	both	CC	O	both	dep	6	SENT_212	[p14l1987t3525r2146b3587],
9	methods	NNS	O	method	conj	6	SENT_212	[p14l8t3635r308b3697],
10	yielded	VBD	O	yield	_	0	SENT_212	[p14l335t3635r598b3716],
11	similar	JJ	O	similar	amod	12	SENT_212	[p14l626t3634r872b3697],
12	results	NNS	O	result	dobj	10	SENT_212	[p14l895t3635r1126b3697],
13	per	IN	O	per	_	0	SENT_212	[p14l1151t3654r1267b3716],
14	patient	NN	O	patient	nn	16	SENT_212	[p14l1289t3635r1534b3716],
15	(	CD	NUMBER	(	num	16	SENT_212	[p14l1561t3635r1642b3712],
16	P	NN	O	p	prep_per	12	SENT_212	[p14l1561t3635r1642b3712],
17	>	JJR	O	>	tmod	10	SENT_212	[p14l1674t3649r1731b3697],
18	0.05	CD	NUMBER	0.05	num	19	SENT_212	[p14l1763t3634r1964b3712],
19	)	NN	O	)	dep	17	SENT_212	[p14l1763t3634r1964b3712],
20	.	.	O	.	_	0	SENT_212	[p14l1763t3634r1964b3712],

1	Capecitabine	NN	O	capecitabine	nn	2	SENT_213	[p15l9t90r475b171],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_213	[p15l508t90r1140b171],

1	Summary	NN	O	summary	nn	4	SENT_214	[p15l10t314r354b394],
2	plasma	NN	O	plasma	nn	4	SENT_214	[p15l392t313r647b394],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_214	[p15l683t313r1280b394],
4	parameters	NNS	O	parameter	nsubjpass	14	SENT_214	[p15l1319t323r1711b394],
5	of	IN	O	of	_	0	SENT_214	[p15l1753t313r1830b376],
6	capecitabine	NN	O	capecitabine	prep_of	4	SENT_214	[p15l1863t313r2142b394, p15l10t424r200b487],
7	and	CC	O	and	_	0	SENT_214	[p15l257t424r383b487],
8	its	PRP$	O	its	poss	9	SENT_214	[p15l436t424r517b487],
9	metabolites	NNS	O	metabolite	nsubjpass	14	SENT_214	[p15l573t424r984b487],
10	for	IN	O	for	_	0	SENT_214	[p15l1041t424r1144b487],
11	26	CD	NUMBER	26	num	12	SENT_214	[p15l1198t424r1282b487],
12	patients	NNS	O	patient	prep_for	9	SENT_214	[p15l1336t424r1614b505],
13	are	VBP	O	be	auxpass	14	SENT_214	[p15l1672t444r1776b487],
14	listed	VBN	O	list	_	0	SENT_214	[p15l1832t424r2024b487],
15	in	IN	O	in	_	0	SENT_214	[p15l2078t424r2145b486],
16	Table	NNP	O	Table	prep_in	14	SENT_214	[p15l8t535r210b598],
17	3	CD	NUMBER	3	num	16	SENT_214	[p15l245t536r304b598],
18	.	.	O	.	_	0	SENT_214	[p15l245t536r304b598],

1	High	JJ	O	high	amod	3	SENT_215	[p15l362t535r539b616],
2	interpatient	JJ	O	interpatient	amod	3	SENT_215	[p15l593t535r1002b616],
3	variability	NN	O	variability	nsubjpass	5	SENT_215	[p15l1055t535r1423b616],
4	was	VBD	O	be	auxpass	5	SENT_215	[p15l1478t555r1612b598],
5	observed	VBN	O	observe	_	0	SENT_215	[p15l1669t535r1990b598],
6	for	IN	O	for	_	0	SENT_215	[p15l2044t535r2147b598],
7	capecitabine	NN	O	capecitabine	prep_for	5	SENT_215	[p15l9t646r456b727],
8	and	CC	O	and	_	0	SENT_215	[p15l507t646r633b708],
9	metabolite	NN	O	metabolite	nn	11	SENT_215	[p15l680t646r1058b708],
10	pharmacokinetic	JJ	O	pharmacokinetic	amod	11	SENT_215	[p15l1106t646r1702b727],
11	parameters	NNS	O	parameter	prep_for	5	SENT_215	[p15l1752t655r2143b727],
12	but	CC	O	but	_	0	SENT_215	[p15l7t757r122b819],
13	was	VBD	O	be	cop	14	SENT_215	[p15l154t776r288b820],
14	similar	JJ	O	similar	conj_but	5	SENT_215	[p15l327t757r572b819],
15	to	TO	O	to	_	0	SENT_215	[p15l604t766r671b819],
16	previous	JJ	O	previous	amod	17	SENT_215	[p15l704t757r1010b838],
17	ﬁndings	NNS	O	ﬁndings	prep_to	14	SENT_215	[p15l1046t757r1329b838],
18	[	VBP	O	[	dep	17	SENT_215	[p15l1370t757r1529b833],
19	30	CD	NUMBER	30	num	20	SENT_215	[p15l1370t757r1529b833],
20	]	CD	NUMBER	]	dobj	18	SENT_215	[p15l1370t757r1529b833],
21	.	.	O	.	_	0	SENT_215	[p15l1370t757r1529b833],

1	The	DT	O	the	det	3	SENT_216	[p15l1566t757r1703b819],
2	interpatient	JJ	O	interpatient	amod	3	SENT_216	[p15l1737t757r2147b838],
3	variability	NN	O	variability	nsubj	18	SENT_216	[p15l8t867r376b948],
4	in	IN	O	in	_	0	SENT_216	[p15l418t867r486b928],
5	the	DT	O	the	det	8	SENT_216	[p15l527t867r634b929],
6	apparent	JJ	O	apparent	amod	8	SENT_216	[p15l678t876r984b948],
7	oral	JJ	O	oral	amod	8	SENT_216	[p15l1026t867r1161b929],
8	clearance	NN	O	clearance	prep_in	3	SENT_216	[p15l1204t867r1541b929],
9	of	IN	O	of	_	0	SENT_216	[p15l1584t867r1661b929],
10	capecitabine	NN	O	capecitabine	nn	11	SENT_216	[p15l1698t867r2145b948],
11	(	NN	O	(	prep_of	8	SENT_216	[p15l11t979r188b1057],
12	42.5	CD	NUMBER	42.5	num	11	SENT_216	[p15l11t979r188b1057],
13	vs.	CC	O	vs.	prep	8	SENT_216	[p15l238t999r332b1042],
14	45.4	CD	PERCENT	45.4	number	15	SENT_216	[p15l381t979r535b1042],
15	%	NN	PERCENT	%	num	16	SENT_216	[p15l572t980r667b1056],
16	)	CD	NUMBER	)	dep	13	SENT_216	[p15l572t980r667b1056],
17	was	VBD	O	be	cop	18	SENT_216	[p15l715t999r849b1042],
18	similar	JJ	O	similar	_	0	SENT_216	[p15l900t979r1146b1042],
19	after	IN	O	after	_	0	SENT_216	[p15l1191t979r1354b1042],
20	correction	NN	O	correction	prep_after	18	SENT_216	[p15l1398t979r1760b1042],
21	for	IN	O	for	_	0	SENT_216	[p15l1805t979r1908b1042],
22	BSA	NN	O	bsa	prep_for	18	SENT_216	[p15l1952t980r2140b1042],
23	.	.	O	.	_	0	SENT_216	[p15l1952t980r2140b1042],

1	There	EX	O	there	expl	2	SENT_217	[p15l8t1091r214b1154],
2	was	VBD	O	be	_	0	SENT_217	[p15l257t1111r391b1154],
3	no	DT	O	no	det	4	SENT_217	[p15l435t1111r521b1154],
4	correlation	NN	O	correlation	nsubj	2	SENT_217	[p15l564t1091r950b1154],
5	observed	VBN	O	observe	partmod	4	SENT_217	[p15l993t1091r1314b1154],
6	between	IN	O	between	_	0	SENT_217	[p15l1354t1091r1652b1154],
7	pharmacoki	NN	O	pharmacokus	nn	10	SENT_217	[p15l1692t1091r2143b1172],
8	—	NN	O	—	nn	10	SENT_217	[p15l1692t1091r2143b1172],
9	netic	JJ	O	netic	amod	10	SENT_217	[p15l8t1202r179b1265],
10	parameters	NNS	O	parameter	num	14	SENT_217	[p15l213t1211r604b1283],
11	and	CC	O	and	_	0	SENT_217	[p15l641t1202r767b1265],
12	toxicity	NN	O	toxicity	num	14	SENT_217	[p15l798t1202r1071b1283],
13	(	CD	NUMBER	(	num	12	SENT_217	[p15l1107t1203r1188b1279],
14	P	NN	O	p	npadvmod	15	SENT_217	[p15l1107t1203r1188b1279],
15	>	JJR	O	>	prep_between	5	SENT_217	[p15l1220t1216r1276b1265],
16	0.05	CD	NUMBER	0.05	num	17	SENT_217	[p15l1309t1202r1510b1279],
17	)	NN	O	)	dobj	5	SENT_217	[p15l1309t1202r1510b1279],
18	.	.	O	.	_	0	SENT_217	[p15l1309t1202r1510b1279],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_218	[p15l8t1425r708b1506],

1	We	PRP	O	we	nsubj	2	SENT_219	[p15l7t1650r130b1712],
2	assessed	VBD	O	assess	dep	29	SENT_219	[p15l159t1649r458b1711],
3	the	DT	O	the	det	4	SENT_219	[p15l484t1649r591b1711],
4	association	NN	O	association	dobj	2	SENT_219	[p15l619t1649r1015b1711],
5	of	IN	O	of	_	0	SENT_219	[p15l1042t1649r1119b1711],
6	capecitabine	NN	O	capecitabine	nn	9	SENT_219	[p15l1139t1649r1586b1730],
7	and	CC	O	and	_	0	SENT_219	[p15l1616t1649r1741b1711],
8	metabolite	NN	O	metabolite	nn	9	SENT_219	[p15l1767t1649r2145b1711],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	4	SENT_219	[p15l7t1760r639b1841],
10	with	IN	O	with	_	0	SENT_219	[p15l715t1760r872b1823],
11	common	JJ	O	common	amod	13	SENT_219	[p15l946t1779r1257b1822],
12	germline	NN	O	germline	nn	13	SENT_219	[p15l1332t1760r1648b1841],
13	variants	NNS	O	variant	prep_with	2	SENT_219	[p15l1723t1760r2003b1823],
14	in	IN	O	in	_	0	SENT_219	[p15l2078t1760r2146b1822],
15	carboxylesterase	NN	O	carboxylesterase	prep_in	13	SENT_219	[p15l9t1870r625b1951],
16	,	,	O	,	_	0	SENT_219	[p15l9t1870r625b1951],
17	cytidine	NN	O	cytidine	nn	18	SENT_219	[p15l681t1870r968b1951],
18	deaminase	NN	O	deaminase	dobj	2	SENT_219	[p15l1022t1870r1417b1944],
19	,	,	O	,	_	0	SENT_219	[p15l1022t1870r1417b1944],
20	dihydropyrimidine	NN	O	dihydropyrimidine	nn	21	SENT_219	[p15l1475t1870r2144b1951],
21	dehydrogenase	NN	O	dehydrogenase	dobj	2	SENT_219	[p15l9t1982r563b2063],
22	,	,	O	,	_	0	SENT_219	[p15l9t1982r563b2063],
23	and	CC	O	and	_	0	SENT_219	[p15l635t1982r761b2045],
24	the	DT	O	the	det	27	SENT_219	[p15l826t1982r933b2045],
25	solute	JJ	O	solute	amod	27	SENT_219	[p15l1003t1982r1211b2045],
26	carrier	NN	O	carrier	nn	27	SENT_219	[p15l1279t1982r1512b2045],
27	SLC28Al	NN	O	slc28al	conj_and	18	SENT_219	[p15l1579t1983r1929b2045],
28	(	CD	NUMBER	(	dep	27	SENT_219	[p15l2006t1983r2145b2060],
29	see	VBP	O	see	_	0	SENT_219	[p15l2006t1983r2145b2060],
30	Table	NNP	O	Table	dobj	29	SENT_219	[p15l8t2093r210b2156],
31	4	CD	NUMBER	4	num	30	SENT_219	[p15l243t2093r334b2170],
32	)	CD	NUMBER	)	nsubj	29	SENT_219	[p15l243t2093r334b2170],
33	.	.	O	.	_	0	SENT_219	[p15l243t2093r334b2170],

1	All	DT	O	all	det	3	SENT_220	[p15l376t2093r487b2155],
2	genotype	NN	O	genotype	nn	3	SENT_220	[p15l526t2103r851b2174],
3	frequencies	NNS	O	frequency	nsubj	4	SENT_220	[p15l890t2093r1300b2174],
4	were	VBD	O	be	_	0	SENT_220	[p15l1340t2113r1510b2156],
5	in	IN	O	in	_	0	SENT_220	[p15l1549t2093r1616b2155],
6	Hardy	NNP	LOCATION	Hardy	prep_in	4	SENT_220	[p15l1654t2093r2143b2174],
7	.	.	O	.	_	0	SENT_220	[p15l1654t2093r2143b2174],

1	—	NN	O	—	_	0	SENT_221	[p15l1654t2093r2143b2174],
2	.	.	O	.	_	0	SENT_221	[p15l1654t2093r2143b2174],

1	Wein	NNP	PERSON	Wein	_	0	SENT_222	[p15l1654t2093r2143b2174],
2	berg	NN	O	berg	nn	3	SENT_222	[p15l7t2204r164b2285],
3	equilibrium	NN	O	equilibrium	dep	1	SENT_222	[p15l227t2204r662b2285],
4	.	.	O	.	_	0	SENT_222	[p15l227t2204r662b2285],

1	No	DT	O	no	det	2	SENT_223	[p15l727t2206r833b2267],
2	patient	NN	O	patient	nsubjpass	12	SENT_223	[p15l894t2204r1139b2285],
3	with	IN	O	with	_	0	SENT_223	[p15l1200t2204r1356b2267],
4	a	DT	O	a	det	6	SENT_223	[p15l1418t2224r1455b2267],
5	mutant	JJ	O	mutant	amod	6	SENT_223	[p15l1515t2213r1764b2267],
6	allele	NN	O	allele	prep_with	2	SENT_223	[p15l1825t2204r2016b2267],
7	in	IN	O	in	_	0	SENT_223	[p15l2078t2204r2146b2266],
8	DPYD	NNP	O	DPYD	nn	10	SENT_223	[p15l8t2316r403b2377],
9	*	CD	NUMBER	*	num	10	SENT_223	[p15l8t2316r403b2377],
10	2A	NN	O	2a	prep_in	6	SENT_223	[p15l8t2316r403b2377],
11	was	VBD	O	be	auxpass	12	SENT_223	[p15l429t2335r563b2378],
12	identiﬁed	VBN	O	identiﬁed	_	0	SENT_223	[p15l590t2315r947b2389],
13	,	,	O	,	_	0	SENT_223	[p15l590t2315r947b2389],
14	which	WDT	O	which	nsubjpass	16	SENT_223	[p15l976t2315r1193b2378],
15	was	VBD	O	be	auxpass	16	SENT_223	[p15l1218t2335r1352b2378],
16	expected	VBN	O	expect	ccomp	12	SENT_223	[p15l1381t2315r1698b2396],
17	on	IN	O	on	_	0	SENT_223	[p15l1725t2335r1810b2378],
18	the	DT	O	the	det	19	SENT_223	[p15l1836t2315r1943b2378],
19	basis	NN	O	basis	prep_on	16	SENT_223	[p15l1968t2315r2144b2378],
20	of	IN	O	of	_	0	SENT_223	[p15l9t2426r86b2489],
21	earlier	JJR	O	earlier	amod	23	SENT_223	[p15l105t2426r334b2489],
22	frequency	NN	O	frequency	nn	23	SENT_223	[p15l357t2426r713b2507],
23	data	NNS	O	datum	prep_of	19	SENT_223	[p15l739t2426r904b2489],
24	.	.	O	.	_	0	SENT_223	[p15l739t2426r904b2489],

1	There	EX	O	there	expl	2	SENT_224	[p15l932t2426r1139b2489],
2	was	VBD	O	be	_	0	SENT_224	[p15l1165t2446r1299b2489],
3	no	DT	O	no	det	4	SENT_224	[p15l1325t2446r1411b2489],
4	correlation	NN	O	correlation	nsubj	2	SENT_224	[p15l1437t2426r1824b2489],
5	between	IN	O	between	_	0	SENT_224	[p15l1847t2426r2146b2489],
6	standard	JJ	O	standard	amod	8	SENT_224	[p15l11t2537r311b2600],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_224	[p15l344t2537r941b2618],
8	parameters	NNS	O	parameter	prep_between	4	SENT_224	[p15l977t2547r1369b2618],
9	and	CC	O	and	_	0	SENT_224	[p15l1408t2537r1534b2600],
10	the	DT	O	the	det	12	SENT_224	[p15l1567t2537r1674b2600],
11	genetic	JJ	O	genetic	amod	12	SENT_224	[p15l1712t2537r1966b2618],
12	variation	NN	O	variation	prep_between	4	SENT_224	[p15l2004t2557r2143b2600, p15l8t2648r211b2710],
13	in	IN	O	in	_	0	SENT_224	[p15l244t2648r311b2710],
14	carboxylesterase	NN	O	carboxylesterase	prep_in	12	SENT_224	[p15l344t2648r960b2729],
15	,	,	O	,	_	0	SENT_224	[p15l344t2648r960b2729],
16	cytidine	NN	O	cytidine	nn	17	SENT_224	[p15l997t2648r1283b2729],
17	deaminase	NN	O	deaminase	conj_and	14	SENT_224	[p15l1318t2648r1713b2722],
18	,	,	O	,	_	0	SENT_224	[p15l1318t2648r1713b2722],
19	dihydropyrimidine	NN	O	dihydropyrimidine	nn	20	SENT_224	[p15l1750t2648r2143b2729, p15l7t2759r310b2821],
20	dehydrogenase	NN	O	dehydrogenase	conj_and	14	SENT_224	[p15l351t2759r906b2840],
21	,	,	O	,	_	0	SENT_224	[p15l351t2759r906b2840],
22	and	CC	O	and	_	0	SENT_224	[p15l950t2759r1076b2821],
23	the	DT	O	the	det	26	SENT_224	[p15l1115t2759r1222b2821],
24	solute	JJ	O	solute	amod	26	SENT_224	[p15l1264t2759r1473b2821],
25	carrier	NN	O	carrier	nn	26	SENT_224	[p15l1513t2759r1747b2821],
26	SLC28Al	NN	O	slc28al	conj_and	14	SENT_224	[p15l1787t2759r2137b2822],
27	(	CD	NUMBER	(	num	28	SENT_224	[p15l11t2869r91b2946],
28	P	NN	O	p	npadvmod	29	SENT_224	[p15l11t2869r91b2946],
29	>	JJR	O	>	amod	4	SENT_224	[p15l124t2883r181b2931],
30	0.05	CD	NUMBER	0.05	advmod	2	SENT_224	[p15l213t2868r388b2943],
31	;	:	O	;	_	0	SENT_224	[p15l213t2868r388b2943],
32	only	RB	O	only	advmod	33	SENT_224	[p15l418t2869r573b2950],
33	data	NNS	O	datum	nsubjpass	37	SENT_224	[p15l600t2869r748b2931],
34	for	IN	O	for	_	0	SENT_224	[p15l772t2868r875b2931],
35	AUCOO	NNP	O	AUCOO	prep_for	33	SENT_224	[p15l899t2869r1146b2946],
36	is	VBZ	O	be	auxpass	37	SENT_224	[p15l1177t2869r1232b2931],
37	presented	VBN	O	present	parataxis	2	SENT_224	[p15l1258t2869r1602b2950],
38	in	IN	O	in	_	0	SENT_224	[p15l1627t2869r1694b2931],
39	Table	NNP	O	Table	prep_in	37	SENT_224	[p15l1718t2869r1920b2931],
40	4	CD	NUMBER	4	number	41	SENT_224	[p15l1954t2869r2044b2946],
41	)	CD	NUMBER	)	dep	39	SENT_224	[p15l1954t2869r2044b2946],
42	.	.	O	.	_	0	SENT_224	[p15l1954t2869r2044b2946],

1	In	IN	O	in	_	0	SENT_225	[p15l2073t2870r2146b2931],
2	addition	NN	O	addition	prep_in	5	SENT_225	[p15l10t2981r320b3055],
3	,	,	O	,	_	0	SENT_225	[p15l10t2981r320b3055],
4	there	EX	O	there	expl	5	SENT_225	[p15l376t2981r553b3044],
5	was	VBD	O	be	_	0	SENT_225	[p15l607t3001r742b3044],
6	no	DT	O	no	det	7	SENT_225	[p15l796t3001r882b3044],
7	correlation	NN	O	correlation	npadvmod	16	SENT_225	[p15l937t2981r1324b3044],
8	between	IN	O	between	_	0	SENT_225	[p15l1375t2981r1674b3044],
9	the	DT	O	the	det	11	SENT_225	[p15l1727t2981r1833b3044],
10	genetic	JJ	O	genetic	amod	11	SENT_225	[p15l1888t2981r2144b3062],
11	variation	NN	O	variation	prep_between	7	SENT_225	[p15l8t3092r326b3155],
12	and	CC	O	and	_	0	SENT_225	[p15l376t3092r502b3155],
13	toxicity	NN	O	toxicity	nn	15	SENT_225	[p15l549t3092r821b3173],
14	(	CD	NUMBER	(	num	15	SENT_225	[p15l873t3093r953b3169],
15	P	NN	O	p	conj_and	11	SENT_225	[p15l873t3093r953b3169],
16	>	JJR	O	>	acomp	5	SENT_225	[p15l986t3106r1043b3155],
17	0.05	CD	NUMBER	0.05	tmod	5	SENT_225	[p15l1075t3092r1250b3166],
18	;	:	O	;	_	0	SENT_225	[p15l1075t3092r1250b3166],
19	data	NNS	O	datum	dep	17	SENT_225	[p15l1302t3092r1450b3155],
20	not	RB	O	not	neg	21	SENT_225	[p15l1497t3102r1611b3155],
21	shown	VBN	O	show	partmod	19	SENT_225	[p15l1660t3092r1936b3169],
22	)	NN	O	)	dep	17	SENT_225	[p15l1660t3092r1936b3169],
23	.	.	O	.	_	0	SENT_225	[p15l1660t3092r1936b3169],

1	This	DT	O	this	det	2	SENT_226	[p15l1988t3092r2144b3155],
2	study	NN	O	study	nsubjpass	4	SENT_226	[p15l11t3203r199b3284],
3	was	VBD	O	be	auxpass	4	SENT_226	[p15l239t3223r373b3266],
4	limited	VBN	O	limit	_	0	SENT_226	[p15l413t3203r666b3266],
5	by	IN	O	by	_	0	SENT_226	[p15l703t3203r791b3284],
6	the	DT	O	the	det	9	SENT_226	[p15l829t3203r936b3266],
7	small	JJ	O	small	amod	9	SENT_226	[p15l978t3203r1167b3266],
8	sample	NN	O	sample	nn	9	SENT_226	[p15l1209t3203r1457b3284],
9	size	NN	O	size	agent	4	SENT_226	[p15l1499t3203r1633b3266],
10	and	CC	O	and	_	0	SENT_226	[p15l1674t3203r1800b3266],
11	the	DT	O	the	det	15	SENT_226	[p15l1837t3203r1944b3266],
12	relatively	RB	O	relatively	advmod	13	SENT_226	[p15l1982t3203r2142b3266, p15l8t3313r210b3394],
13	low	JJ	O	low	amod	15	SENT_226	[p15l244t3313r375b3375],
14	genetic	JJ	O	genetic	amod	15	SENT_226	[p15l409t3313r664b3394],
15	variability	NN	O	variability	agent	4	SENT_226	[p15l699t3313r1085b3394],
16	.	.	O	.	_	0	SENT_226	[p15l699t3313r1085b3394],

1	@	IN	O	@	_	0	SENT_227	[p15l1777t3556r1855b3651],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_227	[p15l1884t3579r2146b3654],

1	140	CD	NUMBER	140	num	3	SENT_228	[p15l56t3729r104b3754],
2	Breast	NN	ORGANIZATION	breast	nn	3	SENT_228	[p15l1450t3729r1540b3754],
3	Cancer	NN	ORGANIZATION	cancer	_	0	SENT_228	[p15l1552t3729r1652b3754],
4	Res	NNP	ORGANIZATION	Res	nn	5	SENT_228	[p15l1664t3729r1716b3754],
5	Treat	NNP	ORGANIZATION	Treat	dep	3	SENT_228	[p15l1729t3729r1803b3754],
6	(	CD	NUMBER	(	num	7	SENT_228	[p15l1817t3729r1908b3760],
7	2013	CD	DATE	2013	dep	5	SENT_228	[p15l1817t3729r1908b3760],
8	)	CD	NUMBER	)	number	9	SENT_228	[p15l1817t3729r1908b3760],
9	139:135	CD	NUMBER	139:135	num	10	SENT_228	[p15l1925t3729r2105b3754],
10	—	NN	O	—	dep	7	SENT_228	[p15l1925t3729r2105b3754],
11	143	CD	NUMBER	143	dep	3	SENT_228	[p15l1925t3729r2105b3754],

1	T	NN	O	t	nn	2	SENT_229	[p16l53t34r75b59],
2	bl	NN	O	bl	_	0	SENT_229	[p16l94t34r122b59],
3	3	CD	NUMBER	3	number	4	SENT_229	[p16l151t34r167b59],
4	C	NN	O	c	amod	5	SENT_229	[p16l190t34r212b59],
5	‘	NN	O	‘	dobj	6	SENT_229	[p16l280t34r284b38],
6	b	NN	O	b	dep	2	SENT_229	[p16l313t34r337b59],
7	‘	CD	NUMBER	‘	num	9	SENT_229	[p16l313t34r337b59],
8	. . .	NN	O	. . .	nn	9	SENT_229	[p16l1876t54r1880b58],[p16l1304t54r1308b58],
9	psariacokﬁfzigtsacgfl	NN	O	psariacokﬁfzigtsacgfl	nsubj	10	SENT_229	[p16l52t38r375b108],
10	ed	VBD	O	ed	ccomp	6	SENT_229	[p16l421t76r453b101],
11	to	TO	O	to	_	0	SENT_229	[p16l466t79r492b101],
12	Current	JJ	DATE	current	amod	15	SENT_229	[p16l1160t54r1267b79],
13	trial	NN	O	trial	nn	15	SENT_229	[p16l1280t54r1336b79],
14	Historical	JJ	O	historical	amod	15	SENT_229	[p16l1786t54r1924b79],
15	C0I21t1	NN	O	c0i21t1	prep_to	10	SENT_229	[p16l1937t54r2036b105],
16	‘	CD	NUMBER	‘	num	17	SENT_229	[p16l1937t54r2036b105],
17	0l	NN	O	0l	dep	25	SENT_229	[p16l1937t54r2036b105],
18	[	CD	NUMBER	[	number	19	SENT_229	[p16l2052t54r2105b84],
19	30	CD	NUMBER	30	dep	17	SENT_229	[p16l2052t54r2105b84],
20	]	CD	NUMBER	]	num	22	SENT_229	[p16l2052t54r2105b84],
21	historical	JJ	O	historical	amod	22	SENT_229	[p16l52t117r183b142],
22	control	NN	O	control	dep	19	SENT_229	[p16l196t118r295b142],
23	[	CD	NUMBER	[	dep	25	SENT_229	[p16l311t118r354b148],
24	30	CD	NUMBER	30	num	25	SENT_229	[p16l311t118r354b148],
25	(	NN	O	(	dep	34	SENT_229	[p16l1161t96r1250b126],
26	1,500	CD	NUMBER	1,500	num	28	SENT_229	[p16l1161t96r1250b126],
27	mg	NN	O	mg	nn	28	SENT_229	[p16l1263t103r1307b128],
28	BID	NNP	O	BID	dep	25	SENT_229	[p16l1320t93r1404b126],
29	)	CD	NUMBER	)	number	30	SENT_229	[p16l1320t93r1404b126],
30	“	CD	NUMBER	“	num	31	SENT_229	[p16l1320t93r1404b126],
31	(	NN	O	(	dep	28	SENT_229	[p16l1787t96r1876b126],
32	1,000	CD	NUMBER	1,000	num	34	SENT_229	[p16l1787t96r1876b126],
33	mg/m	NN	O	mg/m	nn	34	SENT_229	[p16l1888t96r1971b128],
34	BID	NNP	O	BID	dep	2	SENT_229	[p16l1996t93r2080b126],
35	)	CD	NUMBER	)	num	36	SENT_229	[p16l1996t93r2080b126],
36	“	CD	NUMBER	“	dep	34	SENT_229	[p16l1996t93r2080b126],

1	Capecitabine	NN	O	capecitabine	_	0	SENT_230	[p16l1404t214r1884b298],

1	Cmax	NN	O	cmax	nn	3	SENT_231	[p16l1465t330r1642b408],
2	(	CD	NUMBER	(	num	3	SENT_231	[p16l1679t330r1978b412],
3	Hg/IIIL	NN	O	hg/iiil	_	0	SENT_231	[p16l1679t330r1978b412],
4	)	CD	NUMBER	)	num	5	SENT_231	[p16l1679t330r1978b412],
5	AUCOO	NNP	O	AUCOO	dep	3	SENT_231	[p16l1464t444r1718b524],
6	(	CD	NUMBER	(	num	5	SENT_231	[p16l1761t444r2153b528],
7	ng	NN	O	ng	nn	10	SENT_231	[p16l1761t444r2153b528],
8	*	CD	NUMBER	*	num	10	SENT_231	[p16l1761t444r2153b528],
9	h/mL	NN	O	h/ml	nn	10	SENT_231	[p16l1761t444r2153b528],
10	)	NN	O	)	dep	3	SENT_231	[p16l1761t444r2153b528],

1	5	CD	NUMBER	5	_	0	SENT_232	[p16l1405t551r1465b622],
2	’	NN	O	’	dep	1	SENT_232	[p16l1405t551r1465b622],
3	.	.	O	.	_	0	SENT_232	[p16l1474t558r1741b623],

1	—	NN	O	—	_	0	SENT_233	[p16l1474t558r1741b623],
2	.	.	O	.	_	0	SENT_233	[p16l1474t558r1741b623],

1	DFCR	NN	O	dfcr	_	0	SENT_234	[p16l1474t558r1741b623],

1	Cmax	NN	O	cmax	nn	3	SENT_235	[p16l1465t673r1642b751],
2	(	CD	NUMBER	(	num	3	SENT_235	[p16l1679t673r1978b755],
3	Hg/IIIL	NN	O	hg/iiil	_	0	SENT_235	[p16l1679t673r1978b755],
4	)	CD	NUMBER	)	num	5	SENT_235	[p16l1679t673r1978b755],
5	AUCOO	NNP	O	AUCOO	dep	3	SENT_235	[p16l1464t787r1718b866],
6	(	CD	NUMBER	(	num	5	SENT_235	[p16l1761t787r2153b871],
7	ng	NN	O	ng	nn	10	SENT_235	[p16l1761t787r2153b871],
8	*	CD	NUMBER	*	num	10	SENT_235	[p16l1761t787r2153b871],
9	h/mL	NN	O	h/ml	nn	10	SENT_235	[p16l1761t787r2153b871],
10	)	NN	O	)	dep	3	SENT_235	[p16l1761t787r2153b871],

1	5	CD	NUMBER	5	_	0	SENT_236	[p16l1405t916r1746b988],
2	’	NN	O	’	dep	1	SENT_236	[p16l1405t916r1746b988],
3	.	.	O	.	_	0	SENT_236	[p16l1405t916r1746b988],

1	—	NN	O	—	_	0	SENT_237	[p16l1405t916r1746b988],
2	.	.	O	.	_	0	SENT_237	[p16l1405t916r1746b988],

1	DFUR	NN	O	dfur	_	0	SENT_238	[p16l1405t916r1746b988],

1	Cmax	CD	PERCENT	cmax	num	2	SENT_239	[p16l1465t1062r1642b1141],
2	%	NN	PERCENT	%	_	0	SENT_239	[p16l1679t1062r1978b1145],
3	9	CD	NUMBER	9	dep	2	SENT_239	[p16l1679t1062r1978b1145],
4	+	CC	O	+	_	0	SENT_239	[p16l1679t1062r1978b1145],
5	AUCOO	NNP	O	AUCOO	dep	2	SENT_239	[p16l1464t1201r1718b1280],
6	(	CD	NUMBER	(	num	5	SENT_239	[p16l1761t1201r2153b1284],
7	ng	NN	O	ng	nn	10	SENT_239	[p16l1761t1201r2153b1284],
8	*	CD	NUMBER	*	num	10	SENT_239	[p16l1761t1201r2153b1284],
9	h/mL	NN	O	h/ml	nn	10	SENT_239	[p16l1761t1201r2153b1284],
10	)	NN	O	)	dep	2	SENT_239	[p16l1761t1201r2153b1284],

1	a	DT	O	a	det	2	SENT_240	[p16l15t894r43b923],
2	Data	NN	O	datum	nsubjpass	4	SENT_240	[p16l90t902r264b965],
3	is	VBZ	O	be	auxpass	4	SENT_240	[p16l296t900r354b965],
4	presented	VBN	O	present	_	0	SENT_240	[p16l387t901r741b984],
5	as	IN	O	as	cc	7	SENT_240	[p16l775t921r846b965],
6	the	DT	O	the	det	7	SENT_240	[p16l881t900r991b965],
7	mean	NN	O	mean	dobj	4	SENT_240	[p16l13t1029r212b1073],
8	:	:	O	:	_	0	SENT_240	[p16l249t1010r311b1072],
9	|	CD	NUMBER	|	dep	7	SENT_240	[p16l249t1010r311b1072],
10	:	:	O	:	_	0	SENT_240	[p16l249t1010r311b1072],
11	SD	NN	O	sd	dep	7	SENT_240	[p16l350t1009r461b1073],
12	(	CD	PERCENT	(	number	13	SENT_240	[p16l498t1009r597b1088],
13	%	NN	PERCENT	%	num	17	SENT_240	[p16l498t1009r597b1088],
14	C.V.	NNP	O	C.V.	nn	17	SENT_240	[p16l634t1009r833b1088],
15	)	CD	NUMBER	)	num	17	SENT_240	[p16l634t1009r833b1088],
16	AUCOO	NNP	O	AUCOO	nn	17	SENT_240	[p16l7t1149r259b1227],
17	area	NN	O	area	dep	11	SENT_240	[p16l300t1168r451b1212],
18	under	IN	O	under	_	0	SENT_240	[p16l483t1147r693b1212],
19	the	DT	O	the	det	23	SENT_240	[p16l725t1147r835b1212],
20	concentration	NN	O	concentration	nn	23	SENT_240	[p16l14t1256r726b1320],
21	—	CD	NUMBER	—	num	23	SENT_240	[p16l14t1256r726b1320],
22	time	NN	O	time	nn	23	SENT_240	[p16l14t1256r726b1320],
23	curve	NN	O	curve	prep_under	17	SENT_240	[p16l761t1277r962b1320],
24	from	IN	O	from	_	0	SENT_240	[p16l997t1256r1174b1320],
25	time	NN	O	time	prep_from	23	SENT_240	[p16l13t1365r176b1429],
26	zero	CD	NUMBER	zero	num	25	SENT_240	[p16l210t1385r365b1429],
27	to	TO	O	to	_	0	SENT_240	[p16l400t1375r468b1429],
28	inﬁnity	NN	O	inﬁnity	prep_to	25	SENT_240	[p16l502t1365r787b1448],
29	,	,	O	,	_	0	SENT_240	[p16l502t1365r787b1448],
30	BID	NNP	O	BID	dep	7	SENT_240	[p16l821t1367r974b1429],
31	twice	RB	O	twice	quantmod	32	SENT_240	[p16l1008t1365r1206b1430],
32	5	CD	NUMBER	5	dep	30	SENT_240	[p16l1405t1340r1595b1404],
33	'	''	O	'	_	0	SENT_240	[p16l1405t1340r1595b1404],
34	FU	NNP	O	FU	dep	7	SENT_240	[p16l1405t1340r1595b1404],
35	a	DT	DURATION	a	det	36	SENT_240	[p16l15t1493r53b1537],
36	day	NN	DURATION	day	dep	34	SENT_240	[p16l87t1473r236b1556],
37	,	,	O	,	_	0	SENT_240	[p16l87t1473r236b1556],
38	Cmax	NN	O	cmax	nn	41	SENT_240	[p16l277t1474r452b1552],
39	maximum	NN	O	maximum	nn	41	SENT_240	[p16l484t1472r859b1537],
40	plasma	NN	O	plasma	nn	41	SENT_240	[p16l890t1472r1152b1556],
41	Cmax	NN	O	cmax	dep	7	SENT_240	[p16l1465t1478r1642b1556],
42	(	CD	NUMBER	(	num	43	SENT_240	[p16l1679t1478r1978b1561],
43	ng/mL	NN	O	ng/ml	dep	41	SENT_240	[p16l1679t1478r1978b1561],
44	)	CD	NUMBER	)	number	45	SENT_240	[p16l1679t1478r1978b1561],
45	9324	CD	NUMBER	9324	dep	43	SENT_240	[p16l40t1598r197b1655],
46	:	:	O	:	_	0	SENT_240	[p16l229t1598r284b1653],
47	|	CD	NUMBER	|	dep	7	SENT_240	[p16l229t1598r284b1653],
48	:	:	O	:	_	0	SENT_240	[p16l229t1598r284b1653],
49	7015	CD	PERCENT	7015	number	50	SENT_240	[p16l316t1597r470b1654],
50	(	CD	PERCENT	(	dep	7	SENT_240	[p16l506t1597r605b1667],
51	75	CD	PERCENT	75	num	52	SENT_240	[p16l506t1597r605b1667],
52	%	NN	PERCENT	%	dep	50	SENT_240	[p16l641t1598r727b1667],
53	)	CD	NUMBER	)	number	54	SENT_240	[p16l641t1598r727b1667],
54	7255	CD	NUMBER	7255	dep	50	SENT_240	[p16l39t1715r194b1771],
55	3	CD	NUMBER	3	dep	54	SENT_240	[p16l229t1716r284b1770],
56	:	:	O	:	_	0	SENT_240	[p16l229t1716r284b1770],
57	4180	CD	PERCENT	4180	number	58	SENT_240	[p16l315t1715r474b1771],
58	(	CD	PERCENT	(	dep	7	SENT_240	[p16l506t1715r606b1785],
59	58	CD	PERCENT	58	num	60	SENT_240	[p16l506t1715r606b1785],
60	%	NN	PERCENT	%	dep	58	SENT_240	[p16l641t1715r727b1785],
61	)	CD	NUMBER	)	dep	58	SENT_240	[p16l641t1715r727b1785],

1	6353	CD	NUMBER	6353	_	0	SENT_241	[p16l40t1956r193b2013],
2	:	:	O	:	_	0	SENT_241	[p16l229t1957r284b2012],
3	|	CD	NUMBER	|	dep	1	SENT_241	[p16l229t1957r284b2012],
4	:	:	O	:	_	0	SENT_241	[p16l229t1957r284b2012],
5	2590	CD	DATE	2590	num	6	SENT_241	[p16l317t1956r474b2014],
6	(	CD	PERCENT	(	dep	1	SENT_241	[p16l506t1957r602b2026],
7	41	CD	PERCENT	41	num	8	SENT_241	[p16l506t1957r602b2026],
8	%	NN	PERCENT	%	dep	6	SENT_241	[p16l641t1957r727b2026],
9	)	CD	NUMBER	)	number	10	SENT_241	[p16l641t1957r727b2026],
10	11344	CD	NUMBER	11344	num	8	SENT_241	[p16l6t2074r197b2131],
11	:	:	O	:	_	0	SENT_241	[p16l229t2075r284b2129],
12	t	NN	O	t	dep	1	SENT_241	[p16l229t2075r284b2129],
13	5583	CD	PERCENT	5583	number	14	SENT_241	[p16l317t2073r470b2131],
14	(	CD	PERCENT	(	dep	12	SENT_241	[p16l506t2074r607b2143],
15	49	CD	PERCENT	49	num	16	SENT_241	[p16l506t2074r607b2143],
16	%	NN	PERCENT	%	dep	1	SENT_241	[p16l641t2074r727b2143],
17	)	CD	NUMBER	)	dep	16	SENT_241	[p16l641t2074r727b2143],

1	4597	CD	NUMBER	4597	_	0	SENT_242	[p16l38t2314r195b2372],
2	:	:	O	:	_	0	SENT_242	[p16l229t2315r284b2370],
3	|	CD	NUMBER	|	dep	1	SENT_242	[p16l229t2315r284b2370],
4	:	:	O	:	_	0	SENT_242	[p16l229t2315r284b2370],
5	2608	CD	DATE	2608	number	6	SENT_242	[p16l317t2314r471b2371],
6	(	CD	PERCENT	(	dep	3	SENT_242	[p16l506t2314r606b2384],
7	57	CD	PERCENT	57	num	8	SENT_242	[p16l506t2314r606b2384],
8	%	NN	PERCENT	%	dep	15	SENT_242	[p16l641t2315r727b2384],
9	)	CD	NUMBER	)	number	10	SENT_242	[p16l641t2315r727b2384],
10	6653	CD	NUMBER	6653	dep	8	SENT_242	[p16l40t2431r193b2489],
11	i	FW	O	i	dep	10	SENT_242	[p16l229t2433r284b2487],
12	2166	CD	DATE	2166	dep	15	SENT_242	[p16l317t2432r474b2489],
13	(	CD	PERCENT	(	num	15	SENT_242	[p16l506t2432r605b2501],
14	33	CD	PERCENT	33	num	15	SENT_242	[p16l506t2432r605b2501],
15	%	NN	PERCENT	%	dep	3	SENT_242	[p16l641t2432r727b2501],
16	)	CD	NUMBER	)	dep	15	SENT_242	[p16l641t2432r727b2501],

1	753	CD	NUMBER	753	_	0	SENT_243	[p16l80t2672r193b2729],
2	:	:	O	:	_	0	SENT_243	[p16l229t2673r284b2728],
3	|	CD	NUMBER	|	dep	1	SENT_243	[p16l229t2673r284b2728],
4	:	:	O	:	_	0	SENT_243	[p16l229t2673r284b2728],
5	1209	CD	PERCENT	1209	number	6	SENT_243	[p16l323t2673r473b2730],
6	(	CD	PERCENT	(	dep	3	SENT_243	[p16l506t2672r648b2742],
7	160	CD	PERCENT	160	num	8	SENT_243	[p16l506t2672r648b2742],
8	%	NN	PERCENT	%	dep	18	SENT_243	[p16l681t2673r767b2742],
9	)	CD	NUMBER	)	num	10	SENT_243	[p16l681t2673r767b2742],
10	concentration	NN	O	concentration	dep	8	SENT_243	[p16l52t2751r251b2780],
11	,	,	O	,	_	0	SENT_243	[p16l52t2751r251b2780],
12	SD	NN	O	sd	nn	14	SENT_243	[p16l265t2752r307b2776],
13	standard	JJ	O	standard	amod	14	SENT_243	[p16l321t2751r439b2776],
14	AUCOo	NN	O	aucoo	appos	10	SENT_243	[p16l606t2765r704b2795],
15	(	CD	NUMBER	(	num	16	SENT_243	[p16l720t2765r870b2797],
16	ng	NN	O	ng	dep	18	SENT_243	[p16l720t2765r870b2797],
17	*	CD	NUMBER	*	num	18	SENT_243	[p16l720t2765r870b2797],
18	h/ml	NN	O	h/ml	dep	3	SENT_243	[p16l720t2765r870b2797],
19	‘	CD	NUMBER	‘	number	20	SENT_243	[p16l720t2765r870b2797],
20	)	CD	NUMBER	)	dep	18	SENT_243	[p16l720t2765r870b2797],
21	deviation	NN	O	deviation	dep	20	SENT_243	[p16l52t2793r183b2817],

1	Discussion	NN	O	discussion	_	0	SENT_244	[p16l7t2979r409b3042],

1	4578	CD	NUMBER	4578	number	2	SENT_245	[p16l1465t1956r1621b2013],
2	1	CD	NUMBER	1	num	4	SENT_245	[p16l1656t1957r1710b2012],
3	2090	CD	DATE	2090	number	4	SENT_245	[p16l1743t1957r1900b2014],
4	(	CD	PERCENT	(	_	0	SENT_245	[p16l1933t1956r2034b2026],
5	46	CD	PERCENT	46	num	6	SENT_245	[p16l1933t1956r2034b2026],
6	%	NN	PERCENT	%	dep	4	SENT_245	[p16l2067t1957r2153b2026],
7	)	CD	NUMBER	)	number	8	SENT_245	[p16l2067t1957r2153b2026],
8	10299	CD	NUMBER	10299	num	6	SENT_245	[p16l1432t2074r1622b2131],
9	i	FW	O	i	dep	4	SENT_245	[p16l1656t2075r1710b2129],
10	3663	CD	PERCENT	3663	number	11	SENT_245	[p16l1745t2074r1897b2131],
11	(	CD	PERCENT	(	amod	9	SENT_245	[p16l1933t2074r2034b2143],
12	36	CD	PERCENT	36	num	13	SENT_245	[p16l1933t2074r2034b2143],
13	%	NN	PERCENT	%	dep	11	SENT_245	[p16l2067t2074r2153b2143],
14	)	CD	NUMBER	)	dep	9	SENT_245	[p16l2067t2074r2153b2143],

1	4906	CD	NUMBER	4906	num	2	SENT_246	[p16l1465t2314r1623b2372],
2	3	CD	NUMBER	3	_	0	SENT_246	[p16l1656t2315r1710b2370],
3	:	:	O	:	_	0	SENT_246	[p16l1656t2315r1710b2370],
4	2928	CD	DATE	2928	number	5	SENT_246	[p16l1743t2315r1898b2372],
5	(	CD	PERCENT	(	dep	2	SENT_246	[p16l1933t2314r2035b2384],
6	60	CD	PERCENT	60	num	7	SENT_246	[p16l1933t2314r2035b2384],
7	%	NN	PERCENT	%	dep	5	SENT_246	[p16l2067t2315r2153b2384],
8	)	CD	NUMBER	)	num	9	SENT_246	[p16l2067t2315r2153b2384],
9	10519	CD	NUMBER	10519	dep	14	SENT_246	[p16l1432t2432r1622b2489],
10	i	FW	O	i	dep	9	SENT_246	[p16l1656t2433r1710b2487],
11	3533	CD	PERCENT	3533	dep	14	SENT_246	[p16l1745t2432r1897b2489],
12	(	CD	PERCENT	(	num	14	SENT_246	[p16l1933t2432r2035b2501],
13	34	CD	PERCENT	34	num	14	SENT_246	[p16l1933t2432r2035b2501],
14	%	NN	PERCENT	%	dep	2	SENT_246	[p16l2067t2432r2153b2501],
15	)	CD	NUMBER	)	dep	14	SENT_246	[p16l2067t2432r2153b2501],

1	Capecitabine	NN	O	capecitabine	nsubjpass	23	SENT_247	[p16l8t3204r476b3285],
2	is	VBZ	O	be	auxpass	3	SENT_247	[p16l521t3204r576b3266],
3	used	VBN	O	use	_	0	SENT_247	[p16l621t3204r785b3266],
4	widely	RB	O	widely	advmod	3	SENT_247	[p16l829t3204r1070b3285],
5	as	IN	O	as	_	0	SENT_247	[p16l1117t3223r1185b3266],
6	a	DT	O	a	det	8	SENT_247	[p16l1233t3223r1270b3266],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_247	[p16l1313t3204r1710b3285],
8	strategy	NN	O	strategy	prep_as	3	SENT_247	[p16l1759t3213r2038b3285],
9	in	IN	O	in	_	0	SENT_247	[p16l2083t3204r2151b3266],
10	patients	NNS	O	patient	prep_in	8	SENT_247	[p16l6t3314r283b3395],
11	with	IN	O	with	_	0	SENT_247	[p16l323t3314r480b3377],
12	metastatic	JJ	O	metastatic	amod	14	SENT_247	[p16l516t3313r879b3376],
13	breast	NN	O	breast	nn	14	SENT_247	[p16l916t3314r1131b3376],
14	cancer	NN	O	cancer	prep_with	3	SENT_247	[p16l1167t3333r1401b3376],
15	in	IN	O	in	_	0	SENT_247	[p16l1436t3314r1504b3375],
16	the	DT	O	the	det	20	SENT_247	[p16l1540t3314r1647b3376],
17	ﬁrst	JJ	O	ﬁrst	amod	20	SENT_247	[p16l1685t3314r1986b3376],
18	—	NN	O	—	nn	20	SENT_247	[p16l1685t3314r1986b3376],
19	line	NN	O	line	nn	20	SENT_247	[p16l1685t3314r1986b3376],
20	setting	NN	O	setting	prep_in	14	SENT_247	[p16l2026t3323r2148b3376, p16l7t3425r144b3506],
21	and	CC	O	and	_	0	SENT_247	[p16l196t3425r323b3487],
22	beyond	IN	O	beyond	advmod	23	SENT_247	[p16l371t3425r635b3506],
23	based	VBN	O	base	conj_and	3	SENT_247	[p16l683t3425r888b3487],
24	on	IN	O	on	_	0	SENT_247	[p16l937t3444r1024b3487],
25	a	DT	O	a	det	29	SENT_247	[p16l1075t3444r1112b3487],
26	relatively	RB	O	relatively	advmod	27	SENT_247	[p16l1160t3425r1500b3506],
27	favorable	JJ	O	favorable	amod	29	SENT_247	[p16l1550t3425r1887b3487],
28	safety	NN	O	safety	nn	29	SENT_247	[p16l1941t3425r2150b3506],
29	proﬁle	NN	O	proﬁle	prep_on	23	SENT_247	[p16l6t3537r239b3618],
30	and	CC	O	and	_	0	SENT_247	[p16l294t3537r420b3600],
31	substantial	JJ	O	substantial	amod	33	SENT_247	[p16l474t3537r854b3600],
32	anti	JJ	O	anti	amod	33	SENT_247	[p16l909t3537r1287b3600],
33	—	NN	O	—	prep_on	23	SENT_247	[p16l909t3537r1287b3600],
34	tumor	NN	O	tumor	nn	35	SENT_247	[p16l909t3537r1287b3600],
35	activity	NN	O	activity	dep	33	SENT_247	[p16l1340t3537r1625b3618],
36	.	.	O	.	_	0	SENT_247	[p16l1340t3537r1625b3618],

1	However	RB	O	however	advmod	9	SENT_248	[p16l1681t3539r2028b3611],
2	,	,	O	,	_	0	SENT_248	[p16l1681t3539r2028b3611],
3	in	IN	O	in	_	0	SENT_248	[p16l2083t3537r2151b3599],
4	clinical	JJ	O	clinical	amod	5	SENT_248	[p17l8t22r270b85],
5	practice	NN	O	practice	prep_in	9	SENT_248	[p17l307t22r611b103],
6	,	,	O	,	_	0	SENT_248	[p17l307t22r611b103],
7	the	DT	O	the	det	8	SENT_248	[p17l650t22r758b85],
8	FDA	NNP	ORGANIZATION	FDA	nsubj	9	SENT_248	[p17l794t23r971b84],
9	recommended	VBD	O	recommend	_	0	SENT_248	[p17l1006t22r1517b85],
10	dose	NN	O	dose	nn	11	SENT_248	[p17l1554t22r1714b85],
11	(	NN	O	(	dobj	9	SENT_248	[p17l1754t22r1980b99],
12	2,500	CD	NUMBER	2,500	num	13	SENT_248	[p17l1754t22r1980b99],
13	mg	NN	O	mg	dep	11	SENT_248	[p17l2013t22r2153b103],
14	/	:	O	/	punct	13	SENT_248	[p17l2013t22r2153b103],
15	m2	NN	O	m2	nsubj	39	SENT_248	[p17l7t114r109b196],
16	given	VBN	O	give	partmod	15	SENT_248	[p17l143t133r340b215],
17	in	IN	O	in	_	0	SENT_248	[p17l373t133r441b196],
18	two	CD	NUMBER	two	prep_in	16	SENT_248	[p17l474t143r605b197],
19	divided	VBN	O	divide	partmod	18	SENT_248	[p17l640t133r908b197],
20	daily	JJ	SET	daily	amod	21	SENT_248	[p17l942t133r1118b215],
21	doses	NNS	O	dose	dobj	19	SENT_248	[p17l1153t133r1347b197],
22	for	IN	O	for	_	0	SENT_248	[p17l1383t133r1486b197],
23	14	CD	DURATION	14	num	24	SENT_248	[p17l1526t134r1604b196],
24	days	NNS	NUMBER	day	prep_for	19	SENT_248	[p17l1638t133r1797b215],
25	followed	VBN	O	follow	partmod	24	SENT_248	[p17l1834t133r2151b197],
26	by	IN	O	by	_	0	SENT_248	[p17l6t245r94b326],
27	7	CD	DURATION	7	num	28	SENT_248	[p17l134t247r173b308],
28	days	NNS	NUMBER	day	agent	25	SENT_248	[p17l209t245r369b326],
29	of	IN	O	of	_	0	SENT_248	[p17l410t245r487b308],
30	rest	NN	O	rest	prep_of	28	SENT_248	[p17l519t246r675b323],
31	)	CD	NUMBER	)	number	32	SENT_248	[p17l519t246r675b323],
32	[	CD	NUMBER	[	dobj	25	SENT_248	[p17l723t246r858b321],
33	11	CD	NUMBER	11	num	34	SENT_248	[p17l723t246r858b321],
34	]	NN	O	]	nsubj	35	SENT_248	[p17l723t246r858b321],
35	is	VBZ	O	be	rcmod	32	SENT_248	[p17l903t245r958b308],
36	often	RB	O	often	advmod	35	SENT_248	[p17l1000t245r1182b308],
37	not	RB	O	not	dep	38	SENT_248	[p17l1221t255r1335b308],
38	well	RB	O	well	advmod	35	SENT_248	[p17l1373t245r1524b308],
39	tolerated	VBD	O	tolerate	dep	13	SENT_248	[p17l1563t245r1879b308],
40	due	JJ	O	due	acomp	39	SENT_248	[p17l1918t245r2044b308],
41	to	TO	O	to	_	0	SENT_248	[p17l2083t255r2150b308],
42	diarrhea	NN	O	diarrhea	prep_to	40	SENT_248	[p17l8t356r320b430],
43	,	,	O	,	_	0	SENT_248	[p17l8t356r320b430],
44	nausea/emesis	NN	O	nausea/emesis	prep_to	40	SENT_248	[p17l349t356r882b430],
45	,	,	O	,	_	0	SENT_248	[p17l349t356r882b430],
46	and	CC	O	and	_	0	SENT_248	[p17l912t356r1039b419],
47	hand	NN	O	hand	nn	50	SENT_248	[p17l1063t356r1428b419],
48	—	CD	NUMBER	—	num	50	SENT_248	[p17l1063t356r1428b419],
49	foot	NN	O	foot	nn	50	SENT_248	[p17l1063t356r1428b419],
50	syndrome	NN	O	syndrome	prep_to	40	SENT_248	[p17l1455t356r1823b437],
51	.	.	O	.	_	0	SENT_248	[p17l1455t356r1823b437],

1	Leonard	NNP	PERSON	Leonard	dep	4	SENT_249	[p17l1852t356r2152b419],
2	et	FW	O	et	nn	4	SENT_249	[p17l8t476r71b530],
3	al.	FW	O	al.	nn	4	SENT_249	[p17l109t467r188b530],
4	[	FW	O	[	dep	7	SENT_249	[p17l235t467r370b543],
5	15	CD	NUMBER	15	num	6	SENT_249	[p17l235t467r370b543],
6	]	CD	NUMBER	]	nsubj	7	SENT_249	[p17l235t467r370b543],
7	suggest	VBP	O	suggest	_	0	SENT_249	[p17l416t476r682b548],
8	that	IN	O	that	complm	14	SENT_249	[p17l717t467r851b530],
9	dose	NN	O	dose	nn	10	SENT_249	[p17l888t467r1049b530],
10	reductions	NNS	O	reduction	nsubj	14	SENT_249	[p17l1085t467r1458b530],
11	can	MD	O	can	aux	14	SENT_249	[p17l1496t487r1619b530],
12	be	VB	O	be	cop	14	SENT_249	[p17l1654t467r1738b530],
13	as	RB	O	as	advmod	14	SENT_249	[p17l1777t487r1846b530],
14	high	JJ	O	high	ccomp	7	SENT_249	[p17l1884t467r2042b548],
15	as	IN	O	as	_	0	SENT_249	[p17l2080t487r2149b530],
16	41	CD	PERCENT	41	num	17	SENT_249	[p17l7t577r86b639],
17	%	NN	PERCENT	%	prep_as	14	SENT_249	[p17l131t577r195b640],
18	when	WRB	O	when	advmod	21	SENT_249	[p17l239t577r431b640],
19	capecitabine	NN	O	capecitabine	nsubjpass	21	SENT_249	[p17l471t577r919b658],
20	is	VBZ	O	be	auxpass	21	SENT_249	[p17l959t577r1015b639],
21	administered	VBN	O	administer	dep	17	SENT_249	[p17l1058t577r1521b639],
22	alone	RB	O	alone	advmod	21	SENT_249	[p17l1561t577r1752b639],
23	and	CC	O	and	_	0	SENT_249	[p17l1794t577r1921b639],
24	65	CD	PERCENT	65	num	25	SENT_249	[p17l1960t577r2042b640],
25	%	NN	PERCENT	%	prep_as	14	SENT_249	[p17l2082t577r2147b640],
26	when	WRB	O	when	advmod	27	SENT_249	[p17l8t688r200b750],
27	combined	VBN	O	combine	dep	25	SENT_249	[p17l233t688r587b750],
28	with	IN	O	with	_	0	SENT_249	[p17l619t688r776b750],
29	docetaxel	NN	O	docetaxel	prep_with	27	SENT_249	[p17l810t688r1171b750],
30	.	.	O	.	_	0	SENT_249	[p17l810t688r1171b750],

1	Therefore	RB	O	therefore	advmod	12	SENT_250	[p17l1208t688r1580b762],
2	,	,	O	,	_	0	SENT_250	[p17l1208t688r1580b762],
3	a	DT	O	a	det	5	SENT_250	[p17l1619t707r1656b750],
4	starting	VBG	O	start	amod	5	SENT_250	[p17l1690t688r1955b769],
5	dose	NN	O	dose	nsubjpass	12	SENT_250	[p17l1989t688r2150b750],
6	of	IN	O	of	_	0	SENT_250	[p17l8t800r86b863],
7	2,000	CD	NUMBER	2,000	num	8	SENT_250	[p17l109t800r307b874],
8	mg/m2	NN	O	mg/m2	prep_of	5	SENT_250	[p17l340t781r582b882],
9	is	VBZ	O	be	auxpass	12	SENT_250	[p17l610t800r666b863],
10	now	RB	DATE	now	advmod	12	SENT_250	[p17l696t820r847b863],
11	commonly	RB	O	commonly	advmod	12	SENT_250	[p17l877t800r1259b882],
12	used	VBN	O	use	_	0	SENT_250	[p17l1287t800r1451b863],
13	in	IN	O	in	_	0	SENT_250	[p17l1478t800r1546b862],
14	clinical	JJ	O	clinical	amod	15	SENT_250	[p17l1575t800r1837b863],
15	practice	NN	O	practice	prep_in	12	SENT_250	[p17l1865t800r2149b882],
16	and	CC	O	and	_	0	SENT_250	[p17l9t912r136b975],
17	in	IN	O	in	_	0	SENT_250	[p17l188t912r256b974],
18	recent	JJ	O	recent	amod	20	SENT_250	[p17l308t922r528b975],
19	clinical	JJ	O	clinical	amod	20	SENT_250	[p17l581t912r844b975],
20	trials	NNS	O	trial	conj_and	15	SENT_250	[p17l898t912r1074b975],
21	[	VBP	O	[	rcmod	20	SENT_250	[p17l1136t913r1271b988],
22	31	CD	NUMBER	31	num	23	SENT_250	[p17l1136t913r1271b988],
23	]	CD	NUMBER	]	dobj	21	SENT_250	[p17l1136t913r1271b988],
24	with	IN	O	with	_	0	SENT_250	[p17l1330t912r1487b975],
25	similar	JJ	O	similar	amod	27	SENT_250	[p17l1544t912r1791b975],
26	apparent	JJ	O	apparent	amod	27	SENT_250	[p17l1844t921r2152b993],
27	efﬁcacy	NN	O	efﬁcacy	prep_with	21	SENT_250	[p17l8t1023r308b1104],
28	.	.	O	.	_	0	SENT_250	[p17l8t1023r308b1104],

1	However	RB	O	however	advmod	23	SENT_251	[p17l342t1025r689b1097],
2	,	,	O	,	_	0	SENT_251	[p17l342t1025r689b1097],
3	the	DT	O	the	det	5	SENT_251	[p17l721t1023r827b1086],
4	persistent	JJ	O	persistent	amod	5	SENT_251	[p17l856t1023r1202b1104],
5	use	NN	O	use	nsubj	23	SENT_251	[p17l1229t1043r1346b1086],
6	of	IN	O	of	_	0	SENT_251	[p17l1377t1023r1454b1086],
7	BSA	NN	O	bsa	prep_of	5	SENT_251	[p17l1477t1023r1885b1086],
8	—	CD	NUMBER	—	num	7	SENT_251	[p17l1477t1023r1885b1086],
9	based	VBN	O	base	partmod	7	SENT_251	[p17l1477t1023r1885b1086],
10	dosing	NN	O	dosing	dobj	9	SENT_251	[p17l1914t1023r2150b1104],
11	despite	IN	O	despite	_	0	SENT_251	[p17l8t1134r259b1215],
12	evidence	NN	O	evidence	prep_despite	9	SENT_251	[p17l309t1134r626b1197],
13	against	IN	O	against	_	0	SENT_251	[p17l677t1134r929b1215],
14	its	PRP$	O	its	nsubj	15	SENT_251	[p17l976t1134r1057b1197],
15	using	VBG	O	use	prepc_against	9	SENT_251	[p17l1106t1134r1298b1215],
16	it	PRP	O	it	dobj	15	SENT_251	[p17l1347t1134r1396b1197],
17	for	IN	O	for	_	0	SENT_251	[p17l1443t1134r1547b1197],
18	many	JJ	O	many	amod	19	SENT_251	[p17l1593t1154r1790b1215],
19	drugs	NNS	O	drug	prep_for	15	SENT_251	[p17l1839t1134r2033b1215],
20	in	IN	O	in	_	0	SENT_251	[p17l2083t1134r2151b1196],
21	clinical	JJ	O	clinical	amod	22	SENT_251	[p17l8t1245r270b1308],
22	practice	NN	O	practice	prep_in	19	SENT_251	[p17l320t1245r604b1326],
23	continues	VBZ	O	continue	_	0	SENT_251	[p17l655t1245r996b1308],
24	despite	IN	O	despite	_	0	SENT_251	[p17l1049t1245r1300b1326],
25	the	DT	O	the	det	26	SENT_251	[p17l1350t1245r1457b1308],
26	lack	NN	O	lack	prep_despite	23	SENT_251	[p17l1508t1245r1658b1308],
27	of	IN	O	of	_	0	SENT_251	[p17l1706t1245r1784b1308],
28	scientiﬁc	NN	O	scientiﬁc	nn	29	SENT_251	[p17l1831t1245r2148b1308],
29	support	NN	O	support	prep_of	26	SENT_251	[p17l10t1366r276b1437],
30	[	CD	NUMBER	[	number	31	SENT_251	[p17l314t1357r399b1432],
31	4	CD	NUMBER	4	dobj	23	SENT_251	[p17l314t1357r399b1432],
32	,	,	O	,	_	0	SENT_251	[p17l314t1357r399b1432],
33	19	CD	NUMBER	19	appos	31	SENT_251	[p17l443t1357r541b1430],
34	,	,	O	,	_	0	SENT_251	[p17l443t1357r541b1430],
35	23	CD	NUMBER	23	appos	33	SENT_251	[p17l578t1357r683b1430],
36	,	,	O	,	_	0	SENT_251	[p17l578t1357r683b1430],
37	27	CD	NUMBER	27	num	38	SENT_251	[p17l721t1357r854b1432],
38	]	NN	O	]	appos	33	SENT_251	[p17l721t1357r854b1432],
39	.	.	O	.	_	0	SENT_251	[p17l721t1357r854b1432],

1	Our	PRP$	O	we	poss	3	SENT_252	[p17l111t1468r248b1530],
2	primary	JJ	O	primary	amod	3	SENT_252	[p17l267t1467r550b1548],
3	hypothesis	NN	O	hypothesis	nsubj	4	SENT_252	[p17l572t1467r953b1548],
4	was	VBD	O	be	_	0	SENT_252	[p17l977t1487r1112b1530],
5	that	IN	O	that	complm	15	SENT_252	[p17l1135t1467r1270b1530],
6	the	DT	O	the	det	9	SENT_252	[p17l1290t1467r1397b1530],
7	standard	JJ	O	standard	amod	9	SENT_252	[p17l1423t1467r1724b1530],
8	BSA	NN	O	bsa	nn	9	SENT_252	[p17l1744t1467r2151b1530],
9	—	NN	O	—	nsubjpass	15	SENT_252	[p17l1744t1467r2151b1530],
10	based	VBN	O	base	partmod	9	SENT_252	[p17l1744t1467r2151b1530],
11	capecitabine	NN	O	capecitabine	nn	12	SENT_252	[p17l8t1578r456b1659],
12	regimen	NNS	O	regimen	dobj	10	SENT_252	[p17l494t1578r788b1659],
13	could	MD	O	could	aux	15	SENT_252	[p17l827t1578r1025b1640],
14	be	VB	O	be	auxpass	15	SENT_252	[p17l1060t1578r1143b1640],
15	simpliﬁed	VBN	O	simpliﬁed	ccomp	4	SENT_252	[p17l1185t1578r1541b1659],
16	by	IN	O	by	_	0	SENT_252	[p17l1576t1578r1664b1659],
17	the	DT	O	the	det	18	SENT_252	[p17l1703t1578r1809b1640],
18	use	NN	O	use	agent	15	SENT_252	[p17l1848t1597r1965b1640],
19	of	IN	O	of	_	0	SENT_252	[p17l2004t1578r2082b1640],
20	a	DT	O	a	det	24	SENT_252	[p17l2115t1597r2152b1640],
21	ﬁxed	JJ	O	ﬁxed	amod	24	SENT_252	[p17l8t1687r379b1750],
22	—	NN	O	—	nn	24	SENT_252	[p17l8t1687r379b1750],
23	dose	NN	O	dose	nn	24	SENT_252	[p17l8t1687r379b1750],
24	regimen	NN	O	regimen	prep_of	18	SENT_252	[p17l415t1688r728b1769],
25	,	,	O	,	_	0	SENT_252	[p17l415t1688r728b1769],
26	providing	VBG	O	provide	xcomp	15	SENT_252	[p17l766t1687r1115b1769],
27	an	DT	O	a	det	31	SENT_252	[p17l1153t1707r1234b1750],
28	effective	JJ	O	effective	amod	31	SENT_252	[p17l1270t1688r1582b1750],
29	and	CC	O	and	_	0	SENT_252	[p17l1622t1688r1749b1750],
30	safe	JJ	O	safe	conj_and	28	SENT_252	[p17l1786t1688r1925b1750],
31	alternative	NN	O	alternative	dobj	26	SENT_252	[p17l1964t1688r2148b1750, p17l7t1799r243b1862],
32	.	.	O	.	_	0	SENT_252	[p17l1964t1688r2148b1750, p17l7t1799r243b1862],

1	While	IN	O	while	mark	6	SENT_253	[p17l267t1799r486b1861],
2	our	PRP$	O	we	poss	3	SENT_253	[p17l507t1818r625b1861],
3	study	NN	O	study	nsubjpass	18	SENT_253	[p17l646t1799r835b1880],
4	did	VBD	O	do	aux	6	SENT_253	[p17l856t1799r969b1861],
5	not	RB	O	not	neg	6	SENT_253	[p17l987t1808r1101b1861],
6	meet	VB	O	meet	advcl	43	SENT_253	[p17l1119t1808r1294b1861],
7	the	DT	O	the	det	9	SENT_253	[p17l1312t1799r1420b1861],
8	pre	JJ	O	pre	amod	9	SENT_253	[p17l1439t1799r1849b1880],
9	—	NN	O	—	dobj	6	SENT_253	[p17l1439t1799r1849b1880],
10	deﬁned	VBN	O	deﬁned	partmod	9	SENT_253	[p17l1439t1799r1849b1880],
11	primary	JJ	O	primary	amod	12	SENT_253	[p17l1866t1799r2150b1880],
12	endpoint	NN	O	endpoint	dobj	10	SENT_253	[p17l8t1911r322b1992],
13	of	IN	O	of	_	0	SENT_253	[p17l345t1911r422b1974],
14	response	NN	O	response	nn	15	SENT_253	[p17l437t1931r750b1992],
15	rate	NN	O	rate	prep_of	12	SENT_253	[p17l773t1920r906b1974],
16	and	CC	O	and	_	0	SENT_253	[p17l932t1911r1058b1974],
17	was	VBD	O	be	auxpass	18	SENT_253	[p17l1081t1931r1215b1974],
18	closed	VBN	O	close	conj_and	6	SENT_253	[p17l1241t1911r1469b1974],
19	after	IN	O	after	_	0	SENT_253	[p17l1493t1911r1656b1974],
20	the	DT	O	the	det	22	SENT_253	[p17l1677t1911r1784b1974],
21	ﬁrst	JJ	O	ﬁrst	amod	22	SENT_253	[p17l1809t1911r1946b1974],
22	stage	NN	O	stage	prep_after	18	SENT_253	[p17l1971t1921r2150b1992],
23	of	IN	O	of	_	0	SENT_253	[p17l8t2022r86b2085],
24	accrual	NN	O	accrual	prep_of	22	SENT_253	[p17l109t2022r385b2096],
25	,	,	O	,	_	0	SENT_253	[p17l109t2022r385b2096],
26	the	DT	O	the	det	32	SENT_253	[p17l416t2022r522b2085],
27	overall	JJ	O	overall	amod	32	SENT_253	[p17l551t2022r799b2085],
28	clinical	JJ	O	clinical	amod	32	SENT_253	[p17l827t2022r1090b2085],
29	beneﬁt	NN	O	beneﬁt	nn	32	SENT_253	[p17l1117t2022r1362b2085],
30	rate	NN	O	rate	nn	32	SENT_253	[p17l1387t2032r1520b2085],
31	(	CD	NUMBER	(	num	32	SENT_253	[p17l1551t2022r1728b2099],
32	lack	NN	O	lack	nsubj	43	SENT_253	[p17l1551t2022r1728b2099],
33	of	IN	O	of	_	0	SENT_253	[p17l1755t2022r1832b2085],
34	progression	NN	O	progression	prep_of	32	SENT_253	[p17l1852t2042r2148b2103, p17l10t2133r154b2196],
35	for	IN	O	for	_	0	SENT_253	[p17l180t2133r284b2196],
36	at	IN	DURATION	at	quantmod	38	SENT_253	[p17l309t2143r372b2196],
37	least	JJS	DURATION	least	mwe	36	SENT_253	[p17l396t2133r560b2196],
38	24	CD	DURATION	24	num	40	SENT_253	[p17l585t2133r670b2195],
39	weeks	NNS	NUMBER	week	nn	40	SENT_253	[p17l704t2133r953b2210],
40	)	NN	O	)	prep_for	34	SENT_253	[p17l704t2133r953b2210],
41	was	VBD	O	be	cop	43	SENT_253	[p17l982t2153r1116b2196],
42	19	CD	PERCENT	19	num	43	SENT_253	[p17l1152t2134r1228b2197],
43	%	NN	PERCENT	%	_	0	SENT_253	[p17l1267t2133r1331b2196],
44	in	IN	O	in	_	0	SENT_253	[p17l1360t2133r1428b2195],
45	a	DT	O	a	det	47	SENT_253	[p17l1455t2153r1492b2196],
46	patient	NN	O	patient	nn	47	SENT_253	[p17l1515t2133r1761b2214],
47	group	NN	O	group	prep_in	43	SENT_253	[p17l1786t2153r1991b2214],
48	that	WDT	O	that	nsubj	49	SENT_253	[p17l2017t2133r2152b2196],
49	included	VBD	O	include	rcmod	43	SENT_253	[p17l7t2244r317b2307],
50	~	CD	PERCENT	~	number	51	SENT_253	[p17l350t2273r409b2293],
51	60	CD	PERCENT	60	num	52	SENT_253	[p17l428t2244r512b2307],
52	%	NN	PERCENT	%	nn	59	SENT_253	[p17l549t2245r614b2307],
53	with	IN	O	with	_	0	SENT_253	[p17l638t2244r796b2307],
54	estrogen	NN	O	estrogen	nn	56	SENT_253	[p17l816t2254r1118b2325],
55	receptor	NN	O	receptor	nn	56	SENT_253	[p17l1137t2244r1747b2325],
56	—	NN	O	—	prep_with	52	SENT_253	[p17l1137t2244r1747b2325],
57	positive	JJ	O	positive	amod	58	SENT_253	[p17l1137t2244r1747b2325],
58	endocrineresistant	JJ	O	endocrineresistant	amod	59	SENT_253	[p17l1768t2244r2148b2307, p17l6t2355r306b2418],
59	disease	NN	O	disease	dobj	49	SENT_253	[p17l345t2355r620b2418],
60	.	.	O	.	_	0	SENT_253	[p17l345t2355r620b2418],

1	Overall	RB	O	overall	advmod	7	SENT_254	[p17l664t2355r949b2429],
2	,	,	O	,	_	0	SENT_254	[p17l664t2355r949b2429],
3	the	DT	O	the	det	4	SENT_254	[p17l992t2355r1099b2418],
4	regimen	NN	O	regimen	nsubjpass	7	SENT_254	[p17l1137t2355r1432b2436],
5	was	VBD	O	be	auxpass	7	SENT_254	[p17l1470t2375r1605b2418],
6	well	RB	O	well	advmod	7	SENT_254	[p17l1646t2355r1797b2418],
7	tolerated	VBN	O	tolerate	_	0	SENT_254	[p17l1836t2355r2152b2418],
8	with	IN	O	with	_	0	SENT_254	[p17l8t2466r165b2529],
9	no	DT	O	no	det	12	SENT_254	[p17l182t2485r269b2528],
10	observed	VBN	O	observe	amod	12	SENT_254	[p17l288t2466r611b2529],
11	adverse	JJ	O	adverse	amod	12	SENT_254	[p17l629t2466r899b2529],
12	events	NNS	O	event	prep_with	7	SENT_254	[p17l919t2475r1144b2528],
13	greater	JJR	O	greater	amod	12	SENT_254	[p17l1164t2475r1413b2547],
14	than	IN	O	than	_	0	SENT_254	[p17l1429t2466r1582b2528],
15	grade	NN	O	grade	prep_than	13	SENT_254	[p17l1601t2466r1797b2547],
16	3	CD	NUMBER	3	num	15	SENT_254	[p17l1818t2466r1876b2540],
17	,	,	O	,	_	0	SENT_254	[p17l1818t2466r1876b2540],
18	and	CC	O	and	_	0	SENT_254	[p17l1900t2466r2026b2528],
19	the	DT	O	the	det	20	SENT_254	[p17l2043t2466r2150b2528],
20	patients	NNS	O	patient	nsubj	23	SENT_254	[p17l6t2577r283b2658],
21	were	VBD	O	be	cop	23	SENT_254	[p17l326t2596r497b2640],
22	generally	RB	O	generally	advmod	23	SENT_254	[p17l540t2577r871b2658],
23	adherent	JJ	O	adherent	conj_and	7	SENT_254	[p17l915t2577r1222b2639],
24	using	VBG	O	use	xcomp	23	SENT_254	[p17l1261t2577r1453b2658],
25	self	NN	O	self	nn	27	SENT_254	[p17l1497t2577r1981b2658],
26	—	NN	O	—	nn	27	SENT_254	[p17l1497t2577r1981b2658],
27	reporting	NN	O	reporting	dobj	24	SENT_254	[p17l1497t2577r1981b2658],
28	and	CC	O	and	_	0	SENT_254	[p17l2025t2577r2151b2639],
29	electronic	JJ	O	electronic	amod	32	SENT_254	[p17l8t2687r360b2749],
30	compliance	NN	O	compliance	nn	32	SENT_254	[p17l388t2687r800b2768],
31	monitoring	NN	O	monitoring	nn	32	SENT_254	[p17l827t2687r1224b2768],
32	methods	NNS	O	method	conj_and	27	SENT_254	[p17l1250t2687r1571b2749],
33	.	.	O	.	_	0	SENT_254	[p17l1250t2687r1571b2749],

1	Despite	IN	O	despite	_	0	SENT_255	[p17l110t2799r381b2880],
2	the	DT	O	the	det	5	SENT_255	[p17l421t2799r528b2862],
3	low	JJ	O	low	amod	5	SENT_255	[p17l568t2799r700b2862],
4	response	NN	O	response	nn	5	SENT_255	[p17l738t2819r1050b2880],
5	rate	NN	O	rate	prep_despite	9	SENT_255	[p17l1090t2808r1223b2862],
6	observed	VBN	O	observe	partmod	5	SENT_255	[p17l1264t2799r1604b2873],
7	,	,	O	,	_	0	SENT_255	[p17l1264t2799r1604b2873],
8	we	PRP	O	we	nsubj	9	SENT_255	[p17l1647t2819r1748b2862],
9	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_255	[p17l1789t2799r2151b2862],
10	that	IN	O	that	complm	16	SENT_255	[p17l7t2910r141b2973],
11	ﬁXed	JJ	O	ﬁxed	amod	14	SENT_255	[p17l201t2910r571b2973],
12	—	NN	O	—	nn	14	SENT_255	[p17l201t2910r571b2973],
13	dose	NN	O	dose	nn	14	SENT_255	[p17l201t2910r571b2973],
14	capecitabine	NN	O	capecitabine	nsubj	16	SENT_255	[p17l631t2910r1079b2991],
15	is	VBZ	O	be	cop	16	SENT_255	[p17l1140t2910r1195b2973],
16	feasible	JJ	O	feasible	ccomp	9	SENT_255	[p17l1256t2910r1554b2984],
17	,	,	O	,	_	0	SENT_255	[p17l1256t2910r1554b2984],
18	and	CC	O	and	_	0	SENT_255	[p17l1618t2910r1745b2973],
19	simpliﬁes	NNS	O	simpliﬁes	nn	20	SENT_255	[p17l1806t2910r2149b2991],
20	dosing	NN	O	dosing	ccomp	9	SENT_255	[p17l8t3021r263b3102],
21	.	.	O	.	_	0	SENT_255	[p17l8t3021r263b3102],

1	Equally	RB	O	equally	advmod	2	SENT_256	[p17l295t3021r574b3102],
2	important	JJ	O	important	ccomp	6	SENT_256	[p17l603t3021r970b3102],
3	,	,	O	,	_	0	SENT_256	[p17l603t3021r970b3102],
4	we	PRP	O	we	nsubj	6	SENT_256	[p17l1003t3041r1104b3084],
5	also	RB	O	also	advmod	6	SENT_256	[p17l1135t3021r1274b3084],
6	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_256	[p17l1304t3021r1668b3084],
7	that	IN	O	that	complm	12	SENT_256	[p17l1695t3021r1829b3084],
8	the	DT	O	the	det	11	SENT_256	[p17l1857t3021r1964b3084],
9	high	JJ	O	high	amod	11	SENT_256	[p17l1993t3021r2151b3102],
10	interpatient	NN	O	interpatient	nn	11	SENT_256	[p17l7t3132r418b3213],
11	variability	NN	O	variability	nsubj	12	SENT_256	[p17l489t3132r858b3213],
12	observed	VBN	O	observe	ccomp	6	SENT_256	[p17l932t3132r1254b3195],
13	for	IN	O	for	_	0	SENT_256	[p17l1326t3132r1430b3195],
14	capecitabine	NN	O	capecitabine	prep_for	12	SENT_256	[p17l1502t3132r1950b3213],
15	and	CC	O	and	advmod	12	SENT_256	[p17l2025t3132r2151b3195],

1	@	IN	O	@	_	0	SENT_257	[p17l6t3375r83b3470],
2	Springer	NNP	PERSON	Springer	prep_@	7	SENT_257	[p17l113t3398r376b3473],
3	metabolite	NN	O	metabolite	nn	4	SENT_257	[p17l7t3500r385b3562],
4	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	7	SENT_257	[p17l423t3500r1056b3581],
5	is	VBZ	O	be	auxpass	7	SENT_257	[p17l1095t3500r1151b3562],
6	not	RB	O	not	neg	7	SENT_257	[p17l1189t3509r1303b3562],
7	attributed	VBN	O	attribute	_	0	SENT_257	[p17l1341t3500r1684b3562],
8	to	TO	O	to	aux	9	SENT_257	[p17l1720t3509r1787b3562],
9	observed	VBN	O	observe	xcomp	7	SENT_257	[p17l1827t3500r2148b3563],
10	pharmacogenetic	JJ	O	pharmacogenetic	amod	13	SENT_257	[p17l6t3611r620b3692],
11	or	CC	O	or	_	0	SENT_257	[p17l662t3630r735b3673],
12	BSA	NN	O	bsa	amod	13	SENT_257	[p17l773t3611r945b3674],
13	differences	NNS	O	difference	dobj	9	SENT_257	[p17l986t3611r1400b3673],
14	.	.	O	.	_	0	SENT_257	[p17l986t3611r1400b3673],

1	The	DT	O	the	det	4	SENT_258	[p17l1445t3611r1582b3673],
2	observed	VBN	O	observe	amod	4	SENT_258	[p17l1624t3611r1945b3674],
3	antitumor	NN	O	antitumor	nn	4	SENT_258	[p17l1986t3611r2144b3673, p17l7t3732r221b3785],
4	activity	NN	O	activity	nsubj	42	SENT_258	[p17l265t3722r531b3803],
5	in	IN	O	in	_	0	SENT_258	[p17l575t3722r642b3784],
6	our	PRP$	O	we	poss	7	SENT_258	[p17l686t3742r804b3785],
7	study	NN	O	study	prep_in	4	SENT_258	[p17l848t3722r1056b3803],
8	,	,	O	,	_	0	SENT_258	[p17l848t3722r1056b3803],
9	although	IN	O	although	mark	11	SENT_258	[p17l1104t3722r1415b3803],
10	far	RB	O	far	advmod	11	SENT_258	[p17l1458t3722r1557b3785],
11	lower	JJR	O	lower	parataxis	42	SENT_258	[p17l1599t3722r1802b3785],
12	than	IN	O	than	_	0	SENT_258	[p17l1844t3722r1997b3785],
13	the	DT	O	the	det	15	SENT_258	[p17l2040t3722r2147b3785],
14	initial	JJ	O	initial	amod	15	SENT_258	[p18l7t22r215b85],
15	studies	NNS	O	study	prep_than	11	SENT_258	[p18l243t22r486b85],
16	that	WDT	O	that	nsubj	17	SENT_258	[p18l511t22r646b85],
17	led	VBD	O	lead	rcmod	15	SENT_258	[p18l669t22r777b85],
18	to	TO	O	to	_	0	SENT_258	[p18l801t32r867b85],
19	regulatory	JJ	O	regulatory	amod	20	SENT_258	[p18l892t22r1260b103],
20	approval	NN	O	approval	prep_to	17	SENT_258	[p18l1287t22r1596b103],
21	of	IN	O	of	_	0	SENT_258	[p18l1623t22r1700b85],
22	single	JJ	O	single	amod	24	SENT_258	[p18l1721t22r1930b103],
23	agent	NN	O	agent	nn	24	SENT_258	[p18l1956t32r2149b103],
24	capecitabine	NN	O	capecitabine	prep_of	17	SENT_258	[p18l8t133r456b214],
25	[	CD	NUMBER	[	number	26	SENT_258	[p18l497t133r612b209],
26	6	CD	NUMBER	6	num	27	SENT_258	[p18l497t133r612b209],
27	]	NN	O	]	dep	17	SENT_258	[p18l497t133r612b209],
28	,	,	O	,	_	0	SENT_258	[p18l497t133r612b209],
29	is	VBZ	O	be	cop	42	SENT_258	[p18l649t133r705b196],
30	potentially	RB	O	potentially	advmod	31	SENT_258	[p18l739t133r1123b214],
31	comparable	JJ	O	comparable	amod	42	SENT_258	[p18l1159t133r1575b214],
32	to	TO	O	to	_	0	SENT_258	[p18l1611t142r1677b196],
33	more	RBR	O	more	advmod	35	SENT_258	[p18l1712t153r1895b196],
34	recent	JJ	O	recent	amod	35	SENT_258	[p18l1928t142r2148b196],
35	studies	NNS	O	study	prep_to	31	SENT_258	[p18l10t243r252b305],
36	in	IN	O	in	_	0	SENT_258	[p18l290t243r358b304],
37	the	DT	O	the	det	39	SENT_258	[p18l393t243r500b305],
38	metastatic	JJ	O	metastatic	amod	39	SENT_258	[p18l536t243r898b305],
39	setting	NN	O	setting	prep_in	35	SENT_258	[p18l938t243r1172b324],
40	[	CD	NUMBER	[	number	41	SENT_258	[p18l1215t243r1374b318],
41	32	CD	NUMBER	32	num	39	SENT_258	[p18l1215t243r1374b318],
42	]	NN	O	]	_	0	SENT_258	[p18l1215t243r1374b318],
43	.	.	O	.	_	0	SENT_258	[p18l1215t243r1374b318],

1	For	IN	O	for	_	0	SENT_259	[p18l1413t244r1538b305],
2	example	NN	O	example	prep_for	57	SENT_259	[p18l1572t243r1894b324],
3	,	,	O	,	_	0	SENT_259	[p18l1572t243r1894b324],
4	a	DT	O	a	det	7	SENT_259	[p18l1934t262r1971b305],
5	ﬂatdose	NN	O	ﬂatdose	nn	7	SENT_259	[p18l2007t243r2145b305, p18l8t355r168b418],
6	capecitabine	NN	O	capecitabine	nn	7	SENT_259	[p18l199t355r647b436],
7	schedule	NN	O	schedule	ccomp	57	SENT_259	[p18l680t355r989b418],
8	(	CD	NUMBER	(	number	9	SENT_259	[p18l1021t356r1088b433],
9	7	CD	DURATION	7	num	10	SENT_259	[p18l1021t356r1088b433],
10	days	NNS	NUMBER	day	npadvmod	11	SENT_259	[p18l1124t356r1283b436],
11	on	IN	O	on	advmod	7	SENT_259	[p18l1316t375r1421b430],
12	,	,	O	,	_	0	SENT_259	[p18l1316t375r1421b430],
13	7	CD	DURATION	7	num	14	SENT_259	[p18l1453t357r1492b418],
14	days	NNS	NUMBER	day	dep	57	SENT_259	[p18l1528t355r1687b436],
15	off	IN	O	off	_	0	SENT_259	[p18l1720t355r1848b433],
16	)	CD	NUMBER	)	prep_off	57	SENT_259	[p18l1720t355r1848b433],
17	starting	VBG	O	start	partmod	16	SENT_259	[p18l1883t355r2146b436],
18	at	IN	O	at	_	0	SENT_259	[p18l9t476r71b529],
19	1,500	CD	NUMBER	1,500	num	20	SENT_259	[p18l125t466r315b541],
20	mg	NN	O	mg	prep_at	17	SENT_259	[p18l347t486r459b547],
21	orally	RB	O	orally	advmod	17	SENT_259	[p18l507t466r712b547],
22	twice	RB	O	twice	advmod	23	SENT_259	[p18l759t466r952b529],
23	daily	JJ	SET	daily	advmod	17	SENT_259	[p18l999t466r1175b547],
24	with	IN	O	with	_	0	SENT_259	[p18l1222t466r1379b529],
25	maximum	NN	O	maximum	nsubj	26	SENT_259	[p18l1425t466r1789b529],
26	tolerated	VBD	O	tolerate	dep	51	SENT_259	[p18l1834t466r2148b529],
27	dose	NN	O	dose	dobj	26	SENT_259	[p18l8t577r168b639],
28	found	VBN	O	find	partmod	27	SENT_259	[p18l201t577r409b639],
29	to	TO	O	to	aux	30	SENT_259	[p18l440t586r507b639],
30	be	VB	O	be	xcomp	28	SENT_259	[p18l538t577r622b639],
31	2,000	CD	NUMBER	2,000	num	32	SENT_259	[p18l656t577r853b651],
32	mg	NN	O	mg	npadvmod	33	SENT_259	[p18l886t596r998b658],
33	twice	RB	O	twice	advmod	30	SENT_259	[p18l1031t577r1223b640],
34	daily	RB	SET	daily	advmod	30	SENT_259	[p18l1257t577r1433b658],
35	give	VB	O	give	ccomp	30	SENT_259	[p18l1467t577r1618b658],
36	to	TO	O	to	_	0	SENT_259	[p18l1651t587r1717b639],
37	21	CD	NUMBER	21	num	38	SENT_259	[p18l1751t577r1829b639],
38	patients	NNS	O	patient	prep_to	35	SENT_259	[p18l1869t577r2145b658],
39	with	IN	O	with	_	0	SENT_259	[p18l8t688r165b751],
40	a	DT	O	a	det	43	SENT_259	[p18l199t707r236b750],
41	similar	JJ	O	similar	amod	43	SENT_259	[p18l271t688r518b750],
42	disease	NN	O	disease	nn	43	SENT_259	[p18l550t688r805b750],
43	phenotype	NN	O	phenotype	nn	49	SENT_259	[p18l838t688r1211b769],
44	(	CD	NUMBER	(	num	45	SENT_259	[p18l1248t688r1451b765],
45	~	NN	O	~	amod	49	SENT_259	[p18l1248t688r1451b765],
46	60	CD	PERCENT	60	num	47	SENT_259	[p18l1248t688r1451b765],
47	%	NN	PERCENT	%	dep	45	SENT_259	[p18l1489t688r1553b751],
48	ER	NN	O	er	nn	49	SENT_259	[p18l1589t688r2044b769],
49	—	NN	O	—	prep_with	38	SENT_259	[p18l1589t688r2044b769],
50	positive	JJ	O	positive	amod	51	SENT_259	[p18l1589t688r2044b769],
51	)	NN	O	)	prep_with	23	SENT_259	[p18l1589t688r2044b769],
52	in	IN	O	in	_	0	SENT_259	[p18l2080t688r2148b750],
53	the	DT	O	the	det	56	SENT_259	[p18l7t799r114b862],
54	ﬁrst	JJ	O	ﬁrst	amod	56	SENT_259	[p18l150t799r287b862],
55	line	NN	O	line	nn	56	SENT_259	[p18l320t799r452b862],
56	setting	NN	O	setting	prep_in	23	SENT_259	[p18l491t799r724b880],
57	resulted	VBD	O	result	_	0	SENT_259	[p18l758t799r1043b862],
58	in	IN	O	in	_	0	SENT_259	[p18l1076t799r1144b861],
59	one	CD	NUMBER	one	num	61	SENT_259	[p18l1179t819r1305b862],
60	partial	JJ	O	partial	amod	61	SENT_259	[p18l1339t799r1567b880],
61	response	NN	O	response	prep_in	57	SENT_259	[p18l1601t819r1913b880],
62	and	CC	O	and	_	0	SENT_259	[p18l1950t799r2076b862],
63	a	DT	O	a	det	71	SENT_259	[p18l2112t819r2149b862],
64	28	CD	PERCENT	28	number	65	SENT_259	[p18l8t911r91b973],
65	%	NN	PERCENT	%	amod	71	SENT_259	[p18l131t911r195b973],
66	clinical	JJ	O	clinical	amod	71	SENT_259	[p18l228t910r491b973],
67	beneﬁt	NN	O	beneﬁt	nn	71	SENT_259	[p18l518t910r763b973],
68	rate	NN	O	rate	nn	71	SENT_259	[p18l789t920r922b973],
69	[	CD	NUMBER	[	number	70	SENT_259	[p18l958t911r1117b986],
70	32	CD	NUMBER	32	num	71	SENT_259	[p18l958t911r1117b986],
71	]	NN	O	]	prep_in	57	SENT_259	[p18l958t911r1117b986],
72	.	.	O	.	_	0	SENT_259	[p18l958t911r1117b986],

1	While	IN	O	while	mark	4	SENT_260	[p18l1148t910r1367b973],
2	it	PRP	O	it	nsubj	4	SENT_260	[p18l1396t910r1445b973],
3	is	VBZ	O	be	cop	4	SENT_260	[p18l1473t910r1528b973],
4	possible	JJ	O	possible	advcl	38	SENT_260	[p18l1557t910r1849b991],
5	that	IN	O	that	complm	15	SENT_260	[p18l1878t910r2012b973],
6	the	DT	O	the	det	7	SENT_260	[p18l2040t910r2147b973],
7	lower	JJR	O	lower	nsubj	15	SENT_260	[p18l7t1021r211b1084],
8	starting	VBG	O	start	_	0	SENT_260	[p18l250t1021r513b1102],
9	dose	NN	O	dose	prep_starting	7	SENT_260	[p18l552t1021r712b1084],
10	in	IN	O	in	_	0	SENT_260	[p18l750t1021r817b1083],
11	our	PRP$	O	we	poss	12	SENT_260	[p18l855t1041r973b1084],
12	study	NN	O	study	prep_in	9	SENT_260	[p18l1011t1021r1199b1102],
13	might	MD	O	might	aux	15	SENT_260	[p18l1237t1021r1446b1102],
14	have	VB	O	have	aux	15	SENT_260	[p18l1481t1021r1648b1084],
15	resulted	VBN	O	result	ccomp	4	SENT_260	[p18l1685t1021r1969b1084],
16	in	IN	O	in	_	0	SENT_260	[p18l2006t1021r2073b1083],
17	a	DT	O	a	det	20	SENT_260	[p18l2112t1041r2149b1084],
18	lower	JJR	O	lower	amod	20	SENT_260	[p18l7t1131r211b1193],
19	clinical	JJ	O	clinical	amod	20	SENT_260	[p18l239t1130r501b1193],
20	activity	NN	O	activity	prep_in	15	SENT_260	[p18l533t1131r798b1212],
21	when	WRB	O	when	advmod	35	SENT_260	[p18l828t1131r1019b1193],
22	compared	VBN	O	compare	_	0	SENT_260	[p18l1049t1131r1402b1212],
23	to	TO	O	to	prepc_compared_to	35	SENT_260	[p18l1430t1140r1496b1193],
24	usual	JJ	O	usual	amod	26	SENT_260	[p18l1525t1131r1712b1193],
25	BSA	NN	O	bsa	nn	26	SENT_260	[p18l1741t1131r2148b1193],
26	—	NN	O	—	pobj	35	SENT_260	[p18l1741t1131r2148b1193],
27	based	VBN	O	base	partmod	26	SENT_260	[p18l1741t1131r2148b1193],
28	dosing	NN	O	dosing	dobj	27	SENT_260	[p18l8t1242r243b1323],
29	of	IN	O	of	_	0	SENT_260	[p18l274t1242r351b1304],
30	2,000	CD	NUMBER	2,000	num	31	SENT_260	[p18l375t1242r572b1316],
31	mg/m2	NN	O	mg/m2	prep_of	28	SENT_260	[p18l605t1223r846b1323],
32	daily	RB	SET	daily	advmod	27	SENT_260	[p18l876t1242r1072b1323],
33	,	,	O	,	_	0	SENT_260	[p18l876t1242r1072b1323],
34	we	PRP	O	we	nsubj	35	SENT_260	[p18l1104t1262r1205b1304],
35	think	VBP	O	think	ccomp	20	SENT_260	[p18l1235t1242r1419b1304],
36	this	DT	O	this	nsubj	38	SENT_260	[p18l1446t1242r1572b1304],
37	is	VBZ	O	be	cop	38	SENT_260	[p18l1602t1242r1657b1304],
38	unlikely	JJ	O	unlikely	_	0	SENT_260	[p18l1686t1242r1980b1323],
39	as	IN	O	as	mark	46	SENT_260	[p18l2011t1262r2080b1304],
40	a	DT	O	a	det	41	SENT_260	[p18l2112t1262r2149b1304],
41	third	JJ	ORDINAL	third	nsubj	46	SENT_260	[p18l7t1352r176b1415],
42	of	IN	O	of	_	0	SENT_260	[p18l203t1353r280b1415],
43	our	PRP$	O	we	poss	44	SENT_260	[p18l302t1372r420b1415],
44	patients	NNS	O	patient	prep_of	41	SENT_260	[p18l444t1353r722b1434],
45	ultimately	RB	O	ultimately	advmod	46	SENT_260	[p18l750t1352r1114b1434],
46	required	VBN	O	require	advcl	38	SENT_260	[p18l1141t1353r1440b1434],
47	dose	NN	O	dose	nn	48	SENT_260	[p18l1467t1353r1627b1415],
48	reduction	NN	O	reduction	nsubj	49	SENT_260	[p18l1654t1352r1993b1415],
49	due	JJ	O	due	xcomp	46	SENT_260	[p18l2021t1353r2147b1415],
50	to	TO	O	to	_	0	SENT_260	[p18l7t1474r74b1528],
51	excessive	JJ	O	excessive	amod	52	SENT_260	[p18l108t1465r449b1528],
52	toxicity	NN	O	toxicity	prep_to	49	SENT_260	[p18l482t1465r774b1546],
53	.	.	O	.	_	0	SENT_260	[p18l482t1465r774b1546],

1	A	DT	O	a	det	3	SENT_261	[p18l109t1577r172b1638],
2	potential	JJ	O	potential	amod	3	SENT_261	[p18l223t1576r523b1657],
3	explanation	NN	O	explanation	nsubj	16	SENT_261	[p18l577t1576r977b1657],
4	for	IN	O	for	_	0	SENT_261	[p18l1030t1576r1130b1639],
5	the	DT	O	the	det	8	SENT_261	[p18l1181t1576r1285b1639],
6	variable	JJ	O	variable	amod	8	SENT_261	[p18l1339t1576r1614b1639],
7	response	NN	O	response	nn	8	SENT_261	[p18l1667t1596r1966b1657],
8	rate	NN	O	rate	prep_for	3	SENT_261	[p18l2019t1585r2147b1639],
9	observed	VBN	O	observe	partmod	8	SENT_261	[p18l8t1687r318b1750],
10	with	IN	O	with	_	0	SENT_261	[p18l334t1687r487b1749],
11	capecitabine	NN	O	capecitabine	prep_with	9	SENT_261	[p18l504t1687r933b1768],
12	between	IN	O	between	_	0	SENT_261	[p18l949t1687r1237b1750],
13	clinical	JJ	O	clinical	amod	14	SENT_261	[p18l1255t1687r1505b1749],
14	trials	NNS	O	trial	prep_between	11	SENT_261	[p18l1523t1687r1690b1749],
15	may	MD	O	may	aux	16	SENT_261	[p18l1709t1706r1857b1768],
16	relate	VB	O	relate	_	0	SENT_261	[p18l1874t1687r2064b1749],
17	to	TO	O	to	_	0	SENT_261	[p18l2082t1696r2147b1749],
18	differences	NNS	O	difference	prep_to	16	SENT_261	[p18l8t1798r386b1861],
19	in	IN	O	in	_	0	SENT_261	[p18l417t1798r483b1860],
20	the	DT	O	the	det	22	SENT_261	[p18l512t1798r615b1861],
21	patient	NN	O	patient	nn	22	SENT_261	[p18l644t1798r880b1879],
22	population	NN	O	population	prep_in	18	SENT_261	[p18l906t1798r1274b1879],
23	enrolled	VBD	O	enrol	partmod	22	SENT_261	[p18l1304t1798r1600b1861],
24	.	.	O	.	_	0	SENT_261	[p18l1304t1798r1600b1861],

1	The	DT	O	the	det	3	SENT_262	[p18l1633t1799r1767b1861],
2	XCALIBr	NN	O	xcalibr	nn	3	SENT_262	[p18l1796t1799r2149b1861],
3	study	NN	O	study	nsubj	4	SENT_262	[p18l10t1909r191b1990],
4	reported	VBD	O	report	_	0	SENT_262	[p18l220t1909r507b1990],
5	an	DT	O	a	det	8	SENT_262	[p18l536t1929r615b1972],
6	overall	JJ	O	overall	amod	8	SENT_262	[p18l645t1909r881b1972],
7	response	NN	O	response	nn	8	SENT_262	[p18l909t1929r1208b1990],
8	rate	NN	O	rate	dobj	4	SENT_262	[p18l1237t1918r1365b1972],
9	of	IN	O	of	_	0	SENT_262	[p18l1396t1909r1471b1972],
10	38	CD	PERCENT	38	num	11	SENT_262	[p18l1496t1910r1575b1972],
11	%	NN	PERCENT	%	prep_of	8	SENT_262	[p18l1613t1910r1678b1972],
12	for	IN	O	for	_	0	SENT_262	[p18l1711t1909r1811b1972],
13	the	DT	O	the	det	14	SENT_262	[p18l1837t1909r1941b1972],
14	combination	NN	O	combination	prep_for	11	SENT_262	[p18l1971t1929r2145b1972, p18l6t2020r288b2083],
15	of	IN	O	of	_	0	SENT_262	[p18l325t2020r401b2083],
16	capecitabine	NN	O	capecitabine	prep_of	14	SENT_262	[p18l432t2020r860b2101],
17	plus	CC	O	plus	_	0	SENT_262	[p18l896t2020r1037b2101],
18	bevacizumab	NN	O	bevacizumab	conj_plus	8	SENT_262	[p18l1074t2020r1529b2083],
19	in	IN	O	in	_	0	SENT_262	[p18l1567t2020r1634b2082],
20	a	DT	O	a	det	25	SENT_262	[p18l1671t2040r1708b2083],
21	human	JJ	O	human	amod	25	SENT_262	[p18l1743t2020r1979b2083],
22	epidermal	JJ	O	epidermal	amod	25	SENT_262	[p18l2016t2020r2145b2101, p18l8t2130r246b2192],
23	growth	NN	O	growth	nn	25	SENT_262	[p18l296t2130r539b2211],
24	factor	NN	O	factor	nn	25	SENT_262	[p18l588t2130r856b2192],
25	—	NN	O	—	prep_in	18	SENT_262	[p18l588t2130r856b2192],
26	2	CD	NUMBER	2	number	27	SENT_262	[p18l588t2130r856b2192],
27	(	CD	NUMBER	(	num	29	SENT_262	[p18l909t2130r1498b2211],
28	HER2	NN	O	her2	nn	29	SENT_262	[p18l909t2130r1498b2211],
29	)	NN	O	)	dep	18	SENT_262	[p18l909t2130r1498b2211],
30	.	.	O	.	_	0	SENT_262	[p18l909t2130r1498b2211],

1	—	NN	O	—	_	0	SENT_263	[p18l909t2130r1498b2211],
2	.	.	O	.	_	0	SENT_263	[p18l909t2130r1498b2211],

1	negative	JJ	O	negative	amod	3	SENT_264	[p18l909t2130r1498b2211],
2	metastatic	JJ	O	metastatic	amod	3	SENT_264	[p18l1547t2130r1893b2192],
3	breast	NN	O	breast	_	0	SENT_264	[p18l1942t2130r2148b2192],
4	cancer	NN	O	cancer	nn	5	SENT_264	[p18l8t2260r233b2303],
5	population	NN	O	population	dep	3	SENT_264	[p18l266t2241r635b2322],
6	with	IN	O	with	_	0	SENT_264	[p18l671t2241r824b2303],
7	a	DT	O	a	det	9	SENT_264	[p18l861t2260r898b2303],
8	response	NN	O	response	nn	9	SENT_264	[p18l932t2260r1232b2322],
9	rate	NN	O	rate	prep_with	5	SENT_264	[p18l1269t2250r1396b2303],
10	of	IN	O	of	_	0	SENT_264	[p18l1435t2241r1511b2303],
11	47	CD	PERCENT	47	num	12	SENT_264	[p18l1540t2241r1624b2303],
12	%	NN	PERCENT	%	prep_of	9	SENT_264	[p18l1661t2241r1725b2303],
13	in	IN	O	in	_	0	SENT_264	[p18l1765t2240r1831b2302],
14	the	DT	O	the	det	16	SENT_264	[p18l1868t2241r1972b2303],
15	ERpositive	JJ	MISC	erpositive	amod	16	SENT_264	[p18l2008t2242r2145b2302, p18l6t2352r276b2433],
16	population	NN	O	population	prep_in	12	SENT_264	[p18l308t2352r677b2433],
17	and	CC	O	and	_	0	SENT_264	[p18l711t2352r833b2414],
18	27	CD	PERCENT	27	num	19	SENT_264	[p18l866t2352r947b2414],
19	%	NN	PERCENT	%	conj_and	12	SENT_264	[p18l985t2352r1049b2414],
20	in	IN	O	in	_	0	SENT_264	[p18l1085t2352r1151b2413],
21	the	DT	O	the	det	23	SENT_264	[p18l1182t2352r1286b2414],
22	ER-negative	JJ	MISC	er-negative	amod	23	SENT_264	[p18l1318t2352r1747b2433],
23	population	NN	O	population	prep_in	19	SENT_264	[p18l1779t2352r2148b2433],
24	[	CD	NUMBER	[	number	25	SENT_264	[p18l13t2465r165b2540],
25	29	CD	NUMBER	29	dep	3	SENT_264	[p18l13t2465r165b2540],
26	]	NN	O	]	dep	25	SENT_264	[p18l13t2465r165b2540],
27	.	.	O	.	_	0	SENT_264	[p18l13t2465r165b2540],

1	Similar	JJ	O	similar	amod	2	SENT_265	[p18l228t2464r480b2527],
2	ﬁndings	NNS	O	ﬁndings	_	0	SENT_265	[p18l535t2464r808b2545],
3	favoring	VBG	O	favor	partmod	2	SENT_265	[p18l866t2464r1154b2545],
4	ER	NN	O	er	nn	5	SENT_265	[p18l1211t2464r1620b2545],
5	—	NN	O	—	dobj	3	SENT_265	[p18l1211t2464r1620b2545],
6	positive	JJ	O	positive	amod	7	SENT_265	[p18l1211t2464r1620b2545],
7	disease	NN	O	disease	nsubjpass	9	SENT_265	[p18l1678t2464r1923b2527],
8	were	VBD	O	be	auxpass	9	SENT_265	[p18l1980t2484r2146b2527],
9	observed	VBN	O	observe	rcmod	5	SENT_265	[p18l8t2575r317b2637],
10	in	IN	O	in	_	0	SENT_265	[p18l360t2575r427b2637],
11	a	DT	O	a	det	14	SENT_265	[p18l473t2594r510b2637],
12	preplanned	JJ	O	preplanned	amod	14	SENT_265	[p18l552t2575r936b2656],
13	exploratory	JJ	O	exploratory	amod	14	SENT_265	[p18l979t2575r1373b2656],
14	analysis	NN	O	analysis	prep_in	9	SENT_265	[p18l1420t2575r1691b2656],
15	of	IN	O	of	_	0	SENT_265	[p18l1738t2575r1813b2637],
16	adjuvant	JJ	O	adjuvant	amod	17	SENT_265	[p18l1854t2575r2149b2656],
17	capecitabine	NN	O	capecitabine	prep_of	14	SENT_265	[p18l8t2686r436b2767],
18	in	IN	O	in	_	0	SENT_265	[p18l479t2686r545b2748],
19	combination	NN	O	combination	prep_in	9	SENT_265	[p18l588t2686r1018b2748],
20	with	IN	O	with	_	0	SENT_265	[p18l1060t2686r1213b2748],
21	docetaxel	NN	O	docetaxel	nn	25	SENT_265	[p18l1255t2686r1601b2760],
22	,	,	O	,	_	0	SENT_265	[p18l1255t2686r1601b2760],
23	cyclophospha	NN	O	cyclophospha	dep	25	SENT_265	[p18l1647t2686r2145b2767],
24	—	CD	NUMBER	—	num	25	SENT_265	[p18l1647t2686r2145b2767],
25	n1ide	NN	O	n1ide	prep_with	19	SENT_265	[p18l7t2797r197b2871],
26	,	,	O	,	_	0	SENT_265	[p18l7t2797r197b2871],
27	and	CC	O	and	_	0	SENT_265	[p18l246t2797r369b2860],
28	epirubicin	NN	O	epirubicin	prep_in	9	SENT_265	[p18l413t2797r777b2878],
29	,	,	O	,	_	0	SENT_265	[p18l413t2797r777b2878],
30	[	CD	NUMBER	[	number	31	SENT_265	[p18l831t2798r960b2873],
31	13	CD	NUMBER	13	num	32	SENT_265	[p18l831t2798r960b2873],
32	]	NN	O	]	appos	28	SENT_265	[p18l831t2798r960b2873],
33	although	IN	O	although	mark	39	SENT_265	[p18l1012t2797r1311b2878],
34	the	DT	O	the	det	35	SENT_265	[p18l1355t2797r1458b2860],
35	patients	NNS	O	patient	nsubj	39	SENT_265	[p18l1502t2797r1767b2878],
36	with	IN	O	with	_	0	SENT_265	[p18l1813t2797r1965b2860],
37	ERnegative	JJ	MISC	ernegative	amod	38	SENT_265	[p18l2008t2799r2145b2859, p18l7t2908r297b2989],
38	disease	NN	O	disease	prep_with	35	SENT_265	[p18l320t2908r566b2971],
39	appeared	VBD	O	appear	advcl	9	SENT_265	[p18l590t2908r899b2989],
40	to	TO	O	to	aux	41	SENT_265	[p18l920t2918r984b2971],
41	beneﬁt	VB	O	beneﬁt	xcomp	39	SENT_265	[p18l1006t2908r1242b2971],
42	more	RBR	O	more	advmod	41	SENT_265	[p18l1262t2928r1438b2971],
43	from	IN	O	from	_	0	SENT_265	[p18l1461t2908r1629b2971],
44	the	DT	O	the	det	45	SENT_265	[p18l1649t2908r1753b2971],
45	addition	NN	O	addition	prep_from	42	SENT_265	[p18l1777t2908r2056b2971],
46	of	IN	O	of	_	0	SENT_265	[p18l2078t2908r2153b2971],
47	adjuvant	JJ	O	adjuvant	amod	48	SENT_265	[p18l9t3019r304b3100],
48	capecitabine	NN	O	capecitabine	prep_of	45	SENT_265	[p18l345t3019r773b3100],
49	to	TO	O	to	_	0	SENT_265	[p18l815t3028r880b3082],
50	standard	JJ	O	standard	amod	51	SENT_265	[p18l926t3019r1213b3082],
51	chemotherapy	NN	O	chemotherapy	prep_to	41	SENT_265	[p18l1254t3019r1741b3100],
52	in	IN	O	in	_	0	SENT_265	[p18l1783t3019r1849b3081],
53	another	DT	O	another	prep_in	51	SENT_265	[p18l1892t3019r2150b3082],
54	randomized	VBN	O	randomize	partmod	53	SENT_265	[p18l6t3128r415b3191],
55	phase	NN	O	phase	dobj	54	SENT_265	[p18l472t3129r667b3210],
56	3	CD	NUMBER	3	num	59	SENT_265	[p18l729t3129r764b3192],
57	adjuvant	JJ	O	adjuvant	amod	59	SENT_265	[p18l830t3129r1125b3210],
58	trial	NN	O	trial	nn	59	SENT_265	[p18l1182t3129r1317b3191],
59	[	NN	O	[	tmod	3	SENT_265	[p18l1383t3129r1535b3204],
60	21	CD	NUMBER	21	num	61	SENT_265	[p18l1383t3129r1535b3204],
61	]	NN	O	]	dep	59	SENT_265	[p18l1383t3129r1535b3204],
62	.	.	O	.	_	0	SENT_265	[p18l1383t3129r1535b3204],

1	Overall	RB	O	overall	advmod	21	SENT_266	[p18l1600t3129r1872b3202],
2	,	,	O	,	_	0	SENT_266	[p18l1600t3129r1872b3202],
3	robust	JJ	O	robust	amod	4	SENT_266	[p18l1933t3129r2148b3191],
4	predictors	NNS	O	predictor	nsubj	21	SENT_266	[p18l6t3240r347b3321],
5	of	IN	O	of	_	0	SENT_266	[p18l394t3240r469b3302],
6	response	NN	O	response	prep_of	4	SENT_266	[p18l506t3259r805b3321],
7	to	TO	O	to	_	0	SENT_266	[p18l850t3249r914b3302],
8	capecitabine	NN	O	capecitabine	prep_to	6	SENT_266	[p18l961t3240r1389b3321],
9	and	CC	O	and	_	0	SENT_266	[p18l1435t3240r1558b3302],
10	the	DT	O	the	det	11	SENT_266	[p18l1601t3240r1704b3302],
11	reasons	NNS	O	reason	prep_of	4	SENT_266	[p18l1748t3259r2003b3302],
12	for	IN	O	for	_	0	SENT_266	[p18l2049t3240r2149b3302],
13	variation	NN	O	variation	prep_for	11	SENT_266	[p18l7t3352r312b3415],
14	in	IN	O	in	_	0	SENT_266	[p18l349t3352r415b3414],
15	patient	NN	O	patient	nn	16	SENT_266	[p18l451t3352r686b3433],
16	outcomes	NNS	O	outcome	prep_in	13	SENT_266	[p18l722t3362r1050b3415],
17	between	IN	O	between	_	0	SENT_266	[p18l1088t3352r1376b3415],
18	clinical	JJ	O	clinical	amod	19	SENT_266	[p18l1414t3352r1664b3415],
19	trials	NNS	O	trial	prep_between	16	SENT_266	[p18l1702t3352r1869b3415],
20	remain	VBP	O	remain	cop	21	SENT_266	[p18l1908t3352r2148b3415],
21	elusive	JJ	O	elusive	_	0	SENT_266	[p18l8t3463r265b3526],
22	.	.	O	.	_	0	SENT_266	[p18l8t3463r265b3526],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_267	[p18l52t3601r142b3626],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_267	[p18l155t3601r255b3626],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_267	[p18l267t3601r318b3626],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_267	[p18l331t3601r406b3626],
5	(	CD	NUMBER	(	num	6	SENT_267	[p18l419t3601r510b3631],
6	2013	CD	DATE	2013	dep	4	SENT_267	[p18l419t3601r510b3631],
7	)	CD	NUMBER	)	number	8	SENT_267	[p18l419t3601r510b3631],
8	139:135	CD	NUMBER	139:135	num	9	SENT_267	[p18l528t3601r708b3626],
9	—	NN	O	—	dep	6	SENT_267	[p18l528t3601r708b3626],
10	143	CD	NUMBER	143	number	11	SENT_267	[p18l528t3601r708b3626],
11	141	CD	NUMBER	141	num	9	SENT_267	[p18l2058t3601r2104b3625],

1	Table	NNP	O	Table	_	0	SENT_268	[p19l53t37r138b63],
2	4	CD	NUMBER	4	num	1	SENT_268	[p19l151t37r167b62],
3	Association	NNP	O	Association	nsubj	12	SENT_268	[p19l189t37r355b62],
4	of	IN	O	of	_	0	SENT_268	[p19l368t37r399b62],
5	capecitabine	NN	O	capecitabine	nn	6	SENT_268	[p19l409t37r585b70],
6	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	3	SENT_268	[p19l598t37r847b70],
7	and	CC	O	and	_	0	SENT_268	[p19l861t37r911b62],
8	genetic	JJ	O	genetic	amod	11	SENT_268	[p19l924t37r1024b70],
9	variation	NN	O	variation	nn	11	SENT_268	[p19l1038t37r1163b62],
10	Variant	JJ	O	variant	amod	11	SENT_268	[p19l52t110r158b135],
11	genotypes	NNS	O	genotype	prep_of	3	SENT_268	[p19l171t114r312b142],
12	Count	VBP	O	count	rcmod	1	SENT_268	[p19l687t110r773b135],
13	(	RB	O	(	advmod	17	SENT_268	[p19l786t110r870b140],
14	total	JJ	O	total	amod	17	SENT_268	[p19l786t110r870b140],
15	)	CD	NUMBER	)	num	17	SENT_268	[p19l786t110r870b140],
16	Allele	NN	O	allele	nn	17	SENT_268	[p19l952t110r1037b135],
17	frequencya	NN	O	frequencya	dobj	12	SENT_268	[p19l1050t108r1203b142],
18	Pharrnacokinetic	JJ	O	pharrnacokinetic	amod	20	SENT_268	[p19l1328t110r1564b135],
19	parameter	NN	O	parameter	nn	20	SENT_268	[p19l1577t114r1719b142],
20	P	NN	O	p	nsubj	21	SENT_268	[p19l1799t111r1821b134],
21	rs	VBZ	O	r	rcmod	17	SENT_268	[p19l1941t118r1965b135],
22	ID	NN	O	id	dobj	21	SENT_268	[p19l1979t111r2014b134],

1	CDA	NNP	O	CDA	nn	2	SENT_269	[p19l11t294r160b349],
2	K27Q	NN	O	k27q	dep	11	SENT_269	[p19l193t294r382b361],
3	(	CD	NUMBER	(	num	4	SENT_269	[p19l413t294r549b361],
4	GG	NNS	O	gg	dep	2	SENT_269	[p19l413t294r549b361],
5	VS.	NNP	O	VS.	nn	7	SENT_269	[p19l576t311r659b349],
6	GT	NN	O	gt	nn	7	SENT_269	[p19l694t294r795b349],
7	VS.	NNP	O	VS.	dep	4	SENT_269	[p19l824t311r907b349],
8	TT	NN	O	tt	dep	11	SENT_269	[p19l940t294r1058b361],
9	)	CD	NUMBER	)	num	8	SENT_269	[p19l940t294r1058b361],
10	16/9/1	CD	NUMBER	16/9/1	num	11	SENT_269	[p19l1434t293r1619b349],
11	(	NN	O	(	dep	17	SENT_269	[p19l1657t293r1781b361],
12	26	CD	NUMBER	26	number	13	SENT_269	[p19l1657t293r1781b361],
13	)	CD	NUMBER	)	dep	11	SENT_269	[p19l1657t293r1781b361],
14	0.79	CD	NUMBER	0.79	num	15	SENT_269	[p19l2019t294r2152b349],
15	CES2-830	NN	O	ces2-830	dep	13	SENT_269	[p19l11t407r329b462],
16	(	CD	NUMBER	(	num	17	SENT_269	[p19l361t407r497b474],
17	GG	NNS	O	gg	dep	21	SENT_269	[p19l361t407r497b474],
18	Vs.	NNP	O	Vs.	nn	20	SENT_269	[p19l525t424r608b462],
19	GC	NN	O	gc	nn	20	SENT_269	[p19l642t407r746b462],
20	VS.	NNP	O	VS.	dep	17	SENT_269	[p19l776t424r859b462],
21	CC	NN	O	cc	dep	24	SENT_269	[p19l893t407r1019b474],
22	)	CD	NUMBER	)	num	21	SENT_269	[p19l893t407r1019b474],
23	1/4/20	CD	DATE	1/4/20	num	24	SENT_269	[p19l1434t407r1626b462],
24	(	NN	O	(	dep	28	SENT_269	[p19l1657t406r1781b474],
25	25	CD	NUMBER	25	number	26	SENT_269	[p19l1657t406r1781b474],
26	)	CD	NUMBER	)	dep	24	SENT_269	[p19l1657t406r1781b474],
27	0.12	CD	NUMBER	0.12	dep	26	SENT_269	[p19l2019t407r2153b462],
28	DPYD	NN	O	dpyd	dep	30	SENT_269	[p19l6t523r211b575],
29	*	CD	NUMBER	*	num	28	SENT_269	[p19l243t521r373b575],
30	2A	NN	O	2a	dep	36	SENT_269	[p19l243t521r373b575],
31	(	CD	NUMBER	(	num	32	SENT_269	[p19l404t521r540b588],
32	GG	NNS	O	gg	dep	30	SENT_269	[p19l404t521r540b588],
33	Vs.	NNP	O	Vs.	nn	36	SENT_269	[p19l567t538r650b576],
34	GA	NNP	O	GA	nn	36	SENT_269	[p19l685t521r795b576],
35	VS.	NNP	O	VS.	nn	36	SENT_269	[p19l823t538r906b576],
36	AA	NNP	O	AA	dep	44	SENT_269	[p19l939t521r1074b588],
37	)	CD	NUMBER	)	number	38	SENT_269	[p19l939t521r1074b588],
38	26/0/0	CD	NUMBER	26/0/0	num	39	SENT_269	[p19l1427t520r1626b576],
39	(	NN	O	(	dep	36	SENT_269	[p19l1657t520r1781b588],
40	26	CD	NUMBER	26	num	41	SENT_269	[p19l1657t520r1781b588],
41	)	CD	NUMBER	)	dep	39	SENT_269	[p19l1657t520r1781b588],
42	1.00	CD	NUMBER	1.00	num	44	SENT_269	[p19l2025t521r2153b576],
43	DPYD	NN	O	dpyd	nn	44	SENT_269	[p19l6t638r211b690],
44	*	NN	O	*	dep	54	SENT_269	[p19l243t636r312b691],
45	5	CD	NUMBER	5	number	46	SENT_269	[p19l243t636r312b691],
46	(	CD	NUMBER	(	num	47	SENT_269	[p19l347t636r483b703],
47	GG	NNS	O	gg	dep	44	SENT_269	[p19l347t636r483b703],
48	VS.	NNP	O	VS.	nn	51	SENT_269	[p19l511t653r594b691],
49	GA	NNP	O	GA	nn	51	SENT_269	[p19l628t636r738b691],
50	VS.	NNP	O	VS.	nn	51	SENT_269	[p19l766t653r849b691],
51	AA	NNP	O	AA	dep	47	SENT_269	[p19l882t636r1017b703],
52	)	CD	NUMBER	)	num	54	SENT_269	[p19l882t636r1017b703],
53	12/13/1	CD	NUMBER	12/13/1	num	54	SENT_269	[p19l1434t636r1659b691],
54	(	NN	O	(	dep	61	SENT_269	[p19l1697t636r1821b703],
55	26	CD	NUMBER	26	number	56	SENT_269	[p19l1697t636r1821b703],
56	)	CD	NUMBER	)	dep	54	SENT_269	[p19l1697t636r1821b703],
57	0.71	CD	NUMBER	0.71	num	59	SENT_269	[p19l2019t636r2147b691],
58	SLC28A1	NN	O	slc28a1	nn	59	SENT_269	[p19l10t750r318b805],
59	V1891	NN	O	v1891	dep	56	SENT_269	[p19l354t750r559b806],
60	(	CD	NUMBER	(	num	61	SENT_269	[p19l597t750r733b817],
61	GG	NNS	O	gg	dep	65	SENT_269	[p19l597t750r733b817],
62	VS.	NNP	O	VS.	nn	64	SENT_269	[p19l761t767r844b805],
63	GT	NN	O	gt	nn	64	SENT_269	[p19l877t750r979b805],
64	VS.	NNP	O	VS.	dep	61	SENT_269	[p19l1008t767r1091b805],
65	TT	NN	O	tt	dep	68	SENT_269	[p19l1124t751r1243b818],
66	)	CD	NUMBER	)	num	65	SENT_269	[p19l1124t751r1243b818],
67	10/14/2	CD	NUMBER	10/14/2	num	68	SENT_269	[p19l1434t750r1665b805],
68	(	NN	O	(	_	0	SENT_269	[p19l1697t750r1821b818],
69	26	CD	NUMBER	26	num	70	SENT_269	[p19l1697t750r1821b818],
70	)	CD	NUMBER	)	dep	68	SENT_269	[p19l1697t750r1821b818],
71	0.65	CD	NUMBER	0.65	number	72	SENT_269	[p19l2019t750r2150b805],
72	0.21	CD	NUMBER	0.21	num	76	SENT_269	[p19l6t863r133b918],
73	Capecitabine	NN	O	capecitabine	nn	76	SENT_269	[p19l425t862r832b933],
74	AUCOO	NN	O	aucoo	nn	76	SENT_269	[p19l862t863r1078b930],
75	0.24	CD	NUMBER	0.24	num	76	SENT_269	[p19l1473t863r1607b918],
76	rs2072671	NN	O	rs2072671	dep	70	SENT_269	[p19l1786t862r2109b918],

1	5	CD	NUMBER	5	_	0	SENT_270	[p19l425t970r711b1030],
2	’	NN	O	’	dep	1	SENT_270	[p19l425t970r711b1030],
3	.	.	O	.	_	0	SENT_270	[p19l425t970r711b1030],

1	—	NN	O	—	_	0	SENT_271	[p19l425t970r711b1030],
2	.	.	O	.	_	0	SENT_271	[p19l425t970r711b1030],

1	DFCR	NN	O	dfcr	nn	2	SENT_272	[p19l425t970r711b1030],
2	AUCOO	NN	O	aucoo	_	0	SENT_272	[p19l739t976r956b1043],
3	0.16	CD	NUMBER	0.16	num	5	SENT_272	[p19l1473t975r1606b1030],
4	5	CD	NUMBER	5	num	5	SENT_272	[p19l425t1082r716b1142],
5	’	NN	O	’	dep	2	SENT_272	[p19l425t1082r716b1142],
6	.	.	O	.	_	0	SENT_272	[p19l425t1082r716b1142],

1	—	NN	O	—	_	0	SENT_273	[p19l425t1082r716b1142],
2	.	.	O	.	_	0	SENT_273	[p19l425t1082r716b1142],

1	DFUR	NN	O	dfur	nn	2	SENT_274	[p19l425t1082r716b1142],
2	AUCOO	NN	O	aucoo	_	0	SENT_274	[p19l743t1088r960b1155],
3	0.28	CD	NUMBER	0.28	num	4	SENT_274	[p19l1473t1088r1605b1142],
4	5	CD	NUMBER	5	dep	2	SENT_274	[p19l425t1201r587b1257],
5	.	.	O	.	_	0	SENT_274	[p19l425t1201r587b1257],

1	—	NN	O	—	_	0	SENT_275	[p19l425t1201r587b1257],
2	.	.	O	.	_	0	SENT_275	[p19l425t1201r587b1257],

1	FU	NNP	O	FU	nn	2	SENT_276	[p19l425t1201r587b1257],
2	AUCOO	NNP	O	AUCOO	_	0	SENT_276	[p19l615t1202r831b1269],
3	0.19	CD	NUMBER	0.19	dep	2	SENT_276	[p19l1473t1202r1606b1257],

1	0.88	CD	NUMBER	0.88	num	3	SENT_277	[p19l6t1316r137b1371],
2	Capecitabine	NN	O	capecitabine	nn	3	SENT_277	[p19l425t1316r832b1386],
3	AUCOO	NN	O	aucoo	_	0	SENT_277	[p19l862t1316r1078b1383],
4	0.94	CD	NUMBER	0.94	num	5	SENT_277	[p19l1473t1316r1607b1371],
5	rs11075646	NN	O	rs11075646	dep	3	SENT_277	[p19l1786t1315r2154b1371],

1	5	CD	NUMBER	5	_	0	SENT_278	[p19l425t1422r712b1482],
2	’	NN	O	’	dep	1	SENT_278	[p19l425t1422r712b1482],
3	.	.	O	.	_	0	SENT_278	[p19l425t1422r712b1482],

1	—	NN	O	—	_	0	SENT_279	[p19l425t1422r712b1482],
2	.	.	O	.	_	0	SENT_279	[p19l425t1422r712b1482],

1	DFCR	NN	O	dfcr	nn	2	SENT_280	[p19l425t1422r712b1482],
2	AUCOO	NN	O	aucoo	_	0	SENT_280	[p19l739t1428r956b1494],
3	0.63	CD	NUMBER	0.63	number	4	SENT_280	[p19l1473t1427r1603b1482],
4	5	CD	NUMBER	5	dep	2	SENT_280	[p19l425t1535r716b1596],
5	’	NN	O	’	dep	4	SENT_280	[p19l425t1535r716b1596],
6	.	.	O	.	_	0	SENT_280	[p19l425t1535r716b1596],

1	—	NN	O	—	_	0	SENT_281	[p19l425t1535r716b1596],
2	.	.	O	.	_	0	SENT_281	[p19l425t1535r716b1596],

1	DFUR	NN	O	dfur	nn	2	SENT_282	[p19l425t1535r716b1596],
2	AUCOO	NN	O	aucoo	_	0	SENT_282	[p19l743t1541r960b1608],
3	0.54	CD	NUMBER	0.54	number	4	SENT_282	[p19l1473t1541r1607b1596],
4	5	CD	NUMBER	5	num	2	SENT_282	[p19l425t1654r587b1709],
5	.	.	O	.	_	0	SENT_282	[p19l425t1654r587b1709],

1	—	NN	O	—	_	0	SENT_283	[p19l425t1654r587b1709],
2	.	.	O	.	_	0	SENT_283	[p19l425t1654r587b1709],

1	FU	NNP	O	FU	nn	2	SENT_284	[p19l425t1654r587b1709],
2	AUCOO	NNP	O	AUCOO	_	0	SENT_284	[p19l615t1654r831b1722],
3	0.10	CD	NUMBER	0.10	dep	2	SENT_284	[p19l1473t1655r1607b1709],

1	o.	NN	O	o.	nn	2	SENT_285	[p19l6t1769r140b1824],
2	oo	NN	O	oo	_	0	SENT_285	[p19l6t1769r140b1824],
3	Capecitabine	NN	O	capecitabine	nn	6	SENT_285	[p19l425t1768r832b1839],
4	AUCOO	NN	O	aucoo	nn	6	SENT_285	[p19l862t1769r1078b1836],
5	n.a.	NN	O	n.a.	nn	6	SENT_285	[p19l1473t1786r1580b1823],
6	rs3918290	NN	O	rs3918290	dep	2	SENT_285	[p19l1786t1769r2115b1824],

1	5	CD	NUMBER	5	_	0	SENT_286	[p19l425t1876r711b1936],
2	’	SYM	O	’	dep	1	SENT_286	[p19l425t1876r711b1936],
3	-	:	O	-	_	0	SENT_286	[p19l425t1876r711b1936],
4	DFCR	NN	O	dfcr	nn	5	SENT_286	[p19l425t1876r711b1936],
5	AUCOO	NN	O	aucoo	dep	1	SENT_286	[p19l739t1881r956b1948],
6	n.a.	NN	O	n.a.	dep	5	SENT_286	[p19l1472t1898r1580b1936],
7	5	CD	NUMBER	5	dobj	6	SENT_286	[p19l425t1988r716b2048],
8	’	NN	O	’	dep	7	SENT_286	[p19l425t1988r716b2048],
9	.	.	O	.	_	0	SENT_286	[p19l425t1988r716b2048],

1	—	NN	O	—	_	0	SENT_287	[p19l425t1988r716b2048],
2	.	.	O	.	_	0	SENT_287	[p19l425t1988r716b2048],

1	DFUR	NN	O	dfur	nn	3	SENT_288	[p19l425t1988r716b2048],
2	AUCOO	NN	O	aucoo	nn	3	SENT_288	[p19l743t1994r960b2061],
3	n.a.	NN	O	n.a.	_	0	SENT_288	[p19l1472t2011r1580b2048],
4	5	CD	NUMBER	5	dep	3	SENT_288	[p19l425t2107r587b2163],
5	.	.	O	.	_	0	SENT_288	[p19l425t2107r587b2163],

1	—	NN	O	—	_	0	SENT_289	[p19l425t2107r587b2163],
2	.	.	O	.	_	0	SENT_289	[p19l425t2107r587b2163],

1	FU	NNP	O	FU	nn	2	SENT_290	[p19l425t2107r587b2163],
2	AUCOO	NNP	O	AUCOO	_	0	SENT_290	[p19l615t2108r831b2175],
3	n.a.	IN	O	n.a.	dep	2	SENT_290	[p19l1472t2125r1580b2162],

1	0.29	CD	NUMBER	0.29	num	3	SENT_291	[p19l6t2222r138b2277],
2	Capecitabine	NN	O	capecitabine	nn	3	SENT_291	[p19l425t2222r832b2292],
3	AUCOO	NN	O	aucoo	_	0	SENT_291	[p19l862t2222r1078b2289],
4	0.78	CD	NUMBER	0.78	num	5	SENT_291	[p19l1473t2222r1605b2277],
5	rs180l159	NN	O	rs180l159	dep	3	SENT_291	[p19l1786t2221r2114b2277],

1	5	CD	NUMBER	5	_	0	SENT_292	[p19l425t2329r711b2389],
2	’	NN	O	’	dep	1	SENT_292	[p19l425t2329r711b2389],
3	.	.	O	.	_	0	SENT_292	[p19l425t2329r711b2389],

1	—	NN	O	—	_	0	SENT_293	[p19l425t2329r711b2389],
2	.	.	O	.	_	0	SENT_293	[p19l425t2329r711b2389],

1	DFCR	NN	O	dfcr	nn	2	SENT_294	[p19l425t2329r711b2389],
2	AUCOO	NN	O	aucoo	_	0	SENT_294	[p19l739t2335r956b2402],
3	0.95	CD	NUMBER	0.95	num	5	SENT_294	[p19l1473t2334r1604b2390],
4	5	CD	NUMBER	5	num	5	SENT_294	[p19l425t2441r716b2502],
5	’	NN	O	’	dep	2	SENT_294	[p19l425t2441r716b2502],
6	.	.	O	.	_	0	SENT_294	[p19l425t2441r716b2502],

1	—	NN	O	—	_	0	SENT_295	[p19l425t2441r716b2502],
2	.	.	O	.	_	0	SENT_295	[p19l425t2441r716b2502],

1	DFUR	NN	O	dfur	nn	2	SENT_296	[p19l425t2441r716b2502],
2	AUCOO	NN	O	aucoo	_	0	SENT_296	[p19l743t2447r960b2514],
3	0.47	CD	NUMBER	0.47	number	4	SENT_296	[p19l1473t2447r1605b2502],
4	5	CD	NUMBER	5	num	2	SENT_296	[p19l425t2560r587b2616],
5	.	.	O	.	_	0	SENT_296	[p19l425t2560r587b2616],

1	—	NN	O	—	_	0	SENT_297	[p19l425t2560r587b2616],
2	.	.	O	.	_	0	SENT_297	[p19l425t2560r587b2616],

1	FU	NNP	O	FU	nn	2	SENT_298	[p19l425t2560r587b2616],
2	AUCOO	NNP	O	AUCOO	_	0	SENT_298	[p19l615t2561r831b2628],
3	0.20	CD	NUMBER	0.20	dep	2	SENT_298	[p19l1473t2561r1607b2616],

1	0.35	CD	NUMBER	0.35	num	3	SENT_299	[p19l6t2675r136b2730],
2	Capecitabine	NN	O	capecitabine	nn	3	SENT_299	[p19l425t2675r832b2746],
3	AUCOO	NN	O	aucoo	_	0	SENT_299	[p19l862t2675r1078b2742],
4	0.33	CD	NUMBER	0.33	num	5	SENT_299	[p19l1473t2675r1603b2730],
5	rs2290272	NN	O	rs2290272	dep	3	SENT_299	[p19l1786t2675r2115b2730],

1	5	CD	NUMBER	5	_	0	SENT_300	[p19l425t2781r711b2841],
2	’	NN	O	’	dep	1	SENT_300	[p19l425t2781r711b2841],
3	.	.	O	.	_	0	SENT_300	[p19l425t2781r711b2841],

1	—	NN	O	—	_	0	SENT_301	[p19l425t2781r711b2841],
2	.	.	O	.	_	0	SENT_301	[p19l425t2781r711b2841],

1	DFCR	NN	O	dfcr	nn	2	SENT_302	[p19l425t2781r711b2841],
2	AUCOO	NN	O	aucoo	_	0	SENT_302	[p19l739t2787r956b2854],
3	0.99	CD	NUMBER	0.99	num	5	SENT_302	[p19l1473t2787r1606b2842],
4	5	CD	NUMBER	5	num	5	SENT_302	[p19l425t2894r716b2955],
5	’	NN	O	’	dep	2	SENT_302	[p19l425t2894r716b2955],
6	.	.	O	.	_	0	SENT_302	[p19l425t2894r716b2955],

1	—	NN	O	—	_	0	SENT_303	[p19l425t2894r716b2955],
2	.	.	O	.	_	0	SENT_303	[p19l425t2894r716b2955],

1	DFUR	NN	O	dfur	nn	2	SENT_304	[p19l425t2894r716b2955],
2	AUCOO	NN	O	aucoo	_	0	SENT_304	[p19l743t2900r960b2967],
3	0.34	CD	NUMBER	0.34	number	4	SENT_304	[p19l1473t2900r1607b2955],
4	5	CD	NUMBER	5	num	2	SENT_304	[p19l425t3015r587b3070],
5	.	.	O	.	_	0	SENT_304	[p19l425t3015r587b3070],

1	—	NN	O	—	_	0	SENT_305	[p19l425t3015r587b3070],
2	.	.	O	.	_	0	SENT_305	[p19l425t3015r587b3070],

1	FU	NNP	O	FU	nn	2	SENT_306	[p19l425t3015r587b3070],
2	AUCOO	NNP	O	AUCOO	_	0	SENT_306	[p19l615t3015r831b3082],
3	0.10	CD	NUMBER	0.10	dep	2	SENT_306	[p19l1473t3015r1607b3070],

1	Statistical	JJ	O	statistical	amod	2	SENT_307	[p19l53t3121r191b3146],
2	associations	NNS	O	association	nsubjpass	4	SENT_307	[p19l205t3121r374b3146],
3	were	VBD	O	be	auxpass	4	SENT_307	[p19l387t3129r455b3146],
4	evaluated	VBN	O	evaluate	_	0	SENT_307	[p19l468t3121r603b3146],
5	using	VBG	O	use	xcomp	4	SENT_307	[p19l615t3121r691b3153],
6	the	DT	O	the	det	7	SENT_307	[p19l704t3121r746b3146],
7	Fisher	NNP	PERSON	Fisher	poss	10	SENT_307	[p19l758t3121r871b3146],
8	’s	POS	O	’s	_	0	SENT_307	[p19l758t3121r871b3146],
9	exact	JJ	O	exact	amod	10	SENT_307	[p19l884t3125r959b3146],
10	test	NN	O	test	nsubj	12	SENT_307	[p19l971t3125r1020b3146],
11	3	CD	NUMBER	3	num	12	SENT_307	[p19l53t3162r64b3174],
12	Hardy	NNP	O	Hardy	xcomp	5	SENT_307	[p19l82t3164r326b3197],
13	.	.	O	.	_	0	SENT_307	[p19l82t3164r326b3197],

1	—	NN	O	—	_	0	SENT_308	[p19l82t3164r326b3197],
2	.	.	O	.	_	0	SENT_308	[p19l82t3164r326b3197],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_309	[p19l82t3164r326b3197],
2	notation	NN	O	notation	_	0	SENT_309	[p19l339t3164r455b3190],
3	for	IN	O	for	_	0	SENT_309	[p19l467t3164r508b3190],
4	allele	NN	O	allele	nn	5	SENT_309	[p19l521t3164r596b3190],
5	frequencies	NNS	O	frequency	prep_for	2	SENT_309	[p19l609t3164r780b3197],
6	;	:	O	;	_	0	SENT_309	[p19l609t3164r780b3197],
7	p	NN	O	p	dep	2	SENT_309	[p19l791t3173r819b3197],
8	,	,	O	,	_	0	SENT_309	[p19l791t3173r819b3197],
9	frequency	NN	O	frequency	appos	7	SENT_309	[p19l832t3164r973b3197],
10	for	IN	O	for	_	0	SENT_309	[p19l986t3164r1027b3190],
11	reference	NN	O	reference	nn	12	SENT_309	[p19l1038t3164r1169b3190],
12	allele	NN	O	allele	prep_for	9	SENT_309	[p19l1183t3164r1258b3190],
13	and	CC	O	and	_	0	SENT_309	[p19l1272t3164r1322b3190],
14	q	NN	O	q	prep_for	9	SENT_309	[p19l1335t3173r1359b3197],
15	,	,	O	,	_	0	SENT_309	[p19l1335t3173r1359b3197],
16	frequency	NN	O	frequency	appos	7	SENT_309	[p19l1373t3164r1513b3197],
17	for	IN	O	for	_	0	SENT_309	[p19l1526t3164r1567b3190],
18	Variant	JJ	O	variant	amod	19	SENT_309	[p19l1579t3164r1677b3190],
19	allele	NN	O	allele	prep_for	16	SENT_309	[p19l1690t3164r1765b3190],
20	CDA	NNP	ORGANIZATION	CDA	nn	22	SENT_309	[p19l54t3208r121b3233],
21	cytidine	NN	O	cytidine	nn	22	SENT_309	[p19l135t3208r248b3240],
22	deaminase	NN	O	deaminase	dep	19	SENT_309	[p19l261t3208r417b3237],
23	,	,	O	,	_	0	SENT_309	[p19l261t3208r417b3237],
24	CES2	NN	O	ces2	nn	25	SENT_309	[p19l433t3208r510b3233],
25	carboxylesterase	NN	O	carboxylesterase	appos	19	SENT_309	[p19l524t3208r758b3240],
26	2	CD	NUMBER	2	dep	25	SENT_309	[p19l772t3208r796b3237],
27	,	,	O	,	_	0	SENT_309	[p19l772t3208r796b3237],
28	DPYD	NN	O	dpyd	nn	30	SENT_309	[p19l809t3209r900b3233],
29	dihydropyrimidine	NN	O	dihydropyrimidine	nn	30	SENT_309	[p19l914t3208r1177b3240],
30	dehydrogenase	NN	O	dehydrogenase	appos	19	SENT_309	[p19l1191t3208r1409b3240],
31	,	,	O	,	_	0	SENT_309	[p19l1191t3208r1409b3240],
32	n.a.	NN	O	n.a.	appos	19	SENT_309	[p19l1423t3217r1473b3233],
33	not	RB	O	not	neg	34	SENT_309	[p19l1488t3212r1533b3233],
34	applicable	JJ	O	applicable	amod	32	SENT_309	[p19l1546t3208r1690b3240],

1	The	DT	O	the	det	2	SENT_310	[p19l109t3402r246b3465],
2	capecitabine	NN	O	capecitabine	nsubj	20	SENT_310	[p19l267t3402r715b3483],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_310	[p19l733t3402r1331b3483],
4	proﬁle	NN	O	proﬁle	nsubj	16	SENT_310	[p19l1351t3402r1583b3483],
5	observed	VBN	O	observe	partmod	4	SENT_310	[p19l1604t3402r1925b3465],
6	in	IN	O	in	_	0	SENT_310	[p19l1944t3402r2012b3464],
7	our	PRP$	O	we	poss	8	SENT_310	[p19l2031t3422r2149b3465],
8	study	NN	O	study	prep_in	5	SENT_310	[p19l10t3513r198b3594],
9	was	VBD	O	be	cop	11	SENT_310	[p19l217t3533r351b3576],
10	highly	RB	O	highly	advmod	11	SENT_310	[p19l370t3513r597b3594],
11	Variable	JJ	O	variable	rcmod	2	SENT_310	[p19l616t3513r903b3576],
12	between	IN	O	between	_	0	SENT_310	[p19l920t3513r1219b3576],
13	patients	NNS	O	patient	prep_between	11	SENT_310	[p19l1235t3513r1512b3594],
14	but	CC	O	but	_	0	SENT_310	[p19l1530t3513r1645b3576],
15	was	VBD	O	be	cop	16	SENT_310	[p19l1661t3533r1796b3576],
16	similar	JJ	O	similar	rcmod	2	SENT_310	[p19l1817t3513r2065b3576],
17	to	TO	O	to	_	0	SENT_310	[p19l2080t3523r2146b3576],
18	previous	JJ	O	previous	amod	19	SENT_310	[p19l6t3624r312b3705],
19	ﬁndings	NNS	O	ﬁndings	prep_to	16	SENT_310	[p19l336t3624r620b3705],
20	[	VBP	O	[	_	0	SENT_310	[p19l648t3625r806b3700],
21	30	CD	NUMBER	30	num	22	SENT_310	[p19l648t3625r806b3700],
22	]	CD	NUMBER	]	dobj	20	SENT_310	[p19l648t3625r806b3700],
23	.	.	O	.	_	0	SENT_310	[p19l648t3625r806b3700],

1	Others	NNS	O	other	nsubj	3	SENT_311	[p19l833t3624r1067b3687],
2	have	VBP	O	have	aux	3	SENT_311	[p19l1088t3624r1256b3687],
3	assessed	VBN	O	assess	_	0	SENT_311	[p19l1279t3624r1579b3687],
4	the	DT	O	the	det	5	SENT_311	[p19l1599t3624r1706b3687],
5	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_311	[p19l1727t3624r2054b3687],
6	of	IN	O	of	prep	5	SENT_311	[p19l2076t3624r2153b3687],

1	BSA	NN	ORGANIZATION	bsa	nsubj	9	SENT_312	[p20l7t22r179b85],
2	on	IN	O	on	_	0	SENT_312	[p20l212t41r298b84],
3	drug	NN	O	drug	nn	4	SENT_312	[p20l331t22r491b103],
4	clearance	NN	O	clearance	prep_on	1	SENT_312	[p20l525t22r862b84],
5	when	WRB	O	when	advmod	6	SENT_312	[p20l896t22r1087b85],
6	utilizing	VBG	O	utilize	dep	4	SENT_312	[p20l1118t22r1417b103],
7	BSA	NN	O	bsa	nn	8	SENT_312	[p20l1450t22r1856b85],
8	—	NN	O	—	dobj	6	SENT_312	[p20l1450t22r1856b85],
9	based	VBN	O	base	_	0	SENT_312	[p20l1450t22r1856b85],
10	dosing	NN	O	dosing	dobj	9	SENT_312	[p20l1889t22r2143b103],
11	.	.	O	.	_	0	SENT_312	[p20l1889t22r2143b103],

1	Since	IN	O	since	mark	3	SENT_313	[p20l9t132r204b195],
2	we	PRP	O	we	nsubj	3	SENT_313	[p20l243t151r344b194],
3	performed	VBD	O	perform	advcl	14	SENT_313	[p20l382t132r756b213],
4	the	DT	O	the	det	5	SENT_313	[p20l794t132r901b194],
5	analysis	NN	O	analysis	dobj	3	SENT_313	[p20l942t132r1225b213],
6	utilizing	VBG	O	utilize	xcomp	3	SENT_313	[p20l1265t132r1562b213],
7	a	DT	O	a	det	10	SENT_313	[p20l1604t151r1641b194],
8	ﬂat	NN	O	ﬂat	nn	10	SENT_313	[p20l1679t132r2004b206],
9	—	CD	NUMBER	—	num	10	SENT_313	[p20l1679t132r2004b206],
10	dose	NN	O	dose	dobj	6	SENT_313	[p20l1679t132r2004b206],
11	,	,	O	,	_	0	SENT_313	[p20l1679t132r2004b206],
12	we	PRP	O	we	nsubj	14	SENT_313	[p20l2046t151r2147b194],
13	were	VBD	O	be	cop	14	SENT_313	[p20l8t262r178b305],
14	able	JJ	O	able	_	0	SENT_313	[p20l224t243r369b305],
15	to	TO	O	to	aux	16	SENT_313	[p20l412t252r479b305],
16	conﬁrm	VB	O	conﬁrm	xcomp	14	SENT_313	[p20l523t242r800b305],
17	previous	JJ	O	previous	amod	18	SENT_313	[p20l841t243r1147b324],
18	ﬁndings	NNS	O	ﬁndings	dobj	16	SENT_313	[p20l1193t243r1476b324],
19	that	WDT	O	that	dobj	25	SENT_313	[p20l1521t243r1654b305],
20	indeed	RB	O	indeed	advmod	22	SENT_313	[p20l1696t243r1934b305],
21	BSA	NN	ORGANIZATION	bsa	nn	22	SENT_313	[p20l1976t243r2148b306],
22	differences	NNS	O	difference	nsubj	25	SENT_313	[p20l8t355r404b418],
23	did	VBD	O	do	aux	25	SENT_313	[p20l448t355r560b418],
24	not	RB	O	not	neg	25	SENT_313	[p20l602t365r716b418],
25	add	VB	O	add	rcmod	18	SENT_313	[p20l758t355r884b418],
26	to	TO	O	to	_	0	SENT_313	[p20l925t364r992b418],
27	the	DT	O	the	det	31	SENT_313	[p20l1035t355r1142b418],
28	observed	VBN	O	observe	amod	31	SENT_313	[p20l1185t355r1507b418],
29	pharmacokinetic	JJ	O	pharmacokinetic	amod	31	SENT_313	[p20l1548t355r2145b436],
30	variability	NN	O	variability	nn	31	SENT_313	[p20l8t466r375b547],
31	[	NN	O	[	prep_to	25	SENT_313	[p20l413t466r527b542],
32	4	CD	NUMBER	4	num	33	SENT_313	[p20l413t466r527b542],
33	]	NN	O	]	dep	31	SENT_313	[p20l413t466r527b542],
34	.	.	O	.	_	0	SENT_313	[p20l413t466r527b542],

1	In	IN	O	in	_	0	SENT_314	[p20l562t468r634b528],
2	addition	NN	O	addition	prep_in	9	SENT_314	[p20l666t466r977b540],
3	,	,	O	,	_	0	SENT_314	[p20l666t466r977b540],
4	the	DT	O	the	det	6	SENT_314	[p20l1011t466r1118b529],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_314	[p20l1148t466r1746b547],
6	variability	NN	O	variability	nsubjpass	9	SENT_314	[p20l1779t466r2147b547],
7	was	VBD	O	be	auxpass	9	SENT_314	[p20l8t597r142b640],
8	not	RB	O	not	neg	9	SENT_314	[p20l174t586r287b640],
9	associated	VBN	O	associate	_	0	SENT_314	[p20l318t577r685b640],
10	with	IN	O	with	_	0	SENT_314	[p20l714t577r871b640],
11	pharmacogenetic	JJ	O	pharmacogenetic	amod	12	SENT_314	[p20l899t577r1513b658],
12	variability	NN	O	variability	prep_with	9	SENT_314	[p20l1544t577r1912b658],
13	in	IN	O	in	_	0	SENT_314	[p20l1942t577r2010b639],
14	the	DT	O	the	det	15	SENT_314	[p20l2040t577r2147b640],
15	enzymes	NNS	O	enzyme	prep_in	9	SENT_314	[p20l8t708r317b769],
16	involved	VBN	O	involve	partmod	15	SENT_314	[p20l343t688r655b751],
17	in	IN	O	in	_	0	SENT_314	[p20l678t688r745b750],
18	capecitabine	NN	O	capecitabine	poss	20	SENT_314	[p20l769t688r1280b769],
19	’s	POS	O	’s	_	0	SENT_314	[p20l769t688r1280b769],
20	disposition	NN	O	disposition	prep_in	16	SENT_314	[p20l1305t688r1715b769],
21	.	.	O	.	_	0	SENT_314	[p20l1305t688r1715b769],

1	Finally	RB	O	finally	advmod	9	SENT_315	[p20l1741t688r2014b769],
2	,	,	O	,	_	0	SENT_315	[p20l1741t688r2014b769],
3	the	DT	O	the	det	5	SENT_315	[p20l2040t688r2147b751],
4	mild	JJ	O	mild	amod	5	SENT_315	[p20l7t799r171b862],
5	toxicities	NNS	O	toxicity	nsubj	9	SENT_315	[p20l195t799r522b862],
6	observed	VBN	O	observe	partmod	5	SENT_315	[p20l551t799r872b862],
7	did	VBD	O	do	aux	9	SENT_315	[p20l898t799r1010b862],
8	not	RB	O	not	neg	9	SENT_315	[p20l1035t809r1149b862],
9	correlate	VB	O	correlate	_	0	SENT_315	[p20l1173t799r1486b862],
10	with	IN	O	with	_	0	SENT_315	[p20l1512t799r1669b862],
11	pharmacoki	NN	O	pharmacokus	nn	12	SENT_315	[p20l1694t799r2145b880],
12	—	NN	O	—	prep_with	9	SENT_315	[p20l1694t799r2145b880],
13	netic	JJ	O	netic	amod	16	SENT_315	[p20l7t910r178b973],
14	or	CC	O	or	_	0	SENT_315	[p20l209t930r282b973],
15	pharmacogenetic	JJ	O	pharmacogenetic	conj_or	13	SENT_315	[p20l307t910r921b991],
16	variability	NN	O	variability	dobj	9	SENT_315	[p20l951t910r1338b991],
17	,	,	O	,	_	0	SENT_315	[p20l951t910r1338b991],
18	but	CC	O	but	cc	22	SENT_315	[p20l1368t910r1483b973],
19	these	DT	O	these	det	21	SENT_315	[p20l1509t910r1691b973],
20	pre	JJ	O	pre	amod	21	SENT_315	[p20l1719t910r2148b991],
21	—	NN	O	—	nsubj	22	SENT_315	[p20l1719t910r2148b991],
22	planned	VBD	O	plan	dep	9	SENT_315	[p20l1719t910r2148b991],
23	analyses	NNS	O	analysis	nsubjpass	25	SENT_315	[p20l9t1021r307b1102],
24	are	VBP	O	be	auxpass	25	SENT_315	[p20l333t1040r437b1083],
25	limited	VBN	O	limit	ccomp	22	SENT_315	[p20l460t1021r715b1083],
26	by	IN	O	by	_	0	SENT_315	[p20l734t1021r821b1102],
27	the	DT	O	the	det	30	SENT_315	[p20l843t1021r950b1083],
28	small	JJ	O	small	amod	30	SENT_315	[p20l975t1021r1164b1083],
29	sample	NN	O	sample	nn	30	SENT_315	[p20l1189t1021r1438b1102],
30	size	NN	O	size	agent	25	SENT_315	[p20l1464t1021r1597b1083],
31	and	CC	O	and	_	0	SENT_315	[p20l1621t1021r1747b1083],
32	do	VBP	O	do	aux	34	SENT_315	[p20l1769t1021r1854b1083],
33	not	RB	O	not	neg	34	SENT_315	[p20l1876t1030r1990b1083],
34	rule	VB	O	rule	conj_and	9	SENT_315	[p20l2009t1021r2147b1083],
35	out	RP	O	out	prt	34	SENT_315	[p20l8t1140r121b1193],
36	potential	JJ	O	potential	amod	37	SENT_315	[p20l144t1131r457b1212],
37	contribution	NN	O	contribution	dobj	34	SENT_315	[p20l484t1131r922b1193],
38	by	IN	O	by	_	0	SENT_315	[p20l945t1131r1033b1212],
39	rare	JJ	O	rare	amod	40	SENT_315	[p20l1058t1150r1195b1193],
40	functional	JJ	O	functional	amod	41	SENT_315	[p20l1222t1130r1584b1193],
41	variants	NNS	O	variant	prep_by	34	SENT_315	[p20l1610t1131r1911b1193],
42	.	.	O	.	_	0	SENT_315	[p20l1610t1131r1911b1193],

1	In	IN	O	in	_	0	SENT_316	[p20l109t1243r182b1303],
2	summary	NN	O	summary	prep_in	24	SENT_316	[p20l215t1261r564b1323],
3	,	,	O	,	_	0	SENT_316	[p20l215t1261r564b1323],
4	despite	IN	O	despite	_	0	SENT_316	[p20l600t1242r850b1323],
5	the	DT	O	the	det	6	SENT_316	[p20l882t1242r989b1304],
6	absence	NN	O	absence	prep_despite	24	SENT_316	[p20l1023t1242r1303b1304],
7	of	IN	O	of	_	0	SENT_316	[p20l1336t1242r1413b1304],
8	a	DT	O	a	det	9	SENT_316	[p20l1440t1261r1477b1304],
9	response	NN	O	response	prep_of	6	SENT_316	[p20l1506t1261r1818b1323],
10	reported	VBD	O	report	partmod	9	SENT_316	[p20l1848t1242r2149b1323],
11	in	IN	O	in	_	0	SENT_316	[p20l7t1354r75b1416],
12	our	PRP$	O	we	poss	13	SENT_316	[p20l123t1374r241b1417],
13	study	NN	O	study	prep_in	10	SENT_316	[p20l289t1354r497b1435],
14	,	,	O	,	_	0	SENT_316	[p20l289t1354r497b1435],
15	a	DT	O	a	det	19	SENT_316	[p20l549t1374r586b1417],
16	small	JJ	O	small	amod	19	SENT_316	[p20l635t1354r824b1417],
17	clinical	JJ	O	clinical	amod	19	SENT_316	[p20l873t1354r1135b1417],
18	beneﬁt	NN	O	beneﬁt	nn	19	SENT_316	[p20l1182t1354r1427b1417],
19	rate	NN	O	rate	nsubjpass	24	SENT_316	[p20l1472t1364r1605b1417],
20	of	IN	O	of	_	0	SENT_316	[p20l1654t1354r1731b1417],
21	19	CD	PERCENT	19	num	22	SENT_316	[p20l1780t1354r1857b1418],
22	%	NN	PERCENT	%	prep_of	19	SENT_316	[p20l1896t1354r1960b1417],
23	was	VBD	O	be	auxpass	24	SENT_316	[p20l2011t1374r2146b1417],
24	observed	VBN	O	observe	_	0	SENT_316	[p20l8t1465r347b1528],
25	.	.	O	.	_	0	SENT_316	[p20l8t1465r347b1528],

1	Flat	RBR	O	flat	advmod	2	SENT_317	[p20l387t1465r527b1528],
2	ﬁxed	JJ	O	ﬁxed	amod	5	SENT_317	[p20l563t1465r932b1528],
3	—	NN	O	—	nn	5	SENT_317	[p20l563t1465r932b1528],
4	dose	NN	O	dose	nn	5	SENT_317	[p20l563t1465r932b1528],
5	capecitabine	NN	O	capecitabine	nsubj	9	SENT_317	[p20l970t1465r1418b1546],
6	is	VBZ	O	be	cop	7	SENT_317	[p20l1454t1465r1510b1528],
7	feasible	JJ	O	feasible	_	0	SENT_317	[p20l1548t1465r1824b1528],
8	and	CC	O	and	_	0	SENT_317	[p20l1863t1465r1990b1528],
9	tolerable	JJ	O	tolerable	conj_and	7	SENT_317	[p20l2024t1465r2145b1528, p20l8t1576r246b1650],
10	;	:	O	;	_	0	SENT_317	[p20l2024t1465r2145b1528, p20l8t1576r246b1650],
11	it	PRP	O	it	nsubj	17	SENT_317	[p20l279t1576r328b1639],
12	simpliﬁes	VBZ	O	simpliﬁes	parataxis	7	SENT_317	[p20l357t1576r700b1657],
13	dosing	NN	O	dosing	dobj	12	SENT_317	[p20l730t1576r986b1657],
14	,	,	O	,	_	0	SENT_317	[p20l730t1576r986b1657],
15	and	CC	O	and	_	0	SENT_317	[p20l1018t1576r1145b1639],
16	may	MD	O	may	aux	17	SENT_317	[p20l1172t1596r1323b1657],
17	reduce	VB	O	reduce	conj_and	12	SENT_317	[p20l1351t1576r1589b1639],
18	errors	NNS	O	error	dobj	17	SENT_317	[p20l1619t1596r1842b1639],
19	.	.	O	.	_	0	SENT_317	[p20l1619t1596r1842b1639],

1	Despite	IN	O	despite	_	0	SENT_318	[p20l1875t1576r2146b1657],
2	overall	JJ	O	overall	amod	4	SENT_318	[p20l8t1687r254b1750],
3	limited	JJ	O	limited	amod	4	SENT_318	[p20l302t1687r556b1750],
4	activity	NN	O	activity	prep_despite	20	SENT_318	[p20l603t1687r869b1768],
5	in	IN	O	in	_	0	SENT_318	[p20l916t1687r984b1749],
6	the	DT	O	the	det	8	SENT_318	[p20l1030t1687r1137b1750],
7	adjuvant	JJ	O	adjuvant	amod	8	SENT_318	[p20l1186t1687r1493b1768],
8	setting	NN	O	setting	prep_in	4	SENT_318	[p20l1542t1687r1795b1768],
9	,	,	O	,	_	0	SENT_318	[p20l1542t1687r1795b1768],
10	[	CD	NUMBER	[	num	11	SENT_318	[p20l1851t1688r1981b1763],
11	20	CD	NUMBER	20	appos	8	SENT_318	[p20l1851t1688r1981b1763],
12	,	,	O	,	_	0	SENT_318	[p20l1851t1688r1981b1763],
13	33	CD	NUMBER	33	num	15	SENT_318	[p20l2033t1688r2141b1763],
14	]	NN	O	]	nn	15	SENT_318	[p20l2033t1688r2141b1763],
15	capecitabine	NN	O	capecitabine	nsubj	20	SENT_318	[p20l8t1798r456b1879],
16	remains	VBZ	O	remain	cop	20	SENT_318	[p20l494t1798r776b1861],
17	an	DT	O	a	det	20	SENT_318	[p20l817t1818r898b1861],
18	important	JJ	O	important	amod	20	SENT_318	[p20l936t1798r1286b1879],
19	therapeutic	JJ	O	therapeutic	amod	20	SENT_318	[p20l1322t1798r1719b1879],
20	strategy	NN	O	strategy	_	0	SENT_318	[p20l1762t1808r2041b1879],
21	in	IN	O	in	_	0	SENT_318	[p20l2080t1798r2148b1860],
22	breast	NN	O	breast	nn	23	SENT_318	[p20l6t1909r220b1972],
23	cancer	NN	O	cancer	prep_in	20	SENT_318	[p20l270t1929r504b1972],
24	due	JJ	O	due	_	0	SENT_318	[p20l553t1909r679b1972],
25	to	TO	O	to	_	0	SENT_318	[p20l729t1919r796b1972],
26	its	PRP$	O	its	poss	28	SENT_318	[p20l846t1909r927b1972],
27	oral	JJ	O	oral	amod	28	SENT_318	[p20l980t1909r1116b1972],
28	formulation	NN	O	formulation	prep_due_to	23	SENT_318	[p20l1166t1909r1608b1984],
29	,	,	O	,	_	0	SENT_318	[p20l1166t1909r1608b1984],
30	ease	NN	O	ease	conj_and	20	SENT_318	[p20l1662t1929r1813b1972],
31	of	IN	O	of	_	0	SENT_318	[p20l1865t1909r1942b1972],
32	dose	NN	O	dose	nn	33	SENT_318	[p20l1986t1909r2147b1972],
33	modiﬁcations	NNS	O	modiﬁcations	prep_of	30	SENT_318	[p20l7t2021r493b2083],
34	and	CC	O	and	_	0	SENT_318	[p20l553t2021r680b2083],
35	administration	NN	O	administration	prep_of	30	SENT_318	[p20l738t2021r1255b2083],
36	in	IN	O	in	_	0	SENT_318	[p20l1311t2021r1379b2083],
37	patients	NNS	O	patient	prep_in	33	SENT_318	[p20l1434t2021r1712b2102],
38	with	IN	O	with	_	0	SENT_318	[p20l1771t2021r1928b2084],
39	liver	NN	O	liver	nn	40	SENT_318	[p20l1985t2021r2149b2084],
40	dysfunction	NN	O	dysfunction	prep_with	37	SENT_318	[p20l8t2132r448b2213],
41	,	,	O	,	_	0	SENT_318	[p20l8t2132r448b2213],
42	and	CC	O	and	_	0	SENT_318	[p20l485t2132r611b2195],
43	the	DT	O	the	det	44	SENT_318	[p20l642t2132r749b2195],
44	lack	NN	O	lack	conj_and	20	SENT_318	[p20l782t2132r932b2195],
45	of	IN	O	of	_	0	SENT_318	[p20l963t2132r1040b2195],
46	cumulative	JJ	O	cumulative	amod	47	SENT_318	[p20l1065t2132r1463b2195],
47	toxicity	NN	O	toxicity	prep_of	44	SENT_318	[p20l1495t2132r1768b2213],
48	following	VBG	O	follow	_	0	SENT_318	[p20l1801t2132r2147b2213],
49	long	JJ	O	long	amod	50	SENT_318	[p20l7t2243r164b2324],
50	periods	NNS	O	period	prep_following	47	SENT_318	[p20l194t2243r455b2324],
51	of	IN	O	of	_	0	SENT_318	[p20l488t2243r565b2306],
52	administration	NN	O	administration	prep_of	50	SENT_318	[p20l591t2243r1125b2306],
53	.	.	O	.	_	0	SENT_318	[p20l591t2243r1125b2306],

1	Future	JJ	DATE	future	amod	2	SENT_319	[p20l1160t2245r1392b2306],
2	studies	NNS	O	study	nsubj	4	SENT_319	[p20l1426t2243r1668b2306],
3	may	MD	O	may	aux	4	SENT_319	[p20l1700t2263r1852b2324],
4	wish	VB	O	wish	_	0	SENT_319	[p20l1884t2243r2050b2306],
5	to	TO	O	to	aux	6	SENT_319	[p20l2079t2253r2146b2306],
6	compare	VB	O	compare	xcomp	4	SENT_319	[p20l8t2374r314b2435],
7	standard	JJ	O	standard	dobj	6	SENT_319	[p20l344t2354r644b2417],
8	versus	CC	O	versus	_	0	SENT_319	[p20l669t2374r894b2417],
9	alternative	JJ	O	alternative	amod	11	SENT_319	[p20l923t2354r1299b2417],
10	capecitabine	NN	O	capecitabine	nn	11	SENT_319	[p20l1326t2354r1773b2435],
11	schedules	NNS	O	schedule	dobj	6	SENT_319	[p20l1803t2354r2146b2417],
12	if	IN	O	if	mark	24	SENT_319	[p20l7t2465r66b2527],
13	robust	JJ	O	robust	amod	14	SENT_319	[p20l86t2465r310b2527],
14	biomarkers	NNS	O	biomarker	nsubjpass	24	SENT_319	[p20l334t2465r736b2527],
15	of	IN	O	of	_	0	SENT_319	[p20l766t2465r843b2527],
16	response	NN	O	response	prep_of	14	SENT_319	[p20l863t2484r1175b2546],
17	to	TO	O	to	_	0	SENT_319	[p20l1203t2474r1269b2527],
18	therapy	NN	O	therapy	prep_to	16	SENT_319	[p20l1297t2465r1564b2546],
19	or	CC	O	or	_	0	SENT_319	[p20l1593t2484r1666b2527],
20	predictors	NNS	O	predictor	prep_of	14	SENT_319	[p20l1690t2465r2046b2546],
21	of	IN	O	of	_	0	SENT_319	[p20l2076t2465r2153b2527],
22	toxicity	NN	O	toxicity	prep_of	20	SENT_319	[p20l7t2575r279b2656],
23	are	VBP	O	be	auxpass	24	SENT_319	[p20l318t2594r423b2637],
24	identiﬁed	VBN	O	identiﬁed	dep	11	SENT_319	[p20l459t2575r816b2649],
25	,	,	O	,	_	0	SENT_319	[p20l459t2575r816b2649],
26	which	WDT	O	which	nsubj	29	SENT_319	[p20l855t2575r1072b2637],
27	is	VBZ	O	be	cop	29	SENT_319	[p20l1107t2575r1162b2637],
28	the	DT	O	the	det	29	SENT_319	[p20l1199t2575r1306b2637],
29	subject	NN	O	subject	rcmod	7	SENT_319	[p20l1346t2575r1596b2656],
30	of	IN	O	of	_	0	SENT_319	[p20l1631t2575r1708b2637],
31	an	DT	O	a	det	33	SENT_319	[p20l1740t2594r1820b2637],
32	ongoing	JJ	O	ongoing	amod	33	SENT_319	[p20l1856t2575r2147b2656],
33	study	NN	O	study	prep_of	29	SENT_319	[p20l10t2686r198b2767],
34	being	VBG	O	be	auxpass	35	SENT_319	[p20l232t2686r429b2767],
35	conducted	VBN	O	conduct	partmod	33	SENT_319	[p20l464t2686r832b2748],
36	by	IN	O	by	_	0	SENT_319	[p20l864t2686r951b2767],
37	the	DT	O	the	det	39	SENT_319	[p20l985t2686r1092b2748],
38	Translational	JJ	ORGANIZATION	translational	amod	39	SENT_319	[p20l1127t2686r1599b2748],
39	Breast	NN	ORGANIZATION	breast	nn	45	SENT_319	[p20l1634t2687r1863b2748],
40	Cancer	NNP	ORGANIZATION	Cancer	nn	45	SENT_319	[p20l1896t2686r2149b2749],
41	Research	NNP	ORGANIZATION	Research	nn	45	SENT_319	[p20l7t2798r335b2861],
42	Consortium	NNP	ORGANIZATION	Consortium	nn	45	SENT_319	[p20l369t2798r791b2861],
43	(	CD	NUMBER	(	num	45	SENT_319	[p20l825t2798r1436b2875],
44	NCTOO977ll9	NN	O	nctoo977ll9	nn	45	SENT_319	[p20l825t2798r1436b2875],
45	)	NN	O	)	agent	35	SENT_319	[p20l825t2798r1436b2875],
46	.	.	O	.	_	0	SENT_319	[p20l825t2798r1436b2875],

1	Acknowledgments	NNS	O	acknowledgment	nsubjpass	5	SENT_320	[p20l6t2962r600b3031],
2	This	DT	O	this	det	3	SENT_320	[p20l680t2963r812b3016],
3	research	NN	O	research	dep	1	SENT_320	[p20l833t2963r1086b3016],
4	was	VBD	O	be	auxpass	5	SENT_320	[p20l1107t2979r1221b3016],
5	supported	VBN	O	support	_	0	SENT_320	[p20l1246t2963r1542b3031],
6	by	IN	O	by	_	0	SENT_320	[p20l1561t2963r1635b3031],
7	funding	VBG	O	fund	agent	5	SENT_320	[p20l1656t2963r1890b3032],
8	from	IN	O	from	_	0	SENT_320	[p20l1911t2963r2058b3016],
9	an	DT	O	a	det	11	SENT_320	[p20l2079t2979r2148b3016],
10	Avon/NCI	NNP	O	Avon/NCI	nn	11	SENT_320	[p20l7t3051r326b3104],
11	Partnership	NNP	O	Partnership	prep_from	7	SENT_320	[p20l358t3050r703b3119],
12	for	IN	O	for	_	0	SENT_320	[p20l737t3050r825b3103],
13	Progress	NNP	O	Progress	nn	14	SENT_320	[p20l856t3052r1114b3119],
14	Grant	NNP	O	Grant	prep_for	11	SENT_320	[p20l1149t3051r1320b3104],
15	(	CD	NUMBER	(	num	18	SENT_320	[p20l1354t3051r1531b3116],
16	3P40	NN	O	3p40	nn	18	SENT_320	[p20l1354t3051r1531b3116],
17	CA006973-41S	NN	O	ca006973-41	nn	18	SENT_320	[p20l1564t3050r2081b3116],
18	)	NN	O	)	dep	14	SENT_320	[p20l1564t3050r2081b3116],
19	,	,	O	,	_	0	SENT_320	[p20l1564t3050r2081b3116],
20	a	DT	O	a	det	23	SENT_320	[p20l2117t3067r2149b3103],
21	Susan	NNP	PERSON	Susan	nn	23	SENT_320	[p20l9t3140r187b3193],
22	G.	NNP	PERSON	G.	nn	23	SENT_320	[p20l219t3140r286b3193],
23	Komen	NNP	PERSON	Komen	conj_and	14	SENT_320	[p20l322t3141r544b3193],
24	for	IN	O	for	_	0	SENT_320	[p20l575t3139r663b3193],
25	the	DT	O	the	det	30	SENT_320	[p20l692t3140r783b3193],
26	Cure	NNP	O	Cure	nn	30	SENT_320	[p20l816t3140r961b3193],
27	Grant	NNP	O	Grant	nn	30	SENT_320	[p20l994t3140r1165b3193],
28	(	CD	NUMBER	(	num	30	SENT_320	[p20l1198t3139r1726b3205],
29	BCTR0504444	NN	O	bctr0504444	nn	30	SENT_320	[p20l1198t3139r1726b3205],
30	)	NN	O	)	prep_for	23	SENT_320	[p20l1198t3139r1726b3205],
31	,	,	O	,	_	0	SENT_320	[p20l1198t3139r1726b3205],
32	Roche	NNP	ORGANIZATION	Roche	nn	33	SENT_320	[p20l1761t3140r1953b3193],
33	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	appos	30	SENT_320	[p20l1984t3140r2146b3193, p20l7t3228r383b3290],
34	,	,	O	,	_	0	SENT_320	[p20l1984t3140r2146b3193, p20l7t3228r383b3290],
35	and	CC	O	and	_	0	SENT_320	[p20l425t3228r532b3281],
36	the	DT	O	the	det	39	SENT_320	[p20l568t3228r659b3281],
37	Analytical	NNP	O	Analytical	nn	39	SENT_320	[p20l697t3228r1013b3296],
38	Pharmacology	NNP	O	Pharmacology	nn	39	SENT_320	[p20l1051t3228r1489b3296],
39	Core	NNP	O	Core	prep_for	11	SENT_320	[p20l1529t3228r1673b3281],
40	of	IN	O	of	_	0	SENT_320	[p20l1712t3228r1777b3281],
41	the	DT	O	the	det	46	SENT_320	[p20l1809t3228r1900b3281],
42	Sidney	NNP	ORGANIZATION	Sidney	nn	46	SENT_320	[p20l1940t3228r2147b3296],
43	Kimmel	NNP	ORGANIZATION	Kimmel	nn	46	SENT_320	[p20l8t3316r255b3369],
44	Comprehensive	NNP	ORGANIZATION	Comprehensive	nn	46	SENT_320	[p20l308t3316r784b3385],
45	Cancer	NNP	ORGANIZATION	Cancer	nn	46	SENT_320	[p20l837t3316r1052b3369],
46	Center	NNP	ORGANIZATION	Center	prep_of	39	SENT_320	[p20l1103t3316r1305b3369],
47	at	IN	O	at	_	0	SENT_320	[p20l1357t3324r1409b3369],
48	Johns	NNP	PERSON	Johns	nn	49	SENT_320	[p20l1460t3316r1630b3369],
49	Hopkins	NNP	PERSON	Hopkins	prep_at	7	SENT_320	[p20l1682t3316r1937b3385],
50	(	CD	NUMBER	(	num	52	SENT_320	[p20l1992t3317r2148b3381],
51	NIH	NNP	ORGANIZATION	NIH	nn	52	SENT_320	[p20l1992t3317r2148b3381],
52	Grants	NNPS	O	Grants	dep	49	SENT_320	[p20l8t3404r207b3457],
53	P30	NN	O	p30	nn	54	SENT_320	[p20l240t3404r356b3457],
54	CA006973	NN	O	ca006973	dep	52	SENT_320	[p20l389t3403r716b3457],
55	and	CC	O	and	_	0	SENT_320	[p20l753t3404r861b3457],
56	UL1	NN	O	ul1	nn	58	SENT_320	[p20l891t3404r1022b3457],
57	RR025005	NN	O	rr025005	nn	58	SENT_320	[p20l1061t3403r1430b3469],
58	)	NN	O	)	dep	52	SENT_320	[p20l1061t3403r1430b3469],
59	.	.	O	.	_	0	SENT_320	[p20l1061t3403r1430b3469],

1	The	DT	O	the	det	2	SENT_321	[p20l1466t3404r1582b3457],
2	project	NN	O	project	nsubjpass	5	SENT_321	[p20l1614t3403r1826b3472],
3	described	VBN	O	describe	partmod	2	SENT_321	[p20l1858t3404r2148b3457],
4	was	VBD	O	be	auxpass	5	SENT_321	[p20l7t3508r122b3545],
5	supported	VBN	O	support	_	0	SENT_321	[p20l158t3492r455b3560],
6	in	IN	O	in	_	0	SENT_321	[p20l486t3492r544b3544],
7	part	NN	O	part	prep_in	5	SENT_321	[p20l576t3500r694b3560],
8	by	IN	O	by	_	0	SENT_321	[p20l725t3492r799b3560],
9	Grant	NNP	O	Grant	nn	12	SENT_321	[p20l834t3492r1005b3545],
10	Number	NNP	O	Number	nn	12	SENT_321	[p20l1036t3492r1286b3545],
11	UL1	NN	O	ul1	nn	12	SENT_321	[p20l1317t3492r1448b3545],
12	RR	NN	O	rr	agent	5	SENT_321	[p20l1487t3493r1587b3544],
13	025005	CD	NUMBER	025005	npadvmod	5	SENT_321	[p20l1619t3491r1842b3545],
14	from	IN	O	from	_	0	SENT_321	[p20l1878t3492r2025b3545],
15	the	DT	O	the	prep_from	5	SENT_321	[p20l2056t3492r2147b3545],

1	National	NNP	ORGANIZATION	National	nn	2	SENT_322	[p21l7t17r268b70],
2	Center	NNP	ORGANIZATION	Center	nsubj	42	SENT_322	[p21l292t17r494b70],
3	for	IN	ORGANIZATION	for	_	0	SENT_322	[p21l516t17r604b70],
4	Research	NNP	ORGANIZATION	Research	nn	5	SENT_322	[p21l625t17r903b70],
5	Resources	NNPS	ORGANIZATION	Resources	prep_for	2	SENT_322	[p21l926t18r1236b70],
6	(	CD	NUMBER	(	num	8	SENT_322	[p21l1262t17r1532b82],
7	NCRR	NN	O	ncrr	nn	8	SENT_322	[p21l1262t17r1532b82],
8	)	NN	O	)	dep	5	SENT_322	[p21l1262t17r1532b82],
9	,	,	O	,	_	0	SENT_322	[p21l1262t17r1532b82],
10	a	DT	O	a	det	11	SENT_322	[p21l1559t33r1591b70],
11	component	NN	O	component	prep_for	2	SENT_322	[p21l1613t25r1951b85],
12	of	IN	O	of	_	0	SENT_322	[p21l1974t17r2039b70],
13	the	DT	O	the	det	20	SENT_322	[p21l2056t17r2147b70],
14	National	NNP	ORGANIZATION	National	dep	20	SENT_322	[p21l7t104r268b158],
15	Institutes	NNPS	ORGANIZATION	Institutes	dep	14	SENT_322	[p21l301t104r577b158],
16	of	IN	ORGANIZATION	of	_	0	SENT_322	[p21l611t104r677b158],
17	Health	NNP	ORGANIZATION	Health	prep_of	14	SENT_322	[p21l704t105r906b158],
18	(	CD	NUMBER	(	num	17	SENT_322	[p21l940t105r1118b170],
19	NIH	NNP	ORGANIZATION	NIH	nn	20	SENT_322	[p21l940t105r1118b170],
20	)	NN	O	)	prep_of	11	SENT_322	[p21l940t105r1118b170],
21	and	CC	O	and	_	0	SENT_322	[p21l1155t105r1262b158],
22	NIH	NNP	ORGANIZATION	NIH	nn	23	SENT_322	[p21l1292t106r1426b158],
23	Roadmap	NNP	ORGANIZATION	Roadmap	prep_of	11	SENT_322	[p21l1457t104r1747b173],
24	for	IN	ORGANIZATION	for	_	0	SENT_322	[p21l1781t104r1869b158],
25	Medical	NNP	ORGANIZATION	Medical	nn	26	SENT_322	[p21l1899t104r2147b158],
26	Research	NNP	ORGANIZATION	Research	prep_for	23	SENT_322	[p21l7t193r301b256],
27	,	,	O	,	_	0	SENT_322	[p21l7t193r301b256],
28	and	CC	O	and	_	0	SENT_322	[p21l332t193r439b246],
29	its	PRP$	O	its	poss	30	SENT_322	[p21l464t193r533b246],
30	contents	NNS	O	contents	prep_for	2	SENT_322	[p21l561t200r812b246],
31	are	VBP	O	be	cop	34	SENT_322	[p21l841t209r930b246],
32	solely	RB	O	solely	advmod	34	SENT_322	[p21l959t193r1136b261],
33	the	DT	O	the	det	34	SENT_322	[p21l1163t193r1254b246],
34	responsibility	NN	O	responsibility	_	0	SENT_322	[p21l1279t193r1694b261],
35	of	IN	O	of	_	0	SENT_322	[p21l1721t193r1787b246],
36	the	DT	O	the	det	37	SENT_322	[p21l1808t193r1898b246],
37	authors	NNS	O	author	prep_of	34	SENT_322	[p21l1927t193r2147b246],
38	and	CC	O	and	_	0	SENT_322	[p21l8t281r116b334],
39	do	VBP	O	do	aux	42	SENT_322	[p21l144t281r217b334],
40	not	RB	O	not	neg	42	SENT_322	[p21l247t289r343b334],
41	necessarily	RB	O	necessarily	advmod	42	SENT_322	[p21l371t281r707b349],
42	represent	VB	O	represent	conj_and	34	SENT_322	[p21l736t289r1016b349],
43	the	DT	O	the	det	45	SENT_322	[p21l1044t281r1135b334],
44	ofﬁcial	JJ	O	ofﬁcial	amod	45	SENT_322	[p21l1165t281r1378b334],
45	view	NN	O	view	dobj	42	SENT_322	[p21l1407t281r1553b334],
46	of	IN	O	of	_	0	SENT_322	[p21l1583t281r1649b334],
47	NCRR	NN	O	ncrr	prep_of	45	SENT_322	[p21l1672t281r1878b334],
48	or	CC	O	or	_	0	SENT_322	[p21l1907t297r1969b334],
49	NIH	NNP	O	NIH	prep_of	45	SENT_322	[p21l1995t282r2144b334],
50	.	.	O	.	_	0	SENT_322	[p21l1995t282r2144b334],

1	We	PRP	O	we	nsubj	2	SENT_323	[p21l6t370r111b422],
2	thank	VBP	O	thank	_	0	SENT_323	[p21l146t369r316b422],
3	Dr.	NNP	O	Dr.	nn	5	SENT_323	[p21l349t370r442b422],
4	Sharyn	NNP	PERSON	Sharyn	nn	5	SENT_323	[p21l483t369r695b438],
5	Baker	NNP	PERSON	Baker	dobj	2	SENT_323	[p21l731t369r912b422],
6	for	IN	O	for	_	0	SENT_323	[p21l947t369r1034b422],
7	her	PRP$	O	she	poss	9	SENT_323	[p21l1068t369r1165b422],
8	scientiﬁc	NN	O	scientiﬁc	nn	9	SENT_323	[p21l1201t369r1471b422],
9	input	NN	O	input	prep_for	5	SENT_323	[p21l1508t369r1681b438],
10	;	:	O	;	_	0	SENT_323	[p21l1508t369r1681b438],
11	Carol	NNP	PERSON	Carol	nn	12	SENT_323	[p21l1721t369r1887b422],
12	Hartke	NNP	PERSON	Hartke	conj_and	5	SENT_323	[p21l1923t369r2145b432],
13	,	,	O	,	_	0	SENT_323	[p21l1923t369r2145b432],
14	Ping	NNP	O	Ping	appos	12	SENT_323	[p21l7t457r144b525],
15	He	PRP	O	he	dep	14	SENT_323	[p21l181t458r284b520],
16	,	,	O	,	_	0	SENT_323	[p21l181t458r284b520],
17	and	CC	O	and	_	0	SENT_323	[p21l323t457r431b510],
18	Aleksandr	NNP	PERSON	Aleksandr	nn	19	SENT_323	[p21l466t457r779b510],
19	Mnatsakanyan	NNP	PERSON	Mnatsakanyan	appos	12	SENT_323	[p21l813t457r1257b525],
20	for	IN	O	for	_	0	SENT_323	[p21l1292t457r1381b510],
21	their	PRP$	O	they	poss	23	SENT_323	[p21l1415t457r1555b510],
22	technical	JJ	O	technical	amod	23	SENT_323	[p21l1589t457r1864b510],
23	support	NN	O	support	prep_for	14	SENT_323	[p21l1902t465r2144b525],
24	;	:	O	;	_	0	SENT_323	[p21l1902t465r2144b525],
25	and	CC	O	and	_	0	SENT_323	[p21l8t545r116b598],
26	Linping	NNP	PERSON	Linping	nn	27	SENT_323	[p21l142t545r382b613],
27	Xu	NNP	PERSON	Xu	dobj	2	SENT_323	[p21l410t546r501b598],
28	for	IN	O	for	_	0	SENT_323	[p21l529t545r617b598],
29	her	PRP$	O	she	poss	31	SENT_323	[p21l642t545r740b598],
30	quality	NN	O	quality	nn	31	SENT_323	[p21l767t545r976b613],
31	assurance	NN	O	assurance	prep_for	27	SENT_323	[p21l1006t561r1299b598],
32	of	IN	O	of	_	0	SENT_323	[p21l1328t545r1393b598],
33	the	DT	O	the	det	34	SENT_323	[p21l1416t545r1507b598],
34	data	NNS	O	datum	prep_of	31	SENT_323	[p21l1535t545r1676b598],
35	.	.	O	.	_	0	SENT_323	[p21l1535t545r1676b598],

1	Conﬂict	NN	O	conﬂict	nsubj	7	SENT_324	[p21l9t722r264b777],
2	of	IN	O	of	_	0	SENT_324	[p21l296t722r363b776],
3	interest	NN	O	interest	nn	5	SENT_324	[p21l389t722r635b776],
4	Dr.	NNP	O	Dr.	nn	5	SENT_324	[p21l712t724r805b776],
5	Wolff	NNP	PERSON	Wolff	prep_of	1	SENT_324	[p21l841t723r1028b776],
6	has	VBZ	O	have	aux	7	SENT_324	[p21l1055t723r1154b776],
7	received	VBN	O	receive	_	0	SENT_324	[p21l1187t723r1446b776],
8	funding	NN	O	funding	dobj	7	SENT_324	[p21l1478t723r1713b792],
9	from	IN	O	from	_	0	SENT_324	[p21l1746t723r1893b776],
10	Genentech	NNP	ORGANIZATION	Genentech	prep_from	7	SENT_324	[p21l1927t724r2146b776, p21l7t811r148b864],
11	.	.	O	.	_	0	SENT_324	[p21l1927t724r2146b776, p21l7t811r148b864],

1	The	DT	O	the	det	2	SENT_325	[p21l179t811r295b864],
2	terms	NNS	O	term	nsubjpass	8	SENT_325	[p21l322t820r488b864],
3	of	IN	O	of	_	0	SENT_325	[p21l517t811r582b864],
4	this	DT	O	this	det	5	SENT_325	[p21l603t811r710b864],
5	arrangement	NN	O	arrangement	prep_of	2	SENT_325	[p21l740t819r1120b880],
6	are	VBP	O	be	aux	8	SENT_325	[p21l1147t828r1236b864],
7	being	VBG	O	be	auxpass	8	SENT_325	[p21l1263t811r1431b880],
8	managed	VBN	O	manage	_	0	SENT_325	[p21l1458t811r1732b880],
9	by	IN	O	by	_	0	SENT_325	[p21l1757t811r1832b880],
10	the	DT	O	the	det	13	SENT_325	[p21l1859t811r1950b864],
11	Johns	NNP	ORGANIZATION	Johns	nn	13	SENT_325	[p21l1977t811r2147b865],
12	Hopkins	NNP	ORGANIZATION	Hopkins	nn	13	SENT_325	[p21l7t899r262b968],
13	University	NNP	ORGANIZATION	University	agent	8	SENT_325	[p21l284t899r604b968],
14	in	IN	O	in	_	0	SENT_325	[p21l627t899r684b951],
15	accordance	NN	O	accordance	prep_in	13	SENT_325	[p21l707t899r1046b952],
16	with	IN	O	with	_	0	SENT_325	[p21l1070t899r1203b952],
17	its	PRP$	O	its	poss	18	SENT_325	[p21l1224t899r1293b952],
18	conﬂict	NN	O	conﬂict	prep_with	8	SENT_325	[p21l1317t899r1544b952],
19	of	IN	O	of	_	0	SENT_325	[p21l1566t899r1631b952],
20	interest	NN	O	interest	nn	21	SENT_325	[p21l1648t899r1872b952],
21	policies	NNS	O	policy	prep_of	18	SENT_325	[p21l1892t899r2144b968],
22	.	.	O	.	_	0	SENT_325	[p21l1892t899r2144b968],

1	@	IN	O	@	_	0	SENT_326	[p21l1779t1130r1856b1225],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_326	[p21l1886t1153r2148b1228],

1	142	CD	NUMBER	142	num	3	SENT_327	[p21l56t1303r104b1327],
2	Breast	NN	ORGANIZATION	breast	nn	3	SENT_327	[p21l1450t1303r1540b1328],
3	Cancer	NN	ORGANIZATION	cancer	_	0	SENT_327	[p21l1552t1303r1652b1328],
4	Res	NNP	ORGANIZATION	Res	nn	5	SENT_327	[p21l1664t1303r1716b1328],
5	Treat	NNP	ORGANIZATION	Treat	dep	3	SENT_327	[p21l1729t1303r1804b1328],
6	(	CD	NUMBER	(	num	7	SENT_327	[p21l1817t1303r1908b1333],
7	2013	CD	DATE	2013	dep	5	SENT_327	[p21l1817t1303r1908b1333],
8	)	CD	NUMBER	)	number	9	SENT_327	[p21l1817t1303r1908b1333],
9	139:135	CD	NUMBER	139:135	num	10	SENT_327	[p21l1925t1303r2105b1328],
10	—	NN	O	—	dep	7	SENT_327	[p21l1925t1303r2105b1328],
11	143	CD	NUMBER	143	dep	3	SENT_327	[p21l1925t1303r2105b1328],

1	References	NNS	O	reference	_	0	SENT_328	[p21l8t1472r424b1536],

1	1	LS	NUMBER	1	_	0	SENT_329	[p21l53t1685r97b1738],
2	.	.	O	.	_	0	SENT_329	[p21l53t1685r97b1738],

1	Gibaldi	NNP	MISC	Gibaldi	nn	2	SENT_330	[p21l140t1685r365b1738],
2	M	NNP	O	M	nsubj	11	SENT_330	[p21l385t1686r467b1748],
3	,	,	O	,	_	0	SENT_330	[p21l385t1686r467b1748],
4	Perrier	NNP	ORGANIZATION	Perrier	nn	5	SENT_330	[p21l490t1685r697b1738],
5	D	NNP	ORGANIZATION	D	appos	2	SENT_330	[p21l716t1686r767b1737],
6	(	CD	NUMBER	(	num	7	SENT_330	[p21l791t1685r987b1750],
7	1982	CD	DATE	1982	dep	5	SENT_330	[p21l791t1685r987b1750],
8	)	CD	NUMBER	)	num	10	SENT_330	[p21l791t1685r987b1750],
9	Noncompartmental	JJ	O	noncompartmental	amod	10	SENT_330	[p21l1009t1685r1597b1754],
10	analysis	NN	O	analysis	dep	5	SENT_330	[p21l1620t1685r1861b1754],
11	based	VBN	O	base	_	0	SENT_330	[p21l1881t1685r2054b1738],
12	on	IN	O	on	_	0	SENT_330	[p21l2075t1702r2148b1738],
13	statistical	JJ	O	statistical	amod	15	SENT_330	[p21l141t1772r425b1825],
14	moment	NN	O	moment	nn	15	SENT_330	[p21l453t1780r703b1825],
15	theory	NN	O	theory	prep_on	11	SENT_330	[p21l728t1772r937b1841],
16	.	.	O	.	_	0	SENT_330	[p21l728t1772r937b1841],

1	In	IN	O	in	_	0	SENT_331	[p21l967t1773r1045b1825],
2	:	:	O	:	_	0	SENT_331	[p21l967t1773r1045b1825],
3	Pharmacokinetics	NNS	O	pharmacokinetic	pobj	1	SENT_331	[p21l1077t1772r1635b1835],
4	,	,	O	,	_	0	SENT_331	[p21l1077t1772r1635b1835],
5	Marcel	NNP	PERSON	Marcel	nn	6	SENT_331	[p21l1664t1772r1879b1825],
6	Dekker	NNP	PERSON	Dekker	appos	3	SENT_331	[p21l1906t1772r2145b1835],
7	,	,	O	,	_	0	SENT_331	[p21l1906t1772r2145b1835],
8	New	NNP	LOCATION	New	nn	9	SENT_331	[p21l138t1861r279b1913],
9	York	NNP	LOCATION	York	appos	3	SENT_331	[p21l308t1860r478b1923],
10	,	,	O	,	_	0	SENT_331	[p21l308t1860r478b1923],
11	pp	NN	O	pp	appos	9	SENT_331	[p21l508t1877r582b1929],
12	409-417	CD	NUMBER	409-417	num	11	SENT_331	[p21l610t1860r872b1914],

1	2	LS	NUMBER	2	_	0	SENT_332	[p21l46t1950r97b2003],
2	.	.	O	.	_	0	SENT_332	[p21l46t1950r97b2003],

1	Ahluwalia	NNP	PERSON	Ahluwalia	nn	2	SENT_333	[p21l138t1950r455b2003],
2	R	NNP	PERSON	R	nsubj	12	SENT_333	[p21l484t1951r549b2013],
3	,	,	O	,	_	0	SENT_333	[p21l484t1951r549b2013],
4	Freimuth	NNP	PERSON	Freimuth	nn	5	SENT_333	[p21l580t1950r859b2003],
5	R	NNP	PERSON	R	appos	2	SENT_333	[p21l888t1951r953b2013],
6	,	,	O	,	_	0	SENT_333	[p21l888t1951r953b2013],
7	McLeod	NNP	PERSON	McLeod	nn	8	SENT_333	[p21l985t1950r1243b2003],
8	HL	NNS	O	hl	appos	2	SENT_333	[p21l1271t1951r1387b2013],
9	,	,	O	,	_	0	SENT_333	[p21l1271t1951r1387b2013],
10	Marsh	NNP	PERSON	Marsh	nn	11	SENT_333	[p21l1419t1950r1612b2003],
11	S	NNP	O	S	appos	2	SENT_333	[p21l1643t1950r1678b2003],
12	(	VBD	O	(	_	0	SENT_333	[p21l1713t1950r1909b2015],
13	2003	CD	DATE	2003	num	15	SENT_333	[p21l1713t1950r1909b2015],
14	)	CD	NUMBER	)	num	15	SENT_333	[p21l1713t1950r1909b2015],
15	Use	NN	O	use	dobj	12	SENT_333	[p21l1940t1951r2056b2003],
16	of	IN	O	of	_	0	SENT_333	[p21l2087t1950r2153b2003],
17	pyrosequencing	NN	O	pyrosequencing	prep_of	15	SENT_333	[p21l138t2038r618b2107],
18	to	TO	O	to	aux	19	SENT_333	[p21l658t2046r715b2091],
19	detect	VB	O	detect	xcomp	12	SENT_333	[p21l755t2038r936b2091],
20	clinically	RB	O	clinically	advmod	21	SENT_333	[p21l975t2038r1257b2107],
21	relevant	JJ	O	relevant	amod	22	SENT_333	[p21l1295t2038r1541b2091],
22	polymorphisms	NNS	O	polymorphism	dobj	19	SENT_333	[p21l1578t2038r2051b2107],
23	in	IN	O	in	_	0	SENT_333	[p21l2090t2038r2148b2090],
24	dihydropyrimidine	NN	O	dihydropyrimidine	nn	25	SENT_333	[p21l139t2125r709b2194],
25	dehydrogenase	NN	O	dehydrogenase	prep_in	22	SENT_333	[p21l738t2125r1208b2194],
26	.	.	O	.	_	0	SENT_333	[p21l738t2125r1208b2194],

1	Clin	NNP	O	Clin	nn	2	SENT_334	[p21l1241t2125r1370b2178],
2	Chem	NNP	O	Chem	_	0	SENT_334	[p21l1398t2125r1578b2178],
3	49:1661	CD	NUMBER	49:1661	number	4	SENT_334	[p21l1605t2125r2043b2179],
4	—	CD	NUMBER	—	dep	2	SENT_334	[p21l1605t2125r2043b2179],
5	1664	CD	DATE	1664	dep	4	SENT_334	[p21l1605t2125r2043b2179],

1	3	LS	NUMBER	3	_	0	SENT_335	[p21l48t2214r97b2267],
2	.	.	O	.	_	0	SENT_335	[p21l48t2214r97b2267],

1	Bajetta	NNP	O	Bajetta	nn	2	SENT_336	[p21l138t2214r354b2283],
2	E	NNP	O	E	dep	37	SENT_336	[p21l395t2215r456b2277],
3	,	,	O	,	_	0	SENT_336	[p21l395t2215r456b2277],
4	Procopio	NNP	PERSON	Procopio	nn	5	SENT_336	[p21l501t2214r773b2283],
5	G	NNP	PERSON	G	appos	2	SENT_336	[p21l817t2214r885b2277],
6	,	,	O	,	_	0	SENT_336	[p21l817t2214r885b2277],
7	Celio	NNP	PERSON	Celio	nn	8	SENT_336	[p21l930t2214r1092b2267],
8	L	NNP	PERSON	L	appos	2	SENT_336	[p21l1134t2215r1196b2277],
9	,	,	O	,	_	0	SENT_336	[p21l1134t2215r1196b2277],
10	Gattinoni	NNP	PERSON	Gattinoni	nn	11	SENT_336	[p21l1241t2214r1526b2267],
11	L	NNP	PERSON	L	appos	2	SENT_336	[p21l1568t2215r1629b2277],
12	,	,	O	,	_	0	SENT_336	[p21l1568t2215r1629b2277],
13	Della	NNP	PERSON	Della	nn	15	SENT_336	[p21l1674t2214r1839b2267],
14	Torre	NNP	PERSON	Torre	nn	15	SENT_336	[p21l1880t2215r2047b2267],
15	S	NN	O	s	appos	2	SENT_336	[p21l2091t2214r2145b2277],
16	,	,	O	,	_	0	SENT_336	[p21l2091t2214r2145b2277],
17	Mariani	NNP	PERSON	Mariani	nn	18	SENT_336	[p21l138t2302r377b2355],
18	L	NNP	PERSON	L	appos	2	SENT_336	[p21l427t2303r489b2365],
19	,	,	O	,	_	0	SENT_336	[p21l427t2303r489b2365],
20	Catena	NNP	ORGANIZATION	Catena	nn	21	SENT_336	[p21l543t2302r753b2355],
21	L	NNP	ORGANIZATION	L	appos	2	SENT_336	[p21l802t2303r863b2365],
22	,	,	O	,	_	0	SENT_336	[p21l802t2303r863b2365],
23	Ricotta	NNP	PERSON	Ricotta	nn	24	SENT_336	[p21l916t2302r1136b2355],
24	R	NNP	PERSON	R	appos	2	SENT_336	[p21l1184t2303r1249b2365],
25	,	,	O	,	_	0	SENT_336	[p21l1184t2303r1249b2365],
26	Longarini	NNP	ORGANIZATION	Longarini	nn	27	SENT_336	[p21l1302t2302r1600b2371],
27	R	NNP	ORGANIZATION	R	appos	2	SENT_336	[p21l1652t2303r1717b2365],
28	,	,	O	,	_	0	SENT_336	[p21l1652t2303r1717b2365],
29	Zilembo	NNP	ORGANIZATION	Zilembo	nn	30	SENT_336	[p21l1768t2302r2026b2355],
30	N	NNP	ORGANIZATION	N	appos	2	SENT_336	[p21l2075t2303r2145b2365],
31	,	,	O	,	_	0	SENT_336	[p21l2075t2303r2145b2365],
32	Buzzoni	NNP	O	Buzzoni	nn	33	SENT_336	[p21l138t2389r390b2442],
33	R	NNP	O	R	appos	2	SENT_336	[p21l422t2390r471b2442],
34	(	CD	NUMBER	(	num	37	SENT_336	[p21l502t2389r699b2455],
35	2005	CD	DATE	2005	num	37	SENT_336	[p21l502t2389r699b2455],
36	)	NNP	O	)	nn	37	SENT_336	[p21l502t2389r699b2455],
37	Safety	NNP	O	Safety	_	0	SENT_336	[p21l734t2389r924b2458],
38	and	CC	O	and	_	0	SENT_336	[p21l956t2389r1064b2442],
39	efﬁcacy	NN	O	efﬁcacy	conj_and	37	SENT_336	[p21l1094t2389r1332b2458],
40	of	IN	O	of	_	0	SENT_336	[p21l1365t2389r1430b2442],
41	two	CD	NUMBER	two	num	43	SENT_336	[p21l1455t2397r1567b2442],
42	different	JJ	O	different	amod	43	SENT_336	[p21l1598t2389r1859b2442],
43	doses	NNS	O	dose	prep_of	37	SENT_336	[p21l1890t2389r2055b2442],
44	of	IN	O	of	_	0	SENT_336	[p21l2087t2389r2153b2442],
45	capecitabine	NN	O	capecitabine	prep_of	43	SENT_336	[p21l139t2477r519b2546],
46	in	IN	O	in	_	0	SENT_336	[p21l548t2477r605b2530],
47	the	DT	O	the	det	48	SENT_336	[p21l633t2477r724b2530],
48	treatment	NN	O	treatment	prep_in	45	SENT_336	[p21l753t2485r1041b2530],
49	of	IN	O	of	_	0	SENT_336	[p21l1069t2477r1135b2530],
50	advanced	JJ	O	advanced	amod	52	SENT_336	[p21l1160t2477r1446b2531],
51	breast	NN	O	breast	nn	52	SENT_336	[p21l1472t2477r1654b2530],
52	cancer	NN	O	cancer	prep_of	48	SENT_336	[p21l1682t2494r1880b2530],
53	in	IN	O	in	_	0	SENT_336	[p21l1907t2477r1965b2530],
54	older	JJR	O	older	amod	55	SENT_336	[p21l1994t2477r2150b2530],
55	women	NNS	O	woman	prep_in	52	SENT_336	[p21l139t2584r376b2620],
56	.	.	O	.	_	0	SENT_336	[p21l139t2584r376b2620],

1	J	NNP	O	J	nn	3	SENT_337	[p21l407t2568r435b2620],
2	Clin	NNP	O	Clin	nn	3	SENT_337	[p21l463t2567r592b2620],
3	Oncol	NNP	O	Oncol	_	0	SENT_337	[p21l620t2567r803b2620],
4	23:2155	CD	NUMBER	23:2155	num	3	SENT_337	[p21l833t2567r1285b2620],
5	—	CD	NUMBER	—	number	6	SENT_337	[p21l833t2567r1285b2620],
6	2161	CD	DATE	2161	num	3	SENT_337	[p21l833t2567r1285b2620],
7	.	.	O	.	_	0	SENT_337	[p21l833t2567r1285b2620],

1	doi	FW	O	doi	_	0	SENT_338	[p21l1318t2567r1966b2620],
2	:	:	O	:	_	0	SENT_338	[p21l1318t2567r1966b2620],
3	JCO	NNP	O	JCO	dep	1	SENT_338	[p21l1318t2567r1966b2620],
4	.2005.02.167	CD	NUMBER	.2005.02.167	num	3	SENT_338	[p21l1318t2567r1966b2620],

1	4	LS	NUMBER	4	_	0	SENT_339	[p21l45t2654r97b2707],
2	.	.	O	.	_	0	SENT_339	[p21l45t2654r97b2707],

1	Baker	NNP	LOCATION	Baker	nn	2	SENT_340	[p21l138t2654r320b2707],
2	SD	NN	LOCATION	sd	nsubj	21	SENT_340	[p21l350t2655r460b2717],
3	,	,	O	,	_	0	SENT_340	[p21l350t2655r460b2717],
4	Verweij	NNP	PERSON	Verweij	nn	5	SENT_340	[p21l492t2654r730b2723],
5	J	NNP	PERSON	J	appos	2	SENT_340	[p21l765t2655r809b2717],
6	,	,	O	,	_	0	SENT_340	[p21l765t2655r809b2717],
7	Rowinsky	NNP	PERSON	Rowinsky	nn	8	SENT_340	[p21l841t2654r1147b2723],
8	EK	NNP	O	EK	appos	2	SENT_340	[p21l1177t2655r1293b2717],
9	,	,	O	,	_	0	SENT_340	[p21l1177t2655r1293b2717],
10	Donehower	NNP	PERSON	Donehower	nn	11	SENT_340	[p21l1325t2654r1680b2707],
11	RC	NNP	O	RC	appos	2	SENT_340	[p21l1709t2654r1824b2717],
12	,	,	O	,	_	0	SENT_340	[p21l1709t2654r1824b2717],
13	Schellens	NNP	O	Schellens	nn	14	SENT_340	[p21l1859t2654r2146b2707],
14	JH	NNP	O	JH	appos	2	SENT_340	[p21l138t2744r236b2805],
15	,	,	O	,	_	0	SENT_340	[p21l138t2744r236b2805],
16	Grochow	NNP	O	Grochow	nn	17	SENT_340	[p21l276t2742r555b2796],
17	LB	NNP	O	LB	appos	2	SENT_340	[p21l590t2744r703b2805],
18	,	,	O	,	_	0	SENT_340	[p21l590t2744r703b2805],
19	Sparreboom	NNP	O	Sparreboom	nn	20	SENT_340	[p21l742t2742r1112b2811],
20	A	NNP	O	A	appos	2	SENT_340	[p21l1146t2743r1200b2795],
21	(	VBD	O	(	_	0	SENT_340	[p21l1237t2743r1433b2808],
22	2002	CD	DATE	2002	num	24	SENT_340	[p21l1237t2743r1433b2808],
23	)	CD	NUMBER	)	num	24	SENT_340	[p21l1237t2743r1433b2808],
24	Role	NN	O	role	dobj	21	SENT_340	[p21l1470t2742r1612b2795],
25	of	IN	O	of	_	0	SENT_340	[p21l1648t2742r1714b2795],
26	body	NN	O	body	nn	28	SENT_340	[p21l1743t2742r1894b2811],
27	surface	NN	O	surface	nn	28	SENT_340	[p21l1932t2742r2147b2795],
28	area	NN	O	area	prep_of	24	SENT_340	[p21l140t2847r265b2884],
29	in	IN	O	in	_	0	SENT_340	[p21l308t2830r366b2883],
30	dosing	NN	O	dosing	prep_in	28	SENT_340	[p21l411t2830r610b2899],
31	of	IN	O	of	_	0	SENT_340	[p21l655t2830r721b2884],
32	investigational	JJ	O	investigational	amod	34	SENT_340	[p21l760t2830r1208b2899],
33	anticancer	JJ	O	anticancer	amod	34	SENT_340	[p21l1254t2830r1567b2884],
34	agents	NNS	O	agent	prep_of	30	SENT_340	[p21l1611t2839r1801b2899],
35	in	IN	O	in	_	0	SENT_340	[p21l1847t2830r1905b2883],
36	adults	NNS	O	adult	prep_in	21	SENT_340	[p21l1950t2831r2145b2893],
37	,	,	O	,	_	0	SENT_340	[p21l1950t2831r2145b2893],
38	1991-2001	CD	DATE	1991-2001	appos	36	SENT_340	[p21l145t2919r494b2973],
39	.	.	O	.	_	0	SENT_340	[p21l145t2919r494b2973],

1	J	NNP	O	J	nn	4	SENT_341	[p21l525t2920r554b2973],
2	Natl	NNP	O	Natl	nn	4	SENT_341	[p21l580t2919r710b2972],
3	Cancer	NNP	O	Cancer	nn	4	SENT_341	[p21l738t2919r953b2972],
4	Inst	NNP	O	Inst	_	0	SENT_341	[p21l980t2920r1093b2972],
5	94:1883	CD	NUMBER	94:1883	number	6	SENT_341	[p21l1121t2919r1556b2973],
6	—	CD	NUMBER	—	dep	4	SENT_341	[p21l1121t2919r1556b2973],
7	1888	CD	DATE	1888	dep	6	SENT_341	[p21l1121t2919r1556b2973],

1	5	CD	NUMBER	5	_	0	SENT_342	[p21l47t3008r97b3062],
2	.	.	O	.	_	0	SENT_342	[p21l47t3008r97b3062],

1	Besnard	NNP	ORGANIZATION	Besnard	nn	2	SENT_343	[p21l138t3008r387b3062],
2	T	NN	ORGANIZATION	t	_	0	SENT_343	[p21l405t3010r466b3071],
3	,	,	O	,	_	0	SENT_343	[p21l405t3010r466b3071],
4	Renee	NNP	PERSON	Renee	nn	5	SENT_343	[p21l488t3010r677b3062],
5	N	NNP	PERSON	N	appos	2	SENT_343	[p21l696t3010r766b3071],
6	,	,	O	,	_	0	SENT_343	[p21l696t3010r766b3071],
7	Etienne	NNP	PERSON	Etienne	appos	5	SENT_343	[p21l788t3008r1320b3062],
8	.	.	O	.	_	0	SENT_343	[p21l788t3008r1320b3062],

1	—	NN	O	—	_	0	SENT_344	[p21l788t3008r1320b3062],
2	.	.	O	.	_	0	SENT_344	[p21l788t3008r1320b3062],

1	Grimaldi	NNP	PERSON	Grimaldi	nn	2	SENT_345	[p21l788t3008r1320b3062],
2	MC	NNP	O	MC	nsubj	9	SENT_345	[p21l1340t3009r1473b3071],
3	,	,	O	,	_	0	SENT_345	[p21l1340t3009r1473b3071],
4	Francois	NNP	PERSON	Francois	nn	5	SENT_345	[p21l1494t3008r1754b3062],
5	E	NNP	PERSON	E	appos	2	SENT_345	[p21l1774t3010r1836b3071],
6	,	,	O	,	_	0	SENT_345	[p21l1774t3010r1836b3071],
7	Milano	NNP	O	Milano	nn	8	SENT_345	[p21l1857t3008r2075b3062],
8	G	NNP	O	G	appos	5	SENT_345	[p21l2097t3009r2149b3062],
9	(	VBD	O	(	_	0	SENT_345	[p21l141t3097r337b3162],
10	2008	CD	DATE	2008	num	11	SENT_345	[p21l141t3097r337b3162],
11	)	CD	NUMBER	)	dobj	9	SENT_345	[p21l141t3097r337b3162],
12	Optimized	VBN	O	optimize	partmod	11	SENT_345	[p21l363t3096r683b3165],
13	blood	NN	O	blood	nn	14	SENT_345	[p21l705t3096r878b3149],
14	sampling	NN	O	sampling	dobj	12	SENT_345	[p21l902t3096r1177b3165],
15	with	IN	O	with	_	0	SENT_345	[p21l1201t3096r1334b3150],
16	cytidine	NN	O	cytidine	nn	18	SENT_345	[p21l1357t3096r1601b3165],
17	deaminase	NN	O	deaminase	nn	18	SENT_345	[p21l1625t3096r1944b3149],
18	inhibitor	NN	O	inhibitor	prep_with	12	SENT_345	[p21l1967t3096r2146b3149, p21l138t3184r244b3237],
19	for	IN	O	for	_	0	SENT_345	[p21l264t3184r353b3237],
20	improved	JJ	O	improved	amod	21	SENT_345	[p21l373t3184r664b3253],
21	analysis	NN	O	analysis	prep_for	18	SENT_345	[p21l687t3184r928b3253],
22	of	IN	O	of	_	0	SENT_345	[p21l952t3184r1018b3237],
23	capecitabine	NN	O	capecitabine	nn	24	SENT_345	[p21l1035t3184r1415b3253],
24	metabolites	NNS	O	metabolite	prep_of	21	SENT_345	[p21l1437t3184r1803b3237],
25	.	.	O	.	_	0	SENT_345	[p21l1437t3184r1803b3237],

1	J	NN	O	j	nn	3	SENT_346	[p21l1829t3185r1857b3237],
2	Chromatogr	NN	O	chromatogr	nn	3	SENT_346	[p21l1880t3184r2146b3237, p21l138t3281r261b3341],
3	B	NN	O	b	_	0	SENT_346	[p21l280t3274r325b3325],
4	870:117	CD	NUMBER	870:117	num	5	SENT_346	[p21l354t3273r766b3326],
5	—	NN	O	—	dep	3	SENT_346	[p21l354t3273r766b3326],
6	120	CD	NUMBER	120	dep	5	SENT_346	[p21l354t3273r766b3326],
7	.	.	O	.	_	0	SENT_346	[p21l354t3273r766b3326],

1	doi	FW	O	doi	_	0	SENT_347	[p21l792t3272r1872b3341],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_347	[p21l792t3272r1872b3341],
3	/	:	O	/	punct	5	SENT_347	[p21l792t3272r1872b3341],
4	j.	NN	O	j.	nn	5	SENT_347	[p21l792t3272r1872b3341],
5	jchromb	NN	O	jchromb	dep	2	SENT_347	[p21l792t3272r1872b3341],
6	.2008.05.040	CD	NUMBER	.2008.05.040	dep	2	SENT_347	[p21l792t3272r1872b3341],

1	6	CD	NUMBER	6	_	0	SENT_348	[p21l47t3360r97b3414],
2	.	.	O	.	_	0	SENT_348	[p21l47t3360r97b3414],

1	Blum	NNP	PERSON	Blum	nn	2	SENT_349	[p21l138t3360r306b3413],
2	JL	NNP	O	JL	dep	36	SENT_349	[p21l330t3362r421b3423],
3	,	,	O	,	_	0	SENT_349	[p21l330t3362r421b3423],
4	Jones	NNP	PERSON	Jones	nn	5	SENT_349	[p21l448t3362r614b3414],
5	SE	NN	O	se	appos	2	SENT_349	[p21l642t3361r743b3423],
6	,	,	O	,	_	0	SENT_349	[p21l642t3361r743b3423],
7	Buzdar	NNP	PERSON	Buzdar	nn	8	SENT_349	[p21l770t3360r990b3413],
8	AU	NN	O	au	appos	2	SENT_349	[p21l1013t3361r1137b3423],
9	,	,	O	,	_	0	SENT_349	[p21l1013t3361r1137b3423],
10	LoRusso	NNP	O	LoRusso	nn	11	SENT_349	[p21l1164t3362r1432b3413],
11	PM	NNP	O	PM	appos	2	SENT_349	[p21l1457t3362r1581b3423],
12	,	,	O	,	_	0	SENT_349	[p21l1457t3362r1581b3423],
13	Kuter	NNP	PERSON	Kuter	nn	17	SENT_349	[p21l1610t3362r1781b3413],
14	I	PRP	O	I	dep	17	SENT_349	[p21l1805t3362r1844b3423],
15	,	,	O	,	_	0	SENT_349	[p21l1805t3362r1844b3423],
16	Vogel	NNP	PERSON	Vogel	dep	17	SENT_349	[p21l1871t3360r2055b3429],
17	C	NNP	O	C	appos	2	SENT_349	[p21l2081t3361r2145b3423],
18	,	,	O	,	_	0	SENT_349	[p21l2081t3361r2145b3423],
19	Osterwalder	NNP	O	Osterwalder	nn	20	SENT_349	[p21l140t3449r510b3502],
20	B	NNP	O	B	appos	2	SENT_349	[p21l540t3450r605b3511],
21	,	,	O	,	_	0	SENT_349	[p21l540t3450r605b3511],
22	Burger	NNP	PERSON	Burger	nn	23	SENT_349	[p21l638t3450r850b3517],
23	HU	NNP	PERSON	HU	appos	2	SENT_349	[p21l879t3450r1002b3512],
24	,	,	O	,	_	0	SENT_349	[p21l879t3450r1002b3512],
25	Brown	NNP	PERSON	Brown	nn	26	SENT_349	[p21l1036t3450r1241b3502],
26	CS	NNP	O	CS	appos	2	SENT_349	[p21l1272t3449r1379b3511],
27	,	,	O	,	_	0	SENT_349	[p21l1272t3449r1379b3511],
28	Grifﬁn	NNP	PERSON	Grifﬁn	nn	29	SENT_349	[p21l1413t3448r1617b3502],
29	T	NN	O	t	appos	2	SENT_349	[p21l1647t3450r1692b3501],
30	(	CD	NUMBER	(	num	29	SENT_349	[p21l1725t3449r1922b3514],
31	1999	CD	DATE	1999	num	36	SENT_349	[p21l1725t3449r1922b3514],
32	)	NNP	O	)	nn	36	SENT_349	[p21l1725t3449r1922b3514],
33	Multicenter	NNP	O	Multicenter	nn	36	SENT_349	[p21l1954t3448r2146b3502, p21l139t3544r325b3589],
34	phase	NN	O	phase	nn	36	SENT_349	[p21l368t3536r540b3605],
35	II	CD	NUMBER	ii	num	36	SENT_349	[p21l586t3537r635b3589],
36	study	NN	O	study	_	0	SENT_349	[p21l683t3536r842b3605],
37	of	IN	O	of	_	0	SENT_349	[p21l889t3536r955b3589],
38	capecitabine	NN	O	capecitabine	prep_of	36	SENT_349	[p21l995t3536r1376b3605],
39	in	IN	O	in	_	0	SENT_349	[p21l1422t3536r1479b3589],
40	paclitaXel	NN	O	paclitaxel	prep_in	38	SENT_349	[p21l1524t3536r2147b3605],
41	—	CD	NUMBER	—	num	45	SENT_349	[p21l1524t3536r2147b3605],
42	refractory	JJ	O	refractory	amod	45	SENT_349	[p21l1524t3536r2147b3605],
43	metastatic	JJ	O	metastatic	amod	45	SENT_349	[p21l139t3625r446b3678],
44	breast	NN	O	breast	nn	45	SENT_349	[p21l474t3625r656b3678],
45	cancer	NN	O	cancer	dep	40	SENT_349	[p21l684t3642r896b3678],
46	.	.	O	.	_	0	SENT_349	[p21l684t3642r896b3678],

1	J	NN	O	j	nn	3	SENT_350	[p21l927t3627r955b3679],
2	Clin	NN	O	clin	nn	3	SENT_350	[p21l983t3625r1112b3679],
3	Oncol	NN	O	oncol	_	0	SENT_350	[p21l1141t3625r1324b3679],
4	17:485	CD	NUMBER	17:485	num	5	SENT_350	[p21l1359t3625r1710b3679],
5	—	NN	O	—	dep	3	SENT_350	[p21l1359t3625r1710b3679],
6	493	CD	NUMBER	493	dep	3	SENT_350	[p21l1359t3625r1710b3679],

1	.	.	O	.	_	0	SENT_351	[p22l88t69r97b78],

1	Eisenhauer	NNP	PERSON	Eisenhauer	nn	2	SENT_352	[p22l138t24r477b78],
2	EA	NN	PERSON	ea	dep	54	SENT_352	[p22l498t25r615b87],
3	,	,	O	,	_	0	SENT_352	[p22l498t25r615b87],
4	Therasse	NN	O	therasse	nn	5	SENT_352	[p22l640t25r909b78],
5	P	NN	O	p	appos	2	SENT_352	[p22l933t26r989b87],
6	,	,	O	,	_	0	SENT_352	[p22l933t26r989b87],
7	Bogaerts	NNPS	O	Bogaerts	nn	8	SENT_352	[p22l1014t26r1282b93],
8	J	NNP	O	J	appos	2	SENT_352	[p22l1306t26r1350b88],
9	,	,	O	,	_	0	SENT_352	[p22l1306t26r1350b88],
10	Schwartz	NNP	ORGANIZATION	Schwartz	nn	11	SENT_352	[p22l1377t25r1656b78],
11	LH	NNP	ORGANIZATION	LH	appos	2	SENT_352	[p22l1680t26r1797b87],
12	,	,	O	,	_	0	SENT_352	[p22l1680t26r1797b87],
13	Sargent	NNP	ORGANIZATION	Sargent	nn	14	SENT_352	[p22l1824t25r2054b93],
14	D	NNP	ORGANIZATION	D	appos	2	SENT_352	[p22l2076t26r2145b87],
15	,	,	O	,	_	0	SENT_352	[p22l2076t26r2145b87],
16	Ford	NNP	ORGANIZATION	Ford	nn	17	SENT_352	[p22l138t113r280b166],
17	R	NNP	ORGANIZATION	R	appos	2	SENT_352	[p22l305t114r370b176],
18	,	,	O	,	_	0	SENT_352	[p22l305t114r370b176],
19	Dancey	NNP	PERSON	Dancey	nn	20	SENT_352	[p22l398t114r628b181],
20	J	NNP	PERSON	J	appos	2	SENT_352	[p22l653t114r697b175],
21	,	,	O	,	_	0	SENT_352	[p22l653t114r697b175],
22	Arbuck	NNP	O	Arbuck	nn	23	SENT_352	[p22l724t113r952b166],
23	S	NNP	O	S	appos	2	SENT_352	[p22l978t113r1032b176],
24	,	,	O	,	_	0	SENT_352	[p22l978t113r1032b176],
25	Gwyther	NNP	PERSON	Gwyther	nn	26	SENT_352	[p22l1061t113r1326b181],
26	S	NNP	O	S	appos	2	SENT_352	[p22l1351t113r1405b176],
27	,	,	O	,	_	0	SENT_352	[p22l1351t113r1405b176],
28	Mooney	NNP	PERSON	Mooney	nn	29	SENT_352	[p22l1433t114r1684b181],
29	M	NNP	O	M	appos	2	SENT_352	[p22l1709t114r1791b175],
30	,	,	O	,	_	0	SENT_352	[p22l1709t114r1791b175],
31	Rubinstein	NNP	PERSON	Rubinstein	nn	32	SENT_352	[p22l1819t113r2148b166],
32	L	NNP	PERSON	L	appos	2	SENT_352	[p22l138t202r199b263],
33	,	,	O	,	_	0	SENT_352	[p22l138t202r199b263],
34	Shankar	NNP	PERSON	Shankar	nn	35	SENT_352	[p22l231t200r478b254],
35	L	NNP	PERSON	L	appos	2	SENT_352	[p22l503t202r564b263],
36	,	,	O	,	_	0	SENT_352	[p22l503t202r564b263],
37	Dodd	NNP	ORGANIZATION	Dodd	nn	38	SENT_352	[p22l592t200r760b253],
38	L	NNP	ORGANIZATION	L	appos	2	SENT_352	[p22l786t202r847b263],
39	,	,	O	,	_	0	SENT_352	[p22l786t202r847b263],
40	Kaplan	NNP	PERSON	Kaplan	nn	41	SENT_352	[p22l878t200r1095b269],
41	R	NNP	PERSON	R	appos	2	SENT_352	[p22l1121t202r1187b263],
42	,	,	O	,	_	0	SENT_352	[p22l1121t202r1187b263],
43	Lacombe	NNP	PERSON	Lacombe	nn	44	SENT_352	[p22l1215t200r1498b253],
44	D	NNP	O	D	appos	2	SENT_352	[p22l1524t202r1594b263],
45	,	,	O	,	_	0	SENT_352	[p22l1524t202r1594b263],
46	Verweij	NNP	O	Verweij	nn	47	SENT_352	[p22l1623t200r1861b269],
47	J	NNP	O	J	appos	2	SENT_352	[p22l1893t202r1921b254],
48	(	CD	NUMBER	(	dep	54	SENT_352	[p22l1950t201r2146b266],
49	2009	CD	DATE	2009	num	54	SENT_352	[p22l1950t201r2146b266],
50	)	NNP	O	)	nn	54	SENT_352	[p22l1950t201r2146b266],
51	New	NNP	O	New	nn	54	SENT_352	[p22l138t290r279b342],
52	response	NN	O	response	nn	54	SENT_352	[p22l311t305r576b357],
53	evaluation	NN	O	evaluation	nn	54	SENT_352	[p22l610t288r926b342],
54	criteria	NNS	O	criterion	dep	59	SENT_352	[p22l959t288r1175b342],
55	in	IN	O	in	_	0	SENT_352	[p22l1206t288r1264b341],
56	solid	JJ	O	solid	amod	57	SENT_352	[p22l1298t288r1443b342],
57	tumours	NNS	O	tumour	prep_in	54	SENT_352	[p22l1475t297r1738b342],
58	:	:	O	:	_	0	SENT_352	[p22l1475t297r1738b342],
59	revised	VBN	O	revise	_	0	SENT_352	[p22l1775t288r1995b342],
60	RECIST	NNP	O	RECIST	nn	63	SENT_352	[p22l2027t290r2146b341, p22l139t377r301b430],
61	guideline	NN	O	guideline	nn	63	SENT_352	[p22l344t377r625b446],
62	(	NN	O	(	nn	63	SENT_352	[p22l669t377r915b442],
63	version	NN	O	version	dobj	59	SENT_352	[p22l669t377r915b442],
64	1.1	CD	NUMBER	1.1	num	65	SENT_352	[p22l964t377r1090b442],
65	)	NN	O	)	dep	63	SENT_352	[p22l964t377r1090b442],
66	.	.	O	.	_	0	SENT_352	[p22l964t377r1090b442],

1	Eur	NNP	MISC	Eur	nn	3	SENT_353	[p22l1134t378r1244b430],
2	J	NNP	MISC	J	nn	3	SENT_353	[p22l1284t378r1312b430],
3	Cancer	NNP	MISC	Cancer	_	0	SENT_353	[p22l1354t377r1568b430],
4	45:228	CD	NUMBER	45:228	number	5	SENT_353	[p22l1608t376r1986b430],
5	-247	CD	NUMBER	-247	num	3	SENT_353	[p22l1608t376r1986b430],
6	.	.	O	.	_	0	SENT_353	[p22l1608t376r1986b430],

1	doi	FW	O	doi	_	0	SENT_354	[p22l2032t377r2142b430],
2	:	:	O	:	_	0	SENT_354	[p22l2032t377r2142b430],
3	S0959-8049	NN	O	s0959-8049	dep	1	SENT_354	[p22l140t465r886b531],
4	(	CD	NUMBER	(	number	5	SENT_354	[p22l140t465r886b531],
5	08	CD	NUMBER	08	dep	3	SENT_354	[p22l140t465r886b531],
6	)	NN	O	)	dep	5	SENT_354	[p22l140t465r886b531],
7	00873-3	CD	NUMBER	00873-3	num	6	SENT_354	[p22l140t465r886b531],

1	.	.	O	.	_	0	SENT_355	[p22l88t598r97b607],

1	El	NNP	O	El	_	0	SENT_356	[p22l138t554r394b607],
2	.	.	O	.	_	0	SENT_356	[p22l138t554r394b607],

1	—	NN	O	—	_	0	SENT_357	[p22l138t554r394b607],
2	.	.	O	.	_	0	SENT_357	[p22l138t554r394b607],

1	Helw	NNP	ORGANIZATION	Helw	nn	2	SENT_358	[p22l138t554r394b607],
2	L	NNP	ORGANIZATION	L	nsubj	17	SENT_358	[p22l418t555r480b616],
3	,	,	O	,	_	0	SENT_358	[p22l418t555r480b616],
4	Coleman	NNP	PERSON	Coleman	nn	5	SENT_358	[p22l507t554r781b607],
5	RE	NNP	O	RE	nsubj	6	SENT_358	[p22l805t555r900b606],
6	(	VBD	O	(	parataxis	17	SENT_358	[p22l926t553r1123b619],
7	2005	CD	DATE	2005	num	8	SENT_358	[p22l926t553r1123b619],
8	)	CD	NUMBER	)	dobj	6	SENT_358	[p22l926t553r1123b619],
9	Reduced	VBN	O	reduce	amod	11	SENT_358	[p22l1149t553r1415b607],
10	dose	NN	O	dose	nn	11	SENT_358	[p22l1439t554r1575b607],
11	capecitabine	NN	O	capecitabine	nsubj	17	SENT_358	[p22l1601t553r1980b622],
12	is	VBZ	O	be	cop	17	SENT_358	[p22l2005t553r2053b607],
13	an	DT	O	a	det	17	SENT_358	[p22l2079t570r2148b607],
14	effective	JJ	O	effective	amod	17	SENT_358	[p22l139t641r404b695],
15	and	CC	O	and	_	0	SENT_358	[p22l433t641r541b695],
16	well-tolerated	JJ	O	well-tolerated	conj_and	14	SENT_358	[p22l566t641r990b695],
17	treatment	NN	O	treatment	_	0	SENT_358	[p22l1017t649r1305b695],
18	in	IN	O	in	_	0	SENT_358	[p22l1331t642r1389b694],
19	patients	NNS	O	patient	prep_in	17	SENT_358	[p22l1414t641r1650b710],
20	with	IN	O	with	_	0	SENT_358	[p22l1679t641r1813b695],
21	metastatic	JJ	O	metastatic	amod	23	SENT_358	[p22l1839t641r2146b695],
22	breast	NN	O	breast	nn	23	SENT_358	[p22l137t731r319b784],
23	cancer	NN	O	cancer	prep_with	19	SENT_358	[p22l347t747r559b784],
24	.	.	O	.	_	0	SENT_358	[p22l347t747r559b784],

1	Breast	NN	O	breast	_	0	SENT_359	[p22l591t732r785b784],
2	14:368	CD	NUMBER	14:368	number	3	SENT_359	[p22l819t731r1189b784],
3	-374	CD	NUMBER	-374	num	1	SENT_359	[p22l819t731r1189b784],
4	.	.	O	.	_	0	SENT_359	[p22l819t731r1189b784],

1	doi	FW	O	doi	_	0	SENT_360	[p22l1221t731r2091b796],
2	:	:	O	:	_	0	SENT_360	[p22l1221t731r2091b796],
3	S0960-9776	NN	O	s0960-9776	dep	1	SENT_360	[p22l1221t731r2091b796],
4	(	CD	NUMBER	(	number	5	SENT_360	[p22l1221t731r2091b796],
5	04	CD	NUMBER	04	dep	3	SENT_360	[p22l1221t731r2091b796],
6	)	NN	O	)	dep	5	SENT_360	[p22l1221t731r2091b796],
7	00245-0	CD	NUMBER	00245-0	num	6	SENT_360	[p22l1221t731r2091b796],
8	.	.	O	.	_	0	SENT_360	[p22l88t863r97b872],

1	Fukunaga	NNP	PERSON	Fukunaga	nn	2	SENT_361	[p22l138t819r438b887],
2	AK	NNP	O	AK	nsubj	15	SENT_361	[p22l477t819r600b881],
3	,	,	O	,	_	0	SENT_361	[p22l477t819r600b881],
4	Marsh	NNP	PERSON	Marsh	nn	5	SENT_361	[p22l642t819r835b872],
5	S	NNP	O	S	appos	2	SENT_361	[p22l876t819r931b881],
6	,	,	O	,	_	0	SENT_361	[p22l876t819r931b881],
7	Murry	NNP	PERSON	Murry	nn	8	SENT_361	[p22l973t820r1165b887],
8	DJ	NNP	PERSON	DJ	appos	2	SENT_361	[p22l1205t820r1303b881],
9	,	,	O	,	_	0	SENT_361	[p22l1205t820r1303b881],
10	Hurley	NNP	PERSON	Hurley	nn	11	SENT_361	[p22l1345t818r1554b887],
11	TD	NNP	O	TD	appos	2	SENT_361	[p22l1594t820r1710b881],
12	,	,	O	,	_	0	SENT_361	[p22l1594t820r1710b881],
13	McLeod	NNP	PERSON	McLeod	nn	14	SENT_361	[p22l1752t818r2009b872],
14	HL	NNS	O	hl	appos	2	SENT_361	[p22l2049t820r2148b871],
15	(	VBP	O	(	_	0	SENT_361	[p22l141t907r337b972],
16	2004	CD	DATE	2004	num	18	SENT_361	[p22l141t907r337b972],
17	)	CD	NUMBER	)	num	18	SENT_361	[p22l141t907r337b972],
18	Identiﬁcation	NN	O	identiﬁcation	dobj	15	SENT_361	[p22l370t906r776b960],
19	and	CC	O	and	_	0	SENT_361	[p22l808t906r915b960],
20	analysis	NN	O	analysis	conj_and	18	SENT_361	[p22l946t906r1187b975],
21	of	IN	O	of	_	0	SENT_361	[p22l1220t906r1285b960],
22	single-nucleotide	JJ	O	single-nucleotide	amod	23	SENT_361	[p22l1313t906r1834b975],
23	polymorphisms	NNS	O	polymorphism	prep_of	20	SENT_361	[p22l1865t907r2146b975, p22l137t995r351b1063],
24	in	IN	O	in	_	0	SENT_361	[p22l382t995r440b1047],
25	the	DT	O	the	det	28	SENT_361	[p22l469t995r560b1048],
26	gemcitabine	NN	O	gemcitabine	nn	28	SENT_361	[p22l591t995r962b1063],
27	pharmacologic	JJ	O	pharmacologic	amod	28	SENT_361	[p22l992t995r1444b1064],
28	pathway	NN	O	pathway	prep_in	23	SENT_361	[p22l1475t995r1747b1063],
29	.	.	O	.	_	0	SENT_361	[p22l1475t995r1747b1063],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_362	[p22l1781t995r2145b1064, p22l139t1083r389b1136],
2	J	NN	O	j	dep	1	SENT_362	[p22l418t1084r447b1136],
3	4:307	CD	NUMBER	4:307	num	2	SENT_362	[p22l473t1083r813b1136],
4	—	NN	O	—	dep	2	SENT_362	[p22l473t1083r813b1136],
5	314	CD	NUMBER	314	num	4	SENT_362	[p22l473t1083r813b1136],
6	.	.	O	.	_	0	SENT_362	[p22l473t1083r813b1136],

1	doi	FW	O	doi	_	0	SENT_363	[p22l845t1083r1665b1152],
2	:10.1038	CD	NUMBER	:10.1038	dep	1	SENT_363	[p22l845t1083r1665b1152],
3	/	:	O	/	punct	4	SENT_363	[p22l845t1083r1665b1152],
4	sj	NN	O	sj	dep	2	SENT_363	[p22l845t1083r1665b1152],
5	.	.	O	.	_	0	SENT_363	[p22l845t1083r1665b1152],

1	tpj	NN	O	tpj	nn	4	SENT_364	[p22l845t1083r1665b1152],
2	.6500259	CD	NUMBER	.6500259	num	4	SENT_364	[p22l845t1083r1665b1152],
3	Gajria	NN	O	gajrium	nn	4	SENT_364	[p22l140t1170r328b1239],
4	D	NN	O	d	nsubj	29	SENT_364	[p22l356t1172r425b1233],
5	,	,	O	,	_	0	SENT_364	[p22l356t1172r425b1233],
6	Feigin	NNP	PERSON	Feigin	nn	7	SENT_364	[p22l455t1170r649b1239],
7	K	NNP	PERSON	K	appos	4	SENT_364	[p22l680t1172r747b1233],
8	,	,	O	,	_	0	SENT_364	[p22l680t1172r747b1233],
9	Tan	NNP	LOCATION	Tan	nn	10	SENT_364	[p22l778t1172r895b1224],
10	LK	NNP	LOCATION	LK	appos	4	SENT_364	[p22l923t1172r1039b1234],
11	,	,	O	,	_	0	SENT_364	[p22l923t1172r1039b1234],
12	Patil	NNP	PERSON	Patil	nn	13	SENT_364	[p22l1071t1170r1209b1224],
13	S	NNP	O	S	appos	4	SENT_364	[p22l1240t1171r1294b1233],
14	,	,	O	,	_	0	SENT_364	[p22l1240t1171r1294b1233],
15	Geneus	NNP	O	Geneus	nn	16	SENT_364	[p22l1326t1171r1550b1224],
16	S	NNP	O	S	appos	4	SENT_364	[p22l1582t1171r1636b1234],
17	,	,	O	,	_	0	SENT_364	[p22l1582t1171r1636b1234],
18	Theodoulou	NNP	O	Theodoulou	nn	19	SENT_364	[p22l1668t1170r2034b1224],
19	M	NNP	O	M	appos	4	SENT_364	[p22l2063t1172r2145b1233],
20	,	,	O	,	_	0	SENT_364	[p22l2063t1172r2145b1233],
21	Norton	NNP	ORGANIZATION	Norton	nn	22	SENT_364	[p22l138t1261r352b1313],
22	L	NNP	ORGANIZATION	L	appos	4	SENT_364	[p22l379t1261r441b1323],
23	,	,	O	,	_	0	SENT_364	[p22l379t1261r441b1323],
24	Hudis	NNP	PERSON	Hudis	nn	25	SENT_364	[p22l472t1260r650b1313],
25	CA	NNP	O	CA	appos	4	SENT_364	[p22l681t1260r799b1323],
26	,	,	O	,	_	0	SENT_364	[p22l681t1260r799b1323],
27	Traina	NNP	ORGANIZATION	Traina	nn	28	SENT_364	[p22l830t1260r1029b1313],
28	TA	NNP	ORGANIZATION	TA	appos	4	SENT_364	[p22l1056t1260r1156b1312],
29	(	VBD	O	(	_	0	SENT_364	[p22l1186t1260r1382b1325],
30	2011	CD	DATE	2011	num	32	SENT_364	[p22l1186t1260r1382b1325],
31	)	CD	NUMBER	)	num	32	SENT_364	[p22l1186t1260r1382b1325],
32	Phase	NN	O	phase	dobj	29	SENT_364	[p22l1413t1260r1588b1313],
33	2	CD	NUMBER	2	num	34	SENT_364	[p22l1618t1260r1652b1312],
34	trial	NN	O	trial	dep	29	SENT_364	[p22l1681t1260r1802b1313],
35	of	IN	O	of	_	0	SENT_364	[p22l1832t1260r1897b1313],
36	a	DT	O	a	det	40	SENT_364	[p22l1922t1276r1953b1313],
37	novel	JJ	O	novel	amod	40	SENT_364	[p22l1980t1260r2148b1313],
38	capecitabine	NN	O	capecitabine	nn	40	SENT_364	[p22l139t1348r519b1417],
39	dosing	NN	O	dosing	nn	40	SENT_364	[p22l552t1348r751b1417],
40	schedule	NN	O	schedule	prep_of	34	SENT_364	[p22l786t1348r1048b1401],
41	in	IN	O	in	_	0	SENT_364	[p22l1080t1348r1138b1400],
42	combination	NN	O	combination	prep_in	34	SENT_364	[p22l1169t1348r1549b1401],
43	with	IN	O	with	_	0	SENT_364	[p22l1582t1348r1715b1401],
44	bevacizumab	NN	O	bevacizumab	prep_with	29	SENT_364	[p22l1745t1348r2147b1401],
45	for	IN	O	for	_	0	SENT_364	[p22l139t1435r227b1488],
46	patients	NNS	O	patient	prep_for	44	SENT_364	[p22l268t1435r503b1504],
47	with	IN	O	with	_	0	SENT_364	[p22l549t1435r683b1488],
48	metastatic	JJ	O	metastatic	amod	50	SENT_364	[p22l726t1435r1034b1488],
49	breast	NN	O	breast	nn	50	SENT_364	[p22l1079t1435r1261b1488],
50	cancer	NN	O	cancer	prep_with	46	SENT_364	[p22l1305t1452r1517b1488],
51	.	.	O	.	_	0	SENT_364	[p22l1305t1452r1517b1488],

1	Cancer	NN	O	cancer	_	0	SENT_365	[p22l1566t1435r1781b1488],
2	117241254131	CD	NUMBER	117241254131	dep	1	SENT_365	[p22l1831t1435r2149b1488, p22l138t1525r303b1578],
3	.	.	O	.	_	0	SENT_365	[p22l1831t1435r2149b1488, p22l138t1525r303b1578],

1	doi	FW	O	doi	nn	2	SENT_366	[p22l336t1525r1062b1579],
2	:10.1002	FW	O	:10.1002	_	0	SENT_366	[p22l336t1525r1062b1579],
3	/	:	O	/	punct	4	SENT_366	[p22l336t1525r1062b1579],
4	cncr	NN	O	cncr	dep	2	SENT_366	[p22l336t1525r1062b1579],
5	.25992	CD	NUMBER	.25992	num	4	SENT_366	[p22l336t1525r1062b1579],
6	Genentech	NNP	ORGANIZATION	Genentech	nn	8	SENT_366	[p22l140t1613r463b1666],
7	USA	NNP	ORGANIZATION	USA	nn	8	SENT_366	[p22l495t1613r645b1666],
8	Inc.	NNP	ORGANIZATION	Inc.	nsubj	9	SENT_366	[p22l675t1614r786b1666],
9	(	VBD	O	(	rcmod	2	SENT_366	[p22l824t1613r1021b1678],
10	2011	CD	DATE	2011	num	11	SENT_366	[p22l824t1613r1021b1678],
11	)	CD	NUMBER	)	dobj	9	SENT_366	[p22l824t1613r1021b1678],
12	XELODA	NNP	LOCATION	XELODA	tmod	9	SENT_366	[p22l1054t1597r1409b1666],
13	®	CD	NUMBER	®	num	12	SENT_366	[p22l1054t1597r1409b1666],
14	(	CD	NUMBER	(	num	17	SENT_366	[p22l1444t1613r1871b1681],
15	capecitabine	NN	O	capecitabine	nn	17	SENT_366	[p22l1444t1613r1871b1681],
16	)	CD	NUMBER	)	num	17	SENT_366	[p22l1444t1613r1871b1681],
17	Tablets	NNS	O	tablet	dep	2	SENT_366	[p22l1906t1613r2145b1676],
18	,	,	O	,	_	0	SENT_366	[p22l1906t1613r2145b1676],
19	Film	NNP	O	Film	nn	20	SENT_366	[p22l138t1701r282b1753],
20	Coated	NNP	O	Coated	appos	17	SENT_366	[p22l311t1701r526b1754],
21	for	IN	O	for	_	0	SENT_366	[p22l555t1701r643b1754],
22	Oral	NNP	O	Oral	nn	23	SENT_366	[p22l673t1701r804b1754],
23	Use	NNP	O	Use	prep_for	20	SENT_366	[p22l834t1702r967b1754],
24	:	:	O	:	_	0	SENT_366	[p22l834t1702r967b1754],
25	Package	NNP	O	Package	nn	26	SENT_366	[p22l1003t1701r1255b1770],
26	Insert	NNP	O	Insert	dep	2	SENT_366	[p22l1285t1702r1473b1764],
27	,	,	O	,	_	0	SENT_366	[p22l1285t1702r1473b1764],
28	South	NNP	LOCATION	South	nn	32	SENT_366	[p22l1507t1701r1682b1754],
29	San	NNP	LOCATION	San	nn	32	SENT_366	[p22l1713t1701r1824b1754],
30	Francisco	NNP	LOCATION	Francisco	nn	32	SENT_366	[p22l1853t1701r2147b1754],
31	(	NN	O	(	nn	32	SENT_366	[p22l141t1789r2141b1857],
32	http://www.gene.com/gene/products/information/Xeloda/pdf/pi	NN	O	http://www.gene.com/gene/products/information/xeloda/pdf/pi	appos	26	SENT_366	[p22l141t1789r2141b1857],
33	.	.	O	.	_	0	SENT_366	[p22l141t1789r2141b1857],

1	pdf	NN	O	pdf	_	0	SENT_367	[p22l137t1878r281b1946],
2	)	NN	O	)	dep	1	SENT_367	[p22l137t1878r281b1946],
3	.	.	O	.	_	0	SENT_367	[p22l137t1878r281b1946],

1	Accessed	VBN	O	access	_	0	SENT_368	[p22l313t1878r604b1931],
2	20	CD	DATE	20	num	3	SENT_368	[p22l633t1878r706b1931],
3	Jan	NNP	DATE	Jan	dobj	1	SENT_368	[p22l735t1879r836b1931],
4	2013	CD	DATE	2013	num	3	SENT_368	[p22l865t1878r1013b1931],
5	Harris	NNP	PERSON	Harris	nsubj	6	SENT_368	[p22l139t1966r325b2019],
6	BE	VB	O	be	rcmod	3	SENT_368	[p22l362t1967r474b2029],
7	,	,	O	,	_	0	SENT_368	[p22l362t1967r474b2029],
8	Song	NN	ORGANIZATION	song	nn	9	SENT_368	[p22l515t1966r666b2035],
9	R	NN	ORGANIZATION	r	dep	19	SENT_368	[p22l702t1967r767b2029],
10	,	,	O	,	_	0	SENT_368	[p22l702t1967r767b2029],
11	Soong	NNP	ORGANIZATION	Soong	nn	12	SENT_368	[p22l808t1966r998b2035],
12	SJ	NNP	ORGANIZATION	SJ	appos	9	SENT_368	[p22l1036t1966r1120b2029],
13	,	,	O	,	_	0	SENT_368	[p22l1036t1966r1120b2029],
14	Diasio	NNP	O	Diasio	appos	9	SENT_368	[p22l1158t1966r1354b2019],
15	RB	NN	O	rb	dep	19	SENT_368	[p22l1391t1967r1487b2018],
16	(	CD	NUMBER	(	num	15	SENT_368	[p22l1529t1966r1725b2032],
17	1990	CD	DATE	1990	num	19	SENT_368	[p22l1529t1966r1725b2032],
18	)	CD	NUMBER	)	num	19	SENT_368	[p22l1529t1966r1725b2032],
19	Relationship	NN	O	relationship	dep	29	SENT_368	[p22l1763t1966r2147b2035],
20	between	IN	O	between	_	0	SENT_368	[p22l137t2053r391b2106],
21	dihydropyrimidine	NN	O	dihydropyrimidine	nn	23	SENT_368	[p22l427t2053r997b2122],
22	dehydrogenase	NN	O	dehydrogenase	nn	23	SENT_368	[p22l1034t2053r1489b2122],
23	activity	NN	O	activity	prep_between	19	SENT_368	[p22l1527t2053r1753b2122],
24	and	CC	O	and	_	0	SENT_368	[p22l1791t2053r1898b2106],
25	plasma	NN	O	plasma	prep_between	19	SENT_368	[p22l1933t2053r2149b2122],
26	5	CD	NUMBER	5	num	29	SENT_368	[p22l140t2143r556b2196],
27	—	NN	O	—	nn	29	SENT_368	[p22l140t2143r556b2196],
28	ﬂuorouracil	NN	O	ﬂuorouracil	nn	29	SENT_368	[p22l140t2143r556b2196],
29	levels	NNS	O	level	dep	6	SENT_368	[p22l601t2143r776b2196],
30	with	IN	O	with	_	0	SENT_368	[p22l823t2143r957b2196],
31	evidence	NN	O	evidence	prep_with	29	SENT_368	[p22l1002t2143r1271b2196],
32	for	IN	O	for	_	0	SENT_368	[p22l1316t2143r1404b2196],
33	circadian	JJ	O	circadian	amod	34	SENT_368	[p22l1448t2143r1727b2196],
34	variation	NN	O	variation	prep_for	6	SENT_368	[p22l1772t2143r2042b2196],
35	of	IN	O	of	_	0	SENT_368	[p22l2087t2143r2153b2196],
36	enzyme	NN	O	enzyme	nn	37	SENT_368	[p22l139t2248r373b2300],
37	activity	NN	O	activity	prep_of	34	SENT_368	[p22l428t2231r654b2300],
38	and	CC	O	and	_	0	SENT_368	[p22l708t2231r815b2284],
39	plasma	NN	O	plasma	nn	41	SENT_368	[p22l866t2231r1082b2300],
40	drug	NN	O	drug	nn	41	SENT_368	[p22l1134t2231r1271b2300],
41	levels	NNS	O	level	conj_and	37	SENT_368	[p22l1323t2231r1499b2284],
42	in	IN	O	in	_	0	SENT_368	[p22l1552t2231r1610b2283],
43	cancer	NN	O	cancer	nn	44	SENT_368	[p22l1662t2248r1861b2284],
44	patients	NNS	O	patient	prep_in	6	SENT_368	[p22l1911t2231r2146b2300],
45	receiving	VBG	O	receive	xcomp	1	SENT_368	[p22l138t2318r420b2387],
46	5	CD	NUMBER	5	num	48	SENT_368	[p22l452t2318r868b2371],
47	—	NN	O	—	nn	48	SENT_368	[p22l452t2318r868b2371],
48	ﬂuorouracil	NN	O	ﬂuorouracil	dobj	45	SENT_368	[p22l452t2318r868b2371],
49	by	IN	O	by	_	0	SENT_368	[p22l898t2318r973b2387],
50	protracted	JJ	O	protracted	amod	52	SENT_368	[p22l1002t2318r1312b2387],
51	continuous	JJ	O	continuous	amod	52	SENT_368	[p22l1342t2318r1673b2371],
52	infusion	NN	O	infusion	prep_by	45	SENT_368	[p22l1705t2318r1967b2371],
53	.	.	O	.	_	0	SENT_368	[p22l1705t2318r1967b2371],

1	Cancer	NN	O	cancer	_	0	SENT_369	[p22l2002t2318r2146b2371, p22l139t2424r231b2460],
2	Res	NNP	O	Res	dep	1	SENT_369	[p22l257t2409r368b2460],
3	502197-201	CD	NUMBER	502197-201	num	2	SENT_369	[p22l398t2407r752b2461],

1	Joensuu	NNP	LOCATION	Joensuu	nn	2	SENT_370	[p22l138t2497r381b2549],
2	H	NNP	O	H	nsubj	72	SENT_370	[p22l409t2497r478b2559],
3	,	,	O	,	_	0	SENT_370	[p22l409t2497r478b2559],
4	Kellokumpu-Lehtinen	NNP	PERSON	Kellokumpu-Lehtinen	nn	5	SENT_370	[p22l510t2496r1186b2565],
5	PL	NNP	O	PL	appos	2	SENT_370	[p22l1213t2497r1317b2559],
6	,	,	O	,	_	0	SENT_370	[p22l1213t2497r1317b2559],
7	Huovinen	NNP	PERSON	Huovinen	nn	8	SENT_370	[p22l1347t2496r1646b2549],
8	R	NNP	PERSON	R	appos	5	SENT_370	[p22l1673t2497r1738b2559],
9	,	,	O	,	_	0	SENT_370	[p22l1673t2497r1738b2559],
10	JukkolaVuorinen	NNP	O	JukkolaVuorinen	nn	11	SENT_370	[p22l1768t2496r2146b2549, p22l139t2583r331b2636],
11	A	NNP	O	A	appos	5	SENT_370	[p22l360t2584r429b2646],
12	,	,	O	,	_	0	SENT_370	[p22l360t2584r429b2646],
13	Tanner	NNP	PERSON	Tanner	nn	14	SENT_370	[p22l461t2584r677b2636],
14	M	NNP	O	M	appos	5	SENT_370	[p22l703t2584r785b2646],
15	,	,	O	,	_	0	SENT_370	[p22l703t2584r785b2646],
16	Asola	NNP	PERSON	Asola	nn	17	SENT_370	[p22l817t2583r993b2636],
17	R	NNP	PERSON	R	appos	5	SENT_370	[p22l1021t2584r1086b2646],
18	,	,	O	,	_	0	SENT_370	[p22l1021t2584r1086b2646],
19	Kokko	NNP	PERSON	Kokko	nn	20	SENT_370	[p22l1119t2583r1322b2636],
20	R	NNP	PERSON	R	appos	5	SENT_370	[p22l1351t2584r1417b2646],
21	,	,	O	,	_	0	SENT_370	[p22l1351t2584r1417b2646],
22	Ahlgren	NNP	PERSON	Ahlgren	nn	23	SENT_370	[p22l1448t2583r1696b2652],
23	J	NNP	PERSON	J	appos	5	SENT_370	[p22l1724t2584r1752b2636],
24	,	,	O	,	_	0	SENT_370	[p22l1757t2627r1768b2646],
25	Auvinen	NNP	PERSON	Auvinen	nn	26	SENT_370	[p22l1800t2583r2060b2636],
26	P	NN	O	p	appos	5	SENT_370	[p22l2089t2584r2145b2646],
27	,	,	O	,	_	0	SENT_370	[p22l2089t2584r2145b2646],
28	Hemminki	NNP	O	Hemminki	nn	29	SENT_370	[p22l139t2671r462b2724],
29	A	NNP	O	A	appos	5	SENT_370	[p22l485t2672r554b2734],
30	,	,	O	,	_	0	SENT_370	[p22l485t2672r554b2734],
31	Paija	NNP	ORGANIZATION	Paija	nn	32	SENT_370	[p22l578t2671r731b2740],
32	O	NNP	ORGANIZATION	O	appos	5	SENT_370	[p22l753t2672r820b2734],
33	,	,	O	,	_	0	SENT_370	[p22l753t2672r820b2734],
34	Helle	NNP	PERSON	Helle	nn	35	SENT_370	[p22l846t2671r1008b2724],
35	L	NNP	PERSON	L	appos	5	SENT_370	[p22l1031t2672r1092b2734],
36	,	,	O	,	_	0	SENT_370	[p22l1031t2672r1092b2734],
37	Nuortio	NNP	ORGANIZATION	Nuortio	nn	38	SENT_370	[p22l1116t2671r1351b2724],
38	L	NNP	ORGANIZATION	L	appos	5	SENT_370	[p22l1373t2672r1435b2734],
39	,	,	O	,	_	0	SENT_370	[p22l1373t2672r1435b2734],
40	Villman	NNP	O	Villman	nn	41	SENT_370	[p22l1460t2671r1708b2724],
41	K	NNP	O	K	appos	5	SENT_370	[p22l1732t2672r1799b2734],
42	,	,	O	,	_	0	SENT_370	[p22l1732t2672r1799b2734],
43	Nilsson	NNP	PERSON	Nilsson	nn	44	SENT_370	[p22l1823t2671r2055b2724],
44	G	NNP	PERSON	G	appos	5	SENT_370	[p22l2077t2671r2145b2734],
45	,	,	O	,	_	0	SENT_370	[p22l2077t2671r2145b2734],
46	Lahtela	NNP	ORGANIZATION	Lahtela	nn	47	SENT_370	[p22l138t2760r367b2813],
47	SL	NNP	ORGANIZATION	SL	appos	5	SENT_370	[p22l410t2760r511b2823],
48	,	,	O	,	_	0	SENT_370	[p22l410t2760r511b2823],
49	Lehtio	NNP	ORGANIZATION	Lehtio	nn	50	SENT_370	[p22l555t2760r752b2813],
50	K	NNP	ORGANIZATION	K	appos	5	SENT_370	[p22l796t2761r864b2823],
51	,	,	O	,	_	0	SENT_370	[p22l796t2761r864b2823],
52	Pajunen	NNP	O	Pajunen	nn	53	SENT_370	[p22l909t2760r1153b2829],
53	M	NNP	O	M	appos	5	SENT_370	[p22l1194t2761r1275b2823],
54	,	,	O	,	_	0	SENT_370	[p22l1194t2761r1275b2823],
55	Poikonen	NNP	PERSON	Poikonen	nn	56	SENT_370	[p22l1320t2760r1606b2813],
56	P	NN	PERSON	p	appos	5	SENT_370	[p22l1648t2761r1704b2823],
57	,	,	O	,	_	0	SENT_370	[p22l1648t2761r1704b2823],
58	Nyandoto	NNP	O	Nyandoto	nn	59	SENT_370	[p22l1748t2760r2046b2829],
59	P	NN	O	p	appos	5	SENT_370	[p22l2089t2761r2145b2823],
60	,	,	O	,	_	0	SENT_370	[p22l2089t2761r2145b2823],
61	Kataja	NNP	PERSON	Kataja	nn	62	SENT_370	[p22l140t2847r337b2916],
62	V	NNP	O	V	appos	5	SENT_370	[p22l373t2848r442b2910],
63	,	,	O	,	_	0	SENT_370	[p22l373t2848r442b2910],
64	Bono	NNP	PERSON	Bono	nn	65	SENT_370	[p22l482t2848r645b2900],
65	P	NN	PERSON	p	appos	5	SENT_370	[p22l683t2848r739b2910],
66	,	,	O	,	_	0	SENT_370	[p22l683t2848r739b2910],
67	Leinonen	NNP	PERSON	Leinonen	nn	68	SENT_370	[p22l779t2847r1066b2900],
68	M	NNP	O	M	appos	5	SENT_370	[p22l1103t2848r1185b2910],
69	,	,	O	,	_	0	SENT_370	[p22l1103t2848r1185b2910],
70	Lindman	NNP	PERSON	Lindman	nn	71	SENT_370	[p22l1225t2847r1500b2900],
71	H	NNP	O	H	appos	5	SENT_370	[p22l1537t2848r1590b2900],
72	(	VBD	O	(	_	0	SENT_370	[p22l1629t2847r1826b2913],
73	2009	CD	DATE	2009	num	74	SENT_370	[p22l1629t2847r1826b2913],
74	)	CD	NUMBER	)	dobj	72	SENT_370	[p22l1629t2847r1826b2913],
75	Adjuvant	JJ	O	adjuvant	amod	76	SENT_370	[p22l1866t2847r2149b2916],
76	capecitabine	NN	O	capecitabine	tmod	72	SENT_370	[p22l139t2935r519b3004],
77	in	IN	O	in	_	0	SENT_370	[p22l555t2935r613b2988],
78	combination	NN	O	combination	prep_in	76	SENT_370	[p22l648t2935r1029b2988],
79	with	IN	O	with	_	0	SENT_370	[p22l1065t2935r1198b2988],
80	docetaxel	NN	O	docetaxel	prep_with	78	SENT_370	[p22l1235t2935r1525b2988],
81	and	CC	O	and	_	0	SENT_370	[p22l1562t2935r1669b2988],
82	cyclophosphamide	NN	O	cyclophosphamide	prep_with	78	SENT_370	[p22l1706t2935r2146b3004, p22l139t3023r289b3076],
83	plus	CC	O	plus	prep	80	SENT_370	[p22l310t3023r435b3092],
84	epirubicin	NN	O	epirubicin	dep	83	SENT_370	[p22l458t3023r766b3092],
85	for	IN	O	for	_	0	SENT_370	[p22l788t3023r876b3076],
86	breast	NN	O	breast	nn	87	SENT_370	[p22l896t3023r1078b3076],
87	cancer	NN	O	cancer	prep_for	84	SENT_370	[p22l1099t3040r1312b3076],
88	:	:	O	:	_	0	SENT_370	[p22l1099t3040r1312b3076],
89	an	DT	O	a	det	94	SENT_370	[p22l1342t3040r1410b3076],
90	open-label	JJ	O	open-label	amod	94	SENT_370	[p22l1433t3023r1769b3092],
91	,	,	O	,	_	0	SENT_370	[p22l1433t3023r1769b3092],
92	randomised	JJ	O	randomised	amod	94	SENT_370	[p22l1793t3023r2148b3076],
93	controlled	JJ	O	controlled	amod	94	SENT_370	[p22l139t3113r447b3166],
94	trial	NN	O	trial	dep	76	SENT_370	[p22l491t3113r628b3166],
95	.	.	O	.	_	0	SENT_370	[p22l491t3113r628b3166],

1	Lancet	NNP	O	Lancet	nn	2	SENT_371	[p22l676t3114r884b3166],
2	Oncol	NNP	O	Oncol	_	0	SENT_371	[p22l929t3113r1112b3166],
3	10:1145	CD	NUMBER	10:1145	num	2	SENT_371	[p22l1164t3113r1610b3166],
4	—	CD	NUMBER	—	number	5	SENT_371	[p22l1164t3113r1610b3166],
5	1151	CD	DATE	1151	num	2	SENT_371	[p22l1164t3113r1610b3166],
6	.	.	O	.	_	0	SENT_371	[p22l1164t3113r1610b3166],

1	doi	FW	O	doi	_	0	SENT_372	[p22l1659t3113r2145b3166],
2	:	:	O	:	_	0	SENT_372	[p22l1659t3113r2145b3166],
3	S1470-2045	NN	O	s1470-2045	dep	1	SENT_372	[p22l1659t3113r2145b3166],

1	(	NN	O	(	dep	6	SENT_373	[p22l141t3202r515b3267],
2	09	CD	NUMBER	09	num	3	SENT_373	[p22l141t3202r515b3267],
3	)	CD	NUMBER	)	dep	1	SENT_373	[p22l141t3202r515b3267],
4	70307-9	CD	NUMBER	70307-9	num	5	SENT_373	[p22l141t3202r515b3267],
5	Laheru	NN	O	laheru	dep	6	SENT_373	[p22l138t3289r353b3342],
6	D	NN	O	d	dep	46	SENT_373	[p22l382t3291r450b3352],
7	,	,	O	,	_	0	SENT_373	[p22l382t3291r450b3352],
8	Croghan	NNP	PERSON	Croghan	nn	9	SENT_373	[p22l483t3289r743b3358],
9	G	NNP	PERSON	G	appos	6	SENT_373	[p22l773t3290r840b3352],
10	,	,	O	,	_	0	SENT_373	[p22l773t3290r840b3352],
11	Bukowski	NNP	PERSON	Bukowski	nn	12	SENT_373	[p22l871t3289r1177b3343],
12	R	NNP	PERSON	R	appos	6	SENT_373	[p22l1207t3291r1272b3352],
13	,	,	O	,	_	0	SENT_373	[p22l1207t3291r1272b3352],
14	Rudek	NNP	PERSON	Rudek	nn	15	SENT_373	[p22l1304t3289r1502b3342],
15	M	NNP	O	M	appos	6	SENT_373	[p22l1529t3291r1611b3352],
16	,	,	O	,	_	0	SENT_373	[p22l1529t3291r1611b3352],
17	Messersmith	NNP	PERSON	Messersmith	nn	18	SENT_373	[p22l1642t3289r2030b3342],
18	W	NNP	O	W	appos	6	SENT_373	[p22l2058t3291r2145b3352],
19	,	,	O	,	_	0	SENT_373	[p22l2058t3291r2145b3352],
20	Erlichman	NNP	PERSON	Erlichman	nn	21	SENT_373	[p22l138t3377r455b3431],
21	C	NNP	O	C	appos	6	SENT_373	[p22l483t3378r547b3440],
22	,	,	O	,	_	0	SENT_373	[p22l483t3378r547b3440],
23	Pelley	NNP	PERSON	Pelley	nn	24	SENT_373	[p22l577t3378r766b3446],
24	R	NNP	PERSON	R	appos	6	SENT_373	[p22l794t3379r859b3440],
25	,	,	O	,	_	0	SENT_373	[p22l794t3379r859b3440],
26	Jimeno	NNP	PERSON	Jimeno	nn	27	SENT_373	[p22l888t3377r1106b3431],
27	A	NNP	O	A	appos	6	SENT_373	[p22l1134t3378r1203b3441],
28	,	,	O	,	_	0	SENT_373	[p22l1134t3378r1203b3441],
29	Donehower	NNP	PERSON	Donehower	nn	30	SENT_373	[p22l1233t3377r1588b3431],
30	R	NNP	PERSON	R	appos	6	SENT_373	[p22l1614t3379r1679b3440],
31	,	,	O	,	_	0	SENT_373	[p22l1614t3379r1679b3440],
32	Boni	NNP	PERSON	Boni	nn	33	SENT_373	[p22l1709t3377r1854b3431],
33	J	NNP	PERSON	J	appos	6	SENT_373	[p22l1882t3379r1910b3431],
34	,	,	O	,	_	0	SENT_373	[p22l1914t3422r1925b3440],
35	Abbas	NNP	PERSON	Abbas	nn	36	SENT_373	[p22l1955t3377r2147b3431],
36	R	NNP	PERSON	R	appos	6	SENT_373	[p22l138t3466r203b3528],
37	,	,	O	,	_	0	SENT_373	[p22l138t3466r203b3528],
38	Martins	NNP	ORGANIZATION	Martins	nn	39	SENT_373	[p22l233t3465r467b3518],
39	P	NN	ORGANIZATION	p	appos	6	SENT_373	[p22l496t3466r552b3528],
40	,	,	O	,	_	0	SENT_373	[p22l496t3466r552b3528],
41	Zacharchuk	NN	O	zacharchuk	nn	42	SENT_373	[p22l582t3465r943b3518],
42	C	NN	O	c	appos	6	SENT_373	[p22l969t3466r1033b3528],
43	,	,	O	,	_	0	SENT_373	[p22l969t3466r1033b3528],
44	Hidalgo	NNP	PERSON	Hidalgo	nn	45	SENT_373	[p22l1063t3465r1306b3534],
45	M	NNP	O	M	appos	6	SENT_373	[p22l1334t3466r1400b3518],
46	(	VBD	O	(	_	0	SENT_373	[p22l1429t3465r1626b3531],
47	2008	CD	DATE	2008	num	48	SENT_373	[p22l1429t3465r1626b3531],
48	)	CD	NUMBER	)	dobj	46	SENT_373	[p22l1429t3465r1626b3531],
49	A	DT	O	a	det	50	SENT_373	[p22l1655t3466r1709b3518],
50	phase	NN	O	phase	dep	46	SENT_373	[p22l1734t3465r1907b3534],
51	I	PRP	O	I	nsubj	52	SENT_373	[p22l1934t3466r1958b3518],
52	study	VBP	O	study	rcmod	50	SENT_373	[p22l1987t3465r2147b3534],

1	@	IN	O	@	_	0	SENT_374	[p23l6t88r83b183],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_374	[p23l113t111r375b186],
3	of	IN	O	of	_	0	SENT_374	[p23l138t198r204b252],
4	EKB	NNP	O	EKB	prep_of	2	SENT_374	[p23l233t198r521b252],
5	—	CD	NUMBER	—	number	6	SENT_374	[p23l233t198r521b252],
6	569	CD	NUMBER	569	npadvmod	4	SENT_374	[p23l233t198r521b252],
7	in	IN	O	in	_	0	SENT_374	[p23l558t199r615b251],
8	combination	NN	O	combination	prep_in	4	SENT_374	[p23l651t198r1031b252],
9	with	IN	O	with	_	0	SENT_374	[p23l1066t198r1200b252],
10	capecitabine	NN	O	capecitabine	prep_with	8	SENT_374	[p23l1235t198r1614b267],
11	in	IN	O	in	_	0	SENT_374	[p23l1650t199r1708b251],
12	patients	NNS	O	patient	prep_in	10	SENT_374	[p23l1741t198r1977b267],
13	with	IN	O	with	_	0	SENT_374	[p23l2014t198r2147b252],
14	advanced	JJ	O	advanced	amod	16	SENT_374	[p23l139t287r424b340],
15	colorectal	JJ	O	colorectal	amod	16	SENT_374	[p23l450t287r748b340],
16	cancer	NN	O	cancer	prep_with	12	SENT_374	[p23l775t304r987b340],
17	.	.	O	.	_	0	SENT_374	[p23l775t304r987b340],

1	Clin	NNP	O	Clin	nn	3	SENT_375	[p23l1017t287r1146b340],
2	Cancer	NNP	O	Cancer	nn	3	SENT_375	[p23l1171t288r1387b340],
3	Res	NNP	O	Res	_	0	SENT_375	[p23l1410t288r1521b340],
4	14:5602	CD	NUMBER	14:5602	num	3	SENT_375	[p23l1555t287r2001b341],
5	—	CD	NUMBER	—	number	6	SENT_375	[p23l1555t287r2001b341],
6	5609	CD	NUMBER	5609	num	3	SENT_375	[p23l1555t287r2001b341],
7	.	.	O	.	_	0	SENT_375	[p23l1555t287r2001b341],

1	doi	FW	O	doi	_	0	SENT_376	[p23l2031t287r2141b340],
2	:	:	O	:	_	0	SENT_376	[p23l2031t287r2141b340],
3	10.1158	CD	NUMBER	10.1158	dep	1	SENT_376	[p23l144t376r1181b430],
4	/	:	O	/	punct	5	SENT_376	[p23l144t376r1181b430],
5	1078-0432	CD	DURATION	1078-0432	dep	3	SENT_376	[p23l144t376r1181b430],
6	.	.	O	.	_	0	SENT_376	[p23l144t376r1181b430],

1	CCR-08-0433	NN	O	ccr-08-0433	nn	3	SENT_377	[p23l144t376r1181b430],
2	Leonard	NNP	PERSON	Leonard	nn	3	SENT_377	[p23l136t464r390b518],
3	R	NNP	PERSON	R	nsubj	13	SENT_377	[p23l429t466r494b527],
4	,	,	O	,	_	0	SENT_377	[p23l429t466r494b527],
5	Hennessy	NNP	PERSON	Hennessy	nn	6	SENT_377	[p23l537t466r830b533],
6	BT	NNP	O	BT	appos	3	SENT_377	[p23l870t466r981b527],
7	,	,	O	,	_	0	SENT_377	[p23l870t466r981b527],
8	Blum	NNP	PERSON	Blum	nn	9	SENT_377	[p23l1024t465r1193b518],
9	JL	NNP	O	JL	appos	3	SENT_377	[p23l1231t466r1321b527],
10	,	,	O	,	_	0	SENT_377	[p23l1231t466r1321b527],
11	O’Shaughnessy	NNP	O	O’Shaughnessy	nn	12	SENT_377	[p23l1365t465r1839b533],
12	J	NNP	O	J	appos	3	SENT_377	[p23l1879t466r1907b518],
13	(	VBD	O	(	_	0	SENT_377	[p23l1948t465r2145b530],
14	2011	CD	DATE	2011	num	15	SENT_377	[p23l1948t465r2145b530],
15	)	CD	NUMBER	)	dobj	13	SENT_377	[p23l1948t465r2145b530],
16	Dose-adjusting	JJ	O	dose-adjusting	amod	17	SENT_377	[p23l137t552r596b621],
17	capecitabine	NN	O	capecitabine	nsubj	18	SENT_377	[p23l648t552r1028b621],
18	minimizes	VBZ	O	minimize	dep	13	SENT_377	[p23l1078t552r1394b605],
19	adverse	JJ	O	adverse	amod	20	SENT_377	[p23l1448t552r1676b605],
20	effects	NNS	O	effect	dobj	18	SENT_377	[p23l1727t552r1927b605],
21	While	IN	O	while	mark	22	SENT_377	[p23l1979t552r2146b605],
22	maintaining	VBG	O	maintain	dep	18	SENT_377	[p23l137t640r500b709],
23	efﬁcacy	NN	O	efﬁcacy	dobj	22	SENT_377	[p23l534t640r789b709],
24	:	:	O	:	_	0	SENT_377	[p23l534t640r789b709],
25	a	DT	O	a	det	27	SENT_377	[p23l828t657r859b693],
26	retrospective	JJ	O	retrospective	amod	27	SENT_377	[p23l889t640r1283b709],
27	review	NN	O	review	dep	23	SENT_377	[p23l1315t640r1521b693],
28	of	IN	O	of	_	0	SENT_377	[p23l1555t640r1620b693],
29	capecitabine	NN	O	capecitabine	prep_of	27	SENT_377	[p23l1647t640r2027b709],
30	for	IN	O	for	_	0	SENT_377	[p23l2060t640r2149b693],
31	metastatic	JJ	O	metastatic	amod	33	SENT_377	[p23l137t729r445b783],
32	breast	NN	O	breast	nn	33	SENT_377	[p23l472t730r654b783],
33	cancer	NN	O	cancer	prep_for	22	SENT_377	[p23l680t746r892b783],
34	.	.	O	.	_	0	SENT_377	[p23l680t746r892b783],

1	Clinical	JJ	O	clinical	amod	3	SENT_378	[p23l924t729r1164b783],
2	breast	NN	O	breast	nn	3	SENT_378	[p23l1190t730r1372b783],
3	cancer	NN	O	cancer	_	0	SENT_378	[p23l1398t746r1597b783],
4	11:349	CD	NUMBER	11:349	number	5	SENT_378	[p23l1629t729r1999b783],
5	-356	CD	NUMBER	-356	num	3	SENT_378	[p23l1629t729r1999b783],
6	.	.	O	.	_	0	SENT_378	[p23l1629t729r1999b783],

1	doi	FW	O	doi	_	0	SENT_379	[p23l2031t730r2141b783],
2	:	:	O	:	_	0	SENT_379	[p23l2031t730r2141b783],
3	10.1016	CD	NUMBER	10.1016	dep	1	SENT_379	[p23l144t819r969b887],
4	/	:	O	/	punct	1	SENT_379	[p23l144t819r969b887],
5	j.	NN	O	j.	nn	6	SENT_379	[p23l144t819r969b887],
6	clbc	NN	O	clbc	nsubj	30	SENT_379	[p23l144t819r969b887],
7	.20	CD	NUMBER	.20	num	8	SENT_379	[p23l144t819r969b887],
8	l1	NN	O	l1	dep	6	SENT_379	[p23l144t819r969b887],
9	.06.005	CD	NUMBER	.06.005	num	11	SENT_379	[p23l144t819r969b887],
10	Leonard	NNP	ORGANIZATION	Leonard	nn	11	SENT_379	[p23l136t906r390b959],
11	RC	NNP	ORGANIZATION	RC	dep	6	SENT_379	[p23l419t907r535b969],
12	,	,	O	,	_	0	SENT_379	[p23l419t907r535b969],
13	Twelves	NNP	O	Twelves	nn	14	SENT_379	[p23l568t906r824b960],
14	C	NNP	O	C	appos	11	SENT_379	[p23l856t907r920b969],
15	,	,	O	,	_	0	SENT_379	[p23l856t907r920b969],
16	Breddy	NNP	PERSON	Breddy	nn	17	SENT_379	[p23l952t906r1174b975],
17	J	NNP	PERSON	J	appos	11	SENT_379	[p23l1205t908r1248b969],
18	,	,	O	,	_	0	SENT_379	[p23l1205t908r1248b969],
19	Chaturvedi	NNP	PERSON	Chaturvedi	nn	20	SENT_379	[p23l1282t906r1617b960],
20	A	NNP	O	A	appos	11	SENT_379	[p23l1649t907r1718b969],
21	,	,	O	,	_	0	SENT_379	[p23l1649t907r1718b969],
22	Hutcheon	NNP	PERSON	Hutcheon	nn	23	SENT_379	[p23l1751t906r2045b959],
23	A	NNP	O	A	appos	11	SENT_379	[p23l2075t907r2144b969],
24	,	,	O	,	_	0	SENT_379	[p23l2075t907r2144b969],
25	Salazar	NNP	PERSON	Salazar	nn	26	SENT_379	[p23l139t994r361b1048],
26	R	NNP	O	R	appos	11	SENT_379	[p23l393t996r458b1057],
27	,	,	O	,	_	0	SENT_379	[p23l393t996r458b1057],
28	Cameron	NNP	PERSON	Cameron	nn	29	SENT_379	[p23l494t995r771b1048],
29	D	NNP	PERSON	D	appos	11	SENT_379	[p23l804t996r856b1047],
30	(	VBD	O	(	dep	1	SENT_379	[p23l891t995r1088b1060],
31	2002	CD	DATE	2002	num	33	SENT_379	[p23l891t995r1088b1060],
32	)	CD	NUMBER	)	num	33	SENT_379	[p23l891t995r1088b1060],
33	Capecitabine	NN	O	capecitabine	dobj	30	SENT_379	[p23l1124t994r1520b1063],
34	named	VBN	O	name	partmod	33	SENT_379	[p23l1553t994r1990b1063],
35	—	JJ	O	—	amod	37	SENT_379	[p23l1553t994r1990b1063],
36	patient	NN	O	patient	nn	37	SENT_379	[p23l1553t994r1990b1063],
37	programme	NN	O	programme	dobj	34	SENT_379	[p23l2021t1011r2145b1063, p23l138t1099r385b1151],
38	for	IN	O	for	_	0	SENT_379	[p23l414t1083r502b1136],
39	patients	NNS	O	patient	prep_for	37	SENT_379	[p23l527t1083r763b1151],
40	with	IN	O	with	_	0	SENT_379	[p23l793t1083r926b1136],
41	advanced	JJ	O	advanced	amod	43	SENT_379	[p23l955t1083r1241b1136],
42	breast	NN	O	breast	nn	43	SENT_379	[p23l1268t1083r1450b1136],
43	cancer	NN	O	cancer	prep_with	34	SENT_379	[p23l1478t1099r1691b1136],
44	:	:	O	:	_	0	SENT_379	[p23l1478t1099r1691b1136],
45	the	DT	O	the	det	47	SENT_379	[p23l1724t1083r1815b1136],
46	UK	NNP	LOCATION	UK	nn	47	SENT_379	[p23l1844t1084r1953b1136],
47	experience	NN	O	experience	dobj	34	SENT_379	[p23l1980t1099r2145b1151, p23l136t1172r337b1225],
48	.	.	O	.	_	0	SENT_379	[p23l1980t1099r2145b1151, p23l136t1172r337b1225],

1	Eur	NNP	MISC	Eur	nn	3	SENT_380	[p23l368t1173r478b1225],
2	J	NNP	MISC	J	nn	3	SENT_380	[p23l505t1173r532b1225],
3	Cancer	NNP	MISC	Cancer	nsubj	30	SENT_380	[p23l560t1172r775b1225],
4	38:2020	CD	NUMBER	38:2020	num	5	SENT_380	[p23l804t1172r1240b1225],
5	—	CD	NUMBER	—	dep	3	SENT_380	[p23l804t1172r1240b1225],
6	2024	CD	DATE	2024	num	8	SENT_380	[p23l804t1172r1240b1225],
7	Marsh	NNP	O	Marsh	nn	8	SENT_380	[p23l137t1260r330b1314],
8	S	NN	O	s	dep	3	SENT_380	[p23l359t1261r413b1324],
9	,	,	O	,	_	0	SENT_380	[p23l359t1261r413b1324],
10	Xiao	NNP	O	Xiao	nn	11	SENT_380	[p23l443t1260r589b1314],
11	M	NNP	O	M	appos	8	SENT_380	[p23l617t1262r699b1324],
12	,	,	O	,	_	0	SENT_380	[p23l617t1262r699b1324],
13	Yu	NNP	PERSON	Yu	nn	14	SENT_380	[p23l730t1262r820b1314],
14	J	NNP	PERSON	J	appos	8	SENT_380	[p23l847t1262r875b1314],
15	,	,	O	,	_	0	SENT_380	[p23l880t1305r892b1324],
16	Ahluwalia	NNP	PERSON	Ahluwalia	nn	17	SENT_380	[p23l921t1260r1238b1314],
17	R	NNP	PERSON	R	appos	8	SENT_380	[p23l1265t1262r1330b1323],
18	,	,	O	,	_	0	SENT_380	[p23l1265t1262r1330b1323],
19	Minton	NNP	PERSON	Minton	nn	20	SENT_380	[p23l1360t1260r1583b1314],
20	M	NNP	O	M	appos	8	SENT_380	[p23l1611t1262r1692b1324],
21	,	,	O	,	_	0	SENT_380	[p23l1611t1262r1692b1324],
22	Freimuth	NNP	ORGANIZATION	Freimuth	nn	23	SENT_380	[p23l1722t1260r2001b1314],
23	RR	NNP	ORGANIZATION	RR	appos	8	SENT_380	[p23l2028t1262r2144b1324],
24	,	,	O	,	_	0	SENT_380	[p23l2028t1262r2144b1324],
25	Kwok	NNP	PERSON	Kwok	nn	26	SENT_380	[p23l138t1349r322b1402],
26	PY	NNP	PERSON	PY	appos	8	SENT_380	[p23l348t1350r459b1412],
27	,	,	O	,	_	0	SENT_380	[p23l348t1350r459b1412],
28	McLeod	NNP	PERSON	McLeod	nn	29	SENT_380	[p23l488t1349r746b1402],
29	HL	NNS	O	hl	appos	8	SENT_380	[p23l773t1350r872b1401],
30	(	VBP	O	(	_	0	SENT_380	[p23l901t1349r1098b1414],
31	2004	CD	DATE	2004	num	32	SENT_380	[p23l901t1349r1098b1414],
32	)	CD	NUMBER	)	nn	34	SENT_380	[p23l901t1349r1098b1414],
33	Pharmacogenomic	JJ	O	pharmacogenomic	amod	34	SENT_380	[p23l1127t1348r1693b1417],
34	assessment	NN	O	assessment	dobj	30	SENT_380	[p23l1723t1357r2059b1402],
35	of	IN	O	of	_	0	SENT_380	[p23l2087t1348r2152b1402],
36	carboxylesterases	NNS	O	carboxylesterase	prep_of	34	SENT_380	[p23l138t1437r672b1505],
37	1	CD	NUMBER	1	num	36	SENT_380	[p23l714t1437r736b1489],
38	and	CC	O	and	_	0	SENT_380	[p23l778t1437r885b1490],
39	2	CD	NUMBER	2	prep_of	34	SENT_380	[p23l919t1437r969b1490],
40	.	.	O	.	_	0	SENT_380	[p23l919t1437r969b1490],

1	Genomics	NNS	O	genomic	_	0	SENT_381	[p23l1007t1437r1311b1490],
2	84:661	CD	NUMBER	84:661	num	1	SENT_381	[p23l1349t1437r1724b1490],
3	-668	CD	NUMBER	-668	num	1	SENT_381	[p23l1349t1437r1724b1490],
4	.	.	O	.	_	0	SENT_381	[p23l1349t1437r1724b1490],

1	doi	FW	O	doi	_	0	SENT_382	[p23l1762t1437r2148b1490],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_382	[p23l1762t1437r2148b1490],
3	/	:	O	/	punct	1	SENT_382	[p23l1762t1437r2148b1490],
4	j.	NN	O	j.	nn	5	SENT_382	[p23l130t1524r759b1593],
5	ygeno	NN	O	ygeno	dep	1	SENT_382	[p23l130t1524r759b1593],
6	.2004.07.008	CD	NUMBER	.2004.07.008	dep	5	SENT_382	[p23l130t1524r759b1593],
7	Mata	NNP	O	Mata	nn	8	SENT_382	[p23l137t1614r293b1666],
8	JF	NNP	O	JF	dep	6	SENT_382	[p23l318t1614r404b1675],
9	,	,	O	,	_	0	SENT_382	[p23l318t1614r404b1675],
10	Garcia	NNP	PERSON	Garcia	appos	6	SENT_382	[p23l434t1612r949b1681],
11	.	.	O	.	_	0	SENT_382	[p23l434t1612r949b1681],

1	—	NN	O	—	_	0	SENT_383	[p23l434t1612r949b1681],
2	.	.	O	.	_	0	SENT_383	[p23l434t1612r949b1681],

1	Manteiga	NNP	O	Manteiga	nn	2	SENT_384	[p23l434t1612r949b1681],
2	JM	NN	O	jm	_	0	SENT_384	[p23l975t1614r1086b1675],
3	,	,	O	,	_	0	SENT_384	[p23l975t1614r1086b1675],
4	Lostao	NNP	O	Lostao	nn	5	SENT_384	[p23l1114t1614r1319b1666],
5	MP	NNP	O	MP	appos	2	SENT_384	[p23l1346t1614r1471b1675],
6	,	,	O	,	_	0	SENT_384	[p23l1346t1614r1471b1675],
7	Fernandez	NNP	PERSON	Fernandez	appos	5	SENT_384	[p23l1499t1612r2060b1666],
8	.	.	O	.	_	0	SENT_384	[p23l1499t1612r2060b1666],

1	—	NN	O	—	_	0	SENT_385	[p23l1499t1612r2060b1666],
2	.	.	O	.	_	0	SENT_385	[p23l1499t1612r2060b1666],

1	Veledo	NNP	O	Veledo	nn	2	SENT_386	[p23l1499t1612r2060b1666],
2	S	NNP	O	S	_	0	SENT_386	[p23l2090t1613r2144b1675],
3	,	,	O	,	_	0	SENT_386	[p23l2090t1613r2144b1675],
4	Guillen	NNP	PERSON	Guillen	appos	2	SENT_386	[p23l138t1701r609b1754],
5	.	.	O	.	_	0	SENT_386	[p23l138t1701r609b1754],

1	—	NN	O	—	_	0	SENT_387	[p23l138t1701r609b1754],
2	.	.	O	.	_	0	SENT_387	[p23l138t1701r609b1754],

1	Gomez	NNP	PERSON	Gomez	nn	2	SENT_388	[p23l138t1701r609b1754],
2	E	NNP	O	E	nsubj	15	SENT_388	[p23l642t1702r703b1764],
3	,	,	O	,	_	0	SENT_388	[p23l642t1702r703b1764],
4	Larrayoz	NNP	O	Larrayoz	nn	5	SENT_388	[p23l737t1702r1010b1769],
5	IM	NNP	O	IM	appos	2	SENT_388	[p23l1043t1702r1150b1764],
6	,	,	O	,	_	0	SENT_388	[p23l1043t1702r1150b1764],
7	Lloberas	NNP	PERSON	Lloberas	nn	8	SENT_388	[p23l1184t1701r1448b1754],
8	J	NNP	PERSON	J	appos	2	SENT_388	[p23l1481t1702r1525b1764],
9	,	,	O	,	_	0	SENT_388	[p23l1481t1702r1525b1764],
10	Casado	NNP	O	Casado	nn	11	SENT_388	[p23l1560t1701r1781b1754],
11	FJ	NNP	O	FJ	appos	2	SENT_388	[p23l1813t1702r1899b1764],
12	,	,	O	,	_	0	SENT_388	[p23l1813t1702r1899b1764],
13	PastorAnglada	NNP	O	PastorAnglada	nn	14	SENT_388	[p23l1933t1702r2145b1754, p23l137t1789r395b1858],
14	M	NNP	O	M	appos	2	SENT_388	[p23l425t1790r490b1841],
15	(	VBD	O	(	_	0	SENT_388	[p23l524t1789r721b1854],
16	2001	CD	DATE	2001	num	18	SENT_388	[p23l524t1789r721b1854],
17	)	CD	NUMBER	)	num	18	SENT_388	[p23l524t1789r721b1854],
18	Role	NN	O	role	dobj	15	SENT_388	[p23l754t1789r896b1842],
19	of	IN	O	of	_	0	SENT_388	[p23l928t1789r994b1842],
20	the	DT	O	the	det	27	SENT_388	[p23l1020t1789r1111b1842],
21	human	JJ	O	human	amod	27	SENT_388	[p23l1142t1789r1349b1842],
22	concentrative	JJ	O	concentrative	amod	27	SENT_388	[p23l1381t1789r1790b1842],
23	nucleoside	NN	O	nucleoside	nn	27	SENT_388	[p23l1822t1789r2146b1842],
24	transporter	NN	O	transporter	nn	27	SENT_388	[p23l137t1884r467b1945],
25	(	CD	NUMBER	(	num	27	SENT_388	[p23l491t1877r763b1942],
26	hCNT1	NN	O	hcnt1	nn	27	SENT_388	[p23l491t1877r763b1942],
27	)	NN	O	)	prep_of	18	SENT_388	[p23l491t1877r763b1942],
28	in	IN	O	in	_	0	SENT_388	[p23l788t1876r845b1929],
29	the	DT	O	the	det	31	SENT_388	[p23l867t1877r958b1930],
30	cytotoxic	JJ	O	cytotoxic	amod	31	SENT_388	[p23l981t1876r1262b1945],
31	action	NN	O	action	prep_in	27	SENT_388	[p23l1287t1876r1471b1930],
32	of	IN	O	of	_	0	SENT_388	[p23l1494t1876r1559b1930],
33	5	CD	NUMBER	5	number	34	SENT_388	[p23l1577t1876r2144b1945],
34	[	CD	NUMBER	[	num	36	SENT_388	[p23l1577t1876r2144b1945],
35	Prime	NNP	O	Prime	nn	36	SENT_388	[p23l1577t1876r2144b1945],
36	]	NN	O	]	prep_of	31	SENT_388	[p23l1577t1876r2144b1945],
37	.	.	O	.	_	0	SENT_388	[p23l1577t1876r2144b1945],

1	—	NN	O	—	_	0	SENT_389	[p23l1577t1876r2144b1945],
2	.	.	O	.	_	0	SENT_389	[p23l1577t1876r2144b1945],

1	deoXy	NN	O	deoxy	_	0	SENT_390	[p23l1577t1876r2144b1945],
2	.	.	O	.	_	0	SENT_390	[p23l1577t1876r2144b1945],

1	—	NN	O	—	_	0	SENT_391	[p23l1577t1876r2144b1945],
2	.	.	O	.	_	0	SENT_391	[p23l1577t1876r2144b1945],

1	5	CD	NUMBER	5	num	2	SENT_392	[p23l1577t1876r2144b1945],
2	ﬂuorouridine	NN	O	ﬂuorouridine	_	0	SENT_392	[p23l138t1966r549b2029],
3	,	,	O	,	_	0	SENT_392	[p23l138t1966r549b2029],
4	an	DT	O	a	det	7	SENT_392	[p23l575t1982r644b2019],
5	active	JJ	O	active	amod	7	SENT_392	[p23l666t1966r845b2019],
6	intermediate	JJ	O	intermediate	amod	7	SENT_392	[p23l867t1966r1247b2019],
7	metabolite	NN	O	metabolite	appos	2	SENT_392	[p23l1269t1966r1590b2019],
8	of	IN	O	of	_	0	SENT_392	[p23l1612t1966r1678b2019],
9	capecitabine	NN	O	capecitabine	prep_of	7	SENT_392	[p23l1694t1966r2092b2034],
10	,	,	O	,	_	0	SENT_392	[p23l1694t1966r2092b2034],
11	a	DT	O	a	det	15	SENT_392	[p23l2116t1982r2148b2019],
12	novel	JJ	O	novel	amod	15	SENT_392	[p23l137t2054r304b2107],
13	oral	JJ	O	oral	amod	15	SENT_392	[p23l333t2054r449b2107],
14	anticancer	JJ	O	anticancer	amod	15	SENT_392	[p23l479t2054r791b2107],
15	drug	NN	O	drug	appos	2	SENT_392	[p23l819t2054r970b2123],
16	.	.	O	.	_	0	SENT_392	[p23l819t2054r970b2123],

1	Mol	NNP	O	Mol	nn	2	SENT_393	[p23l1002t2054r1126b2107],
2	Pharmacol	NNP	O	Pharmacol	nsubj	8	SENT_393	[p23l1154t2054r1478b2107],
3	59:1542	CD	NUMBER	59:1542	num	7	SENT_393	[p23l1508t2054r1942b2108],
4	—	CD	NUMBER	—	num	7	SENT_393	[p23l1508t2054r1942b2108],
5	1548	CD	DATE	1548	num	7	SENT_393	[p23l1508t2054r1942b2108],
6	Miller	NNP	ORGANIZATION	Miller	nn	7	SENT_393	[p23l136t2142r328b2195],
7	AA	NNP	ORGANIZATION	AA	dep	2	SENT_393	[p23l350t2142r458b2194],
8	(	VBD	O	(	_	0	SENT_393	[p23l485t2142r681b2207],
9	2002	CD	DATE	2002	num	10	SENT_393	[p23l485t2142r681b2207],
10	)	CD	NUMBER	)	dobj	8	SENT_393	[p23l485t2142r681b2207],
11	Body	NN	O	body	nn	13	SENT_393	[p23l708t2142r870b2211],
12	surface	NN	O	surface	nn	13	SENT_393	[p23l897t2142r1113b2195],
13	area	NN	O	area	npadvmod	8	SENT_393	[p23l1139t2159r1264b2195],
14	in	IN	O	in	_	0	SENT_393	[p23l1288t2142r1345b2194],
15	dosing	NN	O	dosing	nn	17	SENT_393	[p23l1370t2142r1570b2211],
16	anticancer	JJ	O	anticancer	amod	17	SENT_393	[p23l1597t2142r1909b2195],
17	agents	NNS	O	agent	prep_in	8	SENT_393	[p23l1934t2150r2141b2211],
18	:	:	O	:	_	0	SENT_393	[p23l1934t2150r2141b2211],
19	scratch	VB	O	scratch	parataxis	8	SENT_393	[p23l140t2231r352b2284],
20	the	DT	O	the	det	21	SENT_393	[p23l379t2231r470b2284],
21	surface	NN	O	surface	dobj	19	SENT_393	[p23l501t2231r736b2284],
22	!	.	O	!	_	0	SENT_393	[p23l501t2231r736b2284],

1	J	NNP	O	J	nn	4	SENT_394	[p23l769t2232r797b2284],
2	Natl	NNP	O	Natl	nn	4	SENT_394	[p23l824t2231r954b2284],
3	Cancer	NNP	O	Cancer	nn	4	SENT_394	[p23l983t2231r1198b2284],
4	Inst	NNP	O	Inst	_	0	SENT_394	[p23l1224t2232r1337b2284],
5	94	CD	NUMBER	94	dep	4	SENT_394	[p23l1365t2231r1798b2285],
6	:	:	O	:	_	0	SENT_394	[p23l1365t2231r1798b2285],
7	l822	CD	NUMBER	l822	num	11	SENT_394	[p23l1365t2231r1798b2285],
8	—	CD	NUMBER	—	num	11	SENT_394	[p23l1365t2231r1798b2285],
9	1823	CD	DATE	1823	num	11	SENT_394	[p23l1365t2231r1798b2285],
10	Muss	NNP	O	Muss	nn	11	SENT_394	[p23l136t2320r298b2372],
11	HB	NNP	O	HB	dep	85	SENT_394	[p23l319t2320r439b2382],
12	,	,	O	,	_	0	SENT_394	[p23l319t2320r439b2382],
13	Berry	NNP	PERSON	Berry	nn	14	SENT_394	[p23l462t2320r633b2388],
14	DA	NNP	PERSON	DA	appos	11	SENT_394	[p23l653t2319r776b2382],
15	,	,	O	,	_	0	SENT_394	[p23l653t2319r776b2382],
16	Cirrincione	NNP	PERSON	Cirrincione	nn	17	SENT_394	[p23l800t2319r1145b2372],
17	CT	NNP	O	CT	appos	11	SENT_394	[p23l1166t2319r1277b2382],
18	,	,	O	,	_	0	SENT_394	[p23l1166t2319r1277b2382],
19	Theodoulou	NNP	O	Theodoulou	nn	20	SENT_394	[p23l1300t2319r1666b2372],
20	M	NNP	O	M	appos	11	SENT_394	[p23l1686t2320r1769b2382],
21	,	,	O	,	_	0	SENT_394	[p23l1686t2320r1769b2382],
22	Mauer	NNP	ORGANIZATION	Mauer	nn	23	SENT_394	[p23l1790t2320r1989b2372],
23	AM	NNP	ORGANIZATION	AM	appos	11	SENT_394	[p23l2007t2319r2144b2382],
24	,	,	O	,	_	0	SENT_394	[p23l2007t2319r2144b2382],
25	Kornblith	NNP	ORGANIZATION	Kornblith	nn	26	SENT_394	[p23l138t2407r432b2460],
26	AB	NNP	ORGANIZATION	AB	appos	11	SENT_394	[p23l453t2407r573b2470],
27	,	,	O	,	_	0	SENT_394	[p23l453t2407r573b2470],
28	Partridge	NNP	ORGANIZATION	Partridge	nn	29	SENT_394	[p23l597t2407r874b2476],
29	AH	NNP	O	AH	appos	11	SENT_394	[p23l896t2407r1020b2470],
30	,	,	O	,	_	0	SENT_394	[p23l896t2407r1020b2470],
31	Dressler	NNP	ORGANIZATION	Dressler	nn	32	SENT_394	[p23l1044t2407r1297b2460],
32	LG	NNP	ORGANIZATION	LG	appos	11	SENT_394	[p23l1316t2407r1433b2470],
33	,	,	O	,	_	0	SENT_394	[p23l1316t2407r1433b2470],
34	Cohen	NNP	PERSON	Cohen	nn	35	SENT_394	[p23l1457t2407r1654b2460],
35	HJ	NNP	O	HJ	appos	11	SENT_394	[p23l1675t2408r1773b2470],
36	,	,	O	,	_	0	SENT_394	[p23l1675t2408r1773b2470],
37	Becker	NNP	PERSON	Becker	nn	38	SENT_394	[p23l1798t2407r2013b2460],
38	HP	NNP	O	HP	appos	11	SENT_394	[p23l2033t2408r2144b2470],
39	,	,	O	,	_	0	SENT_394	[p23l2033t2408r2144b2470],
40	Kartcheske	NNP	ORGANIZATION	Kartcheske	nn	41	SENT_394	[p23l138t2495r478b2548],
41	PA	NN	ORGANIZATION	pa	appos	11	SENT_394	[p23l510t2496r621b2558],
42	,	,	O	,	_	0	SENT_394	[p23l510t2496r621b2558],
43	Wheeler	NNP	PERSON	Wheeler	nn	44	SENT_394	[p23l655t2495r914b2548],
44	JD	NNP	O	JD	appos	11	SENT_394	[p23l944t2496r1043b2558],
45	,	,	O	,	_	0	SENT_394	[p23l944t2496r1043b2558],
46	Perez	NNP	ORGANIZATION	Perez	nn	47	SENT_394	[p23l1077t2496r1244b2548],
47	EA	NN	ORGANIZATION	ea	appos	11	SENT_394	[p23l1276t2496r1392b2558],
48	,	,	O	,	_	0	SENT_394	[p23l1276t2496r1392b2558],
49	Wolff	NNP	ORGANIZATION	Wolff	nn	50	SENT_394	[p23l1425t2495r1612b2549],
50	AC	NN	ORGANIZATION	ac	appos	11	SENT_394	[p23l1638t2495r1757b2558],
51	,	,	O	,	_	0	SENT_394	[p23l1638t2495r1757b2558],
52	Gralow	NNP	PERSON	Gralow	nn	53	SENT_394	[p23l1793t2495r2017b2549],
53	JR	NNP	O	JR	appos	11	SENT_394	[p23l2049t2496r2144b2558],
54	,	,	O	,	_	0	SENT_394	[p23l2049t2496r2144b2558],
55	Burstein	NNP	PERSON	Burstein	nn	56	SENT_394	[p23l137t2584r394b2637],
56	HJ	NNP	O	HJ	appos	11	SENT_394	[p23l426t2585r524b2647],
57	,	,	O	,	_	0	SENT_394	[p23l426t2585r524b2647],
58	Mahmood	NNP	ORGANIZATION	Mahmood	nn	59	SENT_394	[p23l559t2584r871b2637],
59	AA	NNP	ORGANIZATION	AA	appos	11	SENT_394	[p23l902t2584r1026b2647],
60	,	,	O	,	_	0	SENT_394	[p23l902t2584r1026b2647],
61	Magrinat	NNP	O	Magrinat	nn	62	SENT_394	[p23l1061t2584r1340b2653],
62	G	NNP	O	G	appos	11	SENT_394	[p23l1373t2584r1440b2647],
63	,	,	O	,	_	0	SENT_394	[p23l1373t2584r1440b2647],
64	Parker	NNP	ORGANIZATION	Parker	nn	65	SENT_394	[p23l1475t2584r1674b2637],
65	BA	NN	ORGANIZATION	ba	appos	11	SENT_394	[p23l1704t2584r1824b2647],
66	,	,	O	,	_	0	SENT_394	[p23l1704t2584r1824b2647],
67	Hart	NNP	PERSON	Hart	nn	68	SENT_394	[p23l1859t2585r1993b2637],
68	RD	NNP	O	RD	appos	11	SENT_394	[p23l2024t2585r2144b2647],
69	,	,	O	,	_	0	SENT_394	[p23l2024t2585r2144b2647],
70	Grenier	NNP	PERSON	Grenier	nn	71	SENT_394	[p23l138t2672r370b2725],
71	D	NNP	PERSON	D	appos	11	SENT_394	[p23l392t2673r461b2735],
72	,	,	O	,	_	0	SENT_394	[p23l392t2673r461b2735],
73	Norton	NNP	ORGANIZATION	Norton	nn	74	SENT_394	[p23l487t2673r702b2725],
74	L	NNP	ORGANIZATION	L	appos	11	SENT_394	[p23l725t2673r786b2735],
75	,	,	O	,	_	0	SENT_394	[p23l725t2673r786b2735],
76	Hudis	NNP	PERSON	Hudis	nn	77	SENT_394	[p23l813t2672r991b2725],
77	CA	NNP	O	CA	appos	11	SENT_394	[p23l1017t2672r1136b2735],
78	,	,	O	,	_	0	SENT_394	[p23l1017t2672r1136b2735],
79	Winer	NNP	PERSON	Winer	nn	81	SENT_394	[p23l1161t2672r1353b2725],
80	EP	NNP	O	EP	nn	81	SENT_394	[p23l1375t2673r1463b2724],
81	(	NNP	O	(	appos	11	SENT_394	[p23l1489t2672r1685b2737],
82	2009	CD	DATE	2009	dep	85	SENT_394	[p23l1489t2672r1685b2737],
83	)	CD	NUMBER	)	num	85	SENT_394	[p23l1489t2672r1685b2737],
84	Adjuvant	JJ	O	adjuvant	amod	85	SENT_394	[p23l1711t2672r1994b2741],
85	chemotherapy	NN	O	chemotherapy	dep	92	SENT_394	[p23l2018t2672r2145b2725, p23l137t2759r461b2828],
86	in	IN	O	in	_	0	SENT_394	[p23l479t2759r536b2812],
87	older	JJR	O	older	amod	88	SENT_394	[p23l553t2759r708b2812],
88	women	NNS	O	woman	prep_in	85	SENT_394	[p23l724t2776r946b2812],
89	with	IN	O	with	_	0	SENT_394	[p23l963t2759r1096b2812],
90	early-stage	JJ	O	early-stage	amod	91	SENT_394	[p23l1113t2759r1445b2828],
91	breast	NN	O	breast	prep_with	88	SENT_394	[p23l1461t2759r1643b2812],
92	cancer	NN	O	cancer	dep	4	SENT_394	[p23l1659t2776r1871b2812],
93	.	.	O	.	_	0	SENT_394	[p23l1659t2776r1871b2812],

1	N	NN	O	n	nn	3	SENT_395	[p23l1892t2760r1946b2812],
2	Engl	NNP	O	Engl	nn	3	SENT_395	[p23l1961t2759r2103b2828],
3	J	NNP	O	J	nsubj	4	SENT_395	[p23l2119t2760r2147b2812],
4	Med	VBD	O	med	_	0	SENT_395	[p23l136t2849r275b2902],
5	360:2055	CD	NUMBER	360:2055	number	6	SENT_395	[p23l298t2848r787b2902],
6	—	CD	NUMBER	—	num	7	SENT_395	[p23l298t2848r787b2902],
7	2065	CD	DATE	2065	dobj	4	SENT_395	[p23l298t2848r787b2902],
8	.	.	O	.	_	0	SENT_395	[p23l298t2848r787b2902],

1	doi	FW	O	doi	nsubj	33	SENT_396	[p23l814t2849r1735b2902],
2	:10.1056	CD	NUMBER	:10.1056	dep	1	SENT_396	[p23l814t2849r1735b2902],
3	/	:	O	/	punct	1	SENT_396	[p23l814t2849r1735b2902],
4	NEJMoa0810266	NN	O	nejmoa0810266	nn	6	SENT_396	[p23l814t2849r1735b2902],
5	O’Shaughnessy	NN	O	o’shaughnessy	nn	6	SENT_396	[p23l138t2937r612b3006],
6	J	NN	O	j	dep	1	SENT_396	[p23l640t2938r668b2990],
7	,	,	O	,	_	0	SENT_396	[p23l673t2981r684b3000],
8	Paul	NNP	PERSON	Paul	nn	9	SENT_396	[p23l714t2937r847b2990],
9	D	NNP	PERSON	D	appos	6	SENT_396	[p23l875t2938r944b3000],
10	,	,	O	,	_	0	SENT_396	[p23l875t2938r944b3000],
11	Stokoe	NNP	PERSON	Stokoe	nn	12	SENT_396	[p23l977t2937r1184b2990],
12	C	NNP	PERSON	C	appos	6	SENT_396	[p23l1213t2937r1260b2990],
13	(	CD	NUMBER	(	num	18	SENT_396	[p23l1291t2937r1487b3002],
14	2010	CD	DATE	2010	num	18	SENT_396	[p23l1291t2937r1487b3002],
15	)	NNP	O	)	nn	18	SENT_396	[p23l1291t2937r1487b3002],
16	First	NNP	ORDINAL	First	nn	18	SENT_396	[p23l1517t2937r1655b2990],
17	efﬁcacy	NN	O	efﬁcacy	nn	18	SENT_396	[p23l1683t2937r1921b3006],
18	results	NNS	O	result	dep	12	SENT_396	[p23l1949t2937r2145b2990],
19	of	IN	O	of	_	0	SENT_396	[p23l138t3024r204b3077],
20	a	DT	O	a	prep_of	1	SENT_396	[p23l233t3041r264b3077],
21	randomized	VBN	O	randomize	partmod	20	SENT_396	[p23l294t3024r670b3087],
22	,	,	O	,	_	0	SENT_396	[p23l294t3024r670b3087],
23	open-label	JJ	O	open-label	appos	20	SENT_396	[p23l707t3024r1043b3093],
24	,	,	O	,	_	0	SENT_396	[p23l707t3024r1043b3093],
25	phase	NN	O	phase	nn	27	SENT_396	[p23l1077t3024r1249b3093],
26	III	CD	NUMBER	iii	num	27	SENT_396	[p23l1282t3025r1356b3077],
27	study	NN	O	study	appos	20	SENT_396	[p23l1391t3024r1550b3093],
28	of	IN	O	of	_	0	SENT_396	[p23l1585t3024r1650b3077],
29	adjuvant	JJ	O	adjuvant	amod	30	SENT_396	[p23l1679t3024r1940b3093],
30	doXorubicin	NN	O	doxorubicin	prep_of	27	SENT_396	[p23l1972t3024r2145b3077, p23l136t3112r352b3165],
31	plus	CC	O	plus	prep	30	SENT_396	[p23l389t3112r514b3181],
32	cyclophosphamide	NN	O	cyclophosphamide	dep	31	SENT_396	[p23l554t3112r1124b3181],
33	followed	VBN	O	follow	conj_or	33	SENT_396	[p23l1164t3112r1433b3166],
34	by	IN	O	by	_	0	SENT_396	[p23l1470t3112r1544b3181],
35	docetaxel	NN	O	docetaxel	prep_by	33	SENT_396	[p23l1584t3112r1874b3165],
36	with	IN	O	with	_	0	SENT_396	[p23l1913t3112r2047b3166],
37	or	CC	O	or	_	0	SENT_396	[p23l2086t3129r2148b3165],
38	without	IN	O	without	_	0	SENT_396	[p23l138t3201r369b3254],
39	capecitabine	NN	O	capecitabine	prep_with	33	SENT_396	[p23l393t3201r773b3270],
40	in	IN	O	in	_	0	SENT_396	[p23l797t3201r855b3253],
41	high-risk	JJ	O	high-risk	amod	44	SENT_396	[p23l878t3201r1154b3270],
42	early	JJ	O	early	amod	44	SENT_396	[p23l1177t3201r1326b3270],
43	breast	NN	O	breast	nn	44	SENT_396	[p23l1350t3201r1532b3254],
44	cancer	NN	O	cancer	prep_in	33	SENT_396	[p23l1556t3218r1768b3254],
45	.	.	O	.	_	0	SENT_396	[p23l1556t3218r1768b3254],

1	Cancer	NN	O	cancer	nn	2	SENT_397	[p23l1797t3201r2012b3254],
2	Res	NNP	O	Res	dep	13	SENT_397	[p23l2035t3202r2145b3254],
3	70	CD	NUMBER	70	number	4	SENT_397	[p23l137t3288r401b3357],
4	(	CD	NUMBER	(	num	5	SENT_397	[p23l137t3288r401b3357],
5	suppl	NN	O	suppl	dep	2	SENT_397	[p23l137t3288r401b3357],
6	24	CD	NUMBER	24	num	7	SENT_397	[p23l430t3288r545b3354],
7	)	NN	O	)	dep	5	SENT_397	[p23l430t3288r545b3354],
8	:	:	O	:	_	0	SENT_397	[p23l430t3288r545b3354],
9	S4	NN	O	s4	dep	5	SENT_397	[p23l580t3288r732b3341],
10	—	NN	O	—	dep	13	SENT_397	[p23l580t3288r732b3341],
11	2	CD	NUMBER	2	num	10	SENT_397	[p23l580t3288r732b3341],
12	O’Shaughnessy	NN	O	o’shaughnessy	nn	13	SENT_397	[p23l138t3376r612b3445],
13	J	NN	O	j	_	0	SENT_397	[p23l635t3378r663b3430],
14	,	,	O	,	_	0	SENT_397	[p23l668t3420r679b3439],
15	Miles	NNP	O	Miles	nn	16	SENT_397	[p23l705t3376r875b3429],
16	D	NNP	O	D	appos	13	SENT_397	[p23l899t3378r968b3439],
17	,	,	O	,	_	0	SENT_397	[p23l899t3378r968b3439],
18	Vukelja	NNP	O	Vukelja	nn	19	SENT_397	[p23l994t3376r1235b3445],
19	S	NNP	O	S	appos	13	SENT_397	[p23l1259t3377r1313b3439],
20	,	,	O	,	_	0	SENT_397	[p23l1259t3377r1313b3439],
21	Moiseyenko	NNP	O	Moiseyenko	nn	22	SENT_397	[p23l1338t3376r1712b3445],
22	V	NNP	O	V	appos	13	SENT_397	[p23l1736t3378r1805b3439],
23	,	,	O	,	_	0	SENT_397	[p23l1736t3378r1805b3439],
24	Ayoub	NNP	PERSON	Ayoub	nn	25	SENT_397	[p23l1831t3376r2034b3445],
25	JP	NNP	O	JP	appos	13	SENT_397	[p23l2058t3378r2144b3439],
26	,	,	O	,	_	0	SENT_397	[p23l2058t3378r2144b3439],
27	Cervantes	NNP	PERSON	Cervantes	nn	28	SENT_397	[p23l138t3466r439b3519],
28	G	NNP	PERSON	G	appos	13	SENT_397	[p23l464t3466r532b3528],
29	,	,	O	,	_	0	SENT_397	[p23l464t3466r532b3528],
30	Fumoleau	NNP	PERSON	Fumoleau	nn	31	SENT_397	[p23l557t3465r860b3519],
31	P	NN	PERSON	p	appos	13	SENT_397	[p23l883t3467r939b3528],
32	,	,	O	,	_	0	SENT_397	[p23l883t3467r939b3528],
33	Jones	NNP	PERSON	Jones	nn	34	SENT_397	[p23l964t3467r1130b3519],
34	S	NNP	O	S	appos	13	SENT_397	[p23l1156t3466r1210b3528],
35	,	,	O	,	_	0	SENT_397	[p23l1156t3466r1210b3528],
36	Lui	NNP	PERSON	Lui	nn	37	SENT_397	[p23l1235t3465r1339b3519],
37	WY	NN	O	wy	appos	13	SENT_397	[p23l1361t3467r1503b3528],
38	,	,	O	,	_	0	SENT_397	[p23l1361t3467r1503b3528],
39	Mauriac	NNP	PERSON	Mauriac	nn	40	SENT_397	[p23l1528t3465r1780b3519],
40	L	NNP	O	L	appos	13	SENT_397	[p23l1804t3467r1865b3528],
41	,	,	O	,	_	0	SENT_397	[p23l1804t3467r1865b3528],
42	Twelves	NNP	O	Twelves	appos	13	SENT_397	[p23l1890t3465r2145b3519],

1	C	NN	O	c	nsubj	12	SENT_398	[p24l138t19r202b82],
2	,	,	O	,	_	0	SENT_398	[p24l138t19r202b82],
3	Van	NNP	PERSON	Van	nn	5	SENT_398	[p24l235t20r359b72],
4	Hazel	NNP	PERSON	Hazel	nn	5	SENT_398	[p24l389t19r565b72],
5	G	NNP	PERSON	G	appos	1	SENT_398	[p24l597t19r664b82],
6	,	,	O	,	_	0	SENT_398	[p24l597t19r664b82],
7	Verma	NNP	PERSON	Verma	nn	8	SENT_398	[p24l697t20r904b72],
8	S	NNP	PERSON	S	appos	1	SENT_398	[p24l934t19r988b82],
9	,	,	O	,	_	0	SENT_398	[p24l934t19r988b82],
10	Leonard	NNP	PERSON	Leonard	nn	11	SENT_398	[p24l1020t19r1274b72],
11	R	NNP	PERSON	R	appos	1	SENT_398	[p24l1303t20r1353b72],
12	(	VBD	O	(	_	0	SENT_398	[p24l1384t19r1581b85],
13	2002	CD	DATE	2002	num	14	SENT_398	[p24l1384t19r1581b85],
14	)	CD	NUMBER	)	dobj	12	SENT_398	[p24l1384t19r1581b85],
15	Superior	NNP	O	Superior	nn	16	SENT_398	[p24l1614t19r1874b88],
16	survival	NN	O	survival	dep	12	SENT_398	[p24l1906t19r2147b72],
17	with	IN	O	with	_	0	SENT_398	[p24l137t107r271b160],
18	capecitabine	NN	O	capecitabine	prep_with	12	SENT_398	[p24l299t107r679b176],
19	plus	CC	O	plus	prep	18	SENT_398	[p24l708t107r832b176],
20	docetaxel	NN	O	docetaxel	nn	22	SENT_398	[p24l863t107r1153b160],
21	combination	NN	O	combination	nn	22	SENT_398	[p24l1183t107r1562b160],
22	therapy	NN	O	therapy	dep	19	SENT_398	[p24l1591t107r1817b176],
23	in	IN	O	in	_	0	SENT_398	[p24l1846t107r1904b160],
24	anthracycline-pretreated	JJ	O	anthracycline-pretreated	amod	25	SENT_398	[p24l1934t107r2145b160, p24l138t195r688b264],
25	patients	NNS	O	patient	prep_in	22	SENT_398	[p24l710t195r945b264],
26	with	IN	O	with	_	0	SENT_398	[p24l969t195r1103b249],
27	advanced	JJ	O	advanced	amod	29	SENT_398	[p24l1127t195r1412b248],
28	breast	NN	O	breast	nn	29	SENT_398	[p24l1433t195r1615b248],
29	cancer	NN	O	cancer	prep_with	12	SENT_398	[p24l1638t212r1851b248],
30	:	:	O	:	_	0	SENT_398	[p24l1638t212r1851b248],
31	phase	NN	O	phase	dep	29	SENT_398	[p24l1878t195r2050b264],
32	III	CD	NUMBER	iii	num	34	SENT_398	[p24l2073t197r2147b248],
33	trial	NN	O	trial	nn	34	SENT_398	[p24l137t284r258b338],
34	results	NNS	O	result	dep	31	SENT_398	[p24l286t284r499b338],
35	.	.	O	.	_	0	SENT_398	[p24l286t284r499b338],

1	J	NNP	O	J	nn	3	SENT_399	[p24l530t286r557b338],
2	Clin	NNP	O	Clin	nn	3	SENT_399	[p24l586t284r715b338],
3	Oncol	NNP	O	Oncol	nsubj	9	SENT_399	[p24l743t285r926b338],
4	20:2812	CD	NUMBER	20:2812	num	8	SENT_399	[p24l955t285r1389b338],
5	—	CD	NUMBER	—	num	8	SENT_399	[p24l955t285r1389b338],
6	2823	CD	DATE	2823	num	8	SENT_399	[p24l955t285r1389b338],
7	Ratain	NNP	O	Ratain	nn	8	SENT_399	[p24l137t372r335b425],
8	MJ	NNP	O	MJ	dep	3	SENT_399	[p24l373t373r469b425],
9	(	VBD	O	(	_	0	SENT_399	[p24l510t372r706b438],
10	1998	CD	DATE	1998	num	11	SENT_399	[p24l510t372r706b438],
11	)	CD	NUMBER	)	dobj	9	SENT_399	[p24l510t372r706b438],
12	Body-surface	JJ	O	body-surface	amod	13	SENT_399	[p24l747t372r1155b441],
13	area	NN	O	area	tmod	9	SENT_399	[p24l1197t389r1322b425],
14	as	IN	O	as	_	0	SENT_399	[p24l1361t389r1420b425],
15	a	DT	O	a	det	16	SENT_399	[p24l1462t389r1493b425],
16	basis	NN	O	basis	prep_as	13	SENT_399	[p24l1530t372r1679b425],
17	for	IN	O	for	_	0	SENT_399	[p24l1720t372r1808b425],
18	dosing	NN	O	dosing	prep_for	16	SENT_399	[p24l1846t372r2045b441],
19	of	IN	O	of	_	0	SENT_399	[p24l2086t372r2152b425],
20	anticancer	JJ	O	anticancer	amod	21	SENT_399	[p24l139t460r451b513],
21	agents	NNS	O	agent	prep_of	18	SENT_399	[p24l494t469r702b529],
22	:	:	O	:	_	0	SENT_399	[p24l494t469r702b529],
23	science	NN	O	science	dep	13	SENT_399	[p24l752t460r989b523],
24	,	,	O	,	_	0	SENT_399	[p24l752t460r989b523],
25	myth	NN	O	myth	dep	13	SENT_399	[p24l1035t460r1206b529],
26	,	,	O	,	_	0	SENT_399	[p24l1035t460r1206b529],
27	or	CC	O	or	_	0	SENT_399	[p24l1252t477r1314b513],
28	habit	NN	O	habit	dep	13	SENT_399	[p24l1355t460r1539b513],
29	?	.	O	?	_	0	SENT_399	[p24l1355t460r1539b513],

1	J	NNP	O	J	nn	3	SENT_400	[p24l1582t462r1610b514],
2	Clin	NNP	O	Clin	nn	3	SENT_400	[p24l1653t460r1782b514],
3	Oncol	NNP	O	Oncol	_	0	SENT_400	[p24l1826t460r2008b514],
4	16	CD	NUMBER	16	num	3	SENT_400	[p24l2059t460r2141b514],
5	:	:	O	:	_	0	SENT_400	[p24l2059t460r2141b514],
6	2297-2298	CD	DATE	2297-2298	num	8	SENT_400	[p24l138t550r475b603],
7	Reigner	NN	O	reigner	nn	8	SENT_400	[p24l137t637r379b706],
8	B	NN	O	b	dep	3	SENT_400	[p24l405t638r470b700],
9	,	,	O	,	_	0	SENT_400	[p24l405t638r470b700],
10	Blesch	NNP	ORGANIZATION	Blesch	nn	11	SENT_400	[p24l501t637r707b690],
11	K	NNP	ORGANIZATION	K	appos	3	SENT_400	[p24l736t638r803b700],
12	,	,	O	,	_	0	SENT_400	[p24l736t638r803b700],
13	Weidekamm	NNP	O	Weidekamm	nn	14	SENT_400	[p24l833t637r1224b690],
14	E	NNP	O	E	nsubj	15	SENT_400	[p24l1251t638r1296b690],
15	(	VBD	O	(	dep	3	SENT_400	[p24l1326t638r1523b703],
16	2001	CD	DATE	2001	num	19	SENT_400	[p24l1326t638r1523b703],
17	)	CD	NUMBER	)	num	19	SENT_400	[p24l1326t638r1523b703],
18	Clinical	JJ	O	clinical	amod	19	SENT_400	[p24l1554t637r1793b690],
19	pharmacokinetics	NNS	O	pharmacokinetic	dobj	15	SENT_400	[p24l1821t637r2145b706, p24l136t725r371b778],
20	of	IN	O	of	_	0	SENT_400	[p24l402t725r467b778],
21	capecitabine	NN	O	capecitabine	prep_of	19	SENT_400	[p24l490t725r886b794],
22	.	.	O	.	_	0	SENT_400	[p24l490t725r886b794],

1	Clin	NNP	O	Clin	nn	2	SENT_401	[p24l919t725r1047b779],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_401	[p24l1075t725r1532b778],
3	40:85	CD	NUMBER	40:85	num	6	SENT_401	[p24l1559t725r1883b779],
4	-104	CD	NUMBER	-104	num	6	SENT_401	[p24l1559t725r1883b779],
5	Rossi	NNP	PERSON	Rossi	nn	6	SENT_401	[p24l137t814r303b868],
6	D	NNP	O	D	dep	2	SENT_401	[p24l343t816r412b878],
7	,	,	O	,	_	0	SENT_401	[p24l343t816r412b878],
8	Alessandroni	NNP	PERSON	Alessandroni	nn	9	SENT_401	[p24l453t814r853b868],
9	P	NN	O	p	appos	6	SENT_401	[p24l891t816r948b878],
10	,	,	O	,	_	0	SENT_401	[p24l891t816r948b878],
11	Catalano	NNP	ORGANIZATION	Catalano	nn	12	SENT_401	[p24l990t814r1258b868],
12	V	NNP	ORGANIZATION	V	appos	6	SENT_401	[p24l1298t816r1367b878],
13	,	,	O	,	_	0	SENT_401	[p24l1298t816r1367b878],
14	Giordani	NNP	PERSON	Giordani	nn	15	SENT_401	[p24l1409t814r1677b868],
15	P	NN	O	p	appos	6	SENT_401	[p24l1716t816r1772b878],
16	,	,	O	,	_	0	SENT_401	[p24l1716t816r1772b878],
17	Fedeli	NNP	ORGANIZATION	Fedeli	nn	18	SENT_401	[p24l1813t814r2002b868],
18	SL	NNP	ORGANIZATION	SL	appos	6	SENT_401	[p24l2043t815r2144b878],
19	,	,	O	,	_	0	SENT_401	[p24l2043t815r2144b878],
20	Fedeli	NNP	PERSON	Fedeli	nn	21	SENT_401	[p24l136t904r326b957],
21	A	NNP	O	A	appos	6	SENT_401	[p24l366t904r435b967],
22	,	,	O	,	_	0	SENT_401	[p24l366t904r435b967],
23	Baldelli	NNP	ORGANIZATION	Baldelli	nn	24	SENT_401	[p24l477t904r717b957],
24	AM	NNP	ORGANIZATION	AM	appos	6	SENT_401	[p24l758t904r894b967],
25	,	,	O	,	_	0	SENT_401	[p24l758t904r894b967],
26	Casadei	NNP	PERSON	Casadei	nn	27	SENT_401	[p24l938t904r1176b957],
27	V	NNP	O	V	appos	6	SENT_401	[p24l1217t905r1286b967],
28	,	,	O	,	_	0	SENT_401	[p24l1217t905r1286b967],
29	Ceccolini	NNP	O	Ceccolini	nn	30	SENT_401	[p24l1329t904r1620b957],
30	M	NNP	O	M	appos	6	SENT_401	[p24l1660t905r1742b967],
31	,	,	O	,	_	0	SENT_401	[p24l1660t905r1742b967],
32	Catalano	NNP	PERSON	Catalano	nn	33	SENT_401	[p24l1785t904r2053b957],
33	G	NNP	PERSON	G	appos	6	SENT_401	[p24l2096t904r2148b957],
34	(	CD	NUMBER	(	num	37	SENT_401	[p24l139t992r336b1057],
35	2007	CD	DATE	2007	num	37	SENT_401	[p24l139t992r336b1057],
36	)	NNP	O	)	nn	37	SENT_401	[p24l139t992r336b1057],
37	Safety	NNP	O	Safety	dep	33	SENT_401	[p24l371t991r561b1060],
38	proﬁle	NN	O	proﬁle	dep	2	SENT_401	[p24l591t991r788b1060],
39	and	CC	O	and	_	0	SENT_401	[p24l821t991r928b1044],
40	activity	NN	O	activity	dep	2	SENT_401	[p24l959t991r1185b1060],
41	of	IN	O	of	_	0	SENT_401	[p24l1217t991r1283b1044],
42	lower	JJR	O	lower	amod	44	SENT_401	[p24l1308t991r1481b1045],
43	capecitabine	NN	O	capecitabine	nn	44	SENT_401	[p24l1511t991r1891b1060],
44	dose	NN	O	dose	prep_of	38	SENT_401	[p24l1922t991r2058b1044],
45	in	IN	O	in	_	0	SENT_401	[p24l2089t991r2147b1044],
46	patients	NNS	O	patient	prep_in	44	SENT_401	[p24l136t1079r371b1148],
47	with	IN	O	with	_	0	SENT_401	[p24l416t1079r549b1133],
48	metastatic	JJ	O	metastatic	amod	50	SENT_401	[p24l591t1079r898b1133],
49	breast	NN	O	breast	nn	50	SENT_401	[p24l942t1079r1124b1133],
50	cancer	NN	O	cancer	prep_with	46	SENT_401	[p24l1167t1096r1379b1133],
51	.	.	O	.	_	0	SENT_401	[p24l1167t1096r1379b1133],

1	Clin	NNP	O	Clin	nn	3	SENT_402	[p24l1426t1079r1555b1133],
2	Breast	NN	O	breast	nn	3	SENT_402	[p24l1597t1081r1791b1133],
3	Cancer	NN	O	cancer	_	0	SENT_402	[p24l1833t1080r2049b1133],
4	7	CD	NUMBER	7	num	6	SENT_402	[p24l2090t1081r2141b1133],
5	:	:	O	:	_	0	SENT_402	[p24l2090t1081r2141b1133],
6	857-860	CD	NUMBER	857-860	dep	3	SENT_402	[p24l140t1168r417b1222],
7	.	.	O	.	_	0	SENT_402	[p24l140t1168r417b1222],

1	doi	FW	O	doi	dep	44	SENT_403	[p24l449t1168r1315b1234],
2	:	:	O	:	_	0	SENT_403	[p24l449t1168r1315b1234],
3	Sl526	NN	O	sl526	dep	10	SENT_403	[p24l449t1168r1315b1234],
4	—	CD	NUMBER	—	num	5	SENT_403	[p24l449t1168r1315b1234],
5	8209	CD	NUMBER	8209	dep	3	SENT_403	[p24l449t1168r1315b1234],
6	(	NN	O	(	dep	10	SENT_403	[p24l449t1168r1315b1234],
7	11	CD	NUMBER	11	num	6	SENT_403	[p24l449t1168r1315b1234],
8	)	CD	NUMBER	)	number	9	SENT_403	[p24l449t1168r1315b1234],
9	70792	CD	NUMBER	70792	num	10	SENT_403	[p24l449t1168r1315b1234],
10	—	NN	O	—	dep	44	SENT_403	[p24l449t1168r1315b1234],
11	3	CD	NUMBER	3	dep	10	SENT_403	[p24l449t1168r1315b1234],
12	Rudek	NNP	PERSON	Rudek	nn	13	SENT_403	[p24l137t1258r336b1311],
13	MA	NNP	PERSON	MA	dep	38	SENT_403	[p24l378t1258r515b1321],
14	,	,	O	,	_	0	SENT_403	[p24l378t1258r515b1321],
15	Zhao	NNP	PERSON	Zhao	nn	16	SENT_403	[p24l562t1258r717b1311],
16	M	NNP	O	M	appos	13	SENT_403	[p24l762t1259r844b1321],
17	,	,	O	,	_	0	SENT_403	[p24l762t1259r844b1321],
18	He	PRP	O	he	dep	19	SENT_403	[p24l890t1259r977b1311],
19	P	NN	O	p	appos	13	SENT_403	[p24l1022t1259r1079b1321],
20	,	,	O	,	_	0	SENT_403	[p24l1022t1259r1079b1321],
21	Hartke	NN	PERSON	hartke	nn	22	SENT_403	[p24l1126t1258r1331b1311],
22	C	NN	O	c	appos	13	SENT_403	[p24l1377t1258r1441b1321],
23	,	,	O	,	_	0	SENT_403	[p24l1377t1258r1441b1321],
24	Gilbert	NNP	PERSON	Gilbert	nn	25	SENT_403	[p24l1490t1258r1704b1311],
25	J	NNP	PERSON	J	appos	13	SENT_403	[p24l1747t1259r1791b1321],
26	,	,	O	,	_	0	SENT_403	[p24l1747t1259r1791b1321],
27	Gore	NNP	PERSON	Gore	nn	28	SENT_403	[p24l1840t1258r1988b1311],
28	SD	NN	O	sd	appos	13	SENT_403	[p24l2035t1258r2144b1321],
29	,	,	O	,	_	0	SENT_403	[p24l2035t1258r2144b1321],
30	Carducci	NNP	PERSON	Carducci	nn	31	SENT_403	[p24l138t1346r410b1400],
31	MA	NNP	O	MA	appos	13	SENT_403	[p24l444t1347r581b1409],
32	,	,	O	,	_	0	SENT_403	[p24l444t1347r581b1409],
33	Baker	NNP	PERSON	Baker	appos	13	SENT_403	[p24l616t1347r798b1400],
34	SD	NN	O	sd	dep	38	SENT_403	[p24l831t1347r922b1400],
35	(	CD	NUMBER	(	num	34	SENT_403	[p24l959t1346r1155b1412],
36	2005	CD	DATE	2005	num	38	SENT_403	[p24l959t1346r1155b1412],
37	)	CD	NUMBER	)	num	38	SENT_403	[p24l959t1346r1155b1412],
38	Pharmacokinetics	NNS	O	pharmacokinetic	dep	44	SENT_403	[p24l1191t1346r1731b1400],
39	of	IN	O	of	_	0	SENT_403	[p24l1766t1346r1832b1400],
40	5	CD	NUMBER	5	num	41	SENT_403	[p24l1860t1346r2144b1400],
41	—	NN	O	—	prep_of	38	SENT_403	[p24l1860t1346r2144b1400],
42	azaciti	NN	O	azacitus	nsubj	44	SENT_403	[p24l1860t1346r2144b1400],
43	—	CD	NUMBER	—	num	42	SENT_403	[p24l1860t1346r2144b1400],
44	dine	VBP	O	dine	_	0	SENT_403	[p24l138t1434r266b1488],
45	administered	VBN	O	administer	dep	44	SENT_403	[p24l293t1434r684b1488],
46	with	IN	O	with	_	0	SENT_403	[p24l709t1434r843b1488],
47	phenylbutyrate	NN	O	phenylbutyrate	prep_with	45	SENT_403	[p24l865t1434r1322b1503],
48	in	IN	O	in	_	0	SENT_403	[p24l1347t1434r1405b1487],
49	patients	NNS	O	patient	prep_in	45	SENT_403	[p24l1428t1434r1663b1503],
50	with	IN	O	with	_	0	SENT_403	[p24l1690t1434r1823b1488],
51	refractory	JJ	O	refractory	amod	53	SENT_403	[p24l1847t1434r2146b1503],
52	solid	JJ	O	solid	amod	53	SENT_403	[p24l140t1523r284b1576],
53	tumors	NNS	O	tumor	prep_with	45	SENT_403	[p24l348t1530r557b1576],
54	or	CC	O	or	_	0	SENT_403	[p24l624t1539r686b1576],
55	hematologic	JJ	O	hematologic	amod	56	SENT_403	[p24l748t1523r1124b1591],
56	malignancies	NNS	O	malignancy	conj_or	53	SENT_403	[p24l1190t1523r1607b1592],
57	.	.	O	.	_	0	SENT_403	[p24l1190t1523r1607b1592],

1	J	NNP	O	J	nn	3	SENT_404	[p24l1676t1524r1704b1576],
2	Clin	NNP	O	Clin	nn	3	SENT_404	[p24l1769t1523r1898b1576],
3	Oncol	NNP	O	Oncol	_	0	SENT_404	[p24l1964t1523r2146b1576],
4	2323906-3911	CD	NUMBER	2323906-3911	dep	3	SENT_404	[p24l138t1611r590b1665],
5	.	.	O	.	_	0	SENT_404	[p24l138t1611r590b1665],

1	doi	FW	O	doi	dep	11	SENT_405	[p24l623t1611r1543b1665],
2	:10.1200	CD	NUMBER	:10.1200	dep	1	SENT_405	[p24l623t1611r1543b1665],
3	/	:	O	/	punct	1	SENT_405	[p24l623t1611r1543b1665],
4	JCO	NNP	ORGANIZATION	JCO	dep	1	SENT_405	[p24l623t1611r1543b1665],
5	.2005.07.450	CD	NUMBER	.2005.07.450	num	4	SENT_405	[p24l623t1611r1543b1665],
6	Sawyer	NNP	O	Sawyer	dep	7	SENT_405	[p24l139t1700r365b1768],
7	M	NN	O	m	dep	4	SENT_405	[p24l387t1701r469b1762],
8	,	,	O	,	_	0	SENT_405	[p24l387t1701r469b1762],
9	Ratain	NNP	O	Ratain	nn	10	SENT_405	[p24l496t1699r694b1753],
10	MJ	NNP	O	MJ	nsubj	11	SENT_405	[p24l718t1701r813b1753],
11	(	VBD	O	(	_	0	SENT_405	[p24l840t1700r1036b1765],
12	2001	CD	DATE	2001	num	13	SENT_405	[p24l840t1700r1036b1765],
13	)	CD	NUMBER	)	dobj	11	SENT_405	[p24l840t1700r1036b1765],
14	Body	NN	O	body	nn	16	SENT_405	[p24l1062t1700r1224b1768],
15	surface	NN	O	surface	nn	16	SENT_405	[p24l1251t1699r1466b1753],
16	area	NN	O	area	npadvmod	11	SENT_405	[p24l1493t1716r1618b1753],
17	as	IN	O	as	_	0	SENT_405	[p24l1643t1716r1701b1753],
18	a	DT	O	a	det	19	SENT_405	[p24l1729t1716r1760b1753],
19	determinant	NN	O	determinant	prep_as	11	SENT_405	[p24l1784t1699r2148b1753],
20	of	IN	O	of	_	0	SENT_405	[p24l138t1788r204b1841],
21	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	19	SENT_405	[p24l240t1788r777b1856],
22	and	CC	O	and	_	0	SENT_405	[p24l823t1788r930b1841],
23	drug	NN	O	drug	nn	24	SENT_405	[p24l972t1788r1109b1857],
24	dosing	NN	O	dosing	prep_of	19	SENT_405	[p24l1153t1788r1368b1857],
25	.	.	O	.	_	0	SENT_405	[p24l1153t1788r1368b1857],

1	Invest	VB	O	invest	ccomp	36	SENT_406	[p24l1414t1789r1599b1841],
2	New	NNP	O	New	nn	3	SENT_406	[p24l1641t1789r1782b1841],
3	Drugs	NNPS	O	Drugs	dobj	1	SENT_406	[p24l1826t1789r2008b1856],
4	19	CD	NUMBER	19	dep	3	SENT_406	[p24l2059t1788r2141b1842],
5	:	:	O	:	_	0	SENT_406	[p24l2059t1788r2141b1842],
6	171-177	CD	NUMBER	171-177	num	8	SENT_406	[p24l144t1877r399b1930],
7	Schuller	NNP	O	Schuller	nn	8	SENT_406	[p24l139t1964r391b2018],
8	J	NNP	O	J	dep	3	SENT_406	[p24l416t1966r460b2028],
9	,	,	O	,	_	0	SENT_406	[p24l416t1966r460b2028],
10	Cassidy	NNP	O	Cassidy	nn	11	SENT_406	[p24l491t1964r728b2033],
11	J	NNP	O	J	appos	8	SENT_406	[p24l755t1966r799b2028],
12	,	,	O	,	_	0	SENT_406	[p24l755t1966r799b2028],
13	Dumont	NNP	O	Dumont	nn	14	SENT_406	[p24l828t1966r1077b2018],
14	E	NNP	O	E	appos	8	SENT_406	[p24l1103t1966r1164b2027],
15	,	,	O	,	_	0	SENT_406	[p24l1103t1966r1164b2027],
16	Roos	NNP	PERSON	Roos	nn	17	SENT_406	[p24l1194t1966r1347b2018],
17	B	NNP	O	B	appos	8	SENT_406	[p24l1375t1966r1440b2027],
18	,	,	O	,	_	0	SENT_406	[p24l1375t1966r1440b2027],
19	Durston	NNP	PERSON	Durston	nn	20	SENT_406	[p24l1469t1966r1713b2018],
20	S	NNP	O	S	appos	8	SENT_406	[p24l1741t1965r1796b2027],
21	,	,	O	,	_	0	SENT_406	[p24l1741t1965r1796b2027],
22	Banken	NNP	ORGANIZATION	Banken	nn	23	SENT_406	[p24l1825t1965r2056b2018],
23	L	NNP	ORGANIZATION	L	appos	8	SENT_406	[p24l2083t1966r2144b2027],
24	,	,	O	,	_	0	SENT_406	[p24l2083t1966r2144b2027],
25	Utoh	NNP	O	Utoh	nn	26	SENT_406	[p24l137t2053r288b2106],
26	M	NNP	O	M	appos	8	SENT_406	[p24l315t2054r397b2116],
27	,	,	O	,	_	0	SENT_406	[p24l315t2054r397b2116],
28	Mori	NNP	LOCATION	Mori	nn	29	SENT_406	[p24l428t2053r578b2106],
29	K	NNP	LOCATION	K	appos	8	SENT_406	[p24l608t2054r676b2116],
30	,	,	O	,	_	0	SENT_406	[p24l608t2054r676b2116],
31	Weidekamm	NNP	O	Weidekamm	nn	32	SENT_406	[p24l706t2053r1097b2106],
32	E	NNP	O	E	appos	8	SENT_406	[p24l1125t2054r1186b2116],
33	,	,	O	,	_	0	SENT_406	[p24l1125t2054r1186b2116],
34	Reigner	NNP	O	Reigner	nn	35	SENT_406	[p24l1217t2053r1458b2121],
35	B	NNP	O	B	nsubj	36	SENT_406	[p24l1485t2054r1530b2105],
36	(	VBD	O	(	_	0	SENT_406	[p24l1564t2053r1761b2118],
37	2000	CD	DATE	2000	num	38	SENT_406	[p24l1564t2053r1761b2118],
38	)	CD	NUMBER	)	nn	40	SENT_406	[p24l1564t2053r1761b2118],
39	Preferential	JJ	O	preferential	amod	40	SENT_406	[p24l1792t2053r2146b2106],
40	activation	NN	O	activation	dobj	36	SENT_406	[p24l139t2141r437b2194],
41	of	IN	O	of	_	0	SENT_406	[p24l464t2141r529b2194],
42	capecitabine	NN	O	capecitabine	prep_of	40	SENT_406	[p24l550t2141r930b2210],
43	in	IN	O	in	_	0	SENT_406	[p24l956t2141r1014b2193],
44	tumor	NN	O	tumor	prep_in	36	SENT_406	[p24l1039t2149r1221b2194],
45	following	VBG	O	follow	_	0	SENT_406	[p24l1245t2141r1538b2210],
46	oral	JJ	O	oral	amod	47	SENT_406	[p24l1565t2141r1681b2194],
47	administration	NN	O	administration	prep_following	44	SENT_406	[p24l1708t2141r2147b2194],
48	to	TO	O	to	_	0	SENT_406	[p24l137t2237r194b2282],
49	colorectal	JJ	O	colorectal	amod	51	SENT_406	[p24l249t2229r548b2282],
50	cancer	NN	O	cancer	nn	51	SENT_406	[p24l602t2246r801b2282],
51	patients	NNS	O	patient	prep_to	47	SENT_406	[p24l853t2229r1105b2298],
52	.	.	O	.	_	0	SENT_406	[p24l853t2229r1105b2298],

1	Cancer	NNP	O	Cancer	nn	3	SENT_407	[p24l1163t2229r1378b2282],
2	Chemother	NNP	PERSON	Chemother	nn	3	SENT_407	[p24l1431t2229r1770b2282],
3	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_407	[p24l1822t2229r2146b2282],
4	45	CD	NUMBER	45	num	3	SENT_407	[p24l136t2318r208b2371],
5	:	:	O	:	_	0	SENT_407	[p24l218t2335r227b2371],
6	29	CD	NUMBER	29	num	7	SENT_407	[p24l236t2318r307b2372],
7	1-297	CD	NUMBER	1-297	dep	3	SENT_407	[p24l318t2318r497b2372],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_408	[p24l52t2447r142b2472],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_408	[p24l155t2447r255b2472],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_408	[p24l267t2447r318b2472],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_408	[p24l331t2447r406b2472],
5	(	CD	NUMBER	(	num	6	SENT_408	[p24l419t2447r510b2477],
6	2013	CD	DATE	2013	dep	4	SENT_408	[p24l419t2447r510b2477],
7	)	CD	NUMBER	)	number	8	SENT_408	[p24l419t2447r510b2477],
8	139:135	CD	NUMBER	139:135	num	10	SENT_408	[p24l528t2447r708b2472],
9	-143	CD	NUMBER	-143	number	10	SENT_408	[p24l528t2447r708b2472],
10	143	CD	NUMBER	143	dep	6	SENT_408	[p24l2058t2447r2105b2472],

1	Sledge	NNP	ORGANIZATION	Sledge	nn	2	SENT_409	[p24l139t2613r343b2682],
2	GW	NNP	ORGANIZATION	GW	_	0	SENT_409	[p24l383t2614r523b2676],
3	,	,	O	,	_	0	SENT_409	[p24l383t2614r523b2676],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_409	[p24l564t2613r756b2667],
5	KD	NN	O	kd	conj_and	2	SENT_409	[p24l794t2615r917b2676],
6	,	,	O	,	_	0	SENT_409	[p24l794t2615r917b2676],
7	Moisa	NNP	O	Moisa	nn	8	SENT_409	[p24l958t2613r1147b2667],
8	CF	NN	O	cf	conj_and	2	SENT_409	[p24l1186t2614r1292b2676],
9	,	,	O	,	_	0	SENT_409	[p24l1186t2614r1292b2676],
10	Gradishar	NNP	PERSON	Gradishar	nn	12	SENT_409	[p24l1335t2613r1634b2667],
11	WJ	NNP	O	WJ	nn	12	SENT_409	[p24l1670t2615r1771b2667],
12	Safety	NNP	O	Safety	conj_and	2	SENT_409	[p24l1812t2613r2003b2682],
13	and	CC	O	and	_	0	SENT_409	[p24l2044t2614r2151b2667],
14	Efﬁcacy	NNP	O	Efﬁcacy	conj_and	2	SENT_409	[p24l137t2701r390b2770],
15	of	IN	O	of	_	0	SENT_409	[p24l439t2701r505b2754],
16	Capecitabine	NNP	O	Capecitabine	nn	18	SENT_409	[p24l548t2701r944b2770],
17	Plus	NNP	O	Plus	nn	18	SENT_409	[p24l992t2701r1120b2754],
18	Bevacizumab	NNP	PERSON	Bevacizumab	prep_of	14	SENT_409	[p24l1170t2701r1583b2754],
19	as	IN	O	as	_	0	SENT_409	[p24l1634t2718r1692b2754],
20	First-Line	NNP	O	First-Line	prep_as	18	SENT_409	[p24l1741t2701r2045b2754],
21	in	IN	O	in	_	0	SENT_409	[p24l2092t2701r2150b2754],
22	Metastatic	JJ	O	metastatic	amod	24	SENT_409	[p24l137t2789r453b2842],
23	Breast	NN	O	breast	nn	24	SENT_409	[p24l490t2791r684b2842],
24	Cancer	NN	O	cancer	prep_in	20	SENT_409	[p24l719t2790r934b2843],
25	(	CD	NUMBER	(	num	26	SENT_409	[p24l971t2790r1303b2855],
26	XCALIBr	NN	O	xcalibr	dep	2	SENT_409	[p24l971t2790r1303b2855],
27	Trial	NN	O	trial	nn	28	SENT_409	[p24l1336t2789r1524b2855],
28	)	NN	O	)	dep	26	SENT_409	[p24l1336t2789r1524b2855],
29	.	.	O	.	_	0	SENT_409	[p24l1336t2789r1524b2855],

1	Paper	NNP	O	Paper	nsubj	2	SENT_410	[p24l1563t2791r1737b2858],
2	presented	VBD	O	present	_	0	SENT_410	[p24l1769t2789r2061b2858],
3	at	IN	O	at	_	0	SENT_410	[p24l2098t2797r2151b2842],
4	the	DT	O	the	det	7	SENT_410	[p24l137t2878r228b2931],
5	Annual	JJ	SET	annual	amod	7	SENT_410	[p24l256t2878r479b2931],
6	ASCO	NNP	ORGANIZATION	ASCO	nn	7	SENT_410	[p24l507t2878r707b2931],
7	meeting	NN	O	meeting	prep_at	2	SENT_410	[p24l735t2877r979b2946],
8	(	CD	NUMBER	(	num	9	SENT_410	[p24l1011t2878r1152b2943],
9	Abs	NNS	O	ab	dobj	2	SENT_410	[p24l1011t2878r1152b2943],
10	1013	CD	DATE	1013	num	11	SENT_410	[p24l1189t2878r1373b2943],
11	)	CD	NUMBER	)	rcmod	9	SENT_410	[p24l1189t2878r1373b2943],
12	,	,	O	,	_	0	SENT_410	[p24l1189t2878r1373b2943],
13	2007	CD	DATE	2007	num	15	SENT_410	[p24l1405t2878r1552b2931],
14	Soepenberg	NN	O	soepenberg	nn	15	SENT_410	[p24l139t2965r495b3034],
15	O	NN	O	o	appos	11	SENT_410	[p24l530t2966r598b3028],
16	,	,	O	,	_	0	SENT_410	[p24l530t2966r598b3028],
17	Dumez	NNP	ORGANIZATION	Dumez	nn	18	SENT_410	[p24l634t2966r852b3018],
18	H	NNP	ORGANIZATION	H	appos	11	SENT_410	[p24l886t2966r955b3028],
19	,	,	O	,	_	0	SENT_410	[p24l886t2966r955b3028],
20	Verweij	NNP	PERSON	Verweij	nn	21	SENT_410	[p24l990t2965r1229b3034],
21	J	NNP	PERSON	J	appos	11	SENT_410	[p24l1268t2966r1312b3028],
22	,	,	O	,	_	0	SENT_410	[p24l1268t2966r1312b3028],
23	Semiond	NNP	O	Semiond	nn	24	SENT_410	[p24l1349t2965r1618b3018],
24	D	NNP	O	D	appos	11	SENT_410	[p24l1650t2966r1719b3028],
25	,	,	O	,	_	0	SENT_410	[p24l1650t2966r1719b3028],
26	deJonge	NNP	O	deJonge	nn	27	SENT_410	[p24l1756t2965r2003b3034],
27	MJ	NNP	O	MJ	appos	11	SENT_410	[p24l2036t2966r2148b3028],
28	,	,	O	,	_	0	SENT_410	[p24l2036t2966r2148b3028],
29	Eskens	NNP	ORGANIZATION	Eskens	nn	30	SENT_410	[p24l137t3053r350b3106],
30	FA	NNP	ORGANIZATION	FA	appos	11	SENT_410	[p24l370t3054r481b3116],
31	,	,	O	,	_	0	SENT_410	[p24l370t3054r481b3116],
32	ter	NN	O	ter	nn	34	SENT_410	[p24l503t3061r584b3106],
33	Steeg	NNP	PERSON	Steeg	nn	34	SENT_410	[p24l603t3054r768b3122],
34	J	NNP	PERSON	J	appos	11	SENT_410	[p24l788t3055r831b3116],
35	,	,	O	,	_	0	SENT_410	[p24l788t3055r831b3116],
36	Selleslach	NNP	O	Selleslach	nn	37	SENT_410	[p24l855t3053r1161b3107],
37	J	NNP	O	J	appos	11	SENT_410	[p24l1180t3055r1224b3116],
38	,	,	O	,	_	0	SENT_410	[p24l1180t3055r1224b3116],
39	Assadourian	NNP	PERSON	Assadourian	nn	40	SENT_410	[p24l1245t3053r1625b3106],
40	S	NNP	O	S	appos	11	SENT_410	[p24l1647t3054r1701b3116],
41	,	,	O	,	_	0	SENT_410	[p24l1647t3054r1701b3116],
42	Sanderink	NNP	ORGANIZATION	Sanderink	nn	43	SENT_410	[p24l1724t3053r2031b3107],
43	GJ	NNP	ORGANIZATION	GJ	appos	11	SENT_410	[p24l2050t3054r2148b3116],
44	,	,	O	,	_	0	SENT_410	[p24l2050t3054r2148b3116],
45	Sparreboom	NNP	O	Sparreboom	nn	46	SENT_410	[p24l139t3142r509b3210],
46	A	NNP	O	A	appos	11	SENT_410	[p24l534t3142r603b3204],
47	,	,	O	,	_	0	SENT_410	[p24l534t3142r603b3204],
48	van	NNP	PERSON	van	nn	49	SENT_410	[p24l632t3158r740b3195],
49	Oosterom	NNP	PERSON	Oosterom	appos	11	SENT_410	[p24l766t3142r1065b3195],
50	AT	IN	O	at	dep	11	SENT_410	[p24l1089t3142r1189b3194],
51	(	CD	NUMBER	(	num	52	SENT_410	[p24l1217t3141r1413b3207],
52	2005	CD	DATE	2005	pobj	50	SENT_410	[p24l1217t3141r1413b3207],
53	)	CD	NUMBER	)	num	55	SENT_410	[p24l1217t3141r1413b3207],
54	Phase	NN	O	phase	nn	55	SENT_410	[p24l1441t3142r1616b3195],
55	I	NN	O	i	dep	9	SENT_410	[p24l1642t3143r1665b3194],
56	and	CC	O	and	_	0	SENT_410	[p24l1692t3142r1800b3195],
57	pharmacokinetic	JJ	O	pharmacokinetic	amod	58	SENT_410	[p24l1824t3141r2148b3210, p24l137t3229r343b3283],
58	study	NN	O	study	conj_and	9	SENT_410	[p24l371t3230r531b3298],
59	of	IN	O	of	_	0	SENT_410	[p24l557t3229r623b3283],
60	oral	JJ	O	oral	amod	61	SENT_410	[p24l642t3230r758b3283],
61	irinotecan	NN	O	irinotecan	prep_of	58	SENT_410	[p24l783t3229r1088b3283],
62	given	VBN	O	give	partmod	61	SENT_410	[p24l1112t3229r1279b3298],
63	once	RB	DATE	once	advmod	64	SENT_410	[p24l1304t3246r1446b3283],
64	daily	RB	SET	daily	advmod	62	SENT_410	[p24l1471t3229r1621b3298],
65	for	IN	O	for	_	0	SENT_410	[p24l1646t3229r1734b3283],
66	5	CD	DURATION	5	num	67	SENT_410	[p24l1758t3229r1789b3283],
67	days	NNS	NUMBER	day	prep_for	62	SENT_410	[p24l1821t3230r1956b3298],
68	every	DT	SET	every	det	70	SENT_410	[p24l1983t3246r2150b3298],
69	3	CD	SET	3	num	70	SENT_410	[p24l140t3318r169b3371],
70	weeks	NNS	NUMBER	week	tmod	62	SENT_410	[p24l201t3317r388b3371],
71	in	IN	O	in	_	0	SENT_410	[p24l418t3317r476b3370],
72	combination	NN	O	combination	prep_in	62	SENT_410	[p24l505t3317r886b3370],
73	with	IN	O	with	_	0	SENT_410	[p24l915t3317r1049b3370],
74	capecitabine	NN	O	capecitabine	prep_with	72	SENT_410	[p24l1079t3317r1459b3386],
75	in	IN	O	in	_	0	SENT_410	[p24l1489t3317r1546b3370],
76	patients	NNS	O	patient	prep_in	74	SENT_410	[p24l1574t3317r1810b3386],
77	with	IN	O	with	_	0	SENT_410	[p24l1841t3317r1975b3371],
78	solid	JJ	O	solid	amod	79	SENT_410	[p24l2006t3317r2151b3370],
79	tumors	NNS	O	tumor	prep_with	76	SENT_410	[p24l137t3415r362b3460],
80	.	.	O	.	_	0	SENT_410	[p24l137t3415r362b3460],

1	J	NNP	O	J	nn	3	SENT_411	[p24l387t3408r415b3460],
2	Clin	NNP	O	Clin	nn	3	SENT_411	[p24l437t3406r566b3460],
3	Oncol	NNP	O	Oncol	_	0	SENT_411	[p24l589t3407r772b3460],
4	23:889	CD	NUMBER	23:889	number	5	SENT_411	[p24l794t3407r1171b3460],
5	-898	CD	NUMBER	-898	num	3	SENT_411	[p24l794t3407r1171b3460],
6	.	.	O	.	_	0	SENT_411	[p24l794t3407r1171b3460],

1	doi	FW	O	doi	dep	7	SENT_412	[p24l1197t3406r2116b3460],
2	:10.1200	CD	NUMBER	:10.1200	dep	1	SENT_412	[p24l1197t3406r2116b3460],
3	/	:	O	/	punct	4	SENT_412	[p24l1197t3406r2116b3460],
4	JCO	NNP	ORGANIZATION	JCO	dep	2	SENT_412	[p24l1197t3406r2116b3460],
5	.2005.01.008	CD	NUMBER	.2005.01.008	dep	7	SENT_412	[p24l1197t3406r2116b3460],
6	Stockler	NNP	ORGANIZATION	Stockler	nn	7	SENT_412	[p24l139t3494r392b3548],
7	MR	NN	ORGANIZATION	mr	_	0	SENT_412	[p24l424t3496r557b3558],
8	,	,	O	,	_	0	SENT_412	[p24l424t3496r557b3558],
9	Harvey	NNP	PERSON	Harvey	nn	10	SENT_412	[p24l594t3496r816b3563],
10	VJ	NNP	PERSON	VJ	appos	7	SENT_412	[p24l851t3496r949b3557],
11	,	,	O	,	_	0	SENT_412	[p24l851t3496r949b3557],
12	Francis	NNP	PERSON	Francis	nn	13	SENT_412	[p24l986t3495r1208b3548],
13	PA	NN	PERSON	pa	appos	7	SENT_412	[p24l1243t3495r1354b3558],
14	,	,	O	,	_	0	SENT_412	[p24l1243t3495r1354b3558],
15	Byme	NNP	O	Byme	nn	16	SENT_412	[p24l1391t3496r1575b3563],
16	MJ	NNP	O	MJ	appos	7	SENT_412	[p24l1609t3496r1721b3557],
17	,	,	O	,	_	0	SENT_412	[p24l1609t3496r1721b3557],
18	Ackland	NNP	ORGANIZATION	Ackland	nn	19	SENT_412	[p24l1758t3494r2015b3548],
19	SP	NN	ORGANIZATION	sp	appos	7	SENT_412	[p24l2051t3495r2148b3557],
20	,	,	O	,	_	0	SENT_412	[p24l2051t3495r2148b3557],
21	Fitzharris	NNP	ORGANIZATION	Fitzharris	nn	22	SENT_412	[p24l137t3584r427b3637],
22	B	NNP	ORGANIZATION	B	appos	7	SENT_412	[p24l461t3585r526b3647],
23	,	,	O	,	_	0	SENT_412	[p24l461t3585r526b3647],
24	Van	NNP	PERSON	Van	nn	26	SENT_412	[p24l562t3585r687b3637],
25	Hazel	NNP	PERSON	Hazel	nn	26	SENT_412	[p24l720t3584r895b3637],
26	G	NNP	PERSON	G	appos	7	SENT_412	[p24l930t3584r998b3647],
27	,	,	O	,	_	0	SENT_412	[p24l930t3584r998b3647],
28	Wilcken	NNP	PERSON	Wilcken	nn	29	SENT_412	[p24l1032t3584r1291b3637],
29	NR	NNP	O	NR	appos	7	SENT_412	[p24l1323t3585r1444b3647],
30	,	,	O	,	_	0	SENT_412	[p24l1323t3585r1444b3647],
31	Grimison	NNP	O	Grimison	nn	32	SENT_412	[p24l1480t3584r1765b3637],
32	PS	NNP	O	PS	appos	7	SENT_412	[p24l1798t3584r1897b3647],
33	,	,	O	,	_	0	SENT_412	[p24l1798t3584r1897b3647],
34	Nowak	NNP	PERSON	Nowak	appos	7	SENT_412	[p24l1931t3584r2152b3637],

1	AK	NNP	O	AK	nsubj	29	SENT_413	[p25l137t20r261b82],
2	,	,	O	,	_	0	SENT_413	[p25l137t20r261b82],
3	Gainford	NNP	O	Gainford	nn	4	SENT_413	[p25l298t19r572b73],
4	MC	NNP	O	MC	appos	1	SENT_413	[p25l603t20r736b82],
5	,	,	O	,	_	0	SENT_413	[p25l603t20r736b82],
6	Fong	NNP	O	Fong	nn	7	SENT_413	[p25l772t21r926b88],
7	A	NNP	O	A	appos	4	SENT_413	[p25l960t20r1029b82],
8	,	,	O	,	_	0	SENT_413	[p25l960t20r1029b82],
9	Paksec	NNP	ORGANIZATION	Paksec	nn	10	SENT_413	[p25l1065t20r1274b73],
10	L	NNP	ORGANIZATION	L	appos	4	SENT_413	[p25l1307t21r1369b82],
11	,	,	O	,	_	0	SENT_413	[p25l1307t21r1369b82],
12	Sourjina	NNP	ORGANIZATION	Sourjina	nn	13	SENT_413	[p25l1407t19r1663b88],
13	T	NN	ORGANIZATION	t	appos	4	SENT_413	[p25l1695t21r1756b82],
14	,	,	O	,	_	0	SENT_413	[p25l1695t21r1756b82],
15	Zannino	NN	PERSON	zannino	nn	16	SENT_413	[p25l1792t19r2044b73],
16	D	NN	PERSON	d	appos	4	SENT_413	[p25l2078t21r2147b83],
17	,	,	O	,	_	0	SENT_413	[p25l2078t21r2147b83],
18	Gebski	NNP	PERSON	Gebski	nn	19	SENT_413	[p25l139t107r350b161],
19	V	NNP	PERSON	V	appos	4	SENT_413	[p25l379t109r448b170],
20	,	,	O	,	_	0	SENT_413	[p25l379t109r448b170],
21	Simes	NNP	PERSON	Simes	nn	22	SENT_413	[p25l481t107r662b161],
22	RJ	NN	PERSON	rj	appos	4	SENT_413	[p25l691t109r786b170],
23	,	,	O	,	_	0	SENT_413	[p25l691t109r786b170],
24	Forbes	NNP	ORGANIZATION	Forbes	nn	25	SENT_413	[p25l816t107r1021b161],
25	JF	NNP	ORGANIZATION	JF	appos	4	SENT_413	[p25l1049t109r1135b170],
26	,	,	O	,	_	0	SENT_413	[p25l1049t109r1135b170],
27	Coates	NNP	PERSON	Coates	nn	28	SENT_413	[p25l1166t108r1370b161],
28	AS	NNP	O	AS	appos	4	SENT_413	[p25l1399t108r1491b161],
29	(	VBD	O	(	_	0	SENT_413	[p25l1524t108r1721b173],
30	2011	CD	DATE	2011	num	31	SENT_413	[p25l1524t108r1721b173],
31	)	CD	NUMBER	)	dobj	29	SENT_413	[p25l1524t108r1721b173],
32	Capecitabine	NNP	O	Capecitabine	nn	35	SENT_413	[p25l1753t107r2149b176],
33	Versus	NNP	O	Versus	nn	35	SENT_413	[p25l138t212r328b249],
34	classical	JJ	O	classical	amod	35	SENT_413	[p25l359t196r616b249],
35	cyclophosphamide	NN	O	cyclophosphamide	dep	29	SENT_413	[p25l645t196r1233b264],
36	,	,	O	,	_	0	SENT_413	[p25l645t196r1233b264],
37	methotrexate	NN	O	methotrexate	conj_and	35	SENT_413	[p25l1264t196r1679b259],
38	,	,	O	,	_	0	SENT_413	[p25l1264t196r1679b259],
39	and	CC	O	and	_	0	SENT_413	[p25l1712t196r1819b249],
40	ﬂuoroura	NN	O	ﬂuoroura	nn	42	SENT_413	[p25l1848t196r2148b249],
41	—	CD	NUMBER	—	num	42	SENT_413	[p25l1848t196r2148b249],
42	cil	NN	O	cil	conj_and	35	SENT_413	[p25l138t284r212b337],
43	as	IN	O	as	_	0	SENT_413	[p25l243t301r301b337],
44	ﬁrst-line	JJ	O	ﬁrst-line	amod	45	SENT_413	[p25l332t284r587b337],
45	chemotherapy	NN	O	chemotherapy	prep_as	29	SENT_413	[p25l617t284r1048b353],
46	for	IN	O	for	_	0	SENT_413	[p25l1078t284r1166b337],
47	advanced	JJ	O	advanced	amod	49	SENT_413	[p25l1195t284r1481b337],
48	breast	NN	O	breast	nn	49	SENT_413	[p25l1508t284r1690b337],
49	cancer	NN	O	cancer	prep_for	45	SENT_413	[p25l1719t301r1932b337],
50	.	.	O	.	_	0	SENT_413	[p25l1719t301r1932b337],

1	J	NNP	O	J	nn	3	SENT_414	[p25l1964t285r1992b337],
2	Clin	NNP	O	Clin	nn	3	SENT_414	[p25l2021t284r2151b337],
3	Oncol	NNP	O	Oncol	_	0	SENT_414	[p25l139t373r322b426],
4	29:4498	CD	NUMBER	29:4498	num	3	SENT_414	[p25l351t372r804b426],
5	—	CD	NUMBER	—	number	6	SENT_414	[p25l351t372r804b426],
6	4504	CD	NUMBER	4504	num	3	SENT_414	[p25l351t372r804b426],
7	.	.	O	.	_	0	SENT_414	[p25l351t372r804b426],

1	doi	FW	O	doi	_	0	SENT_415	[p25l836t372r1790b426],
2	:10.1200	CD	NUMBER	:10.1200	dep	1	SENT_415	[p25l836t372r1790b426],
3	/	:	O	/	punct	4	SENT_415	[p25l836t372r1790b426],
4	JCO	NNP	O	JCO	dep	2	SENT_415	[p25l836t372r1790b426],
5	.2010.33.9101	CD	NUMBER	.2010.33.9101	num	4	SENT_415	[p25l836t372r1790b426],

1	Traina	NNP	PERSON	Traina	nn	2	SENT_416	[p25l136t460r335b514],
2	TA	NNP	O	TA	nsubj	38	SENT_416	[p25l362t461r478b523],
3	,	,	O	,	_	0	SENT_416	[p25l362t461r478b523],
4	Theodoulou	NNP	O	Theodoulou	nn	5	SENT_416	[p25l509t460r877b514],
5	M	NNP	O	M	dep	30	SENT_416	[p25l905t462r987b523],
6	,	,	O	,	_	0	SENT_416	[p25l905t462r987b523],
7	Feigin	NNP	PERSON	Feigin	nn	8	SENT_416	[p25l1017t460r1212b529],
8	K	NNP	PERSON	K	appos	5	SENT_416	[p25l1241t462r1308b523],
9	,	,	O	,	_	0	SENT_416	[p25l1241t462r1308b523],
10	Patil	NNP	PERSON	Patil	nn	11	SENT_416	[p25l1339t460r1478b514],
11	S	NNP	O	S	appos	5	SENT_416	[p25l1508t461r1563b524],
12	,	,	O	,	_	0	SENT_416	[p25l1508t461r1563b524],
13	Tan	NNP	LOCATION	Tan	nn	14	SENT_416	[p25l1593t462r1711b514],
14	KL	NNP	LOCATION	KL	appos	5	SENT_416	[p25l1740t462r1855b523],
15	,	,	O	,	_	0	SENT_416	[p25l1740t462r1855b523],
16	Edwards	NNP	ORGANIZATION	Edwards	nn	17	SENT_416	[p25l1885t461r2149b514],
17	C	NNP	ORGANIZATION	C	appos	5	SENT_416	[p25l136t548r201b611],
18	,	,	O	,	_	0	SENT_416	[p25l136t548r201b611],
19	Dugan	NNP	PERSON	Dugan	nn	20	SENT_416	[p25l229t549r431b617],
20	U	NNP	PERSON	U	appos	5	SENT_416	[p25l457t549r526b611],
21	,	,	O	,	_	0	SENT_416	[p25l457t549r526b611],
22	Norton	NNP	ORGANIZATION	Norton	nn	23	SENT_416	[p25l555t549r770b601],
23	L	NNP	ORGANIZATION	L	appos	5	SENT_416	[p25l795t549r857b611],
24	,	,	O	,	_	0	SENT_416	[p25l795t549r857b611],
25	Hudis	NNP	PERSON	Hudis	nn	26	SENT_416	[p25l886t548r1065b601],
26	C	NNP	O	C	appos	5	SENT_416	[p25l1093t548r1140b601],
27	(	JJ	O	(	dep	30	SENT_416	[p25l1170t548r1367b614],
28	2008	CD	DATE	2008	num	30	SENT_416	[p25l1170t548r1367b614],
29	)	CD	NUMBER	)	num	30	SENT_416	[p25l1170t548r1367b614],
30	Phase	NN	O	phase	dep	2	SENT_416	[p25l1395t548r1571b601],
31	I	PRP	O	I	dep	32	SENT_416	[p25l1598t549r1621b601],
32	study	NN	O	study	dep	30	SENT_416	[p25l1649t548r1810b617],
33	of	IN	O	of	_	0	SENT_416	[p25l1838t548r1904b601],
34	a	DT	O	a	det	37	SENT_416	[p25l1926t565r1958b601],
35	novel	JJ	O	novel	amod	37	SENT_416	[p25l1983t548r2151b601],
36	capecitabine	NN	O	capecitabine	nn	37	SENT_416	[p25l136t636r517b705],
37	schedule	NN	O	schedule	prep_of	32	SENT_416	[p25l550t636r813b689],
38	based	VBN	O	base	_	0	SENT_416	[p25l842t636r1016b689],
39	on	IN	O	on	_	0	SENT_416	[p25l1045t653r1119b689],
40	the	DT	O	the	det	43	SENT_416	[p25l1148t636r1239b689],
41	Norton-Simon	NNP	MISC	Norton-Simon	nn	43	SENT_416	[p25l1269t636r1709b690],
42	mathematical	JJ	O	mathematical	amod	43	SENT_416	[p25l1738t636r2150b689],
43	model	NN	O	model	prep_on	38	SENT_416	[p25l136t724r325b778],
44	in	IN	O	in	_	0	SENT_416	[p25l363t724r421b777],
45	patients	NNS	O	patient	prep_in	38	SENT_416	[p25l459t724r695b793],
46	with	IN	O	with	_	0	SENT_416	[p25l736t724r870b778],
47	metastatic	JJ	O	metastatic	amod	49	SENT_416	[p25l907t724r1216b778],
48	breast	NN	O	breast	nn	49	SENT_416	[p25l1255t724r1438b778],
49	cancer	NN	O	cancer	prep_with	38	SENT_416	[p25l1476t741r1689b778],
50	.	.	O	.	_	0	SENT_416	[p25l1476t741r1689b778],

1	J	NNP	O	J	nn	3	SENT_417	[p25l1731t726r1759b778],
2	Clin	NNP	O	Clin	nn	3	SENT_417	[p25l1799t724r1928b778],
3	Oncol	NNP	O	Oncol	_	0	SENT_417	[p25l1967t724r2150b778],
4	26:1797	CD	NUMBER	26:1797	num	3	SENT_417	[p25l137t813r590b867],
5	—	CD	NUMBER	—	number	6	SENT_417	[p25l137t813r590b867],
6	1802	CD	DATE	1802	num	3	SENT_417	[p25l137t813r590b867],
7	.	.	O	.	_	0	SENT_417	[p25l137t813r590b867],

1	doi	FW	O	doi	_	0	SENT_418	[p25l623t813r1581b867],
2	:10.1200	CD	NUMBER	:10.1200	dep	1	SENT_418	[p25l623t813r1581b867],
3	/	:	O	/	punct	4	SENT_418	[p25l623t813r1581b867],
4	JCO	NNP	O	JCO	dep	2	SENT_418	[p25l623t813r1581b867],
5	.2007.13.8388	CD	NUMBER	.2007.13.8388	num	4	SENT_418	[p25l623t813r1581b867],

1	Untch	NNP	O	Untch	nn	2	SENT_419	[p25l135t902r320b956],
2	M	NNP	O	M	nsubj	59	SENT_419	[p25l369t904r451b965],
3	,	,	O	,	_	0	SENT_419	[p25l369t904r451b965],
4	Loibl	NNP	PERSON	Loibl	nn	5	SENT_419	[p25l502t902r667b956],
5	S	NNP	PERSON	S	appos	2	SENT_419	[p25l718t903r772b965],
6	,	,	O	,	_	0	SENT_419	[p25l718t903r772b965],
7	Bischoff	NNP	PERSON	Bischoff	nn	8	SENT_419	[p25l824t902r1091b956],
8	J	NNP	PERSON	J	appos	5	SENT_419	[p25l1135t904r1163b956],
9	,	,	O	,	_	0	SENT_419	[p25l1167t947r1178b965],
10	Eidtmann	NNP	O	Eidtmann	nn	11	SENT_419	[p25l1230t902r1526b956],
11	H	NNP	O	H	appos	5	SENT_419	[p25l1575t904r1645b965],
12	,	,	O	,	_	0	SENT_419	[p25l1575t904r1645b965],
13	Kaufmann	NNP	PERSON	Kaufmann	nn	14	SENT_419	[p25l1698t902r2018b956],
14	M	NNP	O	M	appos	5	SENT_419	[p25l2066t904r2148b965],
15	,	,	O	,	_	0	SENT_419	[p25l2066t904r2148b965],
16	Blohmer	NNP	PERSON	Blohmer	nn	17	SENT_419	[p25l136t991r403b1044],
17	JU	NNP	PERSON	JU	appos	5	SENT_419	[p25l431t992r530b1053],
18	,	,	O	,	_	0	SENT_419	[p25l431t992r530b1053],
19	Hilfrich	NNP	PERSON	Hilfrich	nn	20	SENT_419	[p25l563t990r803b1044],
20	J	NNP	PERSON	J	appos	5	SENT_419	[p25l832t992r860b1044],
21	,	,	O	,	_	0	SENT_419	[p25l865t1034r876b1053],
22	Strumberg	NNP	PERSON	Strumberg	nn	23	SENT_419	[p25l911t991r1229b1059],
23	D	NNP	O	D	appos	5	SENT_419	[p25l1259t992r1328b1054],
24	,	,	O	,	_	0	SENT_419	[p25l1259t992r1328b1054],
25	Fasching	NNP	ORGANIZATION	Fasching	nn	26	SENT_419	[p25l1361t991r1634b1059],
26	PA	NN	ORGANIZATION	pa	appos	5	SENT_419	[p25l1664t991r1776b1053],
27	,	,	O	,	_	0	SENT_419	[p25l1664t991r1776b1053],
28	Kreienberg	NN	ORGANIZATION	kreienberg	nn	29	SENT_419	[p25l1810t990r2150b1059],
29	R	NN	ORGANIZATION	r	appos	5	SENT_419	[p25l136t1081r201b1143],
30	,	,	O	,	_	0	SENT_419	[p25l136t1081r201b1143],
31	Tesch	NNP	PERSON	Tesch	nn	32	SENT_419	[p25l228t1080r409b1133],
32	H	NNP	O	H	appos	5	SENT_419	[p25l434t1081r503b1143],
33	,	,	O	,	_	0	SENT_419	[p25l434t1081r503b1143],
34	Hanusch	NNP	PERSON	Hanusch	nn	35	SENT_419	[p25l530t1080r796b1133],
35	C	NNP	O	C	appos	5	SENT_419	[p25l822t1080r886b1143],
36	,	,	O	,	_	0	SENT_419	[p25l822t1080r886b1143],
37	Gerber	NNP	O	Gerber	nn	38	SENT_419	[p25l915t1080r1125b1133],
38	B	NNP	O	B	appos	5	SENT_419	[p25l1149t1081r1214b1143],
39	,	,	O	,	_	0	SENT_419	[p25l1149t1081r1214b1143],
40	Rezai	NNP	PERSON	Rezai	nn	41	SENT_419	[p25l1242t1080r1414b1133],
41	M	NNP	O	M	appos	5	SENT_419	[p25l1439t1081r1521b1143],
42	,	,	O	,	_	0	SENT_419	[p25l1439t1081r1521b1143],
43	J	NNP	O	J	nn	45	SENT_419	[p25l1548t1081r1577b1133],
44	ackisch	NN	O	ackisch	nn	45	SENT_419	[p25l1580t1080r1807b1133],
45	C	NN	O	c	appos	5	SENT_419	[p25l1832t1080r1896b1143],
46	,	,	O	,	_	0	SENT_419	[p25l1832t1080r1896b1143],
47	Huober	NNP	O	Huober	nn	48	SENT_419	[p25l1924t1080r2153b1133],
48	J	NNP	O	J	appos	5	SENT_419	[p25l135t1169r163b1221],
49	,	,	O	,	_	0	SENT_419	[p25l168t1211r179b1230],
50	Kuhn	NNP	PERSON	Kuhn	nn	51	SENT_419	[p25l218t1167r385b1220],
51	T	NN	O	t	appos	5	SENT_419	[p25l420t1169r482b1230],
52	,	,	O	,	_	0	SENT_419	[p25l420t1169r482b1230],
53	Nekljudova	NNP	O	Nekljudova	nn	54	SENT_419	[p25l520t1167r876b1236],
54	V	NNP	O	V	appos	5	SENT_419	[p25l911t1169r980b1230],
55	,	,	O	,	_	0	SENT_419	[p25l911t1169r980b1230],
56	Von	NNP	PERSON	Von	nn	58	SENT_419	[p25l1019t1184r1132b1220],
57	Minckwitz	NNP	PERSON	Minckwitz	nn	58	SENT_419	[p25l1167t1167r1496b1220],
58	G	NNP	PERSON	G	appos	5	SENT_419	[p25l1533t1168r1586b1221],
59	(	VBD	O	(	_	0	SENT_419	[p25l1623t1168r1821b1233],
60	2012	CD	DATE	2012	dobj	59	SENT_419	[p25l1623t1168r1821b1233],
61	)	CD	NUMBER	)	num	64	SENT_419	[p25l1623t1168r1821b1233],
62	Lapatinib	NNP	O	Lapatinib	nn	64	SENT_419	[p25l1858t1167r2150b1236],
63	Versus	NNP	O	Versus	nn	64	SENT_419	[p25l136t1272r327b1309],
64	trastuzumab	NN	O	trastuzumab	dep	59	SENT_419	[p25l364t1255r736b1309],
65	in	IN	O	in	_	0	SENT_419	[p25l773t1256r831b1308],
66	combination	NN	O	combination	prep_in	59	SENT_419	[p25l867t1255r1248b1309],
67	with	IN	O	with	_	0	SENT_419	[p25l1285t1255r1419b1309],
68	neoadjuvant	JJ	O	neoadjuvant	amod	74	SENT_419	[p25l1455t1255r1828b1324],
69	anthracy	NN	O	anthracy	nn	74	SENT_419	[p25l1865t1256r2149b1324],
70	—	NN	O	—	nn	74	SENT_419	[p25l1865t1256r2149b1324],
71	cline	NN	O	cline	nn	74	SENT_419	[p25l136t1344r709b1397],
72	—	CD	NUMBER	—	num	74	SENT_419	[p25l136t1344r709b1397],
73	taxane	NN	O	taxane	nn	74	SENT_419	[p25l136t1344r709b1397],
74	—	NN	O	—	prep_with	59	SENT_419	[p25l136t1344r709b1397],
75	based	VBN	O	base	partmod	74	SENT_419	[p25l136t1344r709b1397],
76	chemotherapy	NN	O	chemotherapy	nn	78	SENT_419	[p25l761t1344r1192b1413],
77	(	CD	NUMBER	(	num	78	SENT_419	[p25l1246t1344r1683b1412],
78	GeparQuinto	NNP	O	GeparQuinto	dobj	75	SENT_419	[p25l1246t1344r1683b1412],
79	,	,	O	,	_	0	SENT_419	[p25l1246t1344r1683b1412],
80	GBG	NNP	O	GBG	appos	78	SENT_419	[p25l1738t1344r1897b1397],
81	44	CD	NUMBER	44	number	82	SENT_419	[p25l1946t1344r2062b1409],
82	)	CD	NUMBER	)	dep	80	SENT_419	[p25l1946t1344r2062b1409],
83	:	:	O	:	_	0	SENT_419	[p25l1946t1344r2062b1409],
84	a	DT	O	a	det	86	SENT_419	[p25l2120t1360r2152b1397],
85	randomised	JJ	O	randomised	amod	86	SENT_419	[p25l135t1433r491b1486],
86	phase	NN	O	phase	dep	80	SENT_419	[p25l549t1433r722b1501],
87	3	CD	NUMBER	3	num	88	SENT_419	[p25l785t1433r815b1486],
88	trial	NN	O	trial	dep	86	SENT_419	[p25l878t1433r1016b1486],
89	.	.	O	.	_	0	SENT_419	[p25l878t1433r1016b1486],

1	Lancet	NNP	O	Lancet	nn	2	SENT_420	[p25l1079t1434r1288b1486],
2	Oncol	NNP	O	Oncol	_	0	SENT_420	[p25l1348t1433r1531b1486],
3	13:135	CD	NUMBER	13:135	number	4	SENT_420	[p25l1599t1433r1970b1486],
4	-144	CD	NUMBER	-144	num	2	SENT_420	[p25l1599t1433r1970b1486],
5	.	.	O	.	_	0	SENT_420	[p25l1599t1433r1970b1486],

1	doi	FW	O	doi	_	0	SENT_421	[p25l2035t1433r2146b1486],
2	:	:	O	:	_	0	SENT_421	[p25l2035t1433r2146b1486],
3	S1470-2045	NN	O	s1470-2045	dep	1	SENT_421	[p25l137t1521r887b1587],
4	(	CD	NUMBER	(	number	5	SENT_421	[p25l137t1521r887b1587],
5	11	CD	NUMBER	11	num	6	SENT_421	[p25l137t1521r887b1587],
6	)	NN	O	)	dep	3	SENT_421	[p25l137t1521r887b1587],
7	70397-7	CD	NUMBER	70397-7	num	9	SENT_421	[p25l137t1521r887b1587],
8	Xu	NNP	O	Xu	nn	9	SENT_421	[p25l135t1611r226b1663],
9	Y	NN	O	y	dep	3	SENT_421	[p25l258t1611r327b1672],
10	,	,	O	,	_	0	SENT_421	[p25l258t1611r327b1672],
11	Grem	NNP	O	Grem	nn	12	SENT_421	[p25l362t1610r534b1663],
12	JL	NNP	O	JL	appos	1	SENT_421	[p25l564t1611r639b1663],
13	(	CD	NUMBER	(	dep	12	SENT_421	[p25l672t1610r869b1675],
14	2003	CD	DATE	2003	num	17	SENT_421	[p25l672t1610r869b1675],
15	)	NNP	O	)	nn	17	SENT_421	[p25l672t1610r869b1675],
16	Liquid	NN	O	liquid	nn	17	SENT_421	[p25l903t1609r1106b1678],
17	chromatography	NN	O	chromatography	dep	1	SENT_421	[p25l1137t1610r1813b1678],
18	—	CD	NUMBER	—	num	19	SENT_421	[p25l1137t1610r1813b1678],
19	mass	NN	O	mass	dep	17	SENT_421	[p25l1137t1610r1813b1678],
20	spectrometry	NN	O	spectrometry	nn	21	SENT_421	[p25l1849t1618r2149b1678, p25l136t1706r252b1766],
21	method	NN	O	method	dep	1	SENT_421	[p25l276t1698r504b1751],
22	for	IN	O	for	_	0	SENT_421	[p25l527t1698r616b1751],
23	the	DT	O	the	det	24	SENT_421	[p25l637t1698r728b1751],
24	analysis	NN	O	analysis	prep_for	21	SENT_421	[p25l753t1698r995b1766],
25	of	IN	O	of	_	0	SENT_421	[p25l1020t1698r1086b1751],
26	the	DT	O	the	det	31	SENT_421	[p25l1104t1698r1196b1751],
27	anti	JJ	O	anti	amod	31	SENT_421	[p25l1220t1698r1560b1751],
28	—	NN	O	—	nn	31	SENT_421	[p25l1220t1698r1560b1751],
29	cancer	NN	O	cancer	nn	31	SENT_421	[p25l1220t1698r1560b1751],
30	agent	NN	O	agent	nn	31	SENT_421	[p25l1583t1705r1746b1767],
31	capecitabine	NN	O	capecitabine	prep_of	24	SENT_421	[p25l1769t1698r2150b1766],
32	and	CC	O	and	_	0	SENT_421	[p25l137t1786r244b1839],
33	its	PRP$	O	its	poss	35	SENT_421	[p25l268t1786r337b1839],
34	nucleoside	JJ	O	nucleoside	amod	35	SENT_421	[p25l362t1786r687b1839],
35	metabolites	NNS	O	metabolite	prep_for	21	SENT_421	[p25l712t1786r1062b1839],
36	in	IN	O	in	_	0	SENT_421	[p25l1088t1786r1146b1838],
37	human	JJ	O	human	amod	38	SENT_421	[p25l1169t1786r1377b1839],
38	plasma	NN	O	plasma	prep_in	35	SENT_421	[p25l1400t1786r1631b1855],
39	.	.	O	.	_	0	SENT_421	[p25l1400t1786r1631b1855],

1	J	NN	O	j	nn	3	SENT_422	[p25l1659t1787r1686b1839],
2	Chromatogr	NN	O	chromatogr	nn	3	SENT_422	[p25l1711t1786r2080b1855],
3	B	NN	O	b	_	0	SENT_422	[p25l2102t1787r2147b1838],
4	783:273	CD	NUMBER	783:273	num	5	SENT_422	[p25l136t1874r533b1928],
5	—	NN	O	—	dep	3	SENT_422	[p25l136t1874r533b1928],
6	285	CD	NUMBER	285	dep	3	SENT_422	[p25l136t1874r533b1928],

1	@	IN	O	@	_	0	SENT_423	[p25l1781t2091r1859b2187],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_423	[p25l1888t2115r2152b2190],

